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G-banding  Giemsa  banding 
GBY  gonadoblastorna  gene  on  Y  chromosome 
gm  gram 
HA  heteroduplex  analysis 
HMG  high  mobility  group 
ISCN  International  System  for  Chromosomal  Nomenclature 
ISH  in  situ  hybridisation 
IU  international  units 
KAL  Kallman 
kb  kilobase 
kd  kilo  dalton 
I/L  litre 
LH  liuteinising  hormone 
M  molar 
Mb  megabase 
mg  milligram 
MIS  Mullerian  inhibiting  substance 
ml  inillilitre 
mm  millimolar 
MRC  Medical  Research  Council 
mRNA  messenger  ribonucleic  acid 
Mn  nanometer 
NOR  nucleolar  organizer  region 
0C  degree  centigrade 
OD  optical  density ORF  open  reading  frame 
P  short  arm  of  any  chromosome 
32P 
radioactive  phosphorus 
PAGE  polyacrylamide  gel  electropgoresis 
PAR  pseudo  autosomal.  region 
PBS  phosphate  buffered  saline 
PCR  polymerase  chain  reaction 
PHA  phytohaemagglutinin 
pmol  pico  mole 
q  long  arm  of  any  chromosome 
Q-banding  quinicrine  banding 
RBM  RNA-binding  motif 
RFLP  restriction  fragment  length  polymorphisms 
RNA  ribonucleic  acid 
rpm  revolutions  Per  minute 
RPS4  ribosomal  protein  S4 
RT-PCR  reverse  transcription  polymerase  chain  reaction 
SDS  sodium  dodecyl  sulphate 
SMA  spinal  muscular  atrophy 
SRY  sex  determining  region  on  the  Y 
SSC  saline  sodium  citrate 
SSCP  single  strand  confon-nation  polymorphism 
STS  sequence  tagged  site 
TAE  tris-acetate  ethylenediamine  tetra-acitic  acid 
Taq  Thermus  aquaticus 
TBE  tris-borate  ethylenediamine  tetra-acitic  acid 
TDF  testis  determining  factor 
TE  tris-ethylencdiamine  tetra-acitic  acid 
TEMED  N,  NN,  N-tetramethylethylenediamine 
TGGE  temperature  gradient  gel  electrophoresis 
TM  melting  temperature 
TS  Turners  syndrome 
U  unit 
UV  ultraviolet WCP  whole  chromosome  paint 
WT  Wilm's  tumor 
XIST  X-inactivation  specific  transcript 
YRRM  Y  chromosome  RNA  recognition  motif 
R  microgram 
JA  I  microlitre 
gm  micromolar 
PAR  pseudoautosomal  region 
ZFY  zing  finger  on  Y  chromosome 
TSPY  testis  specific  protein  on  Y  chromosome SUMMARY 
The  aims  of  the  present  study  were  to  optimize  and  apply  methods  that  could 
detect  major  or  minor  DNA  sequence  alterations  in  patients  with  sex  chromosome 
aberrations,  with  sex  determination/differentiation  abnormalities  and  in  patients  with 
idiopathic  male  infertility.  These  strategies  involved  the  application  of  cytogentic, 
molecular  cytogenetic  (FISH)  and  molecular  genetic  investigations.  For  each  of  the 
groups  studied  a  different  mutation  strategy  (or  strategies)  was  chosen.  A  total  of  93 
cases  have  been  included. 
Unicolour,  dual  colour  and  multicolour  FISH  analyses  were  successfully 
optimised  using  different  probe  concentration,  competitor  DNA  concentrations, 
hybridisation  temperature,  and  detection  methods.  The  optimal  final  concentration  of 
the  DNA  mixture  (probe  and  competitor  DNA)/2  cm2  hybrdisation  was  found  to  be 
between  1-300  ng  of  the  probe  and  5-12  gg  of  the  competitor  DNA.  The  optimal 
hybridisation  temperature  was  between  37-42  OC  for  14-16  hours  incubation  time.  A 
total  of  21  probes  were  used,  15  were  specific  for  chromosome  X  and  six  wre 
specific  of  the  Y-chromosome.  All  probes  used  in  this  study  were  optimised  to 
provide  strong  and  well-defined  signals  on  metaphase  and  interphase  spreads. 
Among  patients  with  sex  chromosome  aberrations,  the  optimised  biotin- 
and/or  digoxgenin-labelled  X-  and  Y-chromosome  specific  DNA  probes  were 
applied  to  characterise  the  abnormalities  in  the  sex  chromosomes.  Three  general 
types  of  probes  were  used  for  FISH-based  cytogenetic  analysis;  whole  chromosome 
probes,  chromosome  specific  repeats,  and  probes  targeted  to  specific  loci.  They  were 
used  separately  or  in  combination.  Late  replication  (X-inactivation)  study  using 
BrdU  was  optimised  and  applied  for  structurally  abnormal  X  chromosomes 
particularly  ring  X  and  X-autosome  translocation. 
For  patients  with  sex  determination/differentiation  abnormalities  and  with 
male  infertility,  conventional  cytogenetics  methods  were  applied.  Optimised  FISH 
and  different  molecular  techniques  including  multiplex  PCR,  SSCP,  heteroduplex 
analysis,  CCM  analysis,  Southern  blot  and  DNA  sequencing  were  applied  for  the 
detection  and  full  characterisation  of  mutation(s)  in  the  androgen  receptor  (AR),  SRY 
and  RBMI  genes. 
i Out  of  the  93  patients,  24  patients  had  sex  chromosome  aberrations  diagnosed 
by  conventional  cytogenetics.  Most  of  them  were  ascertained  because  they  had 
Turner  syndrome/variant  phenotypes.  Reassessment  of  the  chromosomal  constitution 
of  those  patients  using  fluorescent  in  situ  hybridization  technique  revealed  that  in  20 
patients  (83.3%)  the  FISH  results  were  consistent  with  the  cytogenetic  findings. 
However,  FISH  analysis  has  confirmed  the  presence  of  mosaicism  and/or  structural 
abnormalities,  delineated  the  breakpoints,  and  identified  the  origin  of  the  marker 
chromosome  among  them.  In  addition,  FISH  investigation  has  detected  cryptic 
rearrangements  in  four  patients  (16.7%).  One  patient  diagnosed  i(Xp)  was  found  by 
FISH  analysis  to  be  t(Xp;  Xq).  A  second  patient  with  46,  XXp+  was  precisely 
diagnosed  as  t(Xp;  16q).  A  third  patient  with  marker  chromosome  was  delineated  as 
t(X;  Y)  and  the  fourth  patient  diagnosed  by  cytogenetics  as  mar(?  der  Y)  has  proved 
by  FISH  to  be  i(Yq),  in  addition  to  the  detection  of  a  third  cell  line  in  the  form  of 
r(Y).  Late  replication  study  using  BrdU  in  cases  of  ring  (X)  showed  active  normal  X 
while  the  ring  (X)  was  either  early  replicating  or  late  replicating  within  the  same 
case.  No  genotype-phenotype  correlation  could  be  made  in  these  cases  in  relation  to 
the  ring  size  or  its  replication  pattern.  In  case  of  t(Xp;  16q),  the  derivative  X  was 
confirmed  to  be  late  replicating  in  all  cells  examined.  However,  the  translocated 
segment  of  16q  demonstrated  a  differential  replication  pattern,  which  could  be 
correlated  with  the  patient  phenotype. 
In  the  remaining  patients,  13  had  sex  determination  /  differentiation 
abnormalities  and  56  had  infertility  problems. 
The  molecular  screening  methods  used  in  this  study  included  chemical 
cleavage  mismatch  analysis  (CCM),  single  strand  conformational  analysis  (SSCP), 
Multiplex  PCR,  Southern  blotting  and  DNA  sequencing.  The  strategy  of  using  DNA 
as  template  for  PCR  and  use  of  SSCP,  heteroduplex  and  DNA  sequencing  analysis  as 
the  main  screening  methods  has  proved  to  be  a  useful  screening  strategy  for  detection 
of  mutations  within  AR,  SRY,  and  RBMI  gene.  Molecular  genetic  analysis  for 
diagnostic  purposes  employing  SSCP  has  proven  to  be  a  very  useful  approach  for  a 
variety  of  diseases. 
Among  the  5  cases  of  androgen  insensitivity  syndrome  (46,  XY  female),  a 
point  mutation  in  the  steroid  binding  domain  (exon  8)  of  the  AR  gene  was  detected 
by  PCR-SSCP  analysis  in  one  patient  with  the  complete  fon-n  of  the  disease.  The 
ii substitution  resulted  from  a  point  mutation  at  nucleotide  4109  G-+T  causing 
replacement  of  Val  889  by  Leu. 
Molecular  analysis  of  the  SRY  ORF,  promoter  and  the  poly-A  tail  regions  in 
4  patients  with  either  complete  or  partial  46,  XY  gonadal  dysgenesis  has  revealed  no 
mutations  in  this  region  suggesting  that  these  patients  have  a  non-nal  SRY  gene. 
However,  the  failure  to  detect  mutations  in  these  unrelated  cases  does  not  exclude  the 
existence  of  mutations. 
In  the  present  study,  cytogenetic  analysis,  FISH  and  molecular  amplification 
have  been  used  to  detect  the  presence  or  absence  of  Y  sequences  and  to  characterise 
the  transfer  of  Yp  fragments  to  Xp22.3  in  4  XX  males.  FISH  techniques  using 
GMGY10  and  hoSRY  probes  specific  for  the  Ypl1.2  region  were  applied  on  the 
metaphase  spreads  and  revealed  the  presence  of  the  Yp  11.2  sequences  on  the  short 
arm  of  the  X  chromosome  in  three  patients  while  it  was  absent  in  the  fourth  one. 
DNA  analysis  of  these  4  patients  using  SRY,  ZFY,  PAR  and  Yl/Y2  sequence 
amplification  confirmed  the  existence  of  the  SRY,  AZF,  and  PAR  sequences  in  three 
patients  and  its  absence  in  the  fourth  patient. 
Fifty-six  cases  with  male  infertility  were  first  analysed  by  routine 
cytogenetics.  Abnormal  karyotypes  were  found  in  5  cases  (8.9%).  Four  cases  (7.1%) 
had  47,  XXY  and  one  case  had  47,  XYY.  Out  of  the  50  men  with  idiopathic  infertility 
only  one  azoospermic  male  (2%)  was  found  to  have  aY  chromosome  microdeletion 
by  multiplex  PCR  analysis.  Six  PCR  products  were  absent  in  4  out  of  5  multiplex 
reactions.  These  deletions  involved  sYI53  (subinterval  Q,  sY147  and  Y6HP52pr 
(subinterval  D),  sY  157  and  sY  149  (subinterval  E),  and  Frl5-I  I  pr  (not  determined) 
and  the  breakpoints  in  Yq  II  was  estimated  to  be  in  subinterval  MX-MXII  of  the  Ma 
map  between  interval  6C  and  6F,  according  to  the  Vollrath  deletion  map.  PCR  study 
using  DAZ  specific  primers  showed  that  all  infertile  patient  and  controls  retained  the 
DAZ  gene,  yet  it  was  deleted  in  the  patient  with  microdeletions.  The  father  of  the 
patient  also  retained  DAZ  gene.  Therefore,  the  patient  in  this  study  has  a  de  novo 
microdeltion  in  YqI  I  region,  which  spanned  the  DAZ  gene  region.  Moreover,  FISH 
analysis  and  Southern  blot  hybridisation  to  DNA  from  50  infertile  men  and  50 
controls  using  cDNA  encoding  RBMI  and  RBM2  respectively  revealed  the  multiple 
copies  of  the  gene  without  any  deletions  or  structural  rearrangements.  Accordingly, 
the  possibility  of  the  deletion  or  rearrangement  of  the  RBM  gene  family  was  ruled 
out  as  a  cause  of  the  infertility  in  these  cases.  Finally,  the  DNA  of  50  idiopathic 
iii patients  with  normal  karyotypes  was  amplified  with  intronic  primers  specific  for 
exons  1-12  of  the  RBMI  genes.  Single  strand  conformation  polyinorphism  (SSCP) 
analysis  was  optimised  to  screen  exons  1-11  and  heteroduplex  analysis  (HA)  was 
optimised  to  screen  exon  12  of  the  gene  in  all  cohorts  of  the  studied  patients.  No 
small  deletions  or  structural  rearrangements  were  detected  in  all  cohorts,  including 
the  patient  who  showed  microdeletion  in  YqlI  upon  multiplex  PCR  experiments. 
The  possible  reasons  for  these  findings  are,  (1)  the  responsible  gene  (RB"  may  be 
unimportant  in  the  process  of  spermatogenesis.  (2)  Point  mutations  may  not  be 
present,  or  not  detectable,  or  in  regions  of  the  gene  not  yet  analysed  in  these  patients. 
(3)  RBM  is  a  multicopy  family  of  genes  and  hence  mosaicism  is  not  easily  shown. 
Finally,  in  this  study  no  do  novo  point  mutations  were  found  which  might  have 
indicated  that  the  RBM  genes  are  involved  in  the  failure  of  spermatogenesis  in  all 
investigated  patients. 
iv CHAPTER  I 
INTRODUCTION (1)  INTRODUCTION 
The  genetic  information  is  carried  by  discrete  entities  called 
"chromosomes",  a  characteristic  number  of  which  exist  for  each  species.  In  man 
there  are  46  chromosomes:  22  pairs  (number  1-22)  of  autosomes  and  one  pair  of 
sex  chromosomes  (XX  in  females,  XY  in  males).  The  fundamental  dogma  of 
molecular  biology  is  that  deoxyribonucleic  acid  (DNA)  codes  for  ribonucleic  acid 
(RNA)  which  in  turn  produces  proteins.  Thus  the  genetic  information  in  the  DNA 
specifying  a  particular  function  is  converted  into  an  RNA  copy  which  is  then 
translated  into  protein.  The  action  of  the  protein  then  produces  the  phenotype. 
Phenotypic  variation,  both  normal  and  abnonnal  differences,  can  be  considered  in 
terms  of  several  aetiologies:  (1)  Cytogenetic  disorders,  which  result  from  changes 
in  the  chromosome  number  (deviation  from  the  normal  number)  or  structure 
(deviation  in  chromosomal  morphology).  The  fomer  arises  by  chromosome 
malsegregation  and  the  later  arise  by  either  centromeric  misdivision  or 
chromosome  breakage.  (2)  Mendelian  disorders,  which  result  from  a  mutation  at  a 
single  genetic  locus,  causing  an  abnormal  allele.  (3)  Polygenic  (multifactorial) 
disorders  which  could  result  from  (a)  the  cumulative  effect  of  several  different 
genes,  (b)  multiples  allele  at  a  single  locus,  or  (c)  a  combination  of  genetic  and 
environmental  factors  and  (4)  teratogenic  agents  (Weatheral,  1991;  Connor  and 
Ferguson-Smith,  1991). 
Id  Molecular  Dathology  of  single  gene  disorder 
Any  trait  caused  by  a  single  gene  mutation  is  said  to  be  Mendelian,  or  to 
have  single  gene  inheritance.  Such  traits  can  be  divided  into  autosomal  dominant, 
autosomal  recessive,  sex  linked  and  mitochondrial  (Thompson  et  al,  199  1).  A  gene 
can  be  disrupted  in  many  ways.  Coding  regions  may  be  altered,  promoter  and  other 
regulatory  sequences  may  be  disturbed,  or  processing  signals  such  as  splice  sites 
may  be  modified.  Alterations  may  vary  from  deletions  or  rearrangements 
(insertion,  inversion,  and  duplication)  that  can  remove  an  entire  gene  to  individual 
nucleotide  changes  (single  base-pair  substitution).  These  various  types  of mutations  have  been  detected  and  characterised  in  many  human  genes,  thus 
enabling  the  study  of  the  underlying  mutational  mechanisms. 
Nucleotide  changes  may  or  may  not  cause  altered  amino  acid  synthesis. 
Point  mutations  have  been  classified  into  silent,  missense,  nonsense  and  sense.  In 
silent  mutation,  base  substitution  causes  no  change  in  the  amino  acid  therefore  it 
has  no  consequence  at  the  phenotypic  level.  The  protein  product  of  the  mutant  will 
function  just  as  well  as  that  of  the  wild  type.  In  missense  mutation,  a  codon 
change  results  in  coding  of  different  amino  acid.  The  effect  of  this  mutation  on 
protein  function  depends  on  its  location  in  the  protein  molecules.  In  nonsense 
mutation,  a  stop  codon  (UAA,  UAG,  or  UGA)  is  created,  causing  premature 
termination  of  protein.  In  sense  mutation,  a  termination  codon  is  changed  to  one 
that  codes  to  amino  acids  and  results  in  the  translation  of  protein  beyond  the 
normal  ten-nination  signal  until  another  termination  codon  is  reached  producing 
longer  than  normal  protein  (Weatherall,  199  1). 
Nucleotide  substitutions  are  the  most  common  type  of  mutations  in  coding 
DNA  sequence.  Nucleotide  changes  that  involve  the  substitutions  of  one  purine  for 
another  (A<->G)  or  one  pyrimidine  for  the  other  (T+->C),  called  transition,  are  more 
frequent  than  transversion  (substitution  of  pyrimidine  by  purine  or  vice  versa).  The 
excess  of  transition  can  be  explained  with  finding  that  major  form  of  DNA 
modification  in  the  human  genome  involves  methylation  of  cytosine  residues  to 
form  5'-methylcytosine,  predominantly  in  CpG  dinucleotides  (Cooper  and 
Krawczak,  1993).  Spontaneous  dearnination  of  5'-methylcytosine  to  thymine  in 
CpG  dinucleotides  gives  rise  to  C  ->  T  or  G  -*  A  transition.  Since  35%  of  single 
base  pair  mutation  occurred  within  CpG  dinucleotides  with  transition  substitution 
occurring  with  a  frequency  of  over  90%  (Cooper  and  Krawczak,  1991),  the  CpG 
dinucleotides  appears  to  be  a  hotspots  for  mutation  and  contributes  significantly  to 
the  molecular  pathology  of  many  disorders. 
One  important  aspect  of  RNA  processing  is  the  precise  splicing  out  of 
introns  to  produce  a  mature  mRNA  ready  for  translation.  Nearly  all  eukaryotic 
genes  have  a  dinucleotide  GT  at  the  5'  starting  point  of  the  intron  (the  donor  site) 
and  a  dinucleotide,  AG  at  the  3'  (the  acceptor  site).  There  are  a  wide  variety  of 
mutations  in  introns  that  affect  normal  RNA  splicing  (Krawczak  et  al,  1992). 
Naturally  occurring  mutations  that  affect  mRNA  splicing  can  be  assumed  to  fall 
into  three  main  categories:  (1)  mutations  within  a  5'  or  3'  splice  site.  Such  lesions 
2 usually  reduce  the  amount  of  mature  mRNA  generated  and/or  activate  so-called 
cryptic  (i.  e.  alternative)  splice  sites  resulting  in  the  production  of  mRNA  which 
either  lacks  a  portion  of  the  coding  sequence  (exon  skipping)  or  which  instead 
contain  additional  sequences  of  intronic  origin  (cryptic  splice  site  situation). 
According  to  the  definition  model  proposed  by  Robberson  et  al  (1990),  exons  are 
recognised  and  defined  as  distinct  units  by  the  initial  binding  of  protein  factors  to 
the  3'  end  of  the  intron  followed  by  a  search  for  a  down  stream  5'  splice  site.  Thus 
an  alternative  consequence  of  splice  site  mutation  could  be  for  an  exon  to  be  no 
longer  recognised  as  such,  and  as  a  result  to  be  excluded  from  the  mature  mRNA 
transcript-  a  process  termed  exon  skipping.  (2)  Mutations  within  an  intron.  This 
kind  of  mutation  in  the  introns  includes  those  that  cause  the  activation  of  cryptic 
splice  sites,  by  making  a  sequence  to  be  more  similar  to  an  authentic  consensus 
site  or  by  creating  new  splice  sites  leading  to  the  production  of  aberrant  mRNA 
species.  (3)  Mutations  within  a  branch-point  sequence  (Krawczak  et  al,  1992). 
Alterations  of  gene  structure  by  deletion,  insertion  or  duplications  have 
been  described  in  various  inherited  disorders  and  the  frequency  of  such  mutations 
differs  greatly  among  different  genetic  diseases.  Deletions  may  be  the  underlying 
cause  of  single  gene  Mendelian  disorders.  Deletions  of  multiple  exons  may 
remove  a  portion  of  the  gene  products,  if  newly  juxtaposed  exons  are  not  in  frame, 
a  truncated  product  may  result  (Monaco  AP,  1989).  Gross  gene  deletions  may 
arise  either  by  homologous  unequal  recombination  mediated  by  related  gene 
sequences  or  repetitive  sequences,  or  by  non-homologous  sequences  involving 
DNA  with  minimal  sequence  homology  (Krawczak  and  Cooper,  1991).  Smaller 
deletions  may  remove  specific  amino  acids  from  a  protein  if  the  deletion  involves 
multiples  of  three  bases.  Other  deletions  result  in  frame  shift  that  usually  truncates 
the  protein  product.  Direct  repeats  palindromes  and  symmetric  elements  could  be 
potential  mechanisms  involved  in  gene  deletions, 
Duplications  involving  part  or  all  of  a  gene  can  cause  genetic  disorders 
because  the  inserted  material  disrupts  the  reading  frame  of  a  gene,  leading  to 
premature  termination  of  translation.  Gene  duplications  may  also  occur  due  to 
homologous  or  non-homologous  recombination.  For  instance,  homologous 
recombination  may  arise  between  repetitive  sequences  such  as  Alu  elements 
however,  non-homologous  recombination  may  cause  in  duplication  by  random 
chromatid  breakage  and  rejoining  events. 
3 Insertion  of  <  10  base  pairs  (bp)  sequences  into  human  genome  coding 
region  were  also  investigated  by  Cooper  and  Krawczak  (1991).  They  stated  that 
this  event  is  not  random  and  appears  to  be  highly  dependent  on  the  local  DNA 
sequence  context.  The  majority  of  insertion  can  be  explained  either  by  (1) 
mispairing,  or  by  (2)  inverted  repeats  or  by  (3)  symmetric  elements  (e.  g. 
CTGAAGTC,  GGACAGG)  during  DNA  replication. 
1.2  Sex  determination  and  sex  di  fferentiatiOll 
The  existence  of  males  and  females  is  due  to  two  processes:  sex 
determination  and  sex  differentiation.  Sex  determination  is  the  process  of  choosing 
the  male  or  female  differentiation  pathway  (Goodfellow  and  Lovell-Badge,  1993). 
Sex  determination  and  differentiation  are  sequential  and  complex  processes 
starting  with  the  establishment  of  genetic  sex  at  conception,  followed  by  gonadal 
determination  in  early  ernbryogenesis  and  ends  in  puberty  with  complete  sexual 
maturation  and  the  ability  to  reproduce  (Moore  and  Grumbach,  1992).  The  critical 
factor  in  this  process  is  the  differentiation  of  the  bipotential  genital  ridge  into 
either  a  testis  or  an  ovary.  Sex  differentiation  is  governed  by  a  pathway  involving 
X-linked  and  autosomal  genes  and  the  pathway  is  initiated  by  a  dominant  inducer 
Y  specific  master  gene  called  TDF  (Testis-detennining  factor),  Male  sex 
determination  is  dependent  on  the  presence  of  a  Y-chromosome  and  TDF  (Page 
et  at,  1987).  Male  gonadal  sex  or  testis  formation  is  subsequently  thought  to  be 
determined  by  this  gene  and  by  other  secondary  pathways.  The  male  gonad  in  turn 
normally  produces  hormones  that  regulate  differentiation  of  the  internal  and 
external  genital  structures,  thus  determining  phenotypic  sex.  In  the  absence  of  the 
Y  chromosome  (and  TDF),  the  foetal  gonads  follow  the  ovarian  pathway,  with 
ensuing  female  development  (Ford  et  at,  1959).  When  an  abnormality  develops  in 
any  of  the  above  three  processes  complete  or  incomplete  sex  reversal  individual 
results  due  to  the  discrepancy  in  genetic,  gonadal  and  phenotypic  sex  (Gustafson 
et  at,  1994). 
LZI  Normal  sex  differentiation 
The  early  embryo  has  no  sexual  characteristics  except  for  the  chromosomal 
complement  of  its  cells.  In  human  embryos,  the  gonadal  development  begins 
4 during  the  4th  and  5th  weeks  of  gestation.  The  complete  differentiation  of  normal 
gonads  depends  upon  the  arrival  of  sufficient  numbers  of  viable  primordial  germ 
cells  to  the  genital  ridges  of  the  dorsal  mesentery.  The  germ  cells  arise 
extragonadally  and  therefore  must  migrate  into  the  site  of  gonadal  differentiation. 
Seeding  of  the  ridges  by  primordial  germ  cells  is  an  independent  event  not 
requiring  Y  chromosome  and  TDF  (Moore  and  Grumbach,  1992).  If  they  fail  to 
arrive,  gonads  do  not  develop  (gonadal  agenesis)  and  only  a  fibrous  streak  will 
exist.  At  6  weeks  of  foetal  life,  the  indifferent  gonad  is  bipotential,  capable  of 
forming  either  testis  or  ovary. 
Before  gonadal  differentiation,  Wolffian  ducts  have  already  developed  (by 
4  weeks).  Mullerian  ducts  appear  at  about  7  weeks.  In  an  XY  embryo  (normal 
male)  the  testis-determining  switch  commits  the  primitive  gonads  to  testicular 
development,  resulting  first  in  Sertoli  and  later  in  Leydig  cell  differentiation. 
Sertoli  cells  envelope  the  primordial  germ  cells  and  form  primitive  cords 
(precursors  of  the  seminiferous  tubules),  and  inhibit  germ  cell  meiosis,  Their 
differentiation  is  predominantly  cell  autonomous  and  requires  a  Y-chromosome 
(Moore  and  Grumbach,  1992).  The  developing  testis  secretes  two  hormones  that 
are  important  for  the  subsequent  male  differentiation.  Mullerian-inhibiting 
substance  (MIS)  produced  by  Sertoli  cells  prevents  formation  of  the  uterus, 
fallopian  tubes  and  upper  part  of  the  vagina  (Mullerian  structures)  (Josso  and 
Piccard,  1986).  Leydig  cell  testosterone  secretion  is  responsible  for  persistence  of 
the  Wolffian  ducts  and  their  differentiation  into  epididymis,  vas  deferens,  seminal 
vesicles  and  ejaculatory  ducts,  and  promotes  the  masculanisation  of  the  external 
genitalia.  The  latter  step  requires  conversion  of  testosterone  to  dihydrotestosterone 
(DHT)  (Siiteri  and  Wilson,  1974)  and  the  subsequent  interaction  of  D11T  with 
intracellular  receptors  (androgen  receptors)  (Migeon  et  al,  1981).  DHT  is 
responsible  for  fusion  of  labia,  growth  of  the  phallus  and  formation  of  scrotum. 
Wolffian  development  and  masculanisation  of  the  external  genitalia  begin  at  about 
10  weeks  and  are  completed  by  16-17  weeks  (Marcantonio  et  a],  1994). 
In  the  XX  (normal  female)  individual,  without  the  active  influence  of  aY 
chromosome,  the  bipotential  gonad  is  committed  to  ovarian  development.  The 
gonad  is  silent  until  about  12  weeks  when  oocytes  begin  to  differentiate  and 
primordial  follicles  are  present  by  20  weeks.  In  the  absence  of  Leydig  cell 
testosterone,  the  Wolffian  ducts  virtually  disappear  completely,  The  Mullerian 
5 system,  in  the  absence  of  Sertoli  cell  MIS  secretion,  differentiates  into  upper 
vagina,  uterus  and  falloPian  tubes. 
LZ2  Role  of  chromosomes  in  sex  determination 
It  has  been  known  for  decades  that  sex  determination  in  mammals  is 
accomplished  by  a  chromosomal  mechanism.  Females  have  two  X  chromosomes, 
and  males  have  a  single  X  and  a  small  mainly  heterochromatic  Y  chromosome. 
Analysis  of  individuals  with  unusual  sex  chromosome  combination  has  shown  that 
the  presence  of  the  Y  chromosome  is  critical  for  male  sex  determination  and 
absence  of  the  Y  chromosome  results  in  female  development.  Ford  et  al  (1959) 
showed  that  individuals  with  Turner  syndrome  had  a  single  X  chromosome  and 
were  females  while  patients  with  Klinefilter  syndrome  were  shown  to  have  two  X 
chromosomes  and  a  Y,  and  were  males  (Jacobs  and  Strung,  1959).  These  results 
implied  that  the  Y  chromosome  carries  a  gene  required  for  testis  development.  The 
concept  that  genes  located  on  the  Y  chromosome  play  an  essential  role  in  human 
sex  determination  is  stressed  by  the  existence  of  various  sex  chromosomal 
aberrations.  These  conditions  include  the  46,  XX  male  syndrome,  true 
hermaphrodites,  46,  XY  gonadal  dysgenesis,  and  various  Y  chromosomal 
aberrations  that  result  in  female  development.  From  the  analysis  of  Y  chromosome 
rearrangements  and  their  associated  phenotypes,  the  testis  determination  factor 
(TDF)  has  been  assigned  to  the  short  arm  of  the  Y  chromosome  (Davis  RM,  1981), 
and  more  precisely  mapped  to  the  most  distal  specific  segment  adjacent  to  the 
pseudoautosomal  boundary  (Affara  et  al,  1986;  1987,  Vergnaud  et  al,  1986). 
There  are  two  features  that  make  sex  chromosomes  unique  in  mammalian 
genome.  Most  obviously,  they  determine  sex.  Also,  they  are  morphologically  and 
genetically  different  from  each  other,  a  difference  that  has  accompanied  the 
appearance  of  a  sex  determining  role  on  the  Y  chromosome  and  a  mechanism  of 
dosage  compensation  for  X-linked  genes  in  females,  mediated  by  random  X 
inactivation  (Graves  JAM,  1995). 
The  Y  chromosome  is  composed  of  two  parts  with  different  proportion: 
the  pseudo  autosomal  region  (PAR),  shared  with  the  X  chromosome,  and  the  Y- 
specific  region.  At  male  meiosis  the  Y  chromosome  pairs  with  the  X  chromosome 
and  the  pairing  occurs  within  the  PAR  region  shared  between  the  short  arms  of  the 
6 X  and  Y  chromosomes  (Burgoyne  PS,  1986;  Chandley  et  al,  1984).  An  obligate 
recombination  event  within  the  PAR  is  necessary  to  ensure  correct  meiotic 
segregation  (Burgoyne  PS,  1982).  The  Y-specific  regions  include  the  sex 
determining  factor  JDF)  region  containing  the  SR  Y  gene,  located  proximal  to  the 
PAR,  the  putative  transcription  factor  ZFY  (Zinc  finger  on  Y),  the  gene  for  H-Y 
antigen  (serological  histocompatibility  Y),  genes  necessary  for  spermatogenesis 
(Buhler  EM,  1980;  Goodfellow  et  al,  1985),  anti-Turner  gene  (RPS4;  ribosomal 
protein  S4)  (Fisher  et  al,  1990)  and  genes  implicated  in  the  development  of 
gonadoblastorna  (GBY)  (Page  D,  1987;  Verp  and  Simpson,  1987;  Barbosa  et  al., 
1995).  On  the  distal  portion  of  the  long  arm  of  the  Y  chromosome  is  the 
heterochromatic  region,  which  is  apparently  not  transcribed  and  varies  in  length 
(Fig  1.1). 
The  X  chromosome  is  currently  the  best  characterised  among  all  human 
chromosomes  (McKusick  VA,  1994).  With  the  exception  of  genes  located  in  the 
PAR  (Ellis  and  Goodfellow,  1989),  and  a  few  other  genes  which  have  active 
copies  on  both  the  X  and  Y  chromosomes,  most  genes  on  the  X  chromosome 
display  a  haploid  status  in  males  (Ballabio  and  Andria,  1992).  The  X  chromosome 
is  significantly  larger  than  the  Y  chromosome  but  organised  in  a  similar  fashion, 
having  a  pseudo  autosomal  region  matching  that  of  the  Y  and  an  X-specific  region 
(Fig  1.1).  The  X-specific  region  contains  many  genes  including  some  genes  crucial 
for  male  and  female  sexual  differentiation  and  other  genes  that  are  essential  for  life 
(45,  Y  is  lethal)  (Moore  and  Grumbach,  1992). 
Because  XX  females  have  twice  as  many  X-linked  genes  as  XY  males,  a 
dosage  compensation  mechanism  is  achieved  by  X  chromosome  inactivation  in 
order  to  avoid  the  aneuploidy  effect  that  would  stem  from  the  presence  of  more 
than  one  X  chromosome  (Lyon  M,  1961;  Riggs  and  Pfeifer,  1992).  The 
inactivation  of  one  X  chromosome  is  thought  to  be  an  essential  part  of  female  sex 
differentiation.  X  inactivation  is  associated  with  a  switch  in  the  timing  of 
chromosomal  replication,  the  inactive  X  chromosome  being  the  last  to  initiate 
DNA  synthesis  (Lyon  M,  1992).  This  late  replicating  chromosome  is  relatively 
condensed  during  the  interphase  and  is  visible  cytologically  as  a  Barr  or  sex 
chromatin  body  at  the  nuclear  periphery  (Migeon  B,  1994). 
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Figure  1.1:  Diagrammatic  representation  of  the  G-banded  Y  and  X  chromosomes. 
Functional  regions  and  loci  involved  in  sex  determination  and  differentiation  are 
shown.  (A)  The  Y  chromosome:  SRY=  sex  determining  region;  RPS4Y=  ribosomal 
protein  S4;  ZFY=  zinc  finger  protein.  (B)  The  X  chromosome:  RPS4X=  ribosomal 
protein  S4;  XIST=  X-inactive  specific  transcript;  XIC,  =  X-inactivation  center. The  X  inactivation  begins  early  in  female  embryological  development  and  it 
occurs  randomly  with  respect  to  parental  origin  of  the  chromosome.  Once  silenced 
the  inactive  X  chromosome  usually  remains  silent  in  all  progeny  cells  (clonal 
inheritance).  Although  inactivation  seems  to  affect  the  X  chromosome  as  a  whole 
(inactivating  many  loci),  some  loci  on  the  inactivated  human  X  chromosome  are 
actually  transcribed.  These  transcribed  genes  include  not  only  those  in  the  pseudo 
autosomal  region  (Xp22.3),  but  also  some  of  the  proximal  short  arm  and  the 
proximal  long  arm  of  the  X  chromosome  such  as  zinc  finger  X  (ZFX  at  Xp22.1) 
and  ribosomal  protein  S4  (RPS4X  at  Xql3)  (Fisher  et  al,  1990;  Schnider  et  al, 
1989;  Disteche  et  al,  1995).  Furthermore,  in  female  germ  cells  (oogonia)  only  one 
X  chromosome  is  active  but  the  inactive  X  is  reactivated  at  about  the  time  of  entry 
into  meiosis  (Migeon  and  Jelalian,  1977;  Monk  and  McLaren,  1981).  Therefore 
both  X  chromosomes  are  thought  to  be  active  during  oogenesis  itself  On  the  other 
hand,  in  spermatogenesis  the  single  X  chromosome  is  inactive  (Monk  and 
McLaren,  1981). 
The  precise  nature  of  the  X  inactivation,  its  control  mechanism  and 
sequence  of  imposition  is  still  unclear.  However,  genetic  evidence  strongly 
suggests  the  existence  of  a  specific  locus  required  in  Cis  for  X  inactivation  located 
within  a  segment  of  the  X  chromosome  referred  as  the  X-inactivation  centre  (XIC) 
(Borsani  et  at,  1991).  This  XIC  region  has  been  localised  to  the  long  arm  of  the  X 
chromosome  at  Xq13  (Therman  et  at,  1990;  Brown  et  at,  1991).  Recently,  a  gene 
has  been  isolated  and  mapped  to  Xql3  and  proposed  to  be  a  candidate  for  the 
inactivation  centre.  It  is  referred  to  as  XIST  (X-inactivation  specific  transcript)  in 
human  (Brown  et  at  199  1)  and  Xist  in  mouse  (Borsani  et  at,  199  1;  Brockdorff  et  at, 
1992)  and  is  expressed  from  the  inactive  but  not  the  active  X  chromosome.  The 
complete  cDNA  sequences  of  the  human  (Brown  et  at,  1992)  and  mouse  XIST 
(Brockdorff  et  at,  1992)  have  been  determined  and  no  substantial  open  reading 
frame  has  been  found,  and  the  RNA  is  confined  to  the  nucleus,  It  has  been 
suggested  that  the  gene  product  is  a  structural  RNA,  which  may  act  directly  on 
chromosomal  DNA  by  altering  the  conformation  of  the  chromatin  in  the  region 
(Brockdorff  et  at,  1992;  Brown  et  at,  1992).  Moreover,  in  human  females  whose 
karyotypes  include  tiny  ring  X  chromosomes  were  found  to  be  unable  to  inactivate 
the  tiny  rings  which  were  thus  thought  to  be  responsible  for  their  multiple 
phenotypic  abnormalities  and  severe  mental  retardation  (Migeon  et  at  1993). 
9 The  specific  function  of  XIST  in  the  inactivation  process  is  unclear 
(Ferguson-Smith  MA,  1991).  XIST  probably  plays  a  role  in  the  initiation  of  X 
inactivation,  although  it  is  not  required  for  maintenance  of  the  inactivation  state. 
Maintenance  of  X  inactivation  through  subsequent  cell  division  is  thought  to  result 
at  least  in  part  from  epigenetic  changes  in  the  genes,  including  methylation  of  CpG 
islands  of  some  X-linked  genes  (Cattanach  BM,  1975;  Riggs  AD,  1990),  absence 
of  acetylated  histone  H4  (Rastan  S,  1994),  chromatin  condensation  and  allocyclic 
replication  (Lyon  1992;  Migeon  BR,  1994;  Disteche  CM,  1995). 
1.3  Sex  chromosome  abnormalities  and  chromosomal  intersex 
Sex  chromosome  abnormalities  can  mean  many  things  but  commonly  it 
refers  to  all  abnormalities  of  sex  chromosome  number  and  structure,  and  usually, 
as  well,  to  discrepancies  between  karyotype  and  phenotypic  sex.  Chromosomal 
errors  may  be  divided  into:  (A)  Numerical  changes.  (B)  Structural  changes. 
(A)  Numerical  chromosomal  aberrations: 
If  a  haploid  gamete  or  a  diploid  cell  lacks  the  expected  number  of 
chromosomes  (n  or  2n  respectively),  aneuploidy  exists.  When  the  complement 
contains  one  addition  of  a  whole  chromosome  (2n+l),  trisomy  exists.  The  term  can 
be  applied  to  sex  chromosomal  abnormalities  (e.  g.  47,  XXX)  but  if  an  excess 
number  of  sex  chromosomes  are  present  it  is  customary  to  use  the  term  polysomy. 
If  one  entire  chromosome  is  missing  (2n-1)  monosomy  exists  (i.  e.  45,  X). 
Polyploidy  happens  when  more  than  two  haploid  complements  are  present  within  a 
single  cell.  Triploidy  (3n  =  69  chromosomes)  and  tetraploidy  (4n--92 
chromosomes)  are  the  most  common  types  of  polyploidy.  Both  conditions  are  seen 
in  spontaneous  abortions  and  stillbirths  and  are  essentially  incompatible  with  life 
(Emery  and  Muller,  1992). 
Aneuploidy  results  from  non-disjunction  in  either  the  meiotic  divisions  of 
the  parents  (during  gametogenesis)  or  in  the  early  cleavage  division  of  the  affected 
individual  (during  embryogenesis).  Aneuploidy  for  more  than  one  chromosome  is 
the  result  of  non-disjunction  in  both  meiotic  divisions,  non-disjunction  in  the 
meiosis  of  both  parents  (which  must  be  a  rare  coincidence),  multiple  non- 
10 disjunction  in  the  same  mitosis  or  meiosis,  or  abnormalities  in  more  than  one 
mitosis  (Therman  and  Susman,  1993). 
The  sex  chromosomes  show  a  much  wider  range  of  viable  aneuploidy  than 
do  the  autosomes.  Figurel.  2  summarises  the  non-mosaic  numerical  sex 
chromosome  abnormalities  found  so  far,  their  incidence  in  new  bom  of  the  same 
sex,  and  the  number  of  Barr  bodies  (all  but  one  X  chromosome  in  a  cell  is 
inactivated,  forming  X  chromatin  bodies,  in  the  interphase)  (Therman  and  Susman, 
1993). 
The  incidence  of  45,  X  (Turner  syndrome)  individuals  seems  to  be 
independent  of  maternal  age.  Experimental  evidence  has  shown  that  70  to  80%  of 
patients  with  45,  X  retain  the  maternal  X  chromosome  (Lorda-Sanchez  et  al,  1992; 
Mathur  et  al,  1991).  On  the  other  hand,  the  incidence  of  47,  XXX  and  47,  XXY 
individuals  increases  with  maternal  age.  In  these  cases,  non-disjunction  apparently 
occurs  mainly  in  maternal  meiosis.  Individuals  with  three  X  chromosomes 
(47,  XXX)  do  not  seem  to  form  a  well-defined  syndrome.  They  are  often  mentally 
retarded  and  are  fertile  (Polani  PE,  1977).  Females  with  more  than  three  X 
chromosomes  (e.  g.  48,  XXXX)  suffer  from  severe  mental  retardation  and  several 
somatic  anomalies,  yet  their  sex  development  is  usually  normal  (Nielsen  et  al, 
1977).  In  the  group  of  sex  chromosome  abnormalities  with  a  male  phenotype,  the 
47,  XXY  and  47,  XYY  conditions  occur  approximately  equal  at  birth.  Individuals 
with  47,  XXY  karyotype  form  a  well-defined  syndrome  (Klinefelter  syndrome). 
Klinefelter  syndrome  is  a  condition  in  which  affected  men  are  sterile,  have  very 
small  testes,  sometimes  have  gynecomastia  and  may  be  mentally  retarded  (Connor 
and  Ferguson-Smith,  1991).  Men  with  a  47,  XYY  sex  chromosome  constitution 
have  been  reported  to  be  higher  among  penal  institutions  for  the  mentally 
abnormal  (2/1000)  and  in  mentally  deficient  adult  males  (3/1000)  (Connor  and 
Ferguson-Smith,  1991).  Males  with  one  Y  chromosome  and  more  than  five  X 
chromosomes  are  mentally  retarded  and  display  various  other  symptoms. 
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Figure  1.2:  The  human  X  and  Y  chromosome  constitutions  and  the  Barr  bodies 
formed  by  the  X  chromosomes  (Genotypes  below  the  broken  line  show  mental 
retardation  and/or  mentally  illness:  from  Therman  &  Susman,  1993). (B)  Structural  chromosomal  aberrations: 
Some  structural  variation  exists  in  human  somatic  chromosomes  without 
apparent  phenotypic  consequences.  However,  clearly  abnormal  variations  are 
usually  associated  with  phenotypic  abnormalities.  Aberrations  may  lead  to  genetic 
imbalance  through  deficiency  or  duplication  of  genetic  information.  In  deficiency 
or  duplications  only  portions  of  a  given  chromosome,  not  the  entire  chromosome, 
are  involved.  However,  if  the  variation  is  large  enough  to  be  recognised  by  light 
microscopy,  one  can  assume  that  many  genes  are  duplicated  or  deleted.  Phenotypic 
abnormalities  might  also  result  if  the  position  of  a  gene  with  respect  to  its 
neighbouring  gene(s)  is  altered  (position  effect).  Structural  chromosome 
aberrations  result  from  chromosomal  breakage.  If  only  one  chromosome  is 
involved,  the  result  may  be  a  deletion  (loss  of  genetic  material)  duplication  (gain 
of  genetic  material)  or  inversion  (rearrangement  of  genetic  material)  (Figl.  3). 
When  both  ends  of  a  chromosome  are  deleted  followed  by  joining  of  the  sticky 
ends,  a  ring  chromosome  is  formed  (Figl.  3).  If  the  centromere  divides 
horizontally,  rather  than  longitudinally,  separating  the  two  chromosome  arms 
instead  of  sister  chromatids  in  normal  division,  an  isochromosome  exists 
(Darlington  DC,  1939).  An  isochromosome  can  be  composed  of  identical  long 
arms  (i.  e.  46,  X,  i(Yq)  ),  or  short  arms  (i.  e.  46,  Xi(Yp)).  If  breakage  involves  more 
than  one  chromosome  a  translocation  usually  result  (Figl.  3).  In  reciprocal 
translocations  material  distal  to  the  breakage  points  is  exchanged  between 
homologous  or  non  homologous  chromosomes.  In  balanced  translocation  usually 
there  is  no  net  loss  of  genetic  material  and  the  individual  may  be  perfectly  normal 
(Brock  DJH,  1993). 
Mosaicism  and  chimerism 
A  mosaic  individual  has  two  or  more  genotypes  (cell  lines)  that  originate 
from  a  single  zygote.  Sex  chromosome  mosaicism  is  an  important  cause  of 
abnormal  sexual  differentiation.  Chromosomal  mosaicism  usually  arises  following 
mitotic  non-disj  unction,  with  the  survival  of  at  least  two  cell  lines  that  contain 
different  complement. 
An  individual  with  sex  chromosomal  mosaicism  might,  but  not  invariably, 
differ  phenotypically  from  non-mosaic  individuals  (Hassold  et  al,  1980).  The 
13 differences  presumably  reflect  the  distribution  of  various  cell  lines  in  different 
tissues.  A  great  variety  of  mosaics  have  been  described  in  man.  For  example, 
patients  with  Klinefelter's  syndrome  have  been  found  with  the  following  sex 
chromosomes  constitutions:  XX/XXXY,  XY/XXY,  XYIXXXY,  XXXY/XXXXY, 
and  XY/XXY/XXXY.  The  same  variety  has  been  reported  in  cases  with  Turner 
syndrome  (X/XX,  XfXXX,  X/XX/XXX,  X/XYY,  X/XY). 
A  chimeric  individual  has  two  or  more  genotypes  each  arising  from  a 
different  zygote,  which  subsequently  fuse.  Dispermic  chimeras  are  the  result  of 
fertilisation  of  two  genetically  different  egg  nuclei  by  two  sperms  and  the  resulting 
two  diploid  nuclei  both  contribute  to  the  formation  of  the  individual 
(46,  XX/46,  XY,  true  hermaphrodite).  Blood  chimeras  on  the  other  hand  result  from 
an  exchange  of  cells  between  non-identical  twins  through  the  placenta  while  they 
are  in  the  uterus  (Emery  and  Muller,  1992). 
Numerical  abnormalities  of  human  sex  chromosomes  are  common.  They 
occur  in  approximately  2-3%  of  conceptions  (Hassold  et  al,  1980),  and  are  found 
in  1:  400  male  and  1:  700  female  live  births  (Hamerton  et  al,  1975).  Correlation  of 
the  abnormalities  with  the  phenotype  led  to  the  conclusion  that  the  Y  chromosome 
contains  the  male  determinant  (Jacobs  and  Strung,  1959).  Furthermore  mosaicism 
of  X  and  XY  leads  to  dysgenesis  or  mental  subnormality  often  with 
hypogonadism.  These  patients  with  gonadal  dysgenesis  and  X/XY  mosaicism  have 
a  20%  risk  of  developing  gonadoblastoma  (Verp  and  Simpson,  1987). 
Short  arm  deletions  of  the  X  chromosome  (Xp-)  and  long  arm  X 
isochromosome  [i(Xq)]  both  involve  loss  of  short  arm  material  and  both  result  in 
short  stature,  Turner  stigmata,  and  gonadal  dysgenesis  (Ross  et  al,  1985;  Therman 
and  Susman,  1990).  Patients  with  deletion  of  the  long  arm  (Xq-),  the  critical  region 
(Xql3-Xq26)  or  with  short  arm  X  isochromosomes  [i(Xp)]  both  have  loss  of  X 
chromosome  long  arm  material  and  tend  to  have  gonadal  dysgenesis  with  normal 
stature  and  no  somatic  abnormalities  associated  with  Turner  syndrome  (Therman 
and  Susman,  1990;  Ogata  and  Matuso,  1995).  Other  structural  abnormalities  such 
as  fragments  and  ring  X  chromosome  have  been  described  (Cole  et  al  1980).  These 
abnormalities  are  frequently  associated  with  mosaicism  including  cells  with  X 
chromosome  monosomy,  and  this  makes  correlation  of  the  X  chromosome 
constitution  and  phenotypic  expression  difficult. 
14 X-  autosome  translocation  has  been  associated  with  a  wide  range  of 
phenotypic  expression,  including  gonadal  dysgcnesis  (Sarto  et  al  1973).  The 
correlation  of  phenotypic  expression  and  clinical  manifestation,  with  such  X- 
autosome  translocation  depends  on  the  segment  of  X  chromosome  lost  and  on  the 
arm  of  X  chromosome  involved  (Ballabio,  and  Andria,  1992;  Therman  et  al,  1990). 
Since  22  pairs  of  normal  autosomes  and  at  least  one  normal  X  chromosome 
are  essential  for  survival  of  the  zygote,  there  are  no  phenotypic  males  with  X 
chromosome  monosomy  or  deletion  of  the  short  arm  or  long  arm  of  an  X 
chromosome. 
Structural  abnormalities  of  the  Y  chromosome  are  rare  but  instructive  with 
regard  to  functional  segments,  since  Turner  syndrome,  intersex  status,  and 
maleness  with  infertility  result  from  structural  aberrations  of  the  Y  chromosome 
(Buhler  EM,  1980;  Davis  RM,  1981).  Short  arm  deletion  involving  the  testis 
determining  factor  of  the  Y  chromosome  and  Y  long  arm  isochromosome  [i(Yq)] 
both  involve  loss  of  the  testis  determining  factor  (Yp  11.2)  resulting  in  sex  reversal 
(Davis,  1981).  XY  translocations  involving  the  TDF  are  found  in  sex  reversal 
individuals  (XX  mates)  or  more  rarely  XY  females  (Petit  et  al  1987;  1990). 
Y:  autosome  translocation  leading  to  loss  of  Yp  also  results  in  female  phenotype. 
In  the  absence  of  a  second  X  chromosome  ambiguity  of  internal  organs,  streak 
gonads,  or  gonadoblastorna  are  often  found  (Munke  et  al,  1988).  Structural  Y 
chromosome  abnormalities  resulting  in  deletion  of  the  fluorescent  heterochromatin 
such  as  ring  Y  (Chandley,  and  Edmund,  1971),  short  arm  dicenteric  Y  (Chandely 
et  al  1986)  and  other  cases  of  Yq  deletion  itself  are  documented  in  infertile  men 
(Hartung  et  al,  1988;  Chandley  et  al,  1989).  With  regard  to  structural  abnormalities 
of  the  Y  chromosome,  the  most  constant  feature  observed  has  been  infertility. 
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Figure  1.3:  Structural  chromosome  abnormalities.  A,  Formation  of  terminal  and 
interstitial  deletions.  D,  Formation  of  paracentric  and  pericentric  inversions.  Break 
points  originate  from  same  side  and  on  opposite  sides  of  centromere,  respectively.  C, 
Formation  of  ring  chromosome,  D,  Formation  of  isocbromosome,  E,  Formation  of 
reciprocal  translocation. 1.3.1  Turner  Syndrome  and  variants 
Turner  syndrome  is  a  complex  human  disorder  which  is  usually  associated 
with  a  45,  X  karyotype.  It  is  the  only  monosomy  compatible  with  life.  It  is  a 
genetic  disorder  characterised  by  short  stature,  gonadal  dysgenesis  and  various 
somatic  stigmata  (Zinn  et  al  1993).  Overall  the  incidence  of  all  abnormalities  that 
include  partial  or  complete  monosomy  X  is  about  I  in  2000-2500  live  female  birth 
(Nielsen  and  Wohlert,  1991).  However,  it  is  estimated  that  up  to  99%  of  Turner 
conceptuses  are  spontaneously  aborted,  and  conversely  that  5-10%  of 
spontaneously  aborted  foetuses  have  45,  X  karyotype  (Hassold  TJ,  1986).  In 
contrast,  the  mortality  rate  during  pregnancy  for  foetuses  with  Turner  mosaic 
karyotype  is  at  least  13-fold  lower  than  for  non-mosaic  45,  X  and  this  has  led  to  the 
hypothesis  that  most  if  not  all  livebom  patients  with  45,  X  are  mosaic  with  a 
non-nal  cell  line  present  (Hassold  et  al  1988;  Hook  and  Warburton  1983).  About 
50-59%  of  patients  with  Turner  syndrome  have  a  45,  X  complement.  Structural 
abnormalities  of  the  second  X  [usually  45,  X/46,  X  i(Xq)]  are  seen  in  25%  of  cases. 
45,  X/46,  XX  mosaicism  in  9.5%,  45,  X/47,  XXX  in  3.5%,  45,  X/46,  XY  in  5.5%, 
45,  X/46,  X  +  mar  in  3%,  and  more  complex  karyotype  in  the  rest  (Table  1.1) 
(Magenis  et  al,  1980;  Rooney  and  Czepulkowski,  1994). 
The  somatic  abnormalities  can  be  classified  into  the  following  groups:  (1) 
Anomalies  attributable  to  lymphatic  obstruction  such  as  webbed  neck,  low 
posterior  hair  line,  rotated  auricle,  puffy  hands  and  feet,  redundant  skin,  nail 
dysplasia,  and  whorl  dominant  finger  pattern  type  (Zinn  et  al,  1944).  (2)  Skeletal 
anomalies,  such  as  short  neck,  micrognathia,  high  arched  palate,  cubitus;  valgus, 
geno  valgus,  short  metacarpals  and  metatarsals,  and  scoliosis.  (3)  Cardio-vascular 
and  renal  abnormalities  such  as  coarctation  of  the  aorta  and  horseshoe  kidney.  (4) 
Miscellaneous  anomalies,  such  as  multiple  pigmented  nevi  (Ogata  and  Matsuo, 
1995).  The  absence  of  secondary  sexual  characteristics  is  known  to  be  caused  by 
pre-pubertal  ovarian  failure  and  the  consequent  lack  of  ovarian  sex  steroid 
production.  The  ovaries  initially  develop  normally,  but  at  about  six  months  of 
gestation  massive  oocyte  loss  occurs.  Normal  females  also  undergo  oocyte  loss  in- 
utero,  but  to  a  lesser  extent.  Only  small  streaks  of  fibrous  tissue  remain  in  Turner 
Patients.  Burgoyne  and  Baker  (1984)  proposed  that  incomplete  chromosomal 
pairing  in  meiosis;  might  cause  germ  cell  death. 
17 Table  1.1:  Karyotype  variations  III  'FLIHICI'  SVII(II-0111C. 
Karyotype  Incidence  in  110  cases  of  TS  with  Percent 
chromosome  abnormality* 
45,  X  64  58.2 
45,  X/46,  XX  or  47,  XXX 
46,  X,  i(Xq) 
including  mosaics 
45,  X/46,  X,  r(X) 
45,  X/46,  XY  or  47,  XYY 
46,  X,  Xp- 
46,  X,  t(X;  autosome) 
11 
21 
6 
6 
19.1 
5.5 
5.5 
0.9 
0.9 
*From:  Rooney  and  Czepulkowski,  1994. 
18 The  typical  Turner  phenotype  is  most  frequently  manifested  by  patients 
with  45,  X  karyotype.  The  full  or  partial  Turner  phenotype  also  exists  in  apparently 
non  mosaic  patients  with  various  sex  chromosome  rearrangements  (Ferguson- 
Smith,  1991;  Grumbach  and  Conte,  1992).  Short  stature  is  a  universal  feature  in 
45,  X  and  46,  X,  i(Xq)  or  mosaics;  in  contrast,  normal  stature  occurred  in  20%  of 
45,  X/46,  XX;  50%  of  45,  X/47,  XXX,  and  63%  of  long  arm  deletion  (Neely  and 
Rosenfeld,  1994). 
Gonadal  dysfunction  varied  in  severity  among  different  karyotypes 
45,  X/46,  X,  i(Xq)  ,  46,  X,  idic(Xq),  and  46,  X,  idic(Xp)  were  associated  with  severe 
gonadal  dysfunction.  In  terminal  X  deletions,  the  degree  of  gonadal  dysfunction 
was  roughly  correlated  with  the  deleted  size.  Gonadal  dysfunction  appears  to  be 
mild  in  interstitial  deletions  of  the  X  chromosome  (Ogata  and  Matsuo  1995). 
Spontaneous  pubertal  development  and  menarche,  which  occurred  in  8%  of 
patients  with  X  monosomy,  were  more  likely  in  girls  with  45,  X/46,  XX  mosaicism, 
(21%)  and  deletions  of  the  short  arm  (25%)  (Neely  and  Rosenfeld,  1994).  There  is 
considerable  diversity,  however,  in  reports  regarding  the  incidence  of  other 
anomalies. 
1.3.2  Hermaphrodites  or  intersexes 
Intersexuality  can  be  defined  as  the  "possession  at  birth  of  both  male  and 
female  characteristics  in  the  gonads  and/or  in  the  internal  or  external  genitalia" 
(Jacobs  PA,  1969).  In  the  majority  of  forms  of  intersex,  there  is  only  one  type  of 
gonad  present:  a  testis  (male  pseudohermaphroditism)  or  an  ovary  (female 
pseudohermaphroditism).  An  example  of  the  former  would  be  testicular 
ferninisation  syndrome  and  for  the  latter,  congenital  adrenal  hyperplasia. 
Patients  identified  as  true  hermaphrodites  have  both  testicular  and  ovarian 
tissues,  although  the  distribution  of  these  two  gonadal  tissues  between  the  left  and 
right  sides  is  variable.  There  may  be  any  combination  of  the  following;  ovary, 
testis,  and  ovotestis.  One  might  expect  that  true  hermaphrodites  would  be  due  to 
mosaicism  (XX/XY),  some  of  cells  having  an  XX  sex  chromosome  complement 
and  others  having  an  XY  sex  constitution.  In  fact  some  hermaphrodites  are 
XX/XY  mosaicism  (Josso  et  al,  1965;  Jacobs  PA,  1972),  but  for  some  reason 
which  is  still  not  clear  the  sex  chromosome  constitution  of  many  of  these  patients 
19 appears  to  be  46,  XX  (60%).  46,  XY  constitution  has  been  found  in  15%  of  these 
patients  (Hunter  RF,  1995).  Of  course  hermaphroditism  in  the  presence  of  an  XX 
karyotype  contradicts  the  requirement  for  aY  chromosome  (or  TDF)  to  enable 
differentiation  of  testicular  tissue.  Possible  explanations  for  the  presence  of 
testicular  tissue  in  46,  YX  hermaphrodites  include:  (1)  undetected  loss  of  aY 
chromosome  after  initiation  of  testicular  development,  or  undetected  chromosomal 
mosaicism  such  as  X/XY  or  XX/XXY  or  XX/XY  chimaerism.  (2)  The 
translocation  of  TDF  from  the  Y  to  an  X  chromosome  or  to  an  autosome.  (3)  A 
single  gene  mutation  (Eicher  and  Washburn,  1983). 
Since  the  availability  of  suitable  cytogenetic  techniques  in  the  late  1950s  a 
large  variety  of  sex  chromosomal  abnormalities  have  been  documented  in  man. 
Many  but  not  all  of  these,  have  been  shown  to  be  associated  with  different  degrees 
of  abnormalities  of  primary  and  secondary  sex  character.  The  most  frequently 
reported  chromosome  abnormality  associated  with  intersexual.  development  is 
mosaicism,  where  one  cell  line  has  45,  X  constitution  and  the  other  has  46,  XY  or 
45,  X/47,  XXY  sex  chromosome  constitution  (Jacobs  PA,  1969).  The  phenotype  of 
such  individuals  will  depend  on  the  time  after  fertilisation  when  the  error  giving 
rise  to  the  two  cell  lines  happened,  and  the  frequency  and  distribution  of  the  two 
types  of  cells  in  the  embryonic  gonad.  In  fact,  almost  every  degree  of  intersexual 
development  has  been  found  to  be  associated  with  an  X/XY  constitution  (Hunter 
RF,  1995).  Another  type  of  mosaicism  expressed  as  intersex  condition  is  when  one 
cell  line  is  that  of  a  normal  female  while  the  other  has  aY  chromosome  (XX/XXY 
or  XX/XY/XXY)  (De  La  Chapell  A,  1972).  An  intersex  phenotype  may  also  arise 
from  an  XX/XY  chromosome  complement  (Jacobs  PA,  1969;  1972). 
1.4  The  mammalian  sex-determining  master  -regulator  ene  SRY  (sex 
determining  region  on  tile  y  chromosome) 
1.4.1  XX  and  XY  sex  reversal 
One  of  the  more  elegant  lines  of  evidence  for  testis  determination  being 
effected  through  the  Y  chromosome  comes  from  analysis  of  sex  reversal 
individuals,  viz.  46,  XX  males,  XX  true  hermaphrodites,  and  XY  females.  About  I 
in  20,000  newborn  males  have  a  46,  XX  karyotype  and  yet  develop  testes 
(McElreavey  et  al,  1993b).  These  individuals  are  sterile  with  small  testes  and 
20 azoospermia.  Two  phenotypically  distinct  groups  have  been  recognised  among 
subjects  with  46,  XX  sex  reversal.  46,  XX  maleness  is  characterised  by  the  presence 
of  testes  in  a  subject  with  a  female  karyotype.  Most  affected  individuals  have 
normal  male  external  genitalia,  but  about  10%  have  hypospadias  (De  La  Chapell, 
1972). 
46,  XX  true  hermaphrodites  are  characteriscd  by  the  development  of 
ovarian  and  testicular  tissue  in  the  same  individual,  either  in  separate  gonads  or  in 
one  gonad  (Ovotestis)  [Van  Niekerk  and  Retief,  1981;  Torres  et  at,  1996).  These 
patients  usually  present  with  ambiguous  external  genitalia  whereas  the 
development  of  Wolflian  and  Mullerian  duct  derivative  depend  on  the  type  of 
gonad  and  extent  of  testicular  development  in  each  case  (Berkovetz  et  at,  1992; 
Perez-Placios  et  at  1994).  In  1966,  Ferguson-Smith  proposed  that  46,  XX  maleness 
and  46,  XX  true  hermaphrodites  are  generated  by  rare  and  illegitimate  X:  Y 
chromosomal  interchange  during  paternal  meiosis  when  the  X  and  Y 
chromosomes  pair,  enabling  Y-specific  sequences  to  be  transferred  to  the  short 
arm  of  the  paternal  X  (Figl.  4).  The  Y-specific  transferred  sequences  were 
considered  to  include  the  testis  determining  factor  (TDF)  giving  rise  to  either 
complete  (XX  male)  or  partial  (XX  true  hermaphrodite)  masculanization.  Two 
lines  of  evidence  confirmed  this  hypothesis.  First,  cytogenetic  analysis  of  XX 
males  revealed  in  some  cases  that  the  distal  G-bands  of  the  short  arm  of  Y 
(Ypll.  3)  are  translocated  onto  the  distal  end  of  the  short  of  the  paternal  X 
chromosome  (Evans  et  at,  1979;  Magenis  et  at,  1987).  Second,  molecular  studies 
showed  that  about  80%  of  XX  males  and  10%  of  XX  true  hermaphrodites  carry  Y 
sequences  on  the  tip  of  the  short  arm  of  their  paternal-derived  X  chromosome 
(Abbas  et  at,  1990;  McElreavey  et  at,  1992a). 
Human  XY  females  with  pure  gondal  dysgenesis  (also  known  as  Swyer 
syndrome)  have  a  46,  XY  karyotype  and  no  sexual  ambiguity.  Approximately  I  in 
100,000  newborn  females  are  XY  females  (Polani  PE,  1981).  This  syndrome  is 
defined  by  the  presence  of  female  genitalia,  normal  Mullerian  structures,  streak 
gonads  and  the  absence  of  testes  which  result  in  lack  of  puberty,  primary 
amenorrhea  and  high  levels  of  gonadotropins  (Marcantonio  et  al,  1994).  The 
female  phenotype  together  with  an  apparent  absence  of  testicular  tissue  implies  a 
mutation  in  the  initial  steps  of  male  sex  determining  pathway.  In  contrast  to  XX 
males  some  XY  females  have  deletions  of  portions  of  the  Y  chromosome.  Since 
21 the  amount  of  Y  material  whether  absent  (XY  female)  or  present  (XX  male)  is 
variable,  this  allowed  a  precise  genetic  map  of  the  Y  chromosome  to  be 
constructed  (Vergnaud  et  al,  1986)  and  led  to  precise  mapping  of  TDF  to  the  short 
segment  of  Y  chromosome  adjacent  to  the  pseudo-autosomal.  boundary  (Affara  et 
al,  1986;  1987;  Vergnaud  et  al,  1986). 
1.4.2  The  searchfor  the  sex  determination  gene(s) 
For  more  than  10  years,  many  investigators  believed  that  the  male-specific 
H-Y  histocompatibility  antigen  was  the  product  of  TDF  (Wachtel  et  al,  1975). 
However,  the  discovery  of  male  mice  failing  to  express  H-Y  excluded  (in  mouse) 
this  gene  as  a  possible  candidate  (McLaren  et  al,  1984).  By  chromosome  walking 
between  the  break  points  present  in  an  XX  male  and  an  XY  female,  Page  et  al 
(1987)  have  isolated  a  second  candidate  for  TDF.  They  identified  a  zinc  finger 
protein  on  the  Y  chromosome  (ZFY)  that  resembles  a  group  of  transcription 
factors  that  bind  to  cis  acting  DNA  elements  and  regulates  gene  transcription, 
which  is  compatible  with  regulatory  switches  such  as  TDF,  and  therefore  ZFY  was 
thought  to  be  a  candidate  for  TDF.  However,  its  autosomal  location  in  marsupials 
(Sinclair  et  al,  1988),  its  inappropriate  expression  in  mouse  tissue  (Koopman  et  al, 
1989)  and  finally  its  location  outside  minimum  sex  determining  region  of  the 
human  Y  (Palmer  et  al,  1989)  excluded  it  from  this  function. 
Using  the  sarne  strategy  that  identified  ZFY,  Sinclair  et  al  (1990)  and 
Gubby  et  al  (1990)  isolated  SR  Y  (sex  determining  region  on  the  Y  chromosome),  a 
single  copy  gene,  which  meets  the  criteria  for  TDF.  It  is  located  in  the  smallest  Y 
chromosome  region  capable  of  causing  sex  reversal.  It  is  expressed  for  a  short  time 
in  the  genital  ridge  (when  testicular  cords  form)  during  embryonic  development 
(Koopman  et  al,  1990)  and  is  deleted  or  mutated  in  some  cases  of  human  XY 
females  (Berta  et  al  1990;  Jager  et  al  1990;  Hawkin  et  al,  1992).  Finally,  this 
conclusion  was  confirmed  by  the  male  development  of  XX  mice  that  were  made 
transgenic  for  mouse  Sry  (Koopman  et  al,  199  1). 
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Figure  1.4:  A  close-up  view  of  the  region  of  exchange  between  the  X  and  Y 
chromosomes.  (1)  Indicates  the  manner  of  normal  exchange  between  the  pseudo- 
autosomal  regions  [PAR]  (P)  as  indicated  in  A-C.  (2)  Illustrates  the  manner  of 
accidental  interchange  of  testis-determining  region  or  factor  (TDF)  outside  the  so- 
called  pairing  region  from  the  Y  to  X  chromosome  enabling  an  X  chromosome  to 
carry  SRY  during  errors  in  the  paternal  meiosis  generating  XX  males  (F-G).  The 
deleted  Y  chromosome  (SRY  negative)  generates  XY  females  (E)  (from  Burgoyne, 
1992). 1.4.3  The  SRYgene 
The  SRY  gene  as  mentioned  above,  was  identified  by  positional  cloning 
within  the  region  of  the  Y  chromosome  critical  for  male  sexual  development 
(Gubby  et  al  1990;  Sinclair  et  al,  1990).  It  is  an  intronless  gene  potentially  coding 
for  a  protein  with  204  amino  acids  of  which  79  show  homology  to  the  HMG  (High 
Mobility  Group)  box,  similar  to  nuclear  chromosomal  non  histone  protein  HMGI 
and  HMG2,  which  bind  DNA  (Su  and  Lau,  1993).  The  HMG-box  is  very 
conserved  in  a  wide  variety  of  mammals;  conversely,  the  protein  segments 
flanking  the  HMG-box  are  highly  variable  in  sequence  and  length  (Bianchi  et  al, 
1992;  Grosschedl  et  al,  1994).  Human  SRY  and  mouse  Sry  proteins  are  89% 
homologous  in  the  HMG-box  region  but  outside  this  diverge  significantly  (Tucker 
et  al  1993;  Whitfield  et  al  1993;  Pontiggia  et  al  1995).  The  SRY  cDNA  sequences 
correspond  to  a  direct  copy  of  the  genomic  DNA  with  transcript  size  -1.1  kb  on 
Northern  blot  (Sinclair  1990;  Su  and  Lau,  1993)  and  612  bp  translated  (Behlke  et 
al,  1993).  Sequencing  a  cDNA  clone  isolated  ftom  adult  testis  identified  the  3'  end 
of  the  transcript  is  mapping  to  position  747  from  the  first  ATG  (Methionine)  codon 
of  the  open  reading  frame  (ORF).  The  5'  end  of  SRY  transcript  is  difficult  to 
analysis  and  the  results  from  different  groups  are  contradictory.  Vilain  et  al  (1992) 
defined  the  transcription  initiation  site  at  91  bp  upstream  ftom,  the  first  Methionine, 
while  Su  and  Lau  (1993)  defined  two  transcription  start  sites  at  position  78  bp  and 
136  bp.  The  reason  for  these  different  results  is  not  clear  but  it  may  be  due  to  the 
different  tissue  tested  (Goodfellow  and  Lovell-Badge,  1993).  Moreover,  the  SRY 
transcriptional  unit  is  immediately  preceded  by  two  small  GC-rich  segments 
covering  part  of  the  5'  untranslated  region  and  sequence  immediately  5'  of  the  SRY 
gene.  Several  binding  sites  for  the  transcription  factor  SPI  are  identified  among 
these  GC-rich  sequences.  The  5'  flanking  region  lacks  an  obvious  TATA  or  CAAT 
box  within  the  GC-rich  sequences  immediately  upstream  of  the  transcription  start 
sites.  However,  several  partial  sequences  (e.  g.  TATA,  CATA,  GATA,  and  TACA) 
homologous  to  the  TATA  box  are  present  within  this  region,  their  exact  role  as 
promoter  is  unknown  (Su  and  Lau,  1993). 
The  function  of  SRY  is  still  not  completely  clear.  The  SRY  protein  has  been 
shown  to  bind  specifically  to  DNA  (Harley  et  al,  1992b)  and  the  DNA  binding 
24 properties  are  entirely  determined  by  the  HMG-box  (Bianchi  et  at,  1992; 
Grosschedl  et  at,  1994).  Gieze  et  at  (1992)  showed  the  SRY  protein  binds  to  the 
minor  groove  of  the  double  helix  and  recgonizes  a  higher  affinity  binding  site 
defined  by  the  nucleotide  sequences  5'-CCATTGTTCT  and  produces  a  sharp 
bend,  bringing  distinct  regions  of  the  genome  into  juxtaposition  and  possibly 
enhancing  protein-protein  contact.  Alternatively  by  bending  the  DNA,  SRY  could 
inhibit  the  binding  of  other  transcription  factors  and  therefore  could  play  the  role 
of  a  repressor,  preventing  the  female  sex  determining  genes,  thereby  effecting 
transcriptional  control  (Soullier  et  at,  1994).  The  HGM-box  was  found  also  to 
interact  with  high  affinity  to  kinked  DNA  structures  irrespective  of  their  sequences 
(Ferrari  et  at,  1992).  However,  the  importance  of  this  binding  for  SRY  function  is 
not  known.  Furthermore,  point  mutations  associated  with  sex  reversal  in  XY 
human  females  fall  within  the  HMG-box  (Berta  et  at  1990;  Hawkins  et  at  1992; 
Jager  ct  at  1992).  And  it  was  found  that  these  mutations  either  affect  the  affinity  of 
DNA  or  modify  the  geometry  of  the  DNA-  protein  complex  (Pontiggia  et  at,  1994; 
1995). 
In  XY  females  with  gonadal  dysgenesis,  mutations  have  been  identified 
and  so  far  some  23  different  mutations  are  known,  accounting  for  10-20%  of  cases 
(Wolf  et  al,  1992;  Scmitt-Ney  et  al,  1995).  Thus  in  the  majority  of  patients  with 
XY  gonadal  dysgenesis  (80%)  the  SRY  does  not  appear  to  be  affected  and  in  some 
XX  males  the  SRY  gene  is  not  present,  pointing  to  the  existence  of  other  sex 
determining  gene(s)  (Goodfellow  and  Lovell-Badge,  1993;  McElreavey  et  al, 
1993a,  b;  Poulat  et  al,  1994). 
The  mutations  within  the  SRY  gene  identified  so  far  are  with  two 
exceptions  clustered  in  the  HMG-box  region,  indicating  that  this  is  the  functional 
domain  of  the  SRY  protein.  The  exceptions  are  a  case  with  a  deletion  5'  to  the 
gene  which  may  affect  SRY  expression  (McElreavy  et  al,  1992b)  and  two  sibs 
with  an  identical  stop  codon  mutation  3'  to  the  HMG-box  (Tajima  et  al,  1994). 
Five  of  these  mutations  cause  termination  codons  (causing  truncated  protein)  and 
the  others  are  small  deletion  or  point  mutations  (Goodfellow  and  Lovell-Badge, 
1993;  McElreavey  et  al,  1992b;  Schmitt-Ney  et  al,  1995).  Four  familial  cases  of 
XY  sex  reversal  have  been  described  where  the  affected  individuals  share  the  same 
amino  acid  changes  as  their  father  and  sometimes  as  other  male  relatives  (Harley 
et  al,  1992b;  Jager  et  al,  1992;  Vilian  et  al,  1992;  Schmitt-Ney  et  al,  1995). 
25 Familial  mutations  are  considered  to  be  conditional,  their  manifestations  depend 
on  the  genetic  background  and  epigenetic  or  environmental  interaction.  Thus  it  has 
been  suggested  that  for  SRY  to  fulfil  its  biological  function  bending  of  DNA  at  the 
site  of  its  action  must  be  geometrically  precise  (Pontiggia  et  al,  1994). 
In  the  XY  sex-reversal  females  only  the  HMG-box  regions  have  been 
analysed  extensively  for  mutations  therefore,  it  is  possible  that  undetected 
mutations,  lie  elsewhere  in  the  SRY 
1.4.4  Genes  that  interact  with  SRY 
The  evidence  that  SRY  is  the  master  testis  determining  switch  is 
compelling,  but  many  observations  show  that  sex  determination  is  more 
complicated  than  a  simple,  single  switch  (Moore  and  Grumbach,  1992).  SRY  is 
assumed  to  act  on  transcription  only  indirectly  by  promoting  the  association  of 
transcription  factors,  resulting  in  their  activation.  Therefore,  there  are  likely  to  be 
many  other  genes  involved  in  mammalian  sex  determination  upstream  and 
downstream  of  SRY.  There  is  no  evidence  that  any  of  these  lie  on  the  Y 
chromosome.  Several  autosomal  or  X-linked  genes  participating  in  the  pathway 
have  been  proposed  and  reported  (McElreavey  et  al,  1993a,  b;  Bogan  and  Pade, 
1994;  Wolf  U,  1995). 
SRY  gene  is  thought  to  influence  gonadal  morphogenesis  into  male  pattern 
of  dispersed  support  cells  surrounding  germ  cells  in  seminiferous  tubules.  It 
interacts  with  as  yet  unknown  SRY  intermediate  factor(s)  (SRYIF)  to  induce  the 
MIS  gene,  which  in  turn  causes  regression  of  the  female  Mullerian  duct 
derivatives.  SRYIF  may  be  one  of  several  factors  participating  with  SRY  in  the 
determining  of  gonadal  sex.  Sterogenic  factor  I  (SF-1)  is  one  of  the  SRYIF 
candidates  that  play  a  role  in  MIS  regulation.  SRY  may  also  activate  other  target 
genes  on  autosomes  such  as  SRA-1  (autosomal  sex  reversal  factor).  The  dosage 
sensitive  sex  reversal  locus  (DSS)  on  the  X  chromosome  may  also  act  by 
repressing  the  SRY-induced  male  pathway  or  by  activating  expression  of  genes 
required  for  formation  of  female  structure  (Fig  1.5)  (Haqq  et  al,  1994). 
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Figure  1.5:  A  hypothetical  scheme  for  sex  determination  in  mammals.  The  male 
regulatory  pathway  is  initiated  by  SRY.  A  factor  or  factors  (SRYIFs)  mediates 
induction  of  the  MIS  gene  by  SRY.  SRYIF  may  interact  directly  with  the  MIS 
promoter,  or  indirectly  through  modification  of  the  basal  transcription  machinery. 
MIS,  in  turn,  plays  a  key  role  in  male  sexual  development  as  a  diffusible  subsistence 
causing  regression  of  the  female  Mullerian  ducts  derivatives:  uterus,  fallopian  tubes, 
and  vagina.  SRY  may  activates  other  genes  on  autosomes  such  as  SRAI.  The  DSS 
may  represses  the  SRY-induced  male  pathway  or  by  activating  expression  of  genes 
required  for  formation  of  female  strictures  (modified  from  Haqq  et  al  1994). (A)  Autosomal  genes 
(1)  Wilm's  tumour  gene  (TVTI): 
In  man,  one  of  the  genes  frequently  considered  to  be  involved  in  gonadal 
development  and  differentiation  is  WTI,  the  Wilm's  tumour  suppressor  gene  at 
I  lpl3  (Call  et  al,  1990;  Van  Heyningen  and  Hastie,  1992).  Wilm's  turnours  are 
autosomal  dominant  childhood  kidney  cancers  that  affect  I  in  1000  children 
(Mastunga  E,  1981).  Some  patients  with  Wilm"s  tumour  also  have  aniridia, 
genitourinary  abnormalities  and  mental  retardation  (WAGR  syndrome),  and  others 
have  Denys-Drash  syndrome  (nephropathy,  genital  abnorinalities  and 
predisposition  to  the  development  of  Wilm's  tumour).  In  both  clinical  conditions 
there  is  malformation  of  the  gonads  resulting  in  either  ambiguous  genitalia  or 
complete  sex  reversal  without  genital  ambiguities  (MeElreavey  et  al,  1993b).  The 
WTI  gene  encodes  a  zinc  finger  transcription  factor  expressed  in  tissues  that 
develop  into  kidney  and  gonad  (Pelletier  et  al,  1991;  Pritchard-Jones  et  al,  1990). 
Heterozygous  point  mutations  in  the  WTI  gene  have  been  observed  in 
Denys-Drash  syndrome.  And  the  XY  individuals  who  are  heterozygous  for  certain 
mutations  in  WTI  with  Drash  syndrome,  the  gonads  showed  varying  degree  of 
dysgenesis  and  the  phenotypes  ranged  from  normal  female  to  a  male  with 
hypospadias  with  or  without  cryptorchidism  (Pelletier  et  al,  1991;  Baird  et  al, 
1992;  Bruening  et  al,  1992). 
The  role  of  WTI  in  normal  gonad  formation  is  still  unclear.  A  mouse  model 
for  studying  WTI  function  has  been  developed  by  introducing  a  mutation  in  the 
mouse  WTI  gene  (Kreidberg  et  al,  1993).  All  foetuses  homozygous  for  JFTI  null 
allele  showed  a  phenotype  similar  to  Denys-Drash  syndrome  with  streak  gonads. 
Gonadal  development  is  arrested  at  a  very  early  stage,  consistent  with  the  earliest 
expression  of  WTI  observed  in  wild-type  animals  at  9  dpc  (days  post  coitum), 
which  is  before  the  time  of  primary  gonad  differentiation.  Thus  it  is  thought  that 
WTI  is  required  for  early  commitment  of  gonadal  tissue  and  the  establishment  of 
the  bipotential  gonad  (Kreidberg  et  al,  1993).  Also  it  has  been  speculated  that  TFTI 
may  act  upstream  of  SRY  and  sex  determination  and  that  targets  include  genes 
other  than  SR  Y  (B  ogan  and  Pade,  1994). 
(2)  Mullerian  inhibiling  substances  (AIIS): 
MIS  is  thought  to  be  one  of  the  candidate  genes  that  operate  down  stream 
of  the  SRY  gene  (Bogan  and  Pade,  1994;  Haqq  et  al,  1994).  The  MIS  gene  was 
28 cloned  in  1986  and  mapped  to  the  short  arm  of  chromosome  19  (19pl3.3)  (Picard 
et  al,  1986;  Cohen-Haguenauer  et  A  1987;  Cate  and  Wilson,  1993).  It  belongs  to  a 
superfamily  of  growth  factors  important  in  cell  growth,  differentiation  and 
regulation.  The  family  includes  transforming  growth  factor  P,  inhibin,  activin  and 
bone  morphogenetic  factors.  Apart  from  SRY,  MIS  is  the  first  biochemical  marker 
of  differentiation  and  is  secreted  by  Sertoli  cells.  Even  though  MIS  acts  down 
stream  of  SRY  in  sex  differentiation  it  is  not  obvious  that  MIS  function  in  gonadal 
determination  is  strictly  defined.  In  persistent  Mullerian  duct  syndrome  (PDMD),  a 
form  of  male  pseudohermaphroditism,  patients  have  Mullerian  duct  structures  and 
unilateral  or  bilateral  undesended  testes,  but  normal  testicular  differentiation. 
Certain  individuals  with  PDMD  syndrome  harbour  de  novo  mutations  in  MIS 
(Carre-Eusebe  et  al,  1992).  The  lack  of  effect  of  these  mutations  on  testicular 
organogenesis  is  against  MIS  as  a  testicular  differentiation  factor  (Bogan  and  Pade, 
1994). 
The  early  expression  of  MIS  in  testicular  differentiation  raises  the 
possibility  that  the  MIS  gene  is  regulated  by  SRY  directly.  Several  observations 
suggest  that  it  is  not.  Evidence  has  recently  been  provided  that  MIS  expression 
occurs  by  interaction  of  SF-I  with  the  promoter  region  of  MIS  gene,  and  indeed  in 
Sertoli's  cells  the  spatiotemporal  expression  of  MIS  and  SF-l  is  concordant  during 
embryonic  development  (Shen  et  al,  1994).  In  situ  hybridisation  experiment  in 
mice  first  detected  Mis  expression  at  12.5  dpc  in  Sertoli  cells,  approximately  48 
hours  after  the  onset  of  Sry  transcription  (Munsterbeg  and  Lovell-Badge,  1991). 
This  observation  (delayed  onset  of  Mis  expression)  raises  the  possibility  that  other 
steps  are  involved.  In  vitro  studies  of  MIS  expression  demonstrated  that  MIS 
transcription  could  be  induced  by  SR  Y  even  if  the  binding  of  SR  Y  to  MIS  promoter 
is  abolished  by  mutation  (Haqq  et  al,  1994).  Therefore,  MIS  induction  by  SRY  is 
thought  to  be  indirect  and  intervening  SRY-induced  factors  (SRYIF)  are  proposed 
which  transduce  the  SRY  signal  to  the  MIS  promoter.  A  candidate  for  such  factor 
is  SF-1.  SF-I  can  bind  to  a  MIS  regulatory  element  (MIS-RE-1)  and  in  the 
presence  of  SRY,  the  transcription  of  SF-I  is  upregulated,  while  in  its  absence  (in 
female)  SF-I  transcription  decreases  (Shen  et  al,  1994).  Moreover,  SFI  has  been 
shown  either  alone  or  combined  with  SR  Y  to  decrease  the  MIS  expression  (Haqq  et 
al,  1994),  indicating  that  SF-I  acts  as  a  transcriptional  repressor.  The  interaction  of 
SF-  I  with  the  MIS  gene  seems  to  be  established.  However,  its  interaction  with  SR  Y 
29\ appears  to  be  more  indirect  because  of  the  temporal  difference  in  peak  expression 
of  SRY  and  SF-  I  during  testis  differentiation  (Wolf  U,  1995). 
(3)  A  utosomal  sex  reversal: 
An  autosomal  XY  sex  reversal  locus  SRAI  associated  with  campornelic 
dysplasia  has  been  mapped  to  the  distal  long  arm  of  chromosome  17  at  17q24.3- 
q25.1  (Tommerup  et  al,  1993).  An  SRY-related  gene  SOX9  (SRY-related  HMG 
box)  was  isolated  and  found  to  encode  a  transcription  factor  expressed  in  many 
adult  tissues,  in  foetal  testes  and  skeletal  tissues  (Foster  et  al  1994;  Wagner  et  al, 
1994).  Furthermore,  mutations  in  SOX9  gene  demonstrated  that  this  gene  is 
responsible  for  both  campornelic  dysplasia  (severe  skeletal  abnormalities  in  both 
XX  and  XY  individuals)  and  varying  degrees  of  sex  reversal  in  XY  individuals 
only,  including  intersexual  and  female  phenotype,  and  gonadal  dysgenesis  or  even 
ovarian  like  histology  (Houston  et  al,  1983;  Foster  et  al,  1994;  Wagner  et  al, 
1994).  From  the  pleiotropic  effect  it  has  been  speculated  that  SOX9  has  a  function 
in  both  skeletal  and  gonadal  development  (Foster  et  al,  1994).  The  gonadal 
phenotype  in  campornelic  dysplasia  could  result  from  mutation  of  a  gene  involved 
in  forming  the  bipotential  gonad  (like  WT)  or  involved  in  gonadal  sex 
determination  (like  SRY)  (Bogan  and  Pade,  1994). 
(B)  X-linked  genes 
There  are  two  genes  on  the  X  chromosome  which  if  mutated  suppress  male 
development  of  XY  foetuses:  the  androgen  receptor  (AR)  and  dosage  sensitive 
(DSS)  loci. 
Dosage  Sensitive  Sex  reversal  locus  (DSS): 
The  existence  of  an  X-specific  gene  involved  in  human  sex  determination 
was  postulated  after  observations  of  families  with  apparent  X-  linked  modes  of 
inheritance  of  46,  XY  gonadal  dysgcnesis  (Fechner  et  al,  1993).  Furthermore, 
evidence  was  provided  by  the  identification  of  sex  reversal  patients  carrying 
duplications  of  portions  of  the  Xp.  The  fact  that  two  active  copies  of  chromosomal 
region  Xp2l.  1-22.1  can  cause  sex  reversal  was  initially  reported  by  Am  et  al 
(1994)  and  was  referred  to  the  sex  reversal  X  locus  (SRVX).  Shortly  after,  Bardoni 
and  colleagues  (1994)  confined  the  sex  reversal  region  to  Xp2l  and  named  it  the 
dosage  sensitive  sex  reversal  (DSS)  locus  (Bajalica  et  al,  1995).  To  date  twenty 
30 cases  with  partial  duplications  of  the  X  short  arm  and  an  intact  SRY  gene  has  been 
described  (Bajalica  et  al,  1995).  XY  individuals  with  an  X  carrying  the  duplication 
show  various  forms  of  intersexuality  and  sex  reversal  ranging  from  incomplete 
testicular  differentiation  to  streak  gonads.  On  the  other  hand  XY  individuals  with 
deletions  of  the  DSS  region  develop  as  male,  while  females  are  not  affected  by 
heterozygous  duplications  within  this  region.  Therefore,  Bardoni  et  al  (1994) 
concluded  that  the  DSS  gene  is  not  involved  in  testicular  differentiation,  but  a 
double  dose  of  DSS  protein  interferes  with  this  process.  They  speculated  that  DSS 
plays  a  part  in  the  ovarian  pathway  and  that  in  the  presence  of  SR  Ya  single  dosage 
of  DSS  can  be  overcome,  but  not  a  double  dosage  of  it  (Bardoni  et  al,  1994;  Wolf 
U,  1995).  Thus  it  is  thought  that  it  may  act  either  by  repressing  the  SRY-induced 
male  pathway  or  by  activating  the  expression  of  genes  required  for  formation  of 
female  structure  (Haqq  et  al,  1994). 
1.5  Androgen  Recel2tor  (AR)  and  Molecular  Genetics  of  Androgen 
Insensitivity  Syndrome  (AIS) 
Androgens  [testosterone  (T)  and  5  a-dihydrotestosterone  (DHT)]  are 
essential  for  sexual  differentiation  of  the  male  embryo  and  for  the  regulation  of 
virilization  in  the  adult.  Androgens,  secreted  by  foetal  testes  are  responsible  for  the 
initial  growth  and  differentiation  of  the  male  reproductive  tract,  including  the 
Wolfflan  ducts,  the  urogenital  sinus,  and  the  primordial  of  the  external  genitalia 
(Fig  1.6).  During  puberty,  androgens  promote  the  appearance  of  secondary  male 
sex  characteristics,  including  growth  of  the  external  genitalia,  development  of  the 
prostate  and  seminal  vesicles,  male  distribution  of  body  hair,  and  increase  in  total 
muscle  mass.  These  hormones  are  essential  for  initiation  and  maintenance  of 
spermatogenesis  and  they  have  a  negative  feed  back  control  on  the  secretion  of 
gonadotropins  by  the  hypothalamic-pituitary  axis  (Brown  TR,  1995). 
Testosterone,  secreted  by  the  testes,  is  responsible  for  virilization  of  the 
Wolffian  ducts.  Development  of  the  prostate  and  external  genitalia  are  dependent 
upon  the  tissue-specific  conversion  of  testosterone  to  its  more  biologically  potent 
DHT  by  5  oc-reductase  (Griffin  JE,  1992).  Testosterone  and  DIIT  mediate  their 
function  through  the  intracellular  androgen  receptor  (AR)  which  belongs  to  the 
steroid,  thyroid  hormone  and  retinoic  acid  receptor  family  (Evans  RM,  1989). 
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Figure  1.6:  A  model  of  a  target  cell  response  to  androgens,  the  major  actions  of 
which  are  listed  to  the  right  of  the  cell.  Testosterone  enters  the  cell  and  binds  either  to 
the  androgen  receptor  in  the  nucleus  or  is  first  converted  enzymatically  to 
dihydrotestosterone:  action  of  testosterone  is  indicated  by  continuos  arrows,  that  of 
dihydrotestosterone  by  broken  arrows  (From  Wilson,  1992). 
Luteini  sing  horm  me 
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CELL L5.1  Androgen  receptor  (AR)  structure  andfunction 
The  AR  gene  locus  spans  over  90  kb  and  has  been  mapped  to  the  long  arm 
of  the  X  chromosome  qI  1-  12  region  (Brown  et  at,  1989;  Kuiper  et  at,  1989).  The 
human  AR  gene  is  a  single  copy  gene  consists  of  8  exons  (Lubahn  et  at,  1989). 
The  5'  untranslated  region  (5'UTR)  encoded  by  exon  1,  is  1.1  kb  in  length  and 
contains  one  major  and  one  minor  site  of  transcription  initiation  in  a  13  bp  region. 
The  promoter  lacks  TATA  and  CCAAT  like  elements,  but  has  GC  rich  sequences 
including  a  putative  SP-1  binding  motif  at  -50  and  -60  (Tilley  ct  at,  1990;  Faber  et 
at,  1991).  The  3'UTR,  encoded  by  exon  8,  is  6.8  kb  long,  and  is  postulated  to  play 
a  role  in  the  stability  and/or  translation  of  AR  rnRNA  (Mizokami  and  Chang, 
1994).  There  are  two  poly  (A)+  signals.  Northern  blot  analysis  of  RNA  showed  the 
presence  of  a  predominant  10  or  II  kb  mRNA,  with  a  less  abundant,  alternatively 
processed  7  or  8  kb  mRNA  (Faber  et  at,  199  1).  The  I  10-  114  kb  receptor  protein 
contains  910-919  amino  acids  encoded  by  a  2.75  kb  open  reading  frame  (Chang  et, 
at,  1988;  Tilley  et  at,  1989).  Studies  of  the  steroid  receptors  including  human  AR, 
have  revealed  the  presence  of  three  conserved  functional  domains  (Evans  RM, 
1988). 
(i)  The  transactivating  N-terminal  domain: 
The  amino  terminus  is  the  least  conserved  region  with  the  greater  variation 
in  length  among  steroid  receptors,  but  is  important  for  transcriptional  activation  of 
target  gene  by  the  human  AR  (Jenster  et  al,  1991).  It  contains  529-539  amino  acids 
and  is  encoded  by  exon  1.  A  distinguishing  feature  of  the  DNA  sequence  encoding 
the  N-terminal  domain  is  the  presence  of  two  polymorphic  trimcric  repeats  of 
(GGN)n  and  (CAG)n  (Trifiro  et  al  1994).  The  GGN  repeats  (16-27  mer)  encoding 
glycine  stretch,  start  at  codon  449  and  the  (CAG)n  repeats  (IS  -3  1  mer  )  encoding  a 
polyglutamine  stretch,  start  at  codon  189  (Jenster  et  al,  1991).  The  polymorphic 
variation  within  these  segments  accounts  for  the  variable  number  of  amino  acids 
(910-919)  in  the  human  AR  protein  between  individuals. 
0i)  The  DNA-binding  domain: 
The  central  domain,  encoded  by  exons  2  and  3,  contains  66  amino  acids. 
This  cystein-rich  region  is  the  most  highly  conserved  region  within  the  steroid 
receptor  and  is  important  for  DNA-binding  to  target  DNA  (Lubahn  et  al,  1989).  It 
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(GR)  and  progesterone  (PR)  receptors.  By  structural  analogy  to  GR  (Hard  et  al, 
1990;  Luisi  et  al,  1991),  the  DNA-binding  domain  consists  of  two  zinc  fingers 
which  each  of  them  being  teterahedrically  co-ordinated  to  four  cystein  (Evans  RM, 
1988;  Sultan  et  al,  1993).  Crystallography  studies  on  the  GR  have  indicated  that 
the  first  zinc-finger  (N-terminal)  specifies  DNA  recognition  of  the  receptor,  while 
the  second  finger  is  mainly  responsible  for  dimerisation  of  two  receptor  molecules 
during  their  association  of  DNA  (Fawell  et  al,  1990;  Guiocho-Mantel  et  al,  1989). 
This  DNA-binding  domain  interacts  with  cis-acting  elements  of  the  regulated 
genes  [androgen  responsive  element  (ARE)],  which  are  15-nucleotide-long 
palindromic  sequences  located  in  the  flanking  region  of  the  gene  (Sultan  et  al, 
1993;  Ham  et  al,  1988). 
iii)  The  steroid-binding  domain: 
The  carboxy  terminus  (C-terminal)  of  AR  (250  amino  acids)  is  encoded  by 
exons  4-8  and  is  responsible  for  ligand  (steroid)  binding  affinity  and  specificity 
(Jenster  et  al,  1991)  and  in  the  interaction  with  heat-shock  proteins  such  as  HSP90 
(Veldscholte  et  al,  1992).  The  binding  of  the  two  physiologically  active  androgens 
(Testosterone  and  DHT)  to  the  receptor  coincides  with  the  dissociation  of  heat 
shock  proteins  and  conformational  activation  of  the  hormone-receptor  complex 
(Brown  TR,  1995). 
The  actions  of  androgens  on  target  cells  occur  via  the  classical  steroid 
receptor  pathway.  The  action  is  initiated  by  the  interaction  of  the  steroid  with  the 
androgen  expressed  in  target  tissue.  Androgen  binding  induces  a  process  of 
receptor  activation  involving  dissociation  from  receptor-associated  proteins  (Smith 
and  Toft,  1993).  The  activated  receptor  binds  as  a  dimer  (Wong  et  al,  1993)  to  a 
specific  DNA  sequences  (ARE)  in  the  promoter  regions  of  target  genes  and 
modulates  transcription  of  those  genes  (De  Bellis  et  al,  1994). 
I.  S.  2AIS  andgenctic  abnormalities  of  theAR  gene 
Androgen  insensitivity  syndrome  is  a  rare-X  linked  disorder  (1/60,000 
male  birth)  caused  by  an  inability  to  express  the  androgen  effect  in  46,  XY 
individuals  with  testes  able  to  synthesise  androgen.  This  impaired  response  to 
androgen  result  from  the  inability  or  reduced  ability  of  the  androgen  receptor  (AR) 
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differentiation  and  development  of  internal  and  external  genitalia  in  male,  and  thus 
leads  to  male  pseudohermaphroditism  (Griffin  JE,  1992).  Depending  on  the  extent 
of  AR  defect,  the  phenotype  varies  and  usually  the  complete  form  [Complete  AIS] 
(CAIS)]  is  distinguishable  from  the  partial  ones  [partial  AIS  (PAIS)].  In  CAIS, 
primarily  referred  to  as  testicular  ferninisation,  affected  individuals  are  genetic 
males  presenting  with  female  external  genitalia,  without  ambiguity,  however,  the 
vagina  is  short  and  blind.  They  are  usually  diagnosed  in  the  neonatal  period 
because  of  inguinal  hernia,  or  at  puberty  because  of  primary  amenorrhea 
associated  with  normal  breast  development  and  absent  axillary  and  pubic  hair. 
Female  internal  genital  structures  are  usually  absent  and  testicular  histology  show 
spermatogenesis,  to  be  incomplete  or  absent,  although  Leydig  cells  are  abundant. 
Plasma  testosterone  concentrations  are  within  normal  to  elevated  as  a  result  of  the 
increased  stimulation  by  luteinising  hormone  (1,11).  In  contrast,  PAIS  is 
heterogeneous  and  associated  with  a  wide  spectrum  of  clinical  disorder  from  males 
with  severe  ambiguous  genitalia  (i.  e.  Cryptorchidism,  micropenis  and 
hypospadias)  to  a  phenotypic  male  with  severe  hypospadias  (Reifenstein 
syndrome)  (Pinsky  et  al,  1992;  Ris-Stalpers  et  al,  1994),  to  unexplained  male 
infertility  (Aiman  and  Griffin,  1982). 
The  clinical  heterogeneity  of  AIS  is  matched  by  a  diversity  of  biochemical 
abnon-nalities  of  the  AR  receptor.  The  first  indication  that  the  AR  itself  is  defective 
in  AIS  came  from  androgen  studies  on  genital  skin  fibroblast  cell  line  from  AIS 
patient  (Keenan  et  al,  1974;  Hughes  et  al,  1986).  These  defects  can  be  grouped  into 
four  broad  categories:  (a)  Negative  binding  (AR-),  (b)  qualitative  defects  in 
receptor  function  (thermal  instability  of  the  protein),  (c)  deficient  amount  of 
apparently  normal  receptor  (AR),  and  (d)  receptor-binding  positive  (AR+),  a 
category  in  which  the  endocrine,  phenotype,  and  genetic  features  are  compatible 
with  a  receptor  abnormalities  but  no  functional  abnormalities  been  identified 
(McPhaul  et  al,  1991;  McPhaul  et  al,  1993).  The  majority  of  CAIS  patients  are 
receptor  negative.  In  contrast,  no  clear  cut  relationship  between  clinical  phenotype 
and  AR  binding  exist  in  PAIS  patients;  the  majority  of  cases  show  normal  receptor 
binding,  although  a  small  group  show  qualitative  abnormalities  in  the  AR  binding. 
Recently,  cloning  of  the  AR  gene  led  to  molecular  genetic  studies  to 
identify  lesions  in  the  AR  gene.  When  binding  is  negative  or  qualitatively 
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domain  of  the  AR  gene,  whereas  normal  AR  binding  in  CAIS  is  associated  with 
mutations  affecting  the  DNA  binding  region  (Griffin  and  Wilson,  1992;  McPhaul 
et  al,  1993).  A  number  of  mutations  of  the  AR  gene  have  now  been  reported  in 
both  CAIS  and  PAIS.  Complete  or  partial  AR  gene  deletions  have  been  found  in  5- 
10%  of  all  AR  gene  mutation  causing  AIS  (Trifiro  et  al,  1991;  Quigley  et  al, 
1992a,  b;  Brown  TR,  1995).  Deletions  involving  multiple  (4-8,  or  3-8,  and  6-7) 
and  single  exon  (2,3,  or  5)  have  been  reported  for  families  with  CAIS  (Brown  et 
al,  1994).  Deletion  of  part  of  intron  2  and  3  were  reported  in  only  one  case  with 
PAIS  (Ris-Stalpers  et  al,  1992)  and  deletion  of  exon  4  was  detected  in  a  patient 
with  only  azoospermia  (Aiken  et  al,  199  1). 
The  vast  majority  of  mutation  in  both  CAIS  and  PAIS  are  point  mutations 
in  the  coding  region  of  the  AR  gene  causing  amino  acid  substitutions  (Brown  et  al, 
1990;  Maracelli  et  al,  199  1;  McPhaul  et  al,  199  1),  or  premature  termination  (Sai  et 
al,  1990;  Trifiro  et  al,  1991;  De  Bellis  et  al,  1992),  or  aberrant  mRNA  splicing 
(Ris-Stalpers  et  al,  1990;  Brown  TR,  1995).  Most  of  these  substitutions  were 
localised  in  three  regions  of  the  AR:  the  DNA  binding  domain  and  2  segments  of 
the  ligand  binding  domain.  Two  hot  spots  for  mutations  are  present  in  the  AR  gene 
namely  exon  5  and  exon  7  (McPhaul  et  al,  1993;  Sultan  et  al,  1993). 
The  evidence  to  date  indicates  that  mutation  of  the  AR  gene  is  responsible 
for  most  cases  of  CAIS.  In  contrast,  many  patients  with  PAIS  demonstrate  no 
defect  in  androgen  binding  and  no  AR  gene  mutation  can  be  identified  (Batch  et  al, 
1992;  McPhaul  et  al,  1993)  Moreover,  an  attempt  to  assign  a  phenotype  to  a 
particular  mutation  have  failed  (Griffin  JE,  1992;  McPhaul  et  al,  1993).  The  same 
mutation  has  been  reported  to  result  in  different  phenotypes  (McPhaul  et  al,  1991; 
McPhaul  et  al,  1993).  The  reasons  for  such  discrepancies  between  patients 
exhibiting  the  same  molecular  defect  are  still  poorly  understood. 
1.5.3  AR  gene  mulations  in  other  diseases 
It  is  interesting  to  note  that  AR  gene  mutation  is  also  involved  in  other 
diseases.  In  a  study  of  26  patients  with  prostate  cancer,  only  one  somatic  point 
mutation  in  the  ligand-binding  domain  (exon  5)  has  been  described  in  a  patient 
with  early  stage  cancer  (Newmark  et  al,  1992).  The  authors  postulated  that  this 
36 mutation  might  be  involved  in  the  development  or  progression  of  prostate  cancer. 
Moreover,  Wooster  et  al  (1992)  reported  a  germ  line  mutation  responsible  for  an 
Arg-Gln  substitution  at  position  607  in  two  bothers  with  breast  cancer  and  PAIS. 
Lobaccaro  et  al  (1993)  reported  a  substitution  of  position  608  in  one  out  of  13 
male  patients  with  breast  cancer.  Both  mutations  occurred  in  the  DNA  binding 
domain  (in  exon  3).  Lobaccaro  et  al  (1993)  postulated  two  hypotheses  that  may 
explain  the  development  of  breast  cancer  linked  to  AR  mutations.  One  possible 
explanation  is  that  the  mutated  AR  gained  an  ability  to  bind  to  oestrogen 
responsive  element  (ERE),  thus  activating  oestrogen  regulated  gene.  Although  this 
region  of  the  binding  was  never  shown  to  be  involved  in  the  binding  specificity  to 
the  response  elements,  yet  the  authors  claimed  a  'tri-dimensional'  structure 
modification  might  play  a  role.  The  second  hypothesis  is  loss  of  the  protective 
effect  of  the  androgen.  Thomas  et  al  (1992)  suggested  that  the  breast  cancer  in  men 
develop  in  response  to  androgen  deficiency  and  under  conditions  associated  with 
excess  oestrogen.  Lastly,  La  Spada  et  al  (1992)  showed  that  spinal  bulbar  muscle 
atrophy  (SBMA  or  Kennedy  syndrome)  is  due  to  the  expansion  of  the  normal 
polyglutarnine  tract  (Tandem  CAG  repeat)  from  15-31  to  40-50.  This  adult  onset 
neurodegenerative  disorder  is  often  associated  with  mild  androgen  insensitivity 
(gynecomastia,  testicular  atrophy,  and  infertility).  SMA  has  never  been  reported  in 
AIS  with  any  other  AR  mutation.  It  was  postulated  that  this  expansion  of  the 
polyglutarnine  region  could  cause  structural  constraint  of  the  N-terminal  domain 
resulting  in  modification  of  transcription  initiation  complexes  on  target  genes 
(Brown  TR,  1995). 
6  Male  Infertilily 
The  end  process  of  sex  determination  and  differentiation  is  the  ability  to 
reproduce.  Approximately  15-20%  of  couples  have  difficulty  or  are  unable  to 
conceive  (Purvis  and  Christiansen,  1992;  Bhasin  et  al,  1994)  and  in  one-third  of 
cases  it  is  the  male  who  is  considered  the  predominant  reason  for  the  infertility 
(Bhasin  et  al,  1994).  Most  authorities  define  these  patients  as  prematurely  infertile 
if  they  have  been  unable  to  achieve  a  pregnancy  after  twelve  months  of  regular 
intercourse  without  contraception  (Greenhall  and  Vessy,  1990;  te  Velde  and  Beets, 
1992). 
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Spermatogenesis  is  a  complex  developmental  process.  The  progression 
from  spermatogonial  stem  cells  to  mature  spermatozoa  requires  65  days  and 
involves  elaborate  succession  of  distinct  cell  types.  The  process  is  carried  out  by  at 
least  three  mitotic  and  two  meiotic  divisions  (Reijo  et  al,  1995).  The  primitive  cells 
(spermatogonia),  either  divide  to  reproduce  themselves  for  stem  cells  renewal  or 
they  divide  to  produce  daughter  cells  that  will  later  become  spermatocytes.  The 
spermatocytes  then  divide  and  give  rise  to  mature  cell  lines  that  eventually  give 
rise  to  spermatids.  The  spermatids  then  undergo  a  transformation  into  spermatozoa 
(Dym  M,  1994).  Spermatogenesis  begins  at  puberty  and  continues  throughout 
adult-life.  A  human  male  may  produce  1012  to  1013  gametes  during  his  life  time 
(Reijo  et  al,  1995). 
Spermatogenesis  requires  the  stimulatory  effects  of  follicle-stimulating 
hormone  (FSH),  luteinzing  hon-none  (LH),  and  adequate  testosterone  (T) 
concentrations  (Matsumoto  and  Bremner,  1989).  FSH  is  enough  to  be  required  for 
maturation  of  spermatids  but  its  role  in  maintenance  of  spermatogenesis  is  less 
clear  (Soham  et  al,  1994).  Luteinizing  hormone  is  thought  to  have  effect  on 
initiation  and  maintenance  of  spermatogenesis  indirectly  in  that  it  stimulates 
androgenous  testosterone  production  (Purvis  and  Hansson,  1978). 
1.6.2  Causes  of  inale  infertility 
Male  infertility  can  result  from  a  number  of  different  changes  within  the  male 
genital  tract  but  generally  infertile  men  can  be  divided  into  five  major  diagnostic 
categories  (Cummins  et  al,  1994).  (1)  Disorders  related  to  motility  or  function  of 
the  sperm  such  as  congenital  defect  of  the  sperm  tail,  sperm  maturation  defects  and 
immunologic  defect  (sperm  antibodies)  (Purvis  and  Christiansen,  1992;  Cummins 
et  at,  1994).  (2)  Disorders  related  to  obstructive  lesions  (obstructive  defect)  which 
most  commonly  affect  the  excrine  ducts  of  the  testes  but  may  also  involve  the 
more  distal  duct  system  such  as  the  ejaculatory  ducts  themselves  (Cummin  et  al, 
1994).  Around  7-15%  of  all  patients  attending  infertility  clinic  was  shown  to  have 
obstructive  lesions  (Dubin  and  Amelar,  1971).  (3)  Disorders  related  to 
spermatogenetic  failure  as  a  result  of  lesion  in  the  testis  itself  has  been  reported  to 
38 be  present  in  -30%  of  infertile  men  (Jaquier  and  Holmes,  1993).  (4)  Sexual 
dysfunction  disorders  of  erection  and  ejaculation.  (5)  Endocrine  dysfunction. 
Patients  with  endocrinopathy  such  as  hypogonadotropic  hypogonadisim,  are  rarely 
seen  in  the  infertility  clinic,  with  an  incidence  of  approximately  3%  (Purvis  and 
Christiansen,  1992). 
Environmental  factors,  genetic  factors  or  a  combination  of  both  may  cause 
defects  in  male  reproductive  function.  Environmental  factors  with  known  effects 
on  reproductive  function  include  nutrition  (obesity  or  undernutrition),  infection, 
excessive  physical  exercise,  toxic  substances,  radiation,  smoking  and  excessive 
consumption  of  coffee  or  alcohol  (Negro-Vilar  A,  1993;  Fauser  and  Hsueh,  1995). 
Recent  studies  have  begun  to  focus  on  genetic  defects  underlying  disturbed  human 
male  reproductive  function. 
1.6.3  The  genetics  of  male  infertility 
The  genetic  disorders  related  to  male  infertility  can  be  divided  into  three 
categories:  (i)  pre-testicular,  (ii)  testicular  and  (iii)  post-testicular  causes  of  male 
infertility  (Mak  and  Jarvi,  1996).  These  genetic  defects  are  responsible  for  a 
variety  of  clinical  presentations  of  male  infertility,  from  gonadotropin-releasing 
hormone  deficiency  such  as  congenital  hypogonadotropic  syndromes  (Kallmann's, 
Prader-Willi  and  Bardit-Biedl  syndromes),  to  spermatogenic  failure  such  as 
chromosomal  abnormalities  (Klinefelter,  XX  males  and  deletion  of  the 
azoospermia  factor  gene),  to  obstructive  azoospermia  such  as  mutation  in  the 
cystic  fibrosis  transmembrane  regulatory  gene  (CFTR)  (Table  1.2). 
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i)  Pre-testicular: 
DISORDER  CLINICAL  FEATURES  GENETIC  MECHANISM 
Kallmann's  syndrome 
Prader-Willi  syndrome 
Bardt-Biedl  syndrome 
Cerebellar  ataxia  with 
Hypogonadotropic 
hypogonadism 
Sickle  cell  anemia 
P-Thalassemia 
ii)  Testicular  : 
Klinefelter's  syndrome 
XYY 
Deletion  of  azoospermia 
factor  gene 
46,  XX  male 
Noonan's  syndrome 
Myotonic  dystrophy 
Anosmia,  Craniofacial  asymmetry, 
cleft  palate,  delayed  puberty,  small 
testes 
Obesity,  mental  retardation, 
hypotonia;  small  hands  and 
feet 
Obesity,  mental  retardation, 
Retinitis  pigmentosa, 
polydactyly 
Speech  delay,  gait,  lack  of 
secondary  sexual 
characteristics,  eunuchoidism, 
decreased  libido,  small  firm 
testes 
Anemia,  sickling  of 
erythrocytes  at  low  oxygen 
tension 
Anemia,  iron  overload 
Tall  stature, 
azoospermia,  extragonadal 
cell  tumors, 
hypogonadism,  small  firm 
testes,  diminished  secondary 
sexual  characterisitics. 
Tall  stature,  may  exhibit 
aggressive  behaviour. 
Normal 
Phenotypically  masculine 
Small  finn  testes 
Short  stature,  hypertelorism, 
webbed  neckjow  set  ears, 
cubutus  vulgus,  ptosis, 
pulmonary  stenosis,  cardiac 
anomalies,  cryptorchidism, 
testicular  atriphy 
Myotonia,  muscle  wasting, 
cataract,  frontal  balding, 
electrocardiographic  changes, 
testicular  atrophy 
X-linked  recessive,  variable 
inheritance;  defect  in 
KALIG-  I  gene  on  Xp22.3 
chromosome 
Often  due  to  interstitial 
deletion  of  chromosome 
15qI2  (paternally  inherited) 
Autosomal  recessive;  gene 
mapped  to  chromosome 
16q2l 
High  incidence  of  parental 
consanguinity,  Autosomal 
recessive  inheritance 
Autosomal  recessive 
inheritance,  defect  in  gene  for 
P-globin  chain  of  hemoglobin 
Autosomal  dominant 
inheritance,  defect  in  gene  for 
P-globin  chain  of  hemoglobin 
90%  of  cases  47,  XXY 
karyotype.  Remainder  are 
mosaicis  for  polysomy  for  X 
or  Y  chromosome 
Karyotype  47,  XYY 
De  novo  deletion  of 
azoospemia  factor  gene 
mapped  to  Yq  11.22-23 
chromosome 
46,  XX,  SRY  gene  present, 
azoospermia  factor  gene 
absent 
46,  XY,  autosomal  dominant 
inheritance 
Autosomal  dominant 
inheritance,  with  variable 
pcnetrance,  expanded  number 
of  CTG  sequcnccrepeats  in 
gene  mapped  to  l9ql3.3 
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DISORDER  CLINICAL  FEATURES  GENETIC  MECHANISM 
Cystic  fibrosis 
Congenital  bilateral 
absence  of  vas  deferens 
Idiopathic  epididymal 
obstruction 
Young's  syndrome 
Polycystic  kidney  disease 
Immotile  cilia  syndrome 
5-a-reductase  deficiency 
Chronic  respiratory 
infections,  pancreatic 
insufficiency,  elevated  sweat 
chloride,  wolfflan  duct 
derivatives  atrophic  or  absent. 
Wolfflan  duct  derivative 
atrophic  or  absent,  otherwise 
healthy 
Obstructed  epididymis, 
otherwise  healthy 
Chronic  sinopulmonary 
infections,  obstructed 
epidydymis 
Multiple  cysts  in  kidney, 
liver,  spleen,  pancreas,  lung, 
ovary,  testes,  epididymis, 
seminal  vesicle,  cerebral 
aneurysms,  mitral  valve 
prolapse,  colonic 
diverticulosis 
Chronic  retinits  and  sinusitis, 
nasal  polyposis, 
bronchiectasis,  immotile 
spermatozoa 
Perineoscrotal  hypospadiasis, 
ventral  urethral  groove,  blind 
vaginal  pouch,  female  habitus 
without  breast  development 
Autosomal  recessive 
inheritance,  defect  in  CFTR 
gene  on  chromosome  7q3  1.1 
Autosornal.  recessive 
inheritance,  defect  in  CFTR 
gene  in  patients  without 
concomitant  renal  anomalies 
Defect  in  CFTR  gene 
implicated 
Autosornal  recessive 
inheritance,  defect  in  CFTR 
gene  implicated 
Autosomal.  dominant 
inheritance,  2  genes 
implicated  (PKD  I  on  16p  13.3 
and  PKD2  on  4q 
chromosomes) 
Autosomal  recessive 
inheritance,  genetic 
heterogeneity 
Autosomal  recessive 
inheritance,  gene  encoding 
5-ce-reductase  iso-enzymes  I 
and  2  located  on  chromosome 
5p  15  and  2p23 
Androgen  Insensitivity  Complete  /incomplete  46,  XY,  X-linked  recessive 
syndrome  testicular  feminization,  inheritance,  defect  in 
Reifenstein's  syndrome,  androgen  receptor  gene 
infertile  male  syndrome  located  on  Xq  11-12 
chromosome 
*Modified  from:  Mak  and  Jarvi,  1996. 
41 1.6.3.1  Chromosomal  abnormalities  as  a  cause  of  male  infertility: 
(1)  Numerical  chromosome  abnormalities: 
Klinefelter  syndrome  is  a  genetic  disorder  due  to  the  presence  of  an  extra  X 
chromosome  in  the  male,  the  common  karyotype  is  either  47,  XXY  (classic  form) 
in  90%  of  cases  or  46,  XY/47,  XXY  (the  mosaic  form)  in  10%  of  cases.  This 
disorder  is  a  common  genetic  cause  of  male  infertility,  with  an  incidence  of  1/1000 
male  births  (Connor  and  Ferguson-Smith,  1991).  More  than  30  karyotypic 
varieties  of  Klinefelter  syndrome  has  been  described  such  as,  XXYY,  XXXY, 
XXXXY,  and  various  mosaicisms  of  X  chromosome  with  or  without  associated 
structural  abnormalities  of  the  X  chromosome  (Griffin  and  Wilson,  1992). 
Characteristically,  these  individuals  have  small,  firm  testes,  delayed  sexual 
maturation,  azoospermia  and  gynecomastia.  Testicular  biopsy  often  reveals 
sclerosis  and  hyalinization  of  the  seminiferous  tubules,  absence  of 
spermatogenesis  and  increased  Leydig  cells.  LH  and  FSH  levels  are 
characteristically  elevated.  Testosterone  levels  can  range  from  normal  to  low  and 
decrease  with  age. 
The  mosaic  variant  of  Klinefelter  syndrome  (46,  XY/47,  XXY)  is  usually 
not  as  severe  as  the  classic  form  and  fertility  has  been  documented  in  some 
patients  with  mosaicism  (Foss  et  al,  1971).  The  testes  may  be  normal  in  size  and 
gynecomastia  and  azoospermia  are  less  common.  The  frequency  of  the  mosaic 
form  may  be  underestimated,  since  chromosomal  mosaicism  may  occur  only  in  the 
testes  while  karyotypes  on  peripheral  leukocytes  may  be  normal  (Griffin  and 
Wilson,  1992). 
The  incidence  of  the  XYY  syndrome  (1per  1000  male  birth)  (Connor  and 
Furguson-Smith,  1991)  is  the  same  as  that  of  Klinefelter  syndrome  but  its 
phenotype  expression  is  more  variable.  These  patients  are  excessively  tall  and  I- 
2%  has  anti-social  behaviour.  Semen  from  these  patients  may  vary  from 
azoospermia  to  normal.  Testicular  biopsy  specimens  show  maturation  arrest  to 
complete  genninal  aplasia.  Most  have  a  normal  L11  and  testosterone  level  with  the 
FSH  level  dependent  on  the  extent  of  germ  cell  damage. 
42 (2)  Structural  chromosome  abnormalities:  Structural  Y  chromosome  disorders 
include  46,  XX  male  karyotype  and  deletion  of  the  azoosPermia  factor  gene. 
XX  disorder  or  sex  reversal  syndrome:  it  is  a  variant  of  Klinefelter  syndrome. 
Male  individuals  with  this  disorder  are  phenotypically  masculine  but  have  a  46,  XX 
karyotype.  The  signs  are  similar  except  for  the  average  height  which  is  less  than 
normal,  hypospadias  is  common  and  decreased  incidence  of  mental  deficiency. 
These  patients  have  a  46,  XX  chromosome  complement  with  an  incidence  of 
1/20000  males  (McElearvey  et  al  1992a).  It  is  postulated  that  in  these  patients,  the 
sex  determining  region  of  the  Y  chromosome  (SRY  gene),  which  encodes  the 
putative  testis  determining  factor,  is  present,  however  the  azoospermia  factor 
(AZF)  is  missing  in  the  genome.  The  mechanism  of  this  disorder  thought  to  be  due 
to  aberrant  X-Y  interchange  at  paternal  meiosis  which  may  occur  because  of  the 
proximity  of  TDF  (SRY)  to  the  pseudo-autosomal  region  where  recombination 
between  X  and  Y  chromosomes  normally  occurs  (Page  et  al,  1987). 
1.6.3.2  Deletion  of  the  azoospermia  factor  (AZF) 
Several  genes  are  likely  to  be  involved  in  the  complex  process  of 
spermatogenesis.  There  is  increasing  evidences  for  the  presence  of  such  gene(s)  in 
the  distal  long  arm  of  the  Y  chromosome.  Cytogenetic  studies  in  sterile  men  with 
deletions  of  the  long  arm  and  other  structural  abnormalities  of  the  Y  chromosome 
have  been  observed  in  men  with  azoospermia  and  suggested  the  localisation  of  a 
gene  controlling  spermatogenesis,  named  azoospermia  factor  (AZF),  resides  in 
Yql  1.23  (Tieplo  and  Zuffardi,  1976;  Chandley  et  al,  1989).  Molecular  mapping 
localised  AZF  to  interval  6  of  the  Y  chromosome  (Anderson  et  al,  1988)  as  defined 
by  Vergnaud  et  al  (1986).  As  a  first  step  towards  the  molecular  isolation  of  AZF, 
its  gene  structure  in  Yql  I  has  been  mapped  using  two  interstitial  deletions  in  the 
proximal  and  distal  part  of  Yq1  I  (Ma  et  al,  1992;  Vogt  et  al,  1992a,  b)  and  a 
detailed  map  of  interval  6  was  constructed  (Ma  et  al  1992).  Based  on  these  non 
overlapping  deletions,  Vogt  et  al  (1992a)  postulated  that  there  may  be  two 
spermatogenesis  genes  in  distal  Yq1  1,  AZFA  and  AFZB,  or  a  very  large  gene 
similar  to  the  Y  fertility  gene  of  Drosophila.  Deletion  of  the  azoospermia  factor 
accounts  for  10%  of  46,  XY  men  with  non-obstructive  azoospermia  (Johnson  et  al, 
1989;  Vogt  et  al,  1992a,  b;  Nagafuchi  et  al,  1993).  It  was  estimated  that  at  least 
43 1/10,000  male  newborn  carry  a  de  novo  deletion  of  the  AZF  (Vogt  et  al  1992a). 
Histological  studies  of  testicular  biopsies  from  azoospermic  men  with  deletion  in 
AZF  region  exhibited  a  wide  spectrum  of  spermatogenetic  defects  from  complete 
absence  of  germ  cells  (Sertoli-cell-only  syndrome)  to  maturation  arrest  with 
occasional  production  of  mature,  condensed  spen-natids  (Tiepolo  and  Zuffardi, 
1976;  Chandley  et  al,  1986;  Chandley  et  al,  1989;  Vogt  et  al,  1992a,  b). 
In  1993,  the  finding  of  overlapping  interstitial  Yq  deletion  in  3 
azoospermic  men  led  to  identification  of  YRRMI  and  YRRM2  (Y  chromosome 
ribonucleic  acid  recognition  motif),  now  renamed  as  RBM1  and  RBM2  (RNA 
binding  motif)  (Chandley  and  Cooke,  1994).  It  was  proposed  that  absence  of  these 
closely  related  genes  might  be  the  cause  of  azoospermia  (Ma  et  al,  1993). 
1.6.3,  Z2  Isolation  QfRRMggue-f,  7m 
The  RBM  (YRRM  gene  family  were  originally  cloned,  on  the  basis  of  its 
position,  with  probes  deleted  in  a  small  number  of  infertile  men  with  phenotypes 
ranging  from  oligospermia  to  a  complete  absence  of  genn  cells  (Ma  et  al,  1993). 
Two  RBM  gene  copies  were  isolated  as  cDNA  clones  (MK5,  MK29).  The  1878  bp 
MK5  cDNA  shows  the  AUG  starting  codon  is  present  at  118  bp,  followed  by  an 
open  reading  frame  of  1491  bp  which  predicts  a  novel  peptide  of  469  residue.  The 
1874  bp  MK29  cDNA  displays  7  nucleotide  substitution  and  a5  bp  deletion 
relative  to  MK5  causes  a  translation  frame  shift  that  truncates  the  MK29  open 
reading  frame,  giving  a  predicted  peptide  of  419  residue.  Both  clones  contain  a 
consensus  poly-adenylation  signal,  and  MK29  contains  a  short  poly  (A)+  tail  (Ma 
et  al,  1993). 
L-6.3,  Z3  RHAtl2rolein-contalits  an  RNA-binding--related  mol 
The  predicted  peptide  sequence  showed  5'  homology  to  a  super  family  of 
RNA  binding  protein  (HnRNPs)  that  contains  a  90  amino  acids  RNA  recognition 
motifs  (RRM),  often  in  a  tandernly  repeated  array  (Kenan  et  al,  1991;  Ma  et  al, 
1993).  The  RBM  genes  were  found  to  have  similarity  (60%  amino  acid 
conservation)  to  HnRNPG  (human  glycosylated  nuclear  RNA-binding  protein) 
(Chandley  and  Cooke,  1994).  The  majority  of  the  genes  code  for  protein  which 
44 have  two  copies  of  an  RNA  binding  domain  (RRM)  but  a  subset  has  been  found 
whose  members,  like  RBM  genes  and  HnRNPG,  have  only  a  single  domain.  A 
feature  of  the  RRM  domain  is  a  pair  of  very  highly  conserved  motifs,  an 
octapeptide  RNPI  and  a  hexapeptide  RNP2.  These  parts  of  the  protein  probably 
form  the  beta  sheet,  which  contact  the  RNA  directly  (Ma  et  al,  1993;  Chandley  and 
Cooke,  1994).  Because  of  the  RNA  recognition  motif  and  because  of  their  Y 
chromosome  localisation  these  genes  were  called  RBMI  (MK5)  and  RBM2 
(MK29).  These  RRM  motifs  showed  the  highest  similarities  to  the  third  RRM 
repeat  in  mouse  polyadenylate-binding  protein  (PABP)  (Adam  et  al,  1986;  Sach  et 
al,  1986).  Adjacent  to  RRM  domain  is  a  139  residue  followed  by  four  repeats  of  a 
37  residue  (111  bp),  all  of  which  showed  high  conservation  at  both  the  nucleotide 
and  predicted  protein  level.  The  repeated  domain  is  rich  in  serine,  argenine, 
glycine,  and  tyrosine  content,  with  no  aliphatic  leucine,  isoleucine,  and  methionine 
and  valine  residue.  Adjacent  to  the  tetrapeptide  SRGY  box  (Serine-Arginine- 
Glycine-Tyrosine)  is  a  carboxyl  tail  of  122  amino  acid  in  RBMI  and  45  amino 
acid  in  the  RBM2  gene  due  to  the  deletion  that  is  present  beyond  the  SRGY  box 
(Ma  et  al,  1993). 
Expression  studies  showed  that  RBM  sequences  are  confined  to  germ  cells 
(testis  specific)  and  the  genes  showed  a  male-specific  conservation  of  expression 
in  DNA  from  several  other  mammals  (Ma  et  al,  1993;  Chandley  and  Cooke,  1994). 
Moreover,  interphase  in  situ  hybridisation  and  Southern  blot  studies  showed  that 
the  RBM  sequences  compose  a  multigene  family  clustered  in  1-2  Mb  regions  of 
the  Y  chromosome  with  majority  of  the  genes  in  intervals  5  and  6  of  YqI  1.23.  The 
RBM  gene  family  has  approximately  30  genes  and  pseudogenes,  one  or  some  of 
which  encode  HnRNPG-like  protein  expressed  in  adult  testis  (Prosser  et  al,  1996). 
The  HnRNPG  proteins  are  widely  expressed  proteins  and  these  proteins  are 
abundant  in  the  nucleolus  as  histones  (Soulard  et  al,  1993).  Ma  et  al  (1993)  have 
reported  that  the  RBM  gene  family  may  be  involved  in  RNA  trafficking  between 
nucleus  and  cytoplasm  and  implicated  in  RNA  process.  Therefore,  they  have 
suggested  that  the  RBM  gene  family  may  have  a  role  in  spermatogenesis  and  are 
candidates  for  AZF.  Transcription  of  the  RBM  genes  has  not  been  detected  outside 
the  testis,  distinguishing  them  from  HnRNPG  (Chandley  and  Coole,  1994). 
45 1.6.3.  Z4RBM  deletions  in  oligo-  a  nd  azoog  ermicIzatients 
Ma  et  al  (1993)  detected  deletion  of  RBM  (YRRM  sequences  in  two 
infertile  (oligo  and  azoospermic)  patients  with  no  previous  deleted  mutations. 
Moreover,  Kaboyashi  et  al  (1994)  analysed  DNA  from  63  Japanese  men  with 
either  azoospermia  or  severe  ofigoospermia  whose  Y  chromosomes  were 
cytogenetically  normal.  They  examined  15  loci  included  RBMI  locus  on  the  long 
arm  of  the  Y  chromosome.  They  detected  microdeletion  in  10  of  the  infertile  men. 
The  RBM1  gene  was  involved  in  only  3  of  them.  They  proposed  that  the  RBMI 
(YRRMI)  is  not  the  only  gene  essential  for  spermatogenesis. 
6-3.  Z  5  RBMI  ggne  structurg 
Recently  Prosser  et  al  (1996)  characterised  the  exon/intron  boundaries  of 
the  RBM1  gene.  Twelve  exons  were  defined.  Exons  I-II  consist  of  100  bp  each 
(88-117  bp)  and  the  12th  was  slightly  larger  (<600  bp).  Introns  in  the  repeated 
SRGY  box  region  of  the  3'  half  of  the  gene  are  equal  in  size  (450  bp)  and  each 
repeat  is  in  a  separate  exon  (Exon  7-11).  The  remaining  introns,  1-6  and  II  varied 
from  about  400  bp  to  3  kb  in  length.  The  RRM  motif  extends  from  exon  2-4,  with 
the  highly  conserved  sequences  RBPl  and  RBP2  in  exons  3  and  2  respectively. 
The  1.8  kb  RBMI  transcript  covers  a  genomic  region  of  15kb. 
1.6.3.  Z6  New  candidate  Ugne  efA 
Using  84  sequence-tagged-site  (STS)  markers  covering  the  30-megabase 
euchromatic  region,  Reijo  et  al  (1995)  looked  for  Y  chromosome  deletions  in  89 
azoospermic  males  who  had  no  signs  of  any  physical  obstruction  and  showed  that 
the  RBM1  and  RBM2  genes  were  present  in  all  infertile  men  studied,  including  12 
patients  with  interstitial  Yq  deletion  of  the  azoospermia  factor  region.  In  12  of 
these  patients  (13%),  they  found  overlapping  de  novo  deletions  spanning  a 
common  region  of  about  500  kb  in  the  distal  segment  of  the  Y  long  arm.  They 
identified  a  novel  gene  within  this  region,  which  they  named  "deleted  in 
azoospermia"  (DAZ).  Like  RBM,  DAZ  is  expressed  specifically  in  the  testis  and 
46 contains  an  RNA  recognition  motif,  however,  unlike  RBM,  DAZ  is  a  single-  copy 
gene  in  humans  and  chimpanzees.  These  results  suggest  that  DAZ  is  the  candidate 
gene  for  AZF  and  not  RBM1  and  RBM2. 
At  least  three  different  AZF  genes  are  present  on  the  long  arm  of  the 
human  Y  chromosome  in  YqI  1.  They  are  named  AZFa,  AZFb,  AZFc  (Vogt  P, 
1995;  Vogt  et  al,  1995).  The  positions  of  these  genes  were  marked  according  to  the 
results  of  the  search  for  microdeletion  in  Yql  1  (Henegariu  et  al,  1994).  They 
appeared  as  de  novo  mutations  in  males  with  severe  oligoospermia  and 
azoospermia  (Vogt  et  al,  1995).  Deletions  in  AZFa  or  AZFb  disrupt  the  germ  cell 
development  in  males  before  the  proliferation  phase  of  spermatogonia  or  at 
meiosis,  respectively,  while  deletion  in'AZFc  region  disrupts  the  germ  cells 
development  during  the  maturation  phase  of  spermatids  or  spermatozoa.  Patients 
with  AZFc  deletion  can  display  different  amount  of  mature  sperm  cell  (Vogt  P, 
1995;  Vogt  et  al,  1995).  Candidate  genes  for  expression  of  AZFb  are  copies  of  the 
RBM  gene  family.  Candidate  genes  for  expression  of  AZFc  are  DAZ  and  SPGYI 
(spermatogensis  gene  on  the  Y).  Candidate  genes  for  expression  of  AZFa  are  not 
yet  known  (Vogt  et  al,  1996). 
A  variety  of  other  chromosome  abnormalities  involving  the  sex 
chromosome  and/or  autosomes  associated  with  male  sterility  have  been 
documented  (Chandley  and  Edmund,  1971;  Gabriel-Robez  et  al,  1987;  Speed  and 
Chandley,  1990;  Mohandas  et  al,  1992).  Although  definitive  proof  of  a  causal 
relationship  between  these  chromosomal  abnormalities  and  spermatogenctic 
abnormalities  till  now  is  lacking,  however,  these  reports  suggest  that  genes  within 
such  chromosomal  regions  may  have  a  role  in  spermatogenesis.  At  least  three 
different  mechanisms  resulting  in  abnormal  spermatogenesis  have  been  postulated 
(Maraschio  et  al,  1994).  (1)  Microdeletions  that  could  affect  azoospermia  factor 
involved  in  spermatogenesis  (Ma  et  al,  1992).  (2)  Alteration  of  the  correct 
sequence  order  of  the  Y  chromosome  interfering  with  the  steric  organisation  of  the 
sex  vesicle  (Gonzales  et  al,  1981;  Rivera  and  Diaz-Castanos,  1992)  and  3) 
Autosomal  interference  with  the  X-Y  bivalent  (Chandley  AC,  1981)  through 
interference  with  X-inactivation  at  meiotic  prophase  (Forjt  J,  1982),  a  prerequisite 
for  normal  spermatogenesis  (Lifschytz  and  Lindsley,  1972). 
47 LTMutation  detection  methods 
A  wide  variety  of  techniques  are  available  for  detecting  disease-causing 
mutation  within  human  genes.  These  methods  are  used  to  determine  whether  a 
candidate  gene  is  causally  related  to  a  phenotype  and  also  to  identify  new  alleles  at 
a  known  locus  for  diagnostic,  population  genetics  and  structural  function  studies. 
The  spectrum  of  disease  causing  mutation  ranges  from  cytogenetically 
visible  chromosome  rearrangements  (such  as  large  deletion,  insertion,  inversion,  or 
duplication)  to  microdeletion,  duplication  and  insertion  and  finally  single  base 
changes.  Some  candidate  genes,  such  as  Dystrophin  are  prone  to  deletions 
(Chamberlain  et  al,  1989)  while  others  such  as  CTTR  gene  in  cystic  fibrosis 
patients  are  associated  with  hundreds  of  point  mutations  (Tsui  LC,  1992).  Some 
genes  can  be  as  complex  in  structure  as  dystrophin,  with  a  14  kilobase  (kb)  peptide 
coding  region  and  80  exons  (Koenig  et  al,  1988)  or  as  simple  as  the  SRY  (Sinclair 
et  al,  1990)  locus  with  only  one  large  exon.  Moreover,  many  genes  of  interest  may 
not  be  expressed  in  easily  accessible  samples  such  as  blood,  as  in  male  infertility 
RBM  gene  family  (Ma  et  al,  1993),  leaving  analysis  of  genomic  DNA  as  the  only 
option.  Therefore,  the  most  applicable  screening  method  is  influenced  by  the 
expected  nature  of  the  mutation,  size  and  structure  of  the  gene  in  question, 
availability  of  mRNA,  degree  of  sensitivity  required  and  resources  available 
(Grompe  M,  1993). 
In  general,  the  methods  for  mutation  detection  can  be  divided  into  two 
distinct  groups.  The  first  consists  of  techniques,  which  identify  human  disease 
alleles,  and  the  second  group  consists  of  methods  of  screening  for  unknown 
mutations  (Figure  1.7). 
1.7.1  Screeningfor  unknown  mutations 
Techniques  have  been  devised  to  permit  rapid  screening  for  mutations  in  cases 
where  the  common  mutations  are  not  known.  Each  technique  has  its  advantages 
and  disadvantages  for  a  given  situation. 
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Figure  1.7:  Schematic  representation  of  mutation  detection  strategies. 1.7.1.1  Detection  of  large  gene  alteration 
Methods  for  identifying  mutations  that  grossly  alter  a  gene  (>500  bp 
portion)  are  well  established.  Standard  and  specialised  cytogenetic  techniques  can 
really  identify  mutations  that  significantly  disturb  chromosome  structure. 
Techniques  that  assess  genomic  organisation,  including  pulsed-field  gel 
electrophoresis,  Southern  blot  hybridisation  and  multiplex  polymerase  chain 
reaction  (PCR)  can  be  used  to  identify  large  deletions,  insertions,  inversions,  or 
duplications. 
(A)  Cytogenetic  techniques 
Cytogenetic  analysis  is  one  of  the  most  common  approaches  to  genetic 
testing.  It  is  the  study  of  genetic  material  at  the  cellular  level.  Routine  laboratory 
human  cytogenetics  is  concerned  with  light  microscope  studies  of  chromosomes. 
Almost  all  human  ctyogenetic  studies  involve  the  examination  of  a  dividing  cell 
population  requiring  preliminary  cell  culture  followed  by  blocking  cell  division  at 
metaphase,  with  an  inhibitor  of  spindle  formation. 
There  are  many  different  staining  techniques.  The  Giemsa  (G)  banding 
method  is  the  most  widely  used  for  routine  karyotyping  (Seabright  M,  1971; 
Sumner  et  al,  1971).  This  can  resolve  400-500  bands  (alternating  light  and  dark 
bands)  per  haploid  karyotype.  At  this  level  of  resolution,  deletion  of  the  order  of 
5-10  Mb  can  be  visualised  using  routine  G-banding.  Using  high  resolution  level  of 
banding  (prometaphase)  deletions  as  small  as  2-5  Mb  can  be  detected  (Yunis  J, 
1976).  This  technique  has  led  to  the  identification  of  an  increasing  number  of 
small  deletions  causing  specific  syndromes  such  as  del  (I  Ip  13)  for  aniridia/Wilms 
tumour,  del  (15ql3)  for  Prader-Willi  and  Angelman  syndromes  and  others 
(Ballabio  A,  1991).  The  chromosome  banding  pattern  obtained  is  thought  to  reflect 
both  the  structural  and  functional  composition  of  the  chromosomes  (Holmquist  et 
al,  1982).  Dark  bands  contain  adenine  and  thymine  (A+T)  rich  DNA,  appear  to 
contain  relatively  few  active  genes  and  generally  replicate  their  DNA  late  in  S- 
phase  (Sumner  AT,  1982).  A  similar  banding  pattern  can  be  obtained  by  staining 
50 with  quinacrine  (Q)  and  visualising  with  fluorescent  microscope  (Caspersson  et  al, 
1970).  Polymorphic  variations  in:  (1)  the  centromeric  region  of  chromosomes  1,9, 
16,  (2)  the  satellites  region  of  the  acrocentric  chromosomes,  (3)  and  variation  of 
the  heterochromatic  region  of  the  Y  chromosome  (Yqh)  can  often  be  recognised 
using  the  Q-banding  method.  Reverse  banding  in  which  the  bands  stain  in  opposite 
pattern  from  the  G-bands  is  used  routinely  in  some  laboratories.  This  technique 
may  be  useful  if  the  telomeres  are  involved  in  aberration  (Dutrillaux  et  al,  1973). 
Special  techniques  for  staining  the  highly  repetitive  DNA  in  heterochromatin  at  the 
centromeres  especially  of  chromosomes  1,9,  and  16  and  at  the  distal  region  of  the 
long  arm  of  the  Y  chromosome  (C-banding)  (Arrighi  and  Hsu,  1971)  are  usually 
applied  to  investigate  chromosome  rearrangement  near  centromeres  and  to  confirm 
polymorphism.  On  the  other  hand,  the  nucleolar  organiser  region  (NOR)  using  the 
silver  stain,  can  be  applied  to  selectively  identify  chromosome  containing  genes 
for  ribosomal  RNA  (rRNA)  which  are  located  on  the  short  arm  of  acrocentrics 
chromosomes  (13,14,15,21,22)  (Bloom  and  Goodpasture,  1976).  Furthermore, 
the  differential  replication  staining,  produced  by  incorporation  5-bromodeoxy 
uridine  (BrdU)  into  chromosomes,  is  applied  to  the  detection  of  different  cycles  of 
replication  within  a  single  cell  cycle  (Rooney  and  Czepulkowski,  1992).  Initially 
the  main  technique  for  such  studies  involved  feeding  cells  with  a  radioactive 
chromosome  constituent  and  the  results  were  analysed  with  autoradiography 
(Taylor  JH,  1958).  Recent  methods  however,  are  based  on  the  introduction 
methods  that  detect  the  incorporation  of  Brdu  (thymidine  analogue)  into  the 
chromosome.  Chromosomes  and  chromatids  that  have  incorporated  Brdu,  instead 
of  thymidine,  have  a  different  structure  and  consequently  different  staining 
preparation  form  those  containing  thymidine.  Substitution  with  Brdu  has  also  been 
successfully  demonstrated  in  the  late-labelling  X  chromosome  (late  replicating  X 
chromosome)  and  other  individual  chromosomes  and  segments  that  replicate  in  the 
later  part  of  the  S  period  (Latt  SA,  1973;  1974). 
(B)  MoIccular  cytogenctic  (Fluorescme  in  sint  hybridisation) 
Recently,  the  power  of  cytogenetic  analysis  has  been  enhanced  by  the  use 
of  fluorescence  in  situ  hybridisation  (FISH)  (McNeil  et  al,  1991;  Tkachunk  et  al, 
1991;  Lichter  and  Cremer,  1992).  It  has  been  used  as  an  adjunct  to  routine 
51 cytogenetics  to  achieve  a  higher  sensitivity  and  better  resolution  of  chromosome 
aberrations  as  compared  to  banding  analysis.  Although  chromosome  analysis  by 
conventional  methods  is  very  precise  and  gives  a  comprehensive  view  of  the  23 
pairs  of  chromosomes,  it  is  time  consuming  and  requires  highly  skilled 
cytogeneticists. 
FISH  has  become  a  powerful  tool  both  of  basic  science  and  diagnostic 
applications.  In  basic  science,  FISH  has  strongly  enhanced  gene  and  genome 
analysis  enabling  rapid  mapping  of  genes  (Lawrence  et  al,  1988;  Heng  et  al,  1992; 
Ried  et  al,  1993)  and  large  genomic  clones  using  the  competition  principles  as  well 
as  chromosome  painting  (Lengauer  et  al,  1990;  Lichter  et  al,  1990). 
Diagnostically,  FISH  allows  identification  of  pathological  chromosome 
abnonnalities  in  oncology  (Cremer  et  al,  1988;  Lichter  et  al,  1988,  Ried  et  al, 
1992a)  congenital  malformation  (Callen  et  al,  1995)  and  single  gene  disorder 
(Ried  et  al  1990).  This  is  attributable  to  recent  technical  improvements  with 
respect  to  sensitivity,  multiplicity,  and  resolution. 
In  the  late  1980s,  non-radioactive  methods  of  detecting  genes  and 
chromosomes  were  developed,  resulting  in  techniques  which  make  chromosomes 
look  colorful  (Langer  et  al,  198  1).  The  most  widely  used  and  popular  technique  is 
"Fluorescence  In  situ  Hybridisation"  (FISH).  In  principle  the  FISH  technique  is 
based  on  molecular  biology.  In  brief,  complementary  DNA  complex  present  in 
chromosomes  or  interphase  nuclei  is  denatured  into  single  strands,  Specific 
sequences  of  DNA  (or  probes)  representing  genes  or  chromosomal  regions  are 
tagged  with  one  or  more  hapten  molecules  or  fluorochrome  conjugated 
nucleotides.  These  are  then  mixed  with  the  single  strand  target  DNA  under 
appropriate  conditions,  for  complementary  binding  (hybridisation)  to  take  place. 
The  hybridised  labelled  DNA  sequences  are  visualised  as  fluorescent  signals  on 
Chromosomes  or  intranuclear  locations  (Figure  1.8). 
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ct The  technique  can  be  easily  applied  to  both  dividing  and  non-dividing 
fixed  cells  (interphase  cells),  as  well  as  tissue  sections  (Klinger  et  al,  1992; 
Lawrence  et  al,  1990).  FISH  has  become  one  of  the  most  widely  adopted 
techniques,  because  of  its  sensitivity,  cost-effectiveness  and  rapid  reporting 
turnaround  time  of  24-48  hours.  However,  it  is  mostly  used  as  an  adjunct  to 
routine  high  resolution  cytogenetics  methods.  The  application  of  FISH  in 
detecting  mutations  or  abnormalities  depends  upon  the  availability  of  probes,  for  a 
particular  chromosome  locus.  A  variety  of  FISH  probes  are  currently  made 
available  commercially,  which  are  extensively  used  in  detecting  numerical  and 
structural  chromosomal  abnormalities  (deletion,  duplications)  more  accurately 
than  routine  cytogenetic  method.  DNA  probes  as  small  as  I  kb  can  be  visualised 
on  metaphase  chromosome  (Lawrence  et  al,  1990;  Reid  et  al,  1993)  and  interphase 
chromatin  (Lawrence  et  al,  1988).  Protocols  for  Alu-polymerase  chain  reaction 
(ALU-PCR)  of  yeast  artificial  chromosome  (YAC)  clones  provide  a  better  tool  of 
interphase  diagnosis,  with  a  detection  efficiency  up  to  99%  (Lenguer  et  al,  1992  a, 
b;  Lenguer  et  al,  1993)'.  The  probes  are  available  in  four  different  categories  based 
on  their  property  of  binding,  (a)  centromeric  probes  (cc-sat),  (b)  whole 
chromosome  paints  (WCP),  {c)  unique  DNA-sequences,  and  (d)  telomeric 
probes. 
Chromosome-specific  centromeric  probes 
These  probes  hybridise  to  repeated  alphoid  DNA  sequences  located  at  the 
centromeric/peri-centromeric  region  of  specific  human  chromosomes  (Moyzis  et 
al,  1988).  The  centromeric  probes  are  routinely  utilised  in  detecting  ploidy, 
detection  of  aneuploidy  for  specific  chromosomes  (21,18,13  or  X  and  Y),  in 
metaphase  chromosomes,  interphase  nuclei  (uncultured  fixed  cells)  specimens  or 
tumours,  gametes  as  well  as  in  in  vitro  fertilisation  (Ried  et  al,  1992c).  X  and  Y 
probes  are  widely  used  in  the  determination  of  sex  in  fetuses  or  in  case  of 
ambiguous  genitalia  (Guyot  et  al,  1988).  Centromeric  probes  have  also  been 
applied  in  identifying  marker  chromosomes  (Callen  et  al,  1990).  However, 
centromeric  probes  are  not  suitable  to  detect  structural  unbalanced  chromosomes 
rearrangements,  as  the  FISH  signals  observed  cannot  be  differentiated  between 
54  1 normal  and  abnormal  chromosomes.  Furthermore,  the  introduction  of  the  primed 
in  situ  labelling  (PRINS)  technique  (Koch  et  al,  1991)  provides  another  way  for 
direct  detection  of  repeated  sequences  in  chromosome  (Gosden  et  al,  1991; 
Gosden  and  Lawson,  1995).  It  is  based  on  the  annealing  of  specific 
oligonucleotide  primers  and  subsequent  primer  extension  by  Taq  DNA  polymerase 
in  the  presence  of  labelled  nucleotide. 
Whole  chromosome  paintprobes 
These  are  either  biotin  or  digoxigenin-labelled  DNA  segments 
complementary  to  unique  DNA  segments  covering  the  length  of  the  target 
chromosome.  Hybridisation  of  these  probes  produces  complete  fluorescent  signals 
(appearing  as  paint)  over  the  whole  chromosome.  Whole  chromosome  paints 
(WCP)  are  useful  in  detecting  complete  or  partial  duplication  of  a  specific 
chromosome,  resulting  from  numerical  or  structural  rearrangements  (translocation 
or  deletion),  as  well  as  to  resolve  unidentified  additional  chromosomal  segments  or 
marker  chromosomes  (Cremer  et  al,  1988;  Pinkel  et  al,  1988).  However, 
chromosome  paints  can  not  be  used  in  interphase  nuclei  or  gametes.  WCP  are  not 
useful  in  detecting  structural  rearrangements  other  than  translocations  and 
deletions.  Whole  chromosome  paints  are  available  for  short  or  long  arms  of 
specific  chromosomes,  known  as  chromosome  arm  paints  (CAPS)  (Guan  et  al, 
1996). 
Unique  DNA  sequence  probes  (single  copy  probes) 
These  are  composed  of  specific  DNA  sequences,  which  can  be  targeted 
against  a  specific  'locus'  on  a  chromosome  (chromosome  band)  in  metaphase 
spreads,  or  interphase  nuclei.  The  probe  has  its  application  in  the  precise  diagnosis 
of  submicroscopic  deletions  (microdeletions)  or  duplications  not  detectable  by 
routine  high  resolution  banding  techniques.  The  single  copy  probe  also  is  useful  in 
detecting  translocations,  oncogenes,  and  amplified  genes  in  malignancies  in 
particular  turnour  suppressor  genes  (Albertson  et  al,  1989;  Cherif  et  al,  1989). 
Unique  copy  probe  are  premixed  or  tagged  with  control  probe  (chromosome 
specific)  as  positive  controls. 
55 Telomericprobes 
Telomeric  probes  are  more  recent,  helpful  in  identifying  subtle,  terminal 
deletions  and  tandem  duplications.  They  are  composed  of  unique  DNA  sequences 
which  hybridize  to  complementary  sequences  present  at,  or  near  the  'telomeres' 
[tandem  repeats  (TTAGGG)n]  (Moyzis  et  al,  1988).  They  are  specific  for  either 
short  arm  (p)  or  long  arm  (q),  of  a  chromosome.  The  telomeres  are  mostly  G-band 
negative. 
Multiplex  FISH 
Recent  advances  in  FISH  technology  supported  by  sophisticated  computer 
software  (Smart  Capture),  filters  sets  and  digital  mapping  devices  such  as  charge 
coupled  device  (CCD)  cameras  increased  the  sensitivity  of  FISH.  Multiple 
haptenisation  and  detection  protocols,  and  combinatorial  labelling  approaches 
allow  the  simultaneous  visualisation  of  several  target  regions  in  metaphase 
chromosomes  and  interphase  nuclei  (Nederlof  et  al,  1990;  Ried  et  al,  1992b; 
Dauwcrse  et  al,  1992;  Wiegant  J,  1993;  Tocharoentanaphol  et  al,  1994). 
Finally,  the  application  of  FISH  technology  in  routine  cytogenetic  analysis 
has  helped  in  the  precise  diagnosis  of  several  cases  of  mosaicism,  structural 
rearrangements,  in  particular,  microdeletions  and  marker  chromosomes, 
particularly  the  X  and  Y  chromosomes  (Callen  et  al,  1995;  Hatchwell  et  al,  1996; 
Bettio  et  al,  1997;  Henegariu  et  al,  1997).  FISH  has  tremendous  applications  in 
cancer  cytogenetics.  However,  FISH  does  not  replace  banding,  but  it  aids  in  the 
detection  of  aberrations  precisely. 
(C)  Southern  blot  hybridisation: 
Another  technique  with  wide  application  is  Southern  blot  method. 
Essentially,  the  test  DNA  is  digested  with  one  or  more  restriction  enzymes,  size- 
fragmented  by  agarose  gel  electrophoresis,  denatured,  and  transferred  to  a 
membrane  for  hybridisation  (Southern  et  al,  1975).  The  main  advantage  of  the 
technique  is  that  no  detailed  knowledge  of  the  sequence  and  the  structure  of  a  gene 
is  required  and  a  preliminary  screen  can  be  done  with  a  probe  of  interest 
immediately  after  its  isolation  (Grompe  M,  1993).  Large  deletions,  duplications, 
and  insertions  can  be  detected  by  this  method.  In  X-linked  disorders  such  as 
56 Duchenne  muscular  dystrophy  (DMD),  deletions  result  in  complete  absence  of  a 
sequence  in  an  affected  male.  This  is  readily  detected  on  a  southern  blot  with  a 
cDNA  probe,  because  a  DNA  fragment  will  be  absent  or  have  a  different  length 
(Koenig  et  al,  1987).  For  autosomal  genes  and  for  female  carrier  of  X-linked 
disorders  deletion  detection  is  more  difficult.  Quantitative  Southern  analysis  can 
be  done,  but  such  approach  can  be  laborious  and  subject  to  error  (Abbs  et  al, 
199  1).  Occasionally,  the  deletion  results  injunction  fragment  which  can  be  helpful 
in  heterozygotes  detection.  In  some,  a  mutation  creates  or  destroys  a  restriction 
enzyme  recognition  site  which  may  be  detected  by  southern  analysis,  Finally, 
Southern  analysis  has  been  used  successfully  to  detect  large  trinucleotide  repeat 
expansion  in  patients  with  FRAXA  and  myotonic  dystrophy  (Fu  et  al,  1991; 
Harley  et  al,  1992a). 
(D)  PCR-based  detection  methods: 
Since  the  advent  of  PCR  technology  using  a  thermostable  DNA 
polymerase,  which  allow  the  in  vitro  production  of  large  amount  of  a  target  DNA 
sequence,  various  PCR-based  methodologies  have  been  developed  for  rapid 
detection  of  genetic  variation  (Grompe  M,  1993;  Cotton  R,  1993).  Both,  genomic, 
DNA  and  mRNA  can  be  used  as  templates  for  the  PCR-based  mutation  strategies. 
The  advantage  of  using  mRNA  which  is  reverse  transcribed  to  cDNA  as  template, 
is  that  only  the  coding  region  will  be  analysed,  leading  to  the  rapid  detection  of 
gross  deletions  or  alterations,  minor  alterations,  or  splicing  errors, 
Multiplex  PCR  for  the  detection  of  deletion: 
Because  60%  of  dystrophin  gene  mutations  are  deletions,  a  rapid  and 
efficient  method  of  screening  for  deletions  was  introduced  by  Chamberlain  et  al 
(1989)  to  analyse  six  frequently  deleted  exons  simultaneously  in  a  multiplex 
amplification.  The  multiplex  reaction  efficiently  detected  80-98%  of  all  dystrophin 
gene  deletions  (Chamberlain  et  al,  1989;  Abbs  et  al,  1991).  Recently,  Tuffery  et  al 
(1998)  developed  a  multiplex  PCR  to  analyse  17  exons  of  the  dystrophin  gene  in 
one  reaction.  Therefore,  this  method  has  found  wide  use  in  the  diagnosis  of  DMD 
disorder.  The  deletions  in  homozygotes  are  indicated  by  the  absence  of  some  of 
the  bands  in  the  multiplex  pattern,  while  in  heterozygote,  the  deletions  are  seen  as 
50%  reduction  of  band  intensities  in  a  quantitative  analysis  of  the  multiplex 
57 reaction  (Abbs  and  Bobrow,  1992).  Since  then  the  multiplex  PCR  applied  to  loci 
of  known  sequences  prone  to  deletions  and  had  been  employed  with  other  genes 
such  as  the  8-fragment  multiplex  PCR  reaction  of  the  human  hypoxanthine 
guanine  phosphoribosyl,  transferase  (HPR7)  gene  (Gibbs  et  al,  1990;  Grompe  M, 
1993). 
1.7.1.2  Detection  of  single  base  changes  and  small  sequence  alterations 
Single  base  alterations  are  the  most  common  type  of  mutation  of  most  loci. 
Changes  of  a  single  base  can  result  in  the  insertion  of  incorrect  amino  acid  or  can 
change  an  amino  acid  to  a  stop  codon.  Some  changes  are  conservative,  substituting 
an  amino  acid  with  similar  properties  that  may  not  affect  the  function  of  the 
protein,  and  represent  polymorphisms  and  common  genetic  variants.  In  other 
instances,  non-conservative  changes  result  in  an  alteration  of  protein  function  or 
changes  of  an  amino  acid  codon  to  a  stop  codon,  causing  premature  termination  of 
protein  synthesis.  Point  mutation  can  also  occur  within  an  intron,  where  they  may 
affect  the  fidelity  of  splicing  (Krawczak  et  al,  1992). 
The  detection  of  point  mutation  and  small  sequence  alterations  in  a  DNA 
sequence  represent  technical  obstacles  for  the  genetic  analysis  of  human  inherited 
disease.  To  face  this  problem  many  methods  have  been  developed,  particularly 
after  the  introduction  of  PCR  (Grompe  M,  1993;  Cotton  R,  1993).  Mutations  can 
be  detected  by:  (1)  analysis  of  single  strand  conformational  polymorphisms 
(SSCP;  Orita  et  al,  1989),  (2)  heteroduplex  analysis  (HA;  White  et  al,  1992),  (3) 
denaturing  gradient  gel  electrophoresis  (DGGE;  Fischer  and  Lerman,  1983;  Myers 
et  al  1987)  (4)  chemical  cleavage  mismatch  (CCM;  Cotton  et  al,  1988)  or  RNase 
cleavage  (Myers  et  al,  1985a). 
(A)  Single  strand  conformation  polynsorphism  (SSCP)  analysis: 
Owing  to  its  simplicity  and  sensitivity  SSCP  is  one  of  the  most  widely  used 
method  for  the  detection  of  point  mutation.  It  is  based  on  the  fact  that  single- 
stranded  DNA  has  a  tendency  to  fold  up  and  form  complex  structures  stabilised  by 
weak  intramolecular  bonds,  and  the  electrophoretic  mobility  of  such  structure  on 
non-denaturing  gel  will  depend  not  only  on  their  chain  length  but  also  on  their 
58 conformation,  which  in  turn  depends  on  its  nucleotide  sequence  (Orita  et  al,  1989). 
With  this  method,  PCR  products  are  partially  denatured  to  allow  the  formation  of 
single  stranded  secondary  structures  and  then  electrophoresed  in  a  non-denaturing 
polyacrylamide  gel.  A  test  DNA  sample  that  differs  by  a  single  base  from  a 
standard  DNA  sample  can  be  detected  as  a  comparative  mobility  shift  during 
electrophoresis  if  the  base  results  in  a  change  of  conformation.  There  are  however, 
discrepancies  in  the  reported  sensitivity  of  this  technique  (Hayashi  K,  1992;  Sarkar 
et  al,  1992  a,  b;  Hayahi  and  Yandell,  1993).  Detection  rates  reported  varies  from 
79%  to  96%  when  PCR  product  of  200  bp  or  less  and  rapidly  falls  to  <50%  when 
the  size  is  more  than  400  bp  (Hayashi  K,  1991;  Grompe  M,  1993;  Sarkar  et  al, 
1992  a,  b).  Several  technical  factors  that  might  affect  sensitivity,  including  the  type 
of  gel  matrix,  electrophoresis  condition,  the  dimension  of  the  gel,  overloading  the 
gel,  and  the  isotope  used  (Dianzani  et  al,  1993).  The  sensitivity  of  SSCP  is 
improved  when  the  analysis  is  carried  out  on  an  RNA  copy  of  the  sequence,  since 
the  secondary  structure  of  RNA  is  more  suited  to  SSCP  (Dianzani  et  al,  1993). 
(BIR)  Heteroduplew  analysis:  I 
Heteroduplex  analysis  (HA)  takes  advantages  of  the  formation  of 
heteroduplexes  between  mutant  and  wild  type  sequences.  Heteroduplex  molecules 
containing  single  base  pair  mismatches  can  be  accurately  separated  from  related 
nonhomoduplex  on  nondenaturing  gel  (Keen  et  al,  1991;  White  et  al,  1992).  This 
phenomenon  is  thought  to  be  caused  by  sequence  dependent  conformation  changes 
in  the  double  strand  DNA  induced  by  mismatch.  Although  IIA  is  as  simple  as 
SSCP,  its  application  has  not  been  so  widespread,  because  of  its  later  description 
and  because  of  the  need  for  Hydrolink  gels  in  the  initial  description  (Keen  et  al, 
1991).  Recently,  new  gel  matrices  (Hydrolink  and  MDE  from  AT  Biochem) 
(Grompe  M,  1993)  have  become  available,  which  markedly  enhances  the  ability  to 
detect  mutation  induced  mobility  shifts  in  heteroduplex  molecules.  fleteroduplex 
analysis  on  Hydrolink  gel  has  been  successfully  applied  to  mutation  screening  in 
several  genetic  diseases.  This  simple  technique  was  reported  to  be  able  to  identify 
different  types  of  genetic  alteration  including  point  mutation  and  minor  deletion  or 
insertion  in  PCR  fragments  of  different  sizes  from  about  200  up  to  1400  bp 
(Tassabehji  et  al,  1992).  The  main  disadvantage  of  IIA  is  the  lack  of  100% 
detection  as  in  SSCP  analysis  (80-901/6)  and  the  sensitivity  increase  with 
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White  et  al,  1992).  Both  isotopic  and  non-isotopic  methods  have  been  used  (Perry 
et  al,  1992;  White  et  al,  1992;  Yap  and  McGee,  1992). 
(C)  Denaturing  Gradient  Gel  Electrophoresis  (DGGE): 
This  method  of  mutation  detection  is  developed  by  Myers  et  al  (1985a,  b), 
compares  homoduplexes  with  heteroduplexes  of  wild  type  and  mutant  DNA 
strands  in  terms  of  their  electrophoretic  mobility.  In  principle,  when  a  double 
stranded  DNA  (dsDNA)  fragment  is  subjected  to  electrophoresis  through  a 
gradient  increasing  concentration  of  a  denaturing  agent  it  will  reach  a  certain  point 
in  the  gradient  where  its  lowest  melting  temperature  domain  melt  to  create  a 
branch  molecule  which  effectively  does  not  move  any  further  through  the  gel 
matrix.  The  melting  behaviour  is  sequence  dependent.  Strand  separation  at  a 
domain  in  a  DNA  fragment  is  detected  as  a  reduction  in  the  mobility  of  the 
fragments.  Two  dsDNA  fragments  of  the  same  sizes  but  differing  in  sequences, 
melting  at  different  points  in  a  DGGE  and  can  be  distinguished  by  differential 
migration. 
A  major  draw  back  of  DGGE  technique  initially  was  its  insensitivity  to 
mutations  in  regions  of  the  DNA  which  melt  last  in  the  gradient  of  denaturant, 
because  at  this  point  the  strands  separate  and  the  resolution  is  lost.  To  observe  the 
effect  of  mismatches  in  the  highest  melting  domain,  a  modification  was  designed 
that  involved  the  addition  of  a  GC-rich  fragment  (Myers  et  al,  1985b;  Myers  et  al, 
1985c).  Detection  is  usually  carried  out  by  a  non-radioactive  means  (Fodde  et  al, 
1994).  DGGE  can  detect  mutations  with  95%  accuracy  in  PCR  products  of  up  to 
600  bp  in  length  (Grompe  M,  1993). 
(D)  Chemical  Cleavage  Mismatch  Detection: 
The  cleavage  methods  of  mutation  detection  are  also  based  on  the  principle 
of  detecting  differences  between  wild  type  and  mutant  single-stranded  molecules 
when  a  heteroduplex  is  formed  between  the  two.  In  RNase  cleavage  (Myers  et  al, 
1985a)  a  ribonucleic  acid  probe  hybridised  to  RNA  or  DNA  containing.  one  base 
difference  can  be  cut  at  the  mismatch  by  ribonuclease  (RNase  A).  Mutation  can 
then  be  detected  and  located  after  analysis  of  the  cleavage  products  by  gel 
electrophoresis  (Dianzani  et  al,  1993).  However,  the  method  is  not  very  sensitive, 
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Myers  et  al,  1985a).  Given  the  limitation  of  the  enzymatic  cleavage  methods  of 
mutation  detection,  Cotton  et  al  (1988)  developed  an  assay  for  detection  of 
heteroduplex  mismatches  using  Maxam  and  Gilbert  cleavage  chemistry  (Maxam 
and  Gilbert,  1980).  The  mutation  screening  by  chemical  cleavage  mismatch 
method  (CCM)  is  based  on  the  fact  that  mismatched  cytosine  (C)  and  thymidine 
(T)  are  much  more  reactive  with  the  compounds,  hydroxylamine  and  osmium 
tetroxide,  respectively,  than  are  the  matched  pair  C  and  T.  Double  strand  DNA 
treated  in  this  way  can  then  be  cleaved  opposite  the  modified  bases  by  piperidine 
and  the  fragments  separated  by  gel  electrophoresis.  The  main  advantages  of  CCM 
are  high  detection  rate  (79-100%;  Forrest  et  al  1991)  and  the  ability  to  screen 
kilobase  lengths  of  DNA  or  RNA  (up  to  1.7  kb;  Grompe  M,  1993).  Moreover, 
CCM  gives  in  the  approximate  location  of  the  mutation  by  estimating  the  size  of 
the  cleavage  product  as  well  as  the  type  of  base  change  from  the  cleaving  reagent. 
While  all  of  these  methods  have  been  used  successfully  for  identification  of 
alleles,  which  cause  disease,  SSCP  (because  of  simplicity)  and  DGGE  (because  of 
its  near  100%  sensitivity)  are  the  favoured  techniques.  A  draw  back  of  SSCP  is 
that  two  or  three  different  gel  conditions  are  required  to  detect  all  mutation  in 
fragments  and  DGGE  suffers  from  the  need  for  special  equipment  and  more 
expensive  GC-clamps  (Dean  M,  1995).  Moreover,  some  methods  are  not  suitable 
for  screening  large  numbers  of  individuals,  because  of  their  complexity.  This  is  the 
case  for  RNase  cleavage  and  CCM  methods. 
("'  Direct  sequencing:  ILV 
The  ultimate  molecular  characterisation  of  a  mutation  is  at  the  level  of  the 
nucleotide  sequence  and  with  the  availability  of  the  PCR  technique,  sequence 
information  has  become  readily  available,  Sequencing  can  be  used  either  as  a 
screening  or  a  diagnostic  method.  Direct  sequencing  of  PCR  products  has  been 
used  as  the  primary  mutation  screening  method  to  detect  mutation  in  parts  of  large 
genes  (Higuchi  et  al,  1990)  or  by  sequencing  an  entire  coding  sequences  (Mogne 
et  al,  1992). 
The  methods  of  Sanger  (1977),  Maxam,  and  Gilbert  (1980)  for  rapid  DNA 
sequence  determination  have  formed  the  corner  stone  of  the  sequencing  technique 
used  today.  Of  the  two  methods,  Sanger's  one  is  most  widely  used.  The  Maxam 
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breaks  a  terminally  labelled  DNA  molecule  partially  at  each  repetition  of  a  base. 
The  lengths  of  the  labelled  fragments  then  identify  the  position  of  that  base.  They 
described  a  reaction  that  cleaves  DNA  preferentially  at  guanine,  adenines  and 
guanines  equally,  at  cytosine  and  thymines  equally,  and  at  cytosine  alone.  When 
the  products  of  these  four  reactions  are  separated  by  high  resolution  denaturing 
polyacrylamide  gel  electrophoresis,  the  DNA  sequence  can  be  read  from  the 
pattern  of  radioactive  bands. 
The  Sanger's  method  also  known  as  dideoxy  sequencing  or  chain 
termination  is  an  enzyme-based  method.  In  this  approach  the  usual  first  step  is  to 
prepare  a  single-stranded  DNA  from  the  DNA  to  be  sequenced.  A  chemically 
synthesised  oligonucleotide  primer  is  annealed  to  its  complementary  sequence  on  a 
single  stranded  DNA  template.  The  primer/template  duplex  is  then  used  as  a 
substrate  of  chain  extension  from  the  3'  end  of  the  primer  by  DNA  polymerase. 
Four  separate  synthesis  reactions  are  carried  out.  Each  include  all  four  nucleotide 
dATP,  dCTP,  dGTP,  and  dTTP,  one  of  which  carries  a  radioactive  isotope, 
together  with  one  of  the  four  dideoxy  nucleotide  (ddNTP)  analogue,  ddATP, 
ddCTP,  ddGTP,  and  ddTTP.  Incorporation  of  ddNTPs  causes  chain  termination 
since  they  lack  a  Y-hydroxyl  group,  Random  low  level  incorporation  of  a  specific 
ddNTP,  in  competition  with  the  normal  dNTP  analogue,  will  result  in  mixture  of 
different  length  chains,  all  starting  at  the  5'  end  of  the  primer  and  ending  at  every 
possible  position  where  the  specific  ddNTP  can  be  incorporated  in  place  of  the 
dNTP.  The  average  length  of  the  resulting  chain  can  be  altered  by  changing  the 
ddNTP/dNTP  ratio  within  the  reaction  mixture.  For  example  increasing  relative 
concentration  of  ddNTP  will  result  in  a  short  average  chain  length.  These  four  sets 
of  reactions  are  then  fractionated  alongsidc  each  other  by  denaturing 
polyacrylamide  gel  electrophoresis.  On  conventional  sequencing  gels  about  200- 
400  nucleotides  can  be  determined  from  a  single  DNA  sample. 
1.7.2  Methods  to  detect  knows  sequences  alteration  (diagnostic  techniques) 
Once  a  particular  disease  causing  mutation  has  been  identified  in  a  family, 
diagnostic  techniques  are  called  into  use.  The  genetic  screening  programmes  of  the 
general  population  are  aimed  at  preventing  common  genetic  diseases.  There  are 
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population  and  the  type  of  the  disease  (Caskey  T,  1993).  Genetic  screening  is 
offered  to  populations  at  high  risk  of  autosomal  recessive  disorders  such  as  Tay- 
Sach  disease  (Kaback  M,  1981),  hemoglobinopathesis  (sickle  cell  anemia  or 
thalassemia)  and  lately  for  cystic  fibrosis  (Scriver  and  Fuiwara,  1992).  These 
techniques  are  generally  simpler  than  those  used  in  the  original  identification  of 
mutation.  This  can  be  achieved  by  the  following  methods;  (1)  allele  specific 
oligonucleotide  hybridisation  (ASO)  (Wallace  et  al,  1979),  (2)  allele  specific  PCR 
amplification  or  by  an  amplification  refractory  system  (ASA/ARMS)  (Wu  et  al, 
1989;  Newton  et  al,  1989a),  (3)  restriction  enzyme  digestion  (if  a  site  has  been 
created  or  abolished),  (4)  artificial  introduction  of  a  restriction  site  (AIRS)(Cohen 
and  levinson,  1988),  or  (5)  SSCP  or  HA.  Direct  sequencing  of  PCR  products  may 
also  be  the  method  of  choice. 
(1)  Allele-spcciflic  oligonticleotide  (ASO)  hybridisation 
A  point  mutation,  which  does  not  produce  a  restriction  site  change,  may 
still  be  detected  using  allele-specific  oligonucleotide  (ASO)  probes. 
Oligonucleotide  probes  can  therefore  be  designed  to  hybridise  to  specific  alleles  of 
a  gene,  which  differ  by  a  single  nucleotide  at  a  diagnostic  site.  Two  probes  are 
made,  one  has  the  normal  sequence,  while  the  other  is  identical  except  for  a  single 
altered  base  corresponding  to  a  particular  mutation  (Wallace  et  al,  1979).  ASO 
probes  are  typically  15-20  nucleotides  long  and  are  normally  employed  under 
stringent  hybridisation  conditions  at  which  the  DNA  duplex  between  probe  and 
target  is  only  stable  if  there  is  perfect  base  complementarity  between  them.  ASOs 
can  be  used  in  conventional  Southern  blot  hybridisation,  it  is  more  convenient  to 
use  them  in  dot-blot  assays.  Both  radiolabelled  and  fluorescently  labelled  probes 
have  been  used.  In  reverse  blot  (Saiki  et  al  1989)  different  probes  were  spotted 
onto  the  membrane  and  the  biotin-labelled  target  sample  applied.  The  probes 
forming  duplexes  without  mismatches  and  retaining  the  target  became  stained  with 
HRP  avidin.  The  approach  is  feasible  if  the  DNA  sequence  causing  a  genetic 
disease  is  known  and  if  the  number  of  disease-causing  mutations  is limited  (such 
as  sickle  cell  disease  and  cystic  fibrosis).  DNA  from  normal  individuals  will 
hybridise  only  to  the  wfld-type  oligonucleotides,  heterozygotes,  will  hybridise  to 
both,  and  individual  homozygote  for  the  mutation  will  hybridise  to  only  to  the 
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mixing  several  hybridisation  probes  (Saiki  et  al.  1986). 
(2)  Amplification  refractory  mutation  system  (ARMS) 
The  PCR  depends  on  elongation  from  the  3'  end,  by  Taq  polymerase,  of  a 
double-stranded  template  to  the  target  DNA.  Naturally,  if  the  template  is 
mismatched  at  the  3'  end,  the  PCR  will  proceed  less  efficiently  and,  over  20  or  30 
cycles,  this  will  have  a  significant  effect.  In  the  amplification  refractory  mutation 
system  (ARMS)  two  sets  of  primers  are  used,  each  set  designed  in  such  a  way  that 
amplifies  only  either  the  normal  or  the  mutant  allele.  Primers  that  are  mismatched 
with  either  target  sequence  by  only  single  nucleotide  at  their  3'  ends  will  not 
amplify  the  DNA  to  which  they  anneal.  Two  parallel  reactions  are  ran;  one  will 
prime  with  oligonucleotides  corresponding  to  the  wild  type  sequence,  and  a  second 
corresponding  to  a  known  mutation.  The  former  will  amplify  normal  copy  of  the 
gene,  while  the  later  will  amplify  the  mutant  copy  (Newton  et  al,  1989a).  DNA 
from  heterozygote  individual  will  amplify  with  both  primers.  A  second  pair  of 
primers,  producing  a  different  size  of  product,  is  normally  introduced  in  the  same 
reaction  as  a  positive  control.  ARMS  have  found  wide  spread  use  in  the  diagnostic 
laboratory  and  are  routinely  used  for  diagnosis  of  thalassemia  (Old  et  al,  1990)  and 
cystic  fibrosis  (Newton  et  al,  1989b). 
(3)  Artiflcial  introduction  restriction  sites  (AIRS) 
Many  mutations,  but  not  all,  naturally  create  or  remove  restriction  enzyme 
sites.  The  artificial  introduction  of  restriction  site  system  (AIRS)  provides  an 
alternative  way  of  making  restriction  enzyme  detection  of  sequence  changes, 
which  is  more  universally  applicable  (Cohen  and  Levinson,  1988).  A  mismatch  is 
deliberately  introduced,  by  a  primer  that  has  one  base  mismatched  near  to  the  site 
of  mutation,  to  create  an  artificial  restriction  enzyme  site  in  the  PCR  product, 
either  in  the  normal  or  mutant  cases.  Therefore,  presence  of  the  mutation  will 
make  the  proper  recognition  site  for  a  specific  restriction  endonuclease.  Digestion 
of  the  PCR  products  using  this  enzyme  followed  by  gel  electrophoresis  will  enable 
the  identification  of  the  presence  or  absence  of  the  mutation  in  the  sample.  AIRS 
have  been  used  successfully  to  screen  for  common  mutations  in  different  genes 
such  as  Duchenne  muscular  dystrophy  (Yau  et  al,  1993)  and  phenylketonuria 
(Eiken  et  al,  199  1). 
64 1.8  Aims  of  the  present  project 
The  overall  aims  of  the  present  project  are  to  optimise  and  apply  methods 
that  detect  large  or  small  sequence  DNA  alterations  in  patients  with  sex 
chromosome  aberrations  and  sex  determination  /  differentiation  abnormalities. 
These  patients  were  chosen  because  of  the  differences  with  regard  to  known 
molecular  pathology,  available  gene  information  and  the  availability  of  studying 
material  (DNA  or  chromosomal  fixed  materials).  The  spectrum  of  the  mutations 
ranges  from  cytogenetically  visible  chromosome  abnormalities  to  microdeletions, 
and  finally  to  single  base  alterations.  This  will  involve  the  application  of 
cytogenetic,  molecular  cytogenetic  and  molecular  genetic  investigations.  The 
specific  targets  are  summarised  as  follows: 
I)  Cytogenetic  and  molecular  c  togenetic  studies  Y 
i)  To  optimise  the  FISH  technique  using  different  probes  such  as  the  repeated 
sequences  (e.  g.  the  alpha  satellite  centromeric  probes  of  X  and  Y 
chromosomes),  whole  chromosome  libraries  specific  for  both  the  X  and  Y 
chromosomes  (chromosome  painting),  and  X  and  Y-specific  probes. 
b)  To  optimise  multi-colour  FISH  using  the  optimised  probes  in  the  uni-colour 
FISH  experiments. 
iii)  To  apply  FISH  to  diagnostic  problems  in  clinical  cytogenetics  in  patients  with 
sex  chromosome  abnormalities. 
iv)  To  analyse  the  X-inactivation  pattern  using  BrdU  labelling  (late  replication) 
methods  of  structurally  abnormal  X  chromosomes  particularly  ring  X 
chromosomes  and  to  correlate  it  with  the  phenotype  if  it  is  possible. 
II)  Molecular  Genetic  studies: 
To  detect  and  fully  characterise  mutations  in  the  androgen  receptor  gene  (AR) 
in  patients  with  androgen  insensitivity  syndrome  (AIS). 
ii)  To  detect  mutations  in  the  sex  determining  (SRI)  gene  in  patients  with  sex 
reversal  (46,  XY  female). 
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karyotypes  (46,  XX  male). 
iv)  To  develop  diagnostic  screening  methods  for  mutation  detection  in  male 
patients  with  non-obstructive  infertility.  The  screening  programme  is  based  on: 
(1)  microdeletion  detection  in  azoospen-nia  factor  (AZF)  region(s)  by 
optimising  and  applying  multiplex  PCR  using  28  different  pairs  of  primer  sets. 
2)  To  detect  microdeletions  of  the  RBM  gene  family  by  applying  FISH  and 
Southern  blotting  techniques  using  MK5  and  Mk29  cDNA  probes  (specific  for 
RBM  gene  family)  as  a  first  step  of  the  screening  method.  3)  To  carry  out  a 
comprehensive  search  for  mutations  in  the  RBMI  gene  by  designing  primers 
spanning  the  entire  essential  sequence  of  the  gene  to  enable  PCR-based 
screening  such  as  SSCP,  HA,  and  sequencing. 
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MATERIALS  AND 
METHODS (2)  MATERIALS  AND  METHODS 
2.1  Patients 
A  total  of  93  patients  with  known  or  with  possible  sex  chromosome 
abnormalities  were  investigated.  Table  2.1  summarises  the  patient  categories  and 
the  techniques  applied  for  studying  each  category. 
Twenty  four  patients  were  referred  from  Duncan  Guthrie  Institute  (DGI) 
and  from  Kuwait  Medical  Genetic  Centre  with  known  or  suspected  X  and  Y 
chromosomes  abnormalities.  These  patients  were  studied  at  cytogenetic  and 
molecular  cytogenetic  level.  Out  of  these  seven  patients  with  Turner  phenotype 
carrying  ring  chromosomes  and  one  patient  with  46,  XXp+  karyotype  were  studied 
for  late  X  replication. 
Thirteen  of  the  investigated  patients  were  referred  due  to  sex  disorders. 
Four  male  patients  with  46,  XX  karyotypes  were  investigated  by  cytogenetics, 
molecular  cytogenetics  and  by  molecular  genetics  for  the  presence  or  absence  of  Y 
chromosome  material.  Five  females  with  46,  XY  karyotype  were  clinically 
suspected  to  have  androgen  insensitivity  syndrome,  while  4  females  with  46,  XY 
karyotype  were  clinically  classified  as  gonadal  dysgenesis  syndrome. 
Blood  samples  were  collected  from  two  different  male  infertility  clinics  in 
Kuwait  from  a  total  of  56  males  with  azoospermia  (sperm  number  of  zero)  or 
severe  oligoospermia  (sperm  count  <2  million/ml). 
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Supplemented  RPMI  1640 
To  100  ml.  of  RPMI  1640  the  following  were  added: 
Material  Final  concentration 
PHA  2% 
Fetal  calf  serum 
L-Glutamin 
Penicillin/Streptomycin 
(5000  Unit/ml/5000  gg/ml) 
Stored  at  4T. 
Ix  Iscoves  Medium 
To  100  ml.  of  1x  Iscoves  media  the  following  were  added: 
20% 
2% 
1% 
Material  Final  concentration 
Heparin  (2000  Unit/ml)  1% 
L-glutamin  1% 
PHA  2% 
Penicillin/Streptomycin 
The  media  was  stored  at  4T. 
1% 
Hypotonic  Solution  (0.0  75  Mpotassium  chloride) 
For  every  100  ml  deionized  water  0.5  6  gm  of  KCI  added  and  stored  at  room 
temperature  for  up  to  two  weeks. 
Carnoys  Fixative 
3  parts  methanol  to  I  part  glacial  acetic  acid  prepared  fresh  each  harvest. 
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0.09%  NaCI  (sodium  chloride) 
Sorensens  Buffer  pH  6.8 
(a)  10  X  anhydrous  potassium  phosphate  monobasic  (KH2P04)  Wl  5 
9.09  gm  KH2P04  dissolved  in  100  ml  distilled  H20.  Stored  at  4"C. 
(b) 10  X  Anhydrous  Sodium  phosphate  dibasic  W15 
11.88  gm  Na2HP04  dissolved  in  100  ml  distilled  H20.  Stored  at  4T, 
Working  buffer  was  prepared  by  mixing  5  ml  of  K2HP04  and  5  ml  of  NaH2PO4  in 
90  ml  distilled  water.  Adjusted  PH  to  6.8  and  stored  at  room  temperature. 
10yo  stock  trypsin  solution 
200  mg  trypsin  1:  250  (Difco)  reconstituted  with  20  ml  sterile  normal  saline. 
Aliquoted  in  1.0  ml  lots  and  frozen. 
0.02  %  working  trypsin  solution 
I  ml  10%  stock  trypsin  diluted  in  49  ml  normal  saline.  Prepared  fresh  each 
harvest. 
Gienisa  Stainhig  solution 
Two  gm  of  Giemsa  powder  dissolved  in  132  ml  of  glycerol.  Incubated  in  water 
bath  for  2  hours  at  56*C,  cooled  and  then  132  ml  of  methanol  was  added.  The 
mixture  was  then  shaken  well  and  kept  in  a  dark  place  for  seven  days.  The  stain 
was  then  filtered  through  Whatman  IMM  paper  and  stored  in  brown  bottles  for 
use. 
211o  Giemsa  solution 
ml  Giernsa  added  to  So  ml  (PH  6.8)  working  Sorensens,  buffer  solution. 
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3  gm  of  Leishmans  powder  dissolved  in  2000  ml  of  methanol,  filtered  through 
Whatman  I  MM  paper  and  used 
Fluorodeoxy  uridin  e  (MR)  stock  solution  (4  x  10'4  M 
To  50  ml  distilled  water  added  5  mg  FUdR  stored  frozen  in  dark  vials. 
Uridine  stock  solution  (3  x  10  AD 
To  10  ml  distilled  was  added  10  mg  uridine  and  stored  frozen  as  small  aliquots. 
BrdU  solution  (1.5  mglml.  -  working  solution) 
To  17  ml  distilled  water  added  30  mg  BrdU,  2  ml  uridine  stock  solution,  I  ml 
FUdR  stock  solution.  Filter  sterilised  and  stored  frozen  in  dark  vials.  This  solution 
can  be  used  over  a  period  of  2  weeks. 
Hoechst  33258  solution  (150,  ugr1ml) 
To  100  ml  distilled  water  added  15  mg  Hoechst  33258.  Stored  frozen  in  dark 
vials. 
Phosphate  Buffer  PH  6.8 
Buffer  consisted  of  0.025  M  KH2P04  (3.4  grn/L)  titrated  to  PH  6.8  with  50% 
NaOH  (sodium  hydroxide). 
2XSSCsolution 
To  1000  ml  distilled  water  added  17.5  gm  NaCl,  8.8  gm  sodium  citrate 
(Na3C6H507.2H20). 
70 Staining  Solution 
I  part  Leishmans  stain,  3  parts  phosphate  buffer 
Luria-Broth  Media  (LB) 
To  450  ml  of  deionised  water  the  following  were  added: 
Bacto-tryptone  5.0  gm 
Bacto-yeast  extract  2.5  gm 
NaCl  5.0  gm 
Adjusted  PH  to  7.0  with  concentrated  NaOH.  The  volume  was  adjusted  to  500  ml 
with  deionised  water  and  then  sterilised  by  autoclaving  at  121"C  for  20  minutes. 
The  medium  was  cooled  and  then  an  appropriate  antibiotic  with  final 
concentration  of  60-100  [ig/ml  was  added  under  sterile  conditions  and  kept  at  VC 
until  used. 
SOC  Media  (1.020  litre)  10  gm  bactotrypton 
5  gm  bacto  yeast  extract 
5  gm  NaCl 
PH  7.5,  adjusted  by  5M  NaOH. 
Sodium  citrate  (]AD 
29.4  gm  of  sodium  citrate  was  dissolved  in  90  ml  of  ddH20.  The  PH  was  adjusted 
to  5.8  and  then  the  volume  was  adjusted  to  100  ml  with  d1120, 
ED  TA  (0.1  M) 
3.2  gm  of  EDTA  was  dissolved  in  90  ml  of  d1120.  The  p1l  was  adjusted  to  8  and 
then  the  volume  was  adjusted  to  100  ml  with  d1120. 
71 SM  Potassium  Acetate 
4.9  gm  of  potassium  acetate  was  dissolved  in  10  ml.  H20. 
T.  E.  buffer 
10  mM  Tris-HCI  was  mixed  with  I  mM  EDTA,  PH  8.6.  The  obtained  solution 
was  filter  sterilised  and  stored  at  room  temperature. 
IOx  TAE  buffer 
The  following  were  added: 
Tris  base  108  gm 
Boric  acid  55  gm 
EDTA  9.3  gm 
To  800  ml  of  dH20  and  dissolved.  The  pH  was  adjusted  to  8.1-8.2  with  IN 
NaOH.  The  volume  was  adjusted  to  I  litre  by  dH20  and  stored  at  room 
temperature. 
T.  A.  E  buffer  SOX 
Tris  base  242  gm 
Glacial  acetic  acid  57.1  ml 
0.5M  EDTA,  PH  8.0  100  ml 
dH20  UP  tO  I  litre 
6  XAgarose  gel  loading  Mix 
Bromophenol  blue  0.25  gin 
Sucrose  40%  (w/v) 
Dissolved  in  IX  TBE  buffer 
72 Salmon  Sperm  DNA  (20  mglml) 
200  mg  salmon  sperm  DNA  dissolved  in  10  ml  of  distilled  water  and  incubated  in 
a  701C  water  bath  for  10  minutes.  The  solution  then  sheered  by  repeatedly  passing 
through  a  needle  (21G)  attached  to  a  10  ml  syringe.  The  tube  then  sonicated  for 
3x4  minutes  at  4  volts.  The  fragment  size  of  sonicated  DNA  was  checked  by  gel 
electrophoresis  in  0.8%  agarose  gel  and  stored  at  40C. 
IOOXDenhardt's  solution 
BSA  (bovine  serum  albumin)  2%  (w/v) 
Ficoll  2%  (w/v) 
Plyvinylpyrrolidone  (PVP)  2%  (w/v) 
Hyrhridisation  buffer] 
5  ml  Formamide  (Fluka)  50%  (v/v) 
2  ml  50%  dextran  sulphate  10%  (W/V) 
0.5  ml  20  X  SSC  Ix  ssc 
2.5  ml  sterile  water 
Aliquoted  and  stored  at  -200C 
Hybridisation  buffer  2 
Two  gm  of  dextran  sulphate  was  dissolved  in  4  ml  of  deionised  water  and  then  the 
following  were  added: 
Formamide  (Fluka) 
20  x  SSC 
10  ml 
2.0  ml 
Salmon  Sperm  DNA  (10  mg1ml)  200  ptl 
The  contents  were  mixed  very  well,  aliquoted  in  Iml  volumes  in  eppendorf  tubes 
and  stored  at  -20*C  until  used. 
73 20XSSC 
Tri-sodiurn  citrate  44.1  g 
Sodium  chloride  87.6  g 
Dissolved  in  dH20,  adjusting  the  volume  to  500  ml  and  stored  at  room 
temperature. 
4XSSC,  Tween-20 
100  ml  of  20  X  SSC  diluted  in  400  ml  dH20  then  250  ýtl  of  tween-20  was  added. 
The  solution  was  mixed  and  stored  at  room  temperature. 
Wash  A  solution 
20  X  SSC  100  ml 
Tween-20 
Dried  skimmed  milk 
250  [d 
25  gm 
The  volume  was  adjusted  to  500  ml  with  dH20,  mixed  well  and  then  spun  at  200 
rpm  for  15  minutes.  The  solution  was  freshly  prepared  for  every  experiment. 
DAN  (4,6-diamidino-2-phcnyl-indole)-  working  solution  (40  ýLg/ml) 
I  gl  of  DAPI  (mg/ml)  was  diluted  in  24  gl  of  distilled  water,  mixed  and  stored  in 
dark  at  4  OC  until  used. 
Propidiuns  iodide  -  working  solution  (20  gg/  ml) 
2  gI  of  propidium  iodide  (10  mg/ml)  was  diluted  in  988  gl  of  distilled  water, 
mixed  and  stored  in  dark  at  4  OC. 
TojE  buffer  I  OmM  Tris-HCI,  PH  7.4 
0.1  mM  EDTA 
74 20X  TTE 
CIR  CLEPREP  Kit  BIO  101:  Cat.  No.  CP-1  00) 
216  g  Tris  base 
72  g  taurine 
4gEDTA 
distilled  water  yp  to  I  litre 
The  kit  contains  the  following: 
*  Pre-lysis  buffer.  (Tris/EDTA/  glucose  solution) 
*  Alkaline  lysis  reagent  (0.2  NNaOH  and  1%  SDS). 
Neutralising  solution  (3M  Potassium  acetate) 
Lithium  Chloride  solution  (near  saturated  solution) 
*  Circleprep  Glass  milk 
9  Binding  buffer  (KBrNaI/Tris  mixture) 
&  Wash  solution 
9  Sieve  material 
BRL  Nick  Translation  Kit  (GIBCO  BRL,  Cat.  No.  8160SB) 
The  kit  supplied  the  following  reagents  and  solutions: 
e  Solution  A4:  0.2mM  nucleotides  C,  G  and  A  in  500  mM  Tris-HCL  (PH 
7.8),  50  mM  Magnesium  Chloride. 
Solution  C:  0.4  units/gl  DNA  polymerase  1,40  pg/gl  DNA  Pol  I/DNase  I, 
50  mM  Tris-HCI,  pH  7.5,5  mM  Magnesium  acetate,  mM  2-mercaptoethanol, 
0.1  mM  phenylmethylsulphonyl  fluoride,  50%  glycerol  and  100  gg/gl  bovine 
serum  albumin). 
Solution  D:  300mM  disodium  EDTA,  pH  8. 
Solution  E:  dH20. 
75 Digoxigenin  DNA  labelling  Kit  (Boeshringer  Mannheim  Biochemica'CatBo 
1175033) 
The  kit  contains  the  following: 
"  Unlabelled  control-DNA  1:  One  vial  with  20  ýil  pBR328  DNA,  100  pg/ml. 
"  Unlabelled  control-DNA  2:  One  vial  with  20  41  pBR328,200  ýig/rnl, 
linearised  with  BamH  1. 
"  DNA  dilution  buffer:  Two  vials  with  I  ml  of  50  4g/mI  herring  sperm  DNA 
in  10  nmol/1  Tris-HCl  and  I  mmol/l  EDTA,  pH  8.0  each. 
"  Labelled  control  DNA:  One  vial  with  50  41  linearised  pBR328  DNA, 
labelled  with  digoxigenin. 
"  Hexanucleotieide  Mixture:  One  vial  with  80  ýtl  10  X  concentrated 
hexanucleotide  reaction  mixture. 
"  dNTP  Labelling  Mixture:  One  vial  with  80  41  of  10  X  concentrated  dNTP 
labeling  mixture  containing  dATP,  I  mmol/l;  dGTP,  1  mMol/l;  dTTP,  0.65 
mmol/l;  Dig-dIT[,  0.35  mMol/l;  pH  7.5. 
"  Klenow  EnMe,  labeling  grades:  One  vial  with  40  41  Klenow  enzyme 
labelling  grade,  2  Units/ýtl. 
Slide  cleaning 
Slides  are  cleaned  in  absolute  alcohol  before  use  to  facilitate  uniformity  of 
spreading  and  to  increase  metaphase  quality  and  banding  quality.  Slides  are 
soaked  briefly  in  ethanol,  wiped  with  a  tissue  or  gauze,  and  then  dipped  back  into 
the  absolute  alcohol  before  dipping  in  distilled  water.  Alternatively  slides  are 
soaked  in  detergent  (100%  Decon  90:  Decon  Laboratories  Limited)  then  slides 
were  rinsed  thoroughly  under  running  tap  water  in  order  to  clean  them  completely 
from  the  detergent.  Slides  then  stored  in  70%  alcohol  till  use.  On  the  day  of  using 
the  slides,  slides  were  rinsed  with  tap  water  completely  to  get  rid  of  alcohol. 
76 Table  2.1:  Summary  of  cases  investigated  and  techniques  applied. 
Subjects  No.  of  Remarks/Ref.  Techniques 
Cases  Diagnosis  AP-Plie4 
.......  -  --  -- 
Al  Known  or  suspected  24* 
chromosomal  abnormalities 
BI  Sex-reversal 
i)  46,  XX  males  =3 
ii)  46,  XX  inale  =I 
iii)  46,  XY  females  =5 
iv)  XY  gonadal 
clysgenesis  =4 
C1  Male  infertility 
II 
56** 
cytogenetic 
(a)  Turner  phenotype  =  16  FISH 
(b)  Primary  amenorrhea  =2 
(c)  Failure  to  thrive; 
developmental  delay  =2 
(d)  MCA=  2 
(e)  Ambiguous  genitalia=  I 
(f)  Short  stature  =I 
Infiertility  Cytogenetic 
FISH 
Hypogonmhsm;  Undescended  Molecular 
testes 
CAIS=3  Cytogowtic 
PAIS  =2  Molecular 
Pure  gonadal  dysgenesis  =2  Cytogenetic 
Inconiplete  gonadal  dysgenesis  =2  F'ISI  I 
Molecular 
Cytogenetic 
a)  Azoospermia  =  32  FISI  I 
b)  Severe  oligoospermia  =  24  Molecular 
Total  93 
Refer  to  Table  3.1  for  detailed  description  of  chromosomal  abnormalities. 
**  Refer  to  Table  3.5  for  detailed  description. 
CAIS  =  Complete  androgen  insensitivity  syndrome;  PAIS  =  Partial  androgen  insensitivity 
syndrome.  MCA  =  Multiple  congenital  anomalies 2.3  Cytoffenetic  studie 
2.3.1  Chromosomal  preparation  from  stimulated  Derinheral  blood 
In  principle,  blood  is  cultured  for  72  hours  in  media  containing  mitogen 
[usually  phytohemagglutinin  (PHA)]  which  is  added  to  stimulate 
lymphoproliferation.  Before  harvesting  the  culture  is  treated  with  colcimid  to 
arrest  the  cell  cycle  in  metaphase.  The  culture  is  then  treated  with  a  hypotonic 
solution  to  swell  the  lymphocytes  and  is  subsequently  fixed  in  a  methanol:  acetic 
acid  solution. 
10  ml  of  peripheral  blood  sample  was  collected  in  a  sterile  10  ml  lithium 
heparin  tube  and  gently  mixed  to  prevent  clotting.  0.1  ml  of  blood  was  added  to  10 
ml  complete  RPM  1  1640  supplemented  media  or  I  ml  of  blood  cultured  in  10  ml 
Ix  Iscoves  medium  and  the  cultures  were  incubated  at  37'C  for  72  hours.  0.1  ml 
of  colcimid  (10  ýLg/ml)  was  added  to  each  10  ml  culture  and  incubation  at  37"C 
was  continued  for  an  additional  30-60  minutes.  The  culture  tubes  were  then 
centrifuged  at  1200  rpm  (400g)  for  8  minutes  using  Beckman  GH-3.7  rotor  in  GS- 
6  centrifuge  (Beckman,  California).  Carefully  the  supernatant  was  removed  and 
discarded  into  1/10  volume  Chloros  and  the  pellet  were  resuspended  in  10  ml  of 
0.075  M  KCI.  The  tubes  were  incubated  for  15-20  minutes  at  37"C  and  then 
centrifuged  at  1200  rpm  (400g)  for  8  minutes.  The  pellets  were  resuspended  in  10 
ml  of  fresh  fixative  by  flicking,  pipetting  or  vortexing  and  the  tubes  left  to  stand  at 
room  temperature  for  30-60  minutes.  The  tubes  were  then  centrifuged  at  1200  rpm 
for  8  minutes  and  the  pellets  washed  in  fresh  fixative.  This  step  was  repeated  2-3 
times  before  the  cells  were  resuspended  in  10  ml  fixative  and  stored  at  4"C  or  at  - 
20T  until  needed. 
2.3.2  Slide  jDreparation 
Chromosome  pellets  removed  from  4"C  or  -2011C  storage  and  allowed  to 
come  to  room  temperature.  The  tubes  were  centrifuged  at  1200  rpm  for  8  minutes 
78 resuspended  in  2-3  ml  fresh  fixative  until  the  solution  was  just  slightly  hazy.  A 
few  drops  (3-5  drops)  of  cell  suspension  were  dropped  onto  wet  cold  slides  from 
approximately  15  cin  distance  and  slides  allowed  to  air  dry.  The  slides  were 
viewed  under  phase  contrast  (10x  objective)  to  evaluate  mitotic  index,  metaphase 
quality  and  chromosome  morphology. 
2.3.3  Giemsa  banding 
Giemsa  banding  (G-banding)  has  become  the  most  widely  used  technique 
for  the  routine  staining  of  mammalian  chromosomes.  The  most  common  methods 
to  obtain  this  banding  pattern  are  to  treat  slide  with  a  proteolytic  enzyme  such  as 
trypsin  (Seabright,  M,  1971)  or  to  incubate  the  slides  in  hot  saline  citrate  (Sumner 
et  al,  1971),  although  a  variety  of  other  methods  have  been  used. 
In  this  study  G-banding  was  produced  on  freshly  made  metaphase  spreads 
by  a  modification  of  Seabright  1971  method.  In  general,  slides  for  G-banding 
should  be  aged  3-5  days  at  room  temperature  or  overnight  (16-18  hrs)  at  56-60"C 
for  optimal  results.  To  get  optimal  result  of  G-banding  slides  were  aged  overnight 
at  56-60*C.  Slides  were  then  treated  for  20-40  seconds  in  0.02%  working  trypsin 
solution  (10%  stock  solution).  Slides  then  rinsed  thoroughly  with  normal  saline 
stained  for  5  minutes  in  2%  Giemsa  solution,  rinsed  in  distilled  water,  and  then  air 
dried.  50  cells  were  counted  and  5  cells  were  analysed  for  full  karyotyping  for  all 
cases  using  Axioplan  Carl-Zeis  light  microscope. 
2.3.4  Late  replication  study  of  X-chromosome  LRX  [Reverse  bandina  using 
5-BromodeoxvuridineJ  BrdU)  and  Giemsa  (RBG)] 
Chromosomes  and  their  segments  replicate  at  different  times  during  the  S 
phase.  This  phenomenon  has  been  extensively  studied  both  itself  and  for  its 
implications  for  chromosomes  structure  and  function. 
This  technique  can  be  achieved  for  example  by  growing  lymphocytes  in 
thyrnidine-containing-medium  and  then  a  medium  with  BrdU.  The  late  replicating 
chromosomes  including  inactive  X  chromosome  are  darkly  fluorescent  with 
quinicrine  and  faintly  stain  with  Giemsa.  Yet  the  inactive  X  is  not  completed 
79 inactive,  there  are  several  segments  escaping  inactivation  especially  the  pseudo 
autosomal.  segment  Xp22.3  and  the  postulated  inactivation  centre  at  Xq13.1 
(Rooney  and  Czepulkowski,  1992). 
Differential  replication  studies  were  conducted  using  IH  of  peripheral 
blood  in  9  ml  Ix  Iscoves  culture  medium  containing  PHA.  Cultures  were  then 
incubated  at  37'C  for  63  hours.  0.2  ml  BrdU  solution  (1.5  mg/ml)  was  added  to 
each  culture  and  incubated  in  the  dark  (using  aluminium.  foil)  for  a  finther  6  hours 
at  3711C.  Then  cultures  incubated  with  0.1  ml  of  colcimid  in  dark  at  3711C  for  a 
further  45  minutes.  Cultures  then  harvested  as  normal  as  described  previously 
taking  care  not  to  expose  cultures  to  light  in  order  to  prevent  photodegradation  of 
BrdU.  The  incorporation  of  BrdU  was  detected  using  Hoechst/Giemsa  staining 
procedure  with  some  modification  according  to  Latt  (Latt  SA  1973).  To  each 
prepared  slide  few  drops  of  Hoechst  3358  solution  (150  jig/ml)  were  added, 
covered  with  a  cover  slip  (22X  50  mm)  and  allowed  to  stand  for  15  minutes  in  the 
dark  at  room  temperature.  The  cover  slips  were  carefully  removed  by  forceps 
taking  care  not  to  scratch  the  slide.  Slides  were  then  rinsed  in  distilled  water  and 
allowed  to  air  dry.  The  slides  were  mounted  in  2x  SSC  with  cover  slips  and' 
exposed  to  ultraviolet  (long  wave)  at  a  distance  of  20-25  cm  for  2  hours.  Slides 
then  rinsed  in  distilled  water  and  air-dried.  The  slides  then  stained  in  freshly 
prepared  Leishmans  stain  for  2  minutes,  mounted  in  Histoclear  and  were  viewed 
with  a  Zeiss  Axioskop  microscope. 
2.4  Molecular  cylopenetics:  Fluorescence  in-situ  hybridisation 
(FISH) 
Fluorescence  in  situ  hybridisation.  (FISH)  involves  hybridisation  of  biotin 
or  digoxigenin-  labelled  DNA  probes  to  denatured  metaphase  chromosomes  and 
interphase  nuclei  and  visualisation  of  those  probes  with  fluorochrome  conjugated 
reagents.  Minor  variations  in  hybridisation  and  washing  conditions  permit 
successful  visualisation  of  single-copy  probe,  whole  arm  paint  (CAP),  whole 
chromosome  paint  probes  and  repetitive-element  probes. 
80 2.4.1  Probe  preparation 
Different  types  of  X  and  Y  chromosome  specific  probes  were  used  in  this 
study  (Table  2.2).  Some  of  the  probes  were  prepared  in  this  department  and  some 
were  commercially  obtained.  Probes  used  in  this  study  consisted  of  single-copy 
probes,  repetitive  element  probes,  whole  arm  paints  (CAP),  and  whole 
chromosome  paints. 
Fourteen  different  probes  specific  for  the  X-chromosome  were  used.  A  set 
of  three  overlapping  cosmids  CPT4,  CAL24  and  CPTI,  mapping  to  Xp2l.  1-21.3 
were  used.  These  cosmids  cover  80  Kb  of  the  distal  half  of  intron  44,  exon  45  and 
10  kb  of  the  5'  end  intron  45  of  the  dystrophin  gene  (Blonden  et  al,  1989). 
Another  set  of  three  cosmids  141R,  G9L  and  VK21,  mapping  to  Xq27-28  of  the 
FRAX-A/E  gene  (fragile  site)  were  used.  These  cosmids  correspond  to  the  loci 
G9L  (G9LB,  I  CRFC  104DO8104),  14  1R  (EZI  65,  ICRFC  100132165)  and  VK21 
(G3/1)  respectively  (Hirst  et  al,  1991,  Flynn  et  al,  1993).  The  G9L  locus  lies 
approximately  70  Kb  proximal,  14  1R  120  Kb  distal  and  VK21  up  to  650  Kb  distal 
to  the  FMRI  CpG  island  (Flynn  et  al,  1993). 
The  commercial  probes  that  were  used  in  this  study  were  DXZI,  KAL, 
DXZ4,  XIST  and  X-chromosome  paint.  The  DXZI  (Oncor)  is  a  2.0  Kb  BamH1 
fragment  which  hybridises  to  highly  repeated  alphoid  DNA  located  at  the 
centromere  of  the  X-chromosome  (Waye  and  Willard,  1985).  Both  biotin  and 
digoxigenin  labelled  DXZI  were  used.  The  Kallman  (KAL  and  DXZ1 
commercially  combined  probes  from  Oncor)  allows  the  identification  of  deletion 
in  the  region  of  the  KAL  gene  at  Xp22.3  region  (Ballabio  et  al,  1989).  The  DXZI 
control  probe  is  included  to  facilitate  chromosome  identification.  The  DXZ4 
(Oncor)  is  a  human  X  chromosome  microsatellite  probe  which  detects  satellite 
DNA  at  a  locus  near  band  Xq24.  The  Oncor  probe  (XIST)  for  the  X-inactivation 
locus  was  also  used  in  the  study  for  identifying  the  specific  human  sequences  in 
the  XIST  (Xi-specific  transcript)  gene  in  either  metaphase  chromosomes  or 
81 the  XIST  (Xi-specific  transcript)  gene  in  either  metaphase  chromosomes  or 
interphase  nuclei.  This  probe  is  assigned  to  XqI  3.2  (Brown  et  al,  199  1).  Whole 
chromosome  paint  of  X  chromosome  was  purchased  from  Oncor  or  Cambio  and 
was  either  biotin  or  digoxigenin-labelled.  Whole  arm  paints  specific  for  the  short 
arm  and  long  arm  of  the  X  chromosome  were  purchased  from  Biomedical 
Research  Corp  (Arlington,  VA,  USA). 
Y  specific  probes  used  in  this  study  were  PDP97,  hocSRY  cosmid  probe 
two  cDNA  probes  for  AZF  region  (MK5  and  MK29),  PHY2.1,  GMGIO  and  whole 
Y  chromosome  library  (Y-paint)  probe.  The  PDP97  probe  is  a  sub-clone  derived 
from  cosmid  Y97  (Wolfe  et  al,  1985)  which  at  high  stringency  detects  a  repeated 
Y-specific  EcoRI  fragment  (DYZ3),  a  marker  for  the  centromere  of  the  Y 
chromosome. 
The  hocSRY  cosmid  probe  contains  a  36  Kb  DNA  insert  from  human 
Ypi  I  which  allows  the  identification  of  sex  determination  region  SRY  gene  (Su 
and  Lau,  1993).  The  MK5  and  MK29  are  1.9  Kb  cDNA  cosmid  probes  assigned  to 
human  Yq1  1.2,  a  region  specific  for  azoospermia  factor  in  male.  (Ma  et  al, 
1993).  The  GMG-10  probes  are  6  Kb  HindIII  fragments  which  hybridise  to 
repetitive  DNA  sequences  at  Yp  11.1  -  11.2  (Affara  et  al,  1986).  The  PHY2.1  probe 
is  a  2.45  Kb  HacIII  fragment  that  hybridises  to  highly  repetitive  DNA  sequences 
(in  -2000  copies)  at  the  heterochrornatic  Yq  region.  Whole  chromosome  paints 
specific  for  chromosome  Y  (biotinylated)  were  purchased  from  Cambio  for  use  in 
this  study  (Table  2.3).  All  cosmid  and  plasmid  probes  were  amplified  by  growing 
in  appropriate  culture  media  containing  the  appropriate  antibiotic  (100  ýIg/ml 
ampicilin  or  60  gg/ml  kanamycin)  and  then  were  used  for  DNA  isolation. 
82 Table  2.2:  DNA  probes  specific  for  X  chromosome  used  in  this  study. 
PROBE  I  VECTOR  INFORMATION  MAPLOC,  4770N  REFERENCE 
cPTI  Cosmid  C2RB  BamHI  site;  Xp2l.  1-21.3  Blonden  et  a]  1989 
100gg  Ampicillin  DMD  locus 
cAL24  Cosmid  C2RB  Bam  HI  site;  Xp2l.  1-21.3  Blonden  et  al  1989 
100ýtg  Ampicillin  DMD  locus 
cPT4  Cosmid  C2RB  Bam  HI  site;  Xp2l.  1-21.3  Blonden  et  al  1989 
100ýLg  Ampicillin  DMD  locus 
141R  Cosmid  EZ  I  65.  ICRFC  Xq27-28  Hirst  et  al  1991 
I  OOE2165;  60gg  Kanamycin  DXS296  Flynn  at  al  1993 
FRAX-A/E 
VK21  Cosmid  G3/1;  60gg  Xq27-28  Hirst  et  a]  1991 
Kanamycin  DXS296  Flynn  at  a]  1993 
FRAX-A/E 
G9L  Cosmid  G9LB  ICRFC  140D8104:  Xq27-28  Hirst  et  al  1991 
601ig  Kanamycin  DXS296  Flynn  at  al  1993 
FRAX-A/E Table  2.3:  Y  chromosome  DNA/cDNA  specific  probes  investigated  in  this  study. 
Probe  Vector  Insert  size  Map  location  Reference 
hocSRY  Cosmid  Lorist  5  36Kb  0.9Kb  Ypil.  1  Su  and  Lau  1993 
60  ýLg  HincII  or  12.6Kb  SRY  locus 
Kanarnycin  EcoR  I  or  2.  lKb 
Hind  II 
MK5  Cosmid  A517  1.9  EcoR  I  Yq  11.2  Ma  et  a)  1993 
CDNA  loogg  RBM1  locus 
Ampicillin 
MK29  Cosmid  A5F  1.9  EcoR  I  Yq  11.2  Ma  et  at  1993 
CDNA  I  00ýig  RBM1  locus 
Ampicillin 
GMGY1O  Chorion  21  6Kb  Hind  III  Ypl  1.1-11.2  Affara  et  at  1989 
HindIII 
I  00jig  ampicillin 
PHY2.1  Plasmid  2.4Kb  Hae  III  Yq  I  2-qter  Cooke  et  at  1982 
PSP65SmaI  DYZ2 
I  00jig  Ampicillin 
PDP  97  Cosmid  Yq7  5.5Kb  EcoR  I  Centromere  Wolfe  et  at  1985 
60gg  Ampicillin  DYZ3 2.4.2  Transformation  and  growth  of  the  probe  and  glycerol  stock  preparation 
Probes  hocSRy  specific  for  SRY  gene  were  kindly  provided  by  Dr.  Lu  and 
MK5,  MK29  cDNA  probes  were  generously  provided  by  Dr  Ann  Chandley.  These 
cosmids  were  transferred  to  DH5aTM  E.  Coli  competent  cells  (Gibco  BRQ 
according  to  the  manufacturers  protocol  with  slight  modification,  The  competent 
cells  were  removed  from  -70*C  and  thawed  on  ice.  The  cells  were  gently  mixed 
using  chilled  sterile  pipette  tips  and  50  41  of  cell  mix  transferred  to  ice  chilled 
sterile  1.5  ml  eppendorf  tubes.  10  pI  of  the  cosmid  DNA  (10  ng)  were  added  to  all 
tubes  containing  the  competent  cells  except  one  tube  used  as  a  negative  control. 
Tubes  were  gently  shaken  for  5  seconds  and  then  incubated  on  ice  for  30  minutes. 
The  cells  were  then  subjected  to  heat  shock  in  a  42*C  water  bath  for  2  minutes 
without  shaking  and  rapidly  placed  on  ice  for  a  further  2  minutes.  After  adding 
800  IA  of  SOC  media  to  all  tubes,  the  cultures  were  incubated  at  37*C  with 
shaking  (100  rpm)  for  one  hour.  200  ý1  of  the  transformed  cell  culture  were  spread 
into  LB  agar  plates  containing  the  appropriate  antibiotics  and  left  to  stand  at  room 
temperature  until  the  excess  moisture  had  been  absorbed.  The  plates  then  were 
incubated  at  37*C  for  12-16  hours  and  transferred  to  4'C  for  up  to  one  month. 
Single  colonies  were  observed  in  all  plates  except  the  negative  control.  Once 
transformation  occurred,  a  single  colony  of  each  probe  was  picked  by  sterile  loop 
and  cultured  in  5  ml  of  LB  media  with  the  appropriate  antibiotic  and  grown  for  16 
hours  at  37"C  with  shaking  at  225  rpm.  The  overnight  culture  was  then  used  for 
DNA  isolation  and  glycerol  stock  formation.  Glycerol  stock  was  made  by  mixing 
0.7  ml  of  the  bacterial  growth  with  0.3  ml  sterile  glycerol,  and  was  then  stored  at  - 
70'C  till  use. 
85 Z4.  Zl  Growth  ofplasmidlcosniidprobes 
Glycerol  stocks  of  transformed  bacterial  cells  containing  the  probes  used  in 
this  study  were  grown  to  amplify  the  required  DNA  probe. 
50  ýLl  of  bacterial  stock  was  cultured  in  50  ml  LB  media  containing  the 
appropriate  antibiotic  at  3711C  with  vigorous  shaking  at  225  rpm  for  16  hours.  The 
cultu  res  then  were  used  for  the  extraction  of  recombinant  plasmid/cosmid,  DNA. 
2.4.2.2  Isolation  of  recombinant  plasmidlcosmid  DNA  using  the 
CIRCLEPREP  kit 
Probe  isolation  was  performed  according  to  Circle  prep  protocol  with 
slight  modification.  On  the  day  following  the  culture,  the  cells  were  transferred  to 
50  ml  centrifuge  tubes  and  centrifuged  at  10,000  rpm  (1  2,000g)  for  5  minutes  at 
4'C  in  Beckman  XL-90  centrifuge  using  JA-20  rotor  (Beckman,  California).  The 
supernatant  was  discarded  and  the  tubes  were  drained  for  1-2  minutes.  Then  cell 
pellets  were  resuspended  and  mixed  well  in  4ml  prelysis  buffer  to  obtain 
homogeneous  suspension.  4  ml  of  alkaline  lysis  reagent  was  added  and  mixed  for 
2  minutes  until  all  the  cells  were  lysed  and  cell  suspension  became  viscous.  Then 
4  ml  of  neutralising  solution  was  added  and  mixed  thoroughly  for  1-5  minutes 
until  the  solution  showed  two  phases,  consisting  of  a  white  precipitate  suspended 
in  clear  liquid  of  water-like  viscosity.  The  mixture  was  centrifuged  12,000  rpm 
(I  7,000g)  for  5  minutes  at  4"C.  Carefully  the  supernatant  was  transferred  throu& 
a  sieve  to  a  new  centrifuge  tube.  Equal  volume  of  isopropanol  (approximately  12 
ml)  was  added,  mixed  well  until  a  fine  precipitate  formed  and  then  centrifuged  at 
12,000  rpm  (I  7,000g)  for  5  minutes  at  4*C.  The  supernatant  was  removed  and  the 
pellet  was  drained.  The  cell  pellet  was  dissolved  in  0.5  ml  sterile  water  and  the 
cleared  supernatant  was  transferred  to  a  microcentrifuge  tube.  At  this  stage  the 
supernatant  could  be  stored  at  4"C  or  frozen.  This  cleared  supernatant  consisted  of 
RNA,  cosmid/plasmid  DNA  and  some  cellular  chromosomal  DNA. 
86 To  denature  the  linear  cellular  DNA  without  nicking  supercoiled 
plasmid/cosmid  DNA,  the  cloned  supernatant  was  incubated  in  a  boiling  water 
bath  for  5  minutes  and  then  the  tube  quenched  immediately  on  ice  water  bath  for 
one  minute.  300  gI  of  LiCl  (Lithium  chloride)  was  added  to  the  tube,  mixed  well 
and  allowed  to  stand  at  room  temperature  for  5  minutes.  The  mixture  then  was 
centrifuged  for  30  seconds  at  14,000  rpm  (12,000g)  in  Beckman  microfuge  E 
(Beckman,  California)  to  pellet  down  the  ribosomal  RNA  (rRNA)  and  single- 
strand  DNA  (ssDNA).  The  supernatant  was  transferred  to  a  new  microcentrifuge 
tube,  600  gl  of  isopropanol  was  added,  mixed  thoroughly  and  then  centrifuged  at 
full  speed  for  I  minute.  The  aqueous  phase  was  discarded,  the  pellet  was  drained 
and  then  dissolved  in  0.5  ml  sterile  distilled  water.  Then  300  PI  of  LiCl  was  added 
and  mixed  well.  To  the  mixture  75  gl  of  circle  prep  Glass  milk  was  added  and 
then  incubated  for  5  minutes  at  room  temperature  with  occasional  mixing.  The 
mixture  was  centrifuged  for  a  few  seconds  to  pellet  down  circle  prep  Glass 
milk/DNA  complex,  the  supernatant  was  removed  and  the  pellet  was  washed 
twice  with  I  ml  wash  solution.  After  a  second  wash  the  tube  was  spun  again  for  a 
few  seconds  and  traces  of  liquid  from  the  bottom  of  the  tube  were  carefully 
removed.  The  cosmid/Plasmid  DNA  was  eluted  from  the  glass  milk  by 
resuspending  the  pellet  in  100  ýil  sterile  distilled  water  and  incubating  for  5  minute 
in  65*C  water  bath.  After  incubation  the  mixture  was  centrifuged  for  I  minute  at 
14,000  rpm  (12,000g)  to  form  a  tight  pellet  of  glass  milk  and  a  clear  supernatant 
containing  cosmid/plasmid  DNA  which  was  transferred  to  a  new  microcentrifuge 
tube.  A  second  elution  would  probably  yield  an  additional  10-20% 
cosmid/plasmid  DNA. 
The  concentration  of  DNA  of  each  cosmid/plasmid  DNA  was  estimated 
using  a  spectrophotometer  at  wave  length  260  nm.  10  ýtl  of  purified  DNA  was 
diluted  in  990  pl  distilled  water  (1:  100  dilution  fraction)  and  optical  density  (O.  D) 
was  measured  at  260  nm. 
Because  1  O.  D.  at  260  unit  corresponds  to  50  [Lg  of  DNA  per  ml  and  the 
DNA  was  diluted  by  100,  the  probe  concentration  was  calculated  using  the 
fOllowing  formula:  Probe  concentration  =  OD  260  X  dilution  factor  X  50  =  pg/ml. 
87 2.4.3  Restriction  enzvme  to  release  probe  insert 
To  ensure  that  transformed  bacterial  cells  contained  the  inserted  DNA, 
enzymatic  digestion  of  the  purified  DNA  was  carried  out  to  release  the  inserted 
probes.  14  ýd  of  cosmid/plasmid  DNA  (7-10  gg)  was  digested  in  a  50  gl  reaction 
volume  using  4  ýtl  of  EcoRI  (for  MK5  and  MK  29)  or  5ýtl  HincII  (for  SRY  cosmid 
DNA),  5  ýfl  of  I  OX  enzyme  buffer  and  27pl  ddH20.  The  mixture  was  incubated  at 
37*C  for  2  hours.  The  digest  was  loaded  alongside  I  Kb  ladder  (Gibco  BRL)  on 
I%  low  melting  agarose  gel  (Seakern  agarose,  Fmc  bioproducts)  in  1X  TAE 
buffer  and  electrophoresed  at  100  volts  for  2-3  hours.  The  gel  was  visualised  on  a 
UV  transillurninator  (212nm)  and  1.9  Kb  or  (0.9  Kb)  bands  were  detected 
corresponding  to  the  probe  size  of  each  MK5  and  MK29  or  SRY  respectively. 
2.4.4  Probe  labellin 
Probes  are  labelled  with  reporter  molecules  and  fragmented  into  200-500 
bp  fragment,  a  size  that  maximises  specific  hybridisation  and  decreases 
fluorescence  background.  Typical  reporter  molecules  include  biotin,  digoxigenin 
and  dinitrophenyl  (DNP),  these  reporter  molecules  are  incorporated  as  labelled 
nucleotides  using  nick  translation. 
In  this  study  labelling  of  cosmid/plasmid  probes  was  done  by  nick 
translation  with  biotin-1  1-dUTP  (Sigma)  and/or  digoxgenin  labelling  I  1-dUTP 
(Sigma)  according  to  the  BRL  Nick  translation  Kit  protocol  with  some 
modification. 
(A)  Biotin-labelling  by  nick  translation: 
To  I  pg  DNA,  the  following  solutions  were  added  sequentially  in  1.5  ml 
microcentrifuge  tube,  5  RI  of  solution  A4,2.5  RI  Biotin-I  1-dUTP,  solution  E  up  to 
45  gl  and  5  ýtl  of  solution.  The  mixture  was  incubated  for  90  minutes  at  15"C.  At 
88 the  end  of  labelling  the  reaction  was  stopped  by  adding  5  gl  of  solution  D.  The 
probe  was  then  precipitated  by  adding  4.6  ýtl  of  3M  sodium  acetate  pH  5.2,1  gl 
of  glycogen,  122  gl  iced  ethanol,  mixed  well  by  vortexing  and  then  centrifuged  at 
12,000  rpm  for  30  minutes.  The  supernatant  was  removed  and  the  pellet  washed 
with  75%  alcohol  and  then  vacuum  dried.  The  probe  was  dissolved  in  10  111  TE 
buffer  giving  a  concentration  of  100  ng/41.  The  mixture  was  vortexed,  briefly 
centrifuged  and  kept  at  room  temperature  for  2  hours  with  occasional  mixing  to 
ensure  complete  dissolving  of  the  DNA.  The  probe  was  stored  at  -20"C  until  used. 
(B)  Digoxiggenin-labelling  by  nick  translation: 
The  digoxgenin  labelling  of  probes  was  performed  using  digoxigenin  DNA 
labelling  mixture  and  a  nick  translation  Kit  (Gibco  BRQ.  The  labelling  was 
carried  out  in  the  same  way  as  biotin  labelling  except  that  to  I  ýIg  DNA,  2  gl  of 
digoxigenin-labelling  dNTPs,  solution  E  up  to  45  pl  and  5  PI  of  enzyme  mixture 
(Solution  C,  Nick  translation  kit)  were  added. 
2.4.5  Slide  preparation 
The  quality  of  the  slide  is  one  of  the  most  important  factors  affecting  the 
degree  of  hybridisation.  Metaphase  chromosome  spreads  were  prepared  by 
dropping  3-4  drops  of  fixed  cell  suspension  on  to  cleaned,  wet  slides  and  left  to  air 
dry.  Slides  were  evaluated  for  quality  by  using  phase  contrast  microscope.  The 
slides  were  fixed  for  one  hour  in  3:  1  methanol:  acetic  acid  fixative,  allowed  to  air 
dry  and  then  dehydrated  through  an  ethanol  series  (50%,  70%,  90%  100%)  2 
minutes  each.  The  slides  were  aged  by  overnight  incubation  at  42*C  or  at  room 
temperature.  Alternatively  slides  were  pre-treated  before  hybridisation  in  2X  SSC 
pH  7.0  at  37C  for  30  minutes.  Treatment  in  2XSSC  artificially  ages  the 
chromosome,  making  them  less  sensitive  to  over  denaturation.  However  the 
treatment  was  not  necessary  if  the  slides  were  more  than  2  weeks  old.  Slides  then 
dehydrated  successively  in  70%,  90%,  100%  ethanol  at  room  temperature  for  2 
minutes  each  and  allowed  to  dry. 
89 2.4.6  Uni-colour  flugrescence  in-situ  hybridisation 
To  detect  a  single  target  on  chromosome  metaphases,  uni-colour 
fluorescence  in  situ  hybridisation  was  performed.  Both  biotin  and  digoxigenin 
labelled  probes  were  applied  in  this  project.  The  overall  procedure  of  pre- 
hybridisation  and  hybridisation  steps  is  similar  for  both  biotin  and  digoxigenin 
labelled  probes  except  for  the  detection  step.  The  biotin-labelled  probes  were 
detected  with  either  rhodamine  or  fluorescein  conjugated  avidin  whereas  the 
digoxigenin  labelled  probes  were  detected  with  monoclonal  anti-digoxigenin 
labelled  with  fluorescein  or  with  fluorescent  con  ugated  anti-digoxigenin,  i 
Z4.6.1  Probe  mixture  preparation  andprobe  denaturation 
In  principle,  suppression  using  competitive  DNA  (Blocking  DNA)  is 
required  for  single-copy  clones  in  various  vectors  (e.  g.  plasmid,  phages,  cosmid), 
probes  with  interspersed  repetitive  (IRS)  and  unique  sequences,  and  whole 
chromosome  paint  probes  to  suppress  repetitive  sequences  in  the  probe  and  to 
prevent  non  specific  hybridisation.  For  simultaneous  hybridisation  of  two  or  more 
probes,  10  ýtg  human  Cot-  I  DNA  or  total  human  genome  DNA  should  be  added. 
Generally  large  probes  with  a  large  amount  of  repetitive  sequence  should 
be  preannealed  for  a  longer  time.  Moreover,  repetitive,  alpha-satellite  and 
telemeric  probes  and  most  cDNA  probes  do  not  require  suppression  with  Cot-I 
DNA  because  Cot-I  DNA  contains  repetitive  DNA  sequences. 
In  this  study  hybridisation  mixtures  were  prepared  with  the  proper 
concentration  of  labelled  probes,  the  desired  concentration  of  competitive  DNA's 
and  hybridisation  buffer  immediately  before  application  to  slides  (Table  2.4). 
Generally,  in  experiments  using  a  single  cosmid/plasmid  probe,  50-250  ng 
labelled  DNA  (0.5-2.5  ýil  from  100  ng/pl  stock)  10  pg  sonicated  human  placental 
DNA  (I  pl  from  10  mg/ml stock  solution)  and  0.8  pg  sonicated  salmon  sperm 
DNA  (0.8  pl  from  10  mg/mI  stock  solution)  were  added  to  8.9  pl  hybridisation 
90 buffer.  In  experiments  using  3  cosmids  together  as  with  the  DMD  probes  and 
fragile  X  probes,  100  ng  of  each  labelled  probe  were  used. 
All  prepared  probes  were  denatured  at  7211C  for  10  minutes  to  denature 
DNA.  If  the  probes  did  not  require  suppression,  the  denatured  probe(s)  placed  on 
ice.  If  suppression  was  required,  the  denatured  probe(s)  placed  at  3711C  and  pre- 
annealed  60  minutes  to  several  hours  (Table  2.4  and  2.5). 
When  co-hybridisation  with  X  centromeric  probe  was  performed  I  [d  of 
DXZI  (0.5  pg/  50  ýtl)  was  denatured  in  10  gl  (I  ng/gl)  hybridisation  buffer,  cooled 
on  ice  and  0.5  ptl  of  it  was  combined  with  pre-annealed  probes  just  before 
application  to  slides. 
When  commercial  probes  XIST  and  KAL  (Oncor)  were  used,  the 
experiments  were  carried  out  according  to  the  supplier's  protocols.  The  probes 
were  provided  premixed  with  blocking  DNA  and  suspended  in  Hybrisol  VII  (50% 
formamide  2x  SSC).  The  probes  were  pre-warmed  at  37*C  for  5  minutes,  gently 
vortexed  and  centrifuged  2-3  seconds  to  collect  the  contents  in  the  bottom  of  the 
tube.  Then  10  ýLl  of  probe  solutions  were  applied  to  denatured  slides. 
Microsatellite  DXZ4  probe  was  prepared  according  to  Oncor  protocol  as 
well.  This  probe  was  provided  with  hybrisol  VI  (65%  formamide,  2X  SSc).  The 
probe  was  pre-warmed  at  37"C  for  5  minutes,  vortexed  and  centnged  for  2-3 
seconds.  31.5  ýtl  of  probe  was  placed  in  0.5  ml  microcentrifuge  tube  and 
denatured  by  heating  in  70*C  water  bath  for  5  minutes.  The  probe  was  then  placed 
in  4"C  ice  bath  until  ready  to  hybridise. 
Total  chromosome  (Coatasome  or  Cambio  paint)  probes  were  also 
prepared  according  to  Oncor  or  Cambio  protocol.  Specific  paints  were  pre- 
warmed  at  37T  for  5  minutes,  gently  vortexed  and  centrifuged  2-3  seconds.  10 
pl  of  probe  solution  was  placed  in  0.5  ml  microcentrifuge  tube.  This  probe  was 
provided  with  blocking  DNA  in  hybrisol  VII  (50%  formarnide,  2X  SSQ.  The 
probe  was  denatured  by  heating  in  70*C  water  bath  for  10  minutes  and  then 
incubated  at  37C  for  I  to  2.5  hours  to  preanneal  the  DNA. 
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LA Z  4.6.2  Cellular  DNA  denaturation  and  probe  hybridisation 
The  target  DNA  was  denatured  by  soaking  slides  containing  metaphase 
chromosomes  2  minutes  in  70"C  denaturing  solution  (70%  formamide/  2X  SSC) 
in  a  Coplin  Jar  in  a  72T  water  bath.  Slides  were  rinsed  for  2  minutes  in  ice-Cold 
70%  ethanol  in  coplin  jar  to  stop  denaturation.  Then  continued  dehydration  by 
incubating  slides  2  minutes  each  in  room  temperature  80%,  90%,  and  100% 
ethanol  and  allowed  to  air  dry  maximally  up  to  15  minutes.  Then  10-  12  [d  or  31.5 
gl  of  preannealed  probe  mix  was  added  to  slides  and  covered  by  22  X  22  or  22  X 
So  mm  glass  cover  slip  respectively,  sealed  with  rubber  cement  and  incubated 
overnight  (16-20  hrs)  in  moist  chamber  at  37-42"C  water  bath  (Table  2.4  and  2.5). 
Z4.6.3  Post  hybridisation  washes 
Prior  to  detection,  post  hybridisation  washes  were  performed  to  remove 
non-specifically  bound  and  weakly  hybridised  probes.  During  last  30  minutes  of 
hybridisation,  50  MI  of  50%  formamide/2X  SSC  wash  and  50  ml  2X  SSC  in 
coplin  jars  were  warmed  in  42"C  water  bath.  The  slides  were  removed  from  moist 
chamber,  the  rubber  cement  peeled  off  and  the  cover  slips  carefully  removed. 
Slides  were  rinsed  in  2X  SSC  at  42"C  for  5  minutes.  The  slides  then  washed  twice 
in  50%  formamide/  2X  SSC  and  twice  in  2x  SSC  at  42*C  for  5  minutes  followed 
by  incubation  in  wash-A  solution  for  30  minutes  at  371C. 
2.4.6.4  Amplification  of  hybridisation  signals 
Signals  of  both  biotin  and  digoxigenin-labelled  probes  were  amplified  after 
post  hybridisation  washes. 
Amplification  of  biotinviation  sinals: 
Slides  hybridised  with  biotinylated  probes  exposed  to  avidin  were 
incubated  with  biotin-labelled  antibody  to  avidin.  Since  every  avidin  molecule 
94 contains  four  biotin-binding  sites,  biotin-labelled  antibody  to  avidin  can 
potentially  bind  the  avidin  molecule  by  a  biotin-avidin  interaction  or  an  antibody 
interaction.  A  final  amplification  of  fluorescence-conjugated  avidin  results  in 
significant  signal  amplification.  Detection  of  biotinylated  signals  was  performed 
as  follows:  100  ýd  of  5  ýtg/ml  FITC  conjugated  avidin  (diluted  in  wash-A)  or  100 
ýd  of  5  ýtg/ml  rhodamine-avidin  (prepared  in  wash  A  solution)  were  applied  to 
each  slide,  covered  with  parafilm,  and  incubated  at  37C  for  15-20  minutes.  Slides 
were  rinsed  3X5  minutes  in  wash-A  at  42"C.  Then  100  gl  of  5  gg/ml  biotinylated 
anti-avidin  (diluted  in  wash  A)  was  added  to  each  slide,  covered  with  parafilm, 
and  incubated  at  room  temperature.  For  FITC  conjugated  avidin  detection  system 
a  final  amplification  was  carried  out  by  adding  100  gl  of  5  ýLg/ml  FITC  conjugated 
avidin  (diluted  in  wash  A)  and  incubated  for  15-20  minutes  at  room  temperature. 
Finally,  slides  were  rinsed  2X5  minutes  at  42"C  in  wash-A  and  2X5  minutes  in  4 
X  SSC,  0.5%  Tween-20  at  room  temperature,  dehydrated  through  an  ethanol 
series  50%,  70%,  90%,  100%  2  minutes  each  and  allowed  to  air  dry. 
b)  Amplification  of  signals  from  digoxigenin-labelled  probes: 
Fluorescence  signal  for  digoxgenin-labelled  probes  is  achieved  by 
sandwiching  a  non-fluorescent  fragment  of  sheep  anti-digoxigenin  between  the 
digoxigenin  labelled  probe  and  a  fluorochrome-labelled  anti-sheep  IgG.  Since 
more  than  one  Fab  fragment  can  attach  to  a  single  digoxigenin  molecule  and  each 
of  the  Fab  fragments  is  recognised  by  the  fluorochrome-conjugated  second  anti- 
body,  significant  signal  amplification  occurs,  The  digoxigenin-labelled  probes 
were  detected  as  follows:  100  gl  of  0.6  ýig/ml  anti-digoxigenin  fluorescin  Fab 
fragment  prepared  in  sheep  (prepared  in  wash-A  solution)  was  applied  to  the 
hybridised  area,  covered  with  parafilm  and  incubated  at  37*C  for  15-20  minutes. 
Slides  were  rinsed  3X5  minutes  in  420C  wash  A  and  incubated  with  100  ýtl  of 
2.25  gg/ml  fluorescent  anti-sheep  IgG  for  15-20  minutes  at  room  temperature. 
Slides  were  washed  2X5  minutes  in  420C  wash-A  solution,  2X5  minutes  in  4X 
SSC/  0.5%  Tween-20  at  room  temperature,  dehydrated  through  an  ethanol  series 
50%,  70%  90%  and  100%  two  minutes  each  and  then  air  dried. 
95 Z4.6.5  Chromosome  counter  staining 
Chromosomes  were  stained  by  adding  10-  12  41  of  the  appropriate  counter 
stain.  When  probe  was  detected  by  FITC-avidin  (green),  chromosomes  were 
counter  stained  using  both  DAPI  and  propidium  iodide.  I  ýtl  of  DAPI  (40  JIG/ML) 
and  2  ýtL  of  propidiurn  iodine  (20  gg/ml)  were  diluted  in  97  gI  of  antifade 
mounting  medium  AF  I  (Citifluor  Ltd),  slides  were  covered  with  22  mý  coverslip 
and  sealed  with  nail  polish.  Slides  were  stored  in  the  dark  at  -2011C  till  scored. 
When  rhodamine  (red)  was  used,  chromosomes  were  detected  with  counter 
stain  containing  only  DAP  1.1  pl  of  DAPI  (40  pg/ml)  was  diluted  in  99  ýd  of 
antifade  solution. 
2.4.7  Multi-colour  FISH 
A  dual  colour  and  a  three  colour  combinatorial  mixing  FISH  method  was 
applied  to  metaphase  chromosomes  to  detect  simultaneously  the  probe  sets 
specific  for  X  chromosome  or  Y  chromosome.  A  dual  colour  detection  protocol 
can  be  used  for  two  probes  (one  labelled  with  biotin  and  one  with  digoxigenin)  but 
a  third  probe  labelled  with  both  can  also  be  recognised.  In  dual  colour  the 
hybridisation  mixture  contained  two  specific  probes  of  which  one  was  labelled 
with  biotin-11-dUTP  and  the  other  with  digoxigenin-11-dUTP.  When  ratio- 
mixing  FISH  was  applied  a  third  probe  was  labelled  with  either  biotin  II  -dUTP  or 
digoxigenin  II  -dUTP  and  mixed  in  a  1:  1  combination  (Table  2.6). 
2.4.8  Detection  and  counter  stainina  of  multi-colour  FISH 
The  pre-hybridisation,  hybridisation  and  post  hybridisation  washing  steps 
for  multi-colour  FISH  were  performed  as  for  uni-colour  FISH  except  for  detection 
step.  In  all  multi-colour  FISH  studies  the  biotin-labelled  probes  were  detected  with 
avidin  con  ugated  with  rhodamine  and  the  signals  were  amplified  by  using  j 
biotinylated  anti-avidin  and  adding  a  second  layer  of  avidin  conjugated  with 
rhodamine. 
96 Table  2.6:  Hybridisation  mixtures  applied  in  the  dual  and  in  the  combinatorial  1,  ISH 
studies. 
lliotin  probe  Digoxigenin  Il  Iu  ma  n  I  lybridisation  Pre- 
Probe  placental  Bu  ffer  annealing 
DNA  Time 
DXZ  I=  I  [LI  DMI)  =  3[tl*  1  pi  9  ý11  Ih 
DXZI=l  PI  FRAXA/E*=  3  1  pi  9  pi  III 
ýtl 
KAL  =10  pi  DXZI  =I  pl 
DXZI  =1  [d  XIST  =I  0  [tl 
DXZI  =1  ýtl  DXZ4  =31.5  p] 
PDP97  =I  [LI  DXZI  I  ýtl  I  Old 
DMD  3  ýtl*  XIST  10  ýd 
KAL  10  ýd  DXZ  31.5pt 
DMD  =2.5  Iil  FRAXA/E=  I  pi  8ýd 
2.5[il 
MK5  =  2.5  PI*  PDP97  =  1ýtl  0.6  ýtl  9  ý11 
hocSRY  =  2.5  1.0  IIDP97  =I  [d  0.6  [d  9ýd 
MK29  =  2.5  W*  PDP97  =I  ýtl  0.6  ýd  9  [LI 
GMGY  10  -I  ýtl  III  IY2.1  =I  [tl  -  I  O[LI 
hocSRY  =  2.5  [tl*  DXZI  =I  ýtl  0.6ýtl  9[d 
hocSRY  =  2.5ptl  MK5  2  [LI  0.6pl  9[d 
DXZI=  I  [d  +  DXZI  =I  ýtl 
KAL  =  10  jd 
DXZI  I  pt  DXZl  =I  pi 
XIST  10  pi 
DXZI  I  pl  DXZI  =I  pl  + 
DXZ4  =  31.5  pl 
DXZl  I  ItI  +  DXZl  ýI  [d 
DMD  3  [d  FRAX  =3  ýLl 
DXZI  ýI  pl  +  DXZI  1  [11  + 
KAI,::  10  pi  XIST  10  pi 
DXZI  =I  pi  DXZI  I  ýtl 
DXZ4  31.5  W 
*The  probe  first  pre-annealed  to  the  competitor  DNA  and  then  the  second  probe  was 
added  to  the  mixture  before  application  to  the  slide. 
Note:  I  lybridization  temperature  was  at  390C  to  420C  for  16  hour, The  digoxigenin-labelled  probes  were  detected  by  FITC  conjugated  monoclonal 
anti  mouse  IgG.  The  detection  method  was  as  follows:  100  PLI  of  5  gg/ml  FITC 
conjugated  avidin  was  applied  to  the  hybridised  area,  covered  with  parafilm  and 
incubated  at  37"C  for  15-20  minutes.  Slides  were  rinsed  3X5  minutes  in  42"C 
wash-A.  100  gl  of  mixture  of  5  gg/ml  of  goat  anti-avidin  D  and  5  ptg/ml  of  FITC 
conjugated  monoclonal  anti-digoxin  prepared  in  mouse  (diluted  in  wash-A)  was 
added  to  the  slide,  covered  with  parafilm  and  incubated  at  room  temperature  for 
15-20  minutes.  Slides  were  washed  2X5  minutes.  in  wash-A  at  42"C  and  then 
incubated  at  room  temperature  for  15-20  minutes  with  100  gl  of  a  mixture  of 
rhodamine  avidin  (5  ýtg/ml)  and  FITC  conjugated  anti-mouse  IgG  (5  Jig/ml 
prepared  in  wash-A  solution).  Slides  were  washed  2X5  minutes  in  42T  wash-A 
and  2X5  minutes.  in  4X  SSC/0.5%  Tween-20  at  room  temperature,  dehydrated 
through  ethanol  series  50%,  70%,  90%  and  100%  and  air  dried.  Slides  were 
counter  stained  and  mounted  in  DAPI/antifade  stain  as  previously  mentioned. 
2.4.9  Visualisation 
All  FISH  studies  were  ex=ined  and  analysed  using  a  fluorescence 
microscope  with  epi-illumination  equipped  with  filter  sets  appropriate  for  the 
fluorochrome  used  (Zeiss  Axioplan)  (Table  2.7).  A  DAN  filter  set  was  used  for 
chromosome  identification  and  a  triple-band-pass  filter  set  was  used  for 
simultaneous  viewing  of  multiple  fluorochrome.  The  epifluorescence  microscope 
also  equipped  with  a  Photometric  charge  coupled  device  (CCD)  camera  and 
computer  software  (SmartCapture;  Digital  Scientific).  The  images  were  captured 
and  printed  on  sublimation  printing  paper  (A4-SPW)  using  a  Mitsubishi  colour 
printer. 
98 Table  2.7:  Filters  applied  to  visualize  fluorochromes  by  epifluorescence 
microscopy. 
Fluorochrome  Excitation 
Wavelength  (nm) 
Emission 
Wavelength  (nm) 
Zeiss  - 
Filter 
Colour  of 
Fluorescent 
DAPI  345  425  1,2  Blue 
Propidium  520  610  9  Red 
iodide 
FITC  490  525  9,10  Green 
Rhodamine  540-560  580  15  Red 2.5  Molecular  Genetics  stuft 
2.5.1  DNA  extraction 
DNA  was  extracted  from  whole  blood  following  the  protocol  described  by 
Kunkel  et  al  (1977).  5  -10  ml  EDTA  of  blood  were  transferred  to  a  falcon  tube  and 
lysis  buffer  (0.32  M  sucrose,  10  rnM  Tric-Cl  pH  7.5,5  mM  MgC12,1%  Triton 
100)  was  added  up  to  50  ml.  The  samples  were  mixed  and  centrifuged  in  Beckman 
GS-6  centrifuge  using  GH-3.7  rotor  (Beckman,  California)  at  2,500  rpm  (1,430g) 
for  10  minutes  at  40C.  The  supernatant  discarded  into  a  beaker  containing  5% 
Chloros  and  the  pellet  resuspended  in  3  ml  nuclei  mix  (10  mM  Tris,  0.4  M  NaCl, 
2  mM  EDTA,  pH  8.2.200  ttl  10%  SDS  (Sodium  Dodecyl  Sulphate)  and  100  ý11  of 
protenase  K  (10  mg/ml)  were  added.  The  mixture  then  vortexed  thoroughly  and 
incubated  at  370C  for  16  hr.  I  ml  of  6M  NaCl  was  added  and  the  samples  were 
shaken  vigorously,  and  were  centrifuged  at  3,000  rpm  (2,060g)  for  15  minutes. 
The  top  layer  was  carefully  transferred  into  a  clean  centrifuge  tube  and  800  ýtl 
phenol/chloroform  added  and  mixed  by  inversion  several  times  for  I  minute.  The 
tube  was  then  centrifuged  at  2,500  rpm  (1,430g)  for  15  minutes.  The  supernatant 
was  then  transferred  into  a  sterile  tube  and  the  DNA  was  precipitated  by  the 
addition  of  two  volumes  of  100%  ethanol,  The  DNA  was  spooled  out  using  a 
clean  sealed  Pasteur  pipette,  air  dried  and  dissolved  in  300-500  PI  TE  buffer  (10 
mM  Tris,  I  mM  EDTA  pH  7.5).  The  DNA  was  left  to  dissolve  overnight  at  room 
temperature.  The  concentration  of  DNA  was  calculated  by  measuring  the  optical 
density  at  260  nm  and  the  DNA  stored  at  40C. 
ore.  q 
1%  agarose  gel  was  prepared  by  dissolving  0.5  9  agarose  powder  (Seakem 
GTG,  FMC  Bioproduct)  in  50  ml  IX  T13E  buffer.  The  mixture  was  boiled,  cooled 
down  551C,  I  ýd  ethidium  bromide  was  added  (10  mg/pl)  and  then  allowed  to  set, 
Samples  were  mixed  with  1/5  volume  of  6X  TBE  loading  buffer  (0,25% 
bromophenol  blue,  0.25%  xylene  cyanol,  40%  w/v  sucrose  in  water)  were  loaded 
100 and  the  gel  electrophoresed  in  IX  TBE  buffer  at  10-15  v/cm,  until  the 
bromophenol  blue  in  the  loading  mixture  migrated  two  thirds  of  the  distance  of 
the  gel.  The  DNA  was  then  visualised  with  a  UV  light  (212  run)  transilluminator 
and  photographed. 
2.5.3  Oligonucleotide  design  and  Ilreparation 
Oligonucleotides  were  designed  to  amplify  DNA  sequences  from  both 
YRRM  (RBM-1)  and  SRY  genes  (Appendix  I  Tables  112  and  117).  The  computer 
program  Oligo  TM  version  3.4  (Medprobe)  was  used  for  primer  designing.  Primers 
of  20  to  22  bases  were  designed  to  be,  as  much  as  possible,  free  of  significant 
complementarity  at  their  3'  termini,  free  of  self-complernentarity  and  able  to  form 
a  stable  duplex  (by  calculating  the  free  energy  of  duplex  formation,  AG)  with  the 
specific  site  only  on  the  target  DNA.  The  T.  (melting  temperature)  difference 
between  both  primers  and  between  the  template  and  the  less  stable  primer  is  kept 
to  a  minimum  with  avoidance  of  runs  of  C's  or  G's  at  the  3'  ends  of  the  primers. 
All  primers,  either  published  or  newly  designed  (Appendix  I)  were 
synthesised  in-house  using  an  ABI  391-DNA  synthesiser  with  "  Trityl  off' 
(Applied  Biosystem).  The  end  products  existed  as  phosphate-protected,  base 
protected  phosphotriesters,  therefore,  complete  deprotection.  was  required  to 
produce  active  oligonucleotides.  The  extraction  of  the  primers  from  the  column 
was  carried  out  as  follows: 
The  primers  were  cleaved  and  the  cyanoethyl-protecting  group  (phosphate 
deprotection)  was  removed  by  treating  the  primers  with  fresh  concentrated 
ammonium  hydroxide  for  one  hour.  Base  deprotection  (ammoniolysis  reaction  and 
the  removal  of  benzoyl  and  isobutyryol  base  protecting  group)  was  followed  by 
placing  the  vials  contained  the  collected  oligonucleotides  in  a  55"C  water  bath  for 
5-18  hours.  The  ammonium  hydroxide-oligonucleotide  solution  was  cooled  at 
room  temperature  for  at  least  30  minutes.  Primers  were  then  stored  in  ammonia 
eluant  at  -20"C  till  needed.  Before  using,  purification  of  primers  from  ammonia 
was  performed.  Aliquots  from  the  ammonia  stock  were  left  in  opened  tubes  under 
the  fume  hood  for  16-24  hours  to  ensure  complete  evaporation  of  the  ammonia. 
101 The  concentration  of  the  primers  was  estimated  by  measuring  the  O.  D.  using  UV 
spectroscopy  at  260  mn.  Because  1  O.  D.  260  of  single-strand  oligonucleotide 
represents  approximately  33  microgram  of  DNA/ml  therefore,  primer 
concentrations  were  calculated  as  follows:  Oligonucleotide  concentration  =  OD 
260  X  dilution  factor  X  33  =  pLg/ml.  The  oligonucleotide  solution  was  diluted  to  5 
gM  concentration  and  stored  at  -200C. 
2.5.4  Polvmerase  chain  reaction  (PC 
Different  sets  of  primers,  both  published  and  in  house  designed,  were  used 
for  PCR  to  amplify  exons  and  regions  of  interest  from  different  genes  (Androgen 
receptor  (AR),  SRY,  and  RMB-1]  (Appendix  I).  All  reactions  were  optimised 
individually.  Each  reaction  was  carried  out  in  50  gI  final  volume  containing  250 
ng  of  genomic  DNA  as  a  template,  30  pmol  of  the  relevant  sense  and  antisense 
primer,  200  gM  of  each  dNTPs,  5  gl  of  the  1  OX  PCR  buffer  (100  mM  Tris  Hel  pH 
8.3,500  mM  KCI,  15  rnM  MgC12,0.1%  gelatine)  and  2.5  units  Taq  polymerase. 
The  reactions  were  mixed  and  then  overlaid  with  mineral  oil.  The  samples  were 
subjected  to  28  cycles  of  denaturation  at  940C  for  I  minute,  annealing  at  the 
appropriate  temperature  for  each  segment  for  I  minute  and  extension  at  72  OC  for 
I  minute  followed  by  a  final  extension  step  at  72  OC  for  10  minutes.  PCR  products 
were  checked  by  gel  electrophoresis  on  I%  agarose  mini-gels  with  the  product 
being  compared  against  a  100  bp  or  I  kb  ladder  (Gibco  BRL). 
2.5.5  Multiplex  PC 
Multiplex  PCR  screening  methods  were  performed  using  28  primer  pairs 
(Appendix  1,  Table  1-5)  in  five  multiplex  PCR  experiments.  These  primer  pairs 
were  used  to  screen  for  the  presence  or  absence  of  28  Y-specific  DNA  sequences 
in  Yq  II  in  S6  infertile  male  patients.  The  screening  method  was  applied  according 
to  Henegariu  et  al  (1994)  with  some  modifications. 
Primer  start  solutions  for  the  multiplex  PCR  were  optimised  so  that  each 
primer  concentration  in  each  multiplex  reaction  was  optimal  for  the  amplification 
Of  its  corresponding  genomic  template  (Table2.8). 
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10 Each  multiplex  PCR  was  performed  in  25  gI  PCR  reaction,  To  each 
multiplex  primer  start  solution,  I  SOng  of  genomic  DNA,  200  gM  dNTP  mix,  5% 
DMSO  (dimethyl  sulfoxide),  2.5pd  of  1OX  PCR  buffer,  and  2.5  unit  of  DNA  Taq 
polymerase,  was  added  (Table  2.8).  The  complete  PCR  mix  was  overlaid  with 
mineral  oil  and  put  directly  in  a  thermocycler  preheated  to  940C.  The  templates 
were  initially  denatured  at  940C  for  5  minutes  followed  by  45  cycles  at  940C  for 
30  seconds  (melting);  540C  for  45  seconds  (annealing)  and  650C  for  120  seconds 
(extension).  A  final  extension  at  650C  for  5  minutes  was  performed.  At  the  end  of 
PCR  amplification  the  tubes  were  stored  at  40C  or  -200C  till  use. 
2.5.6  Gel  analysis  of  multiplex  PCR 
The  PCR  products  were  separated  on  3%  agrose  gels  (Seakern  LE  quality) 
by  electrophoresis  in  I  XTAE  buffer  at  room  temperature  using  a  voltage  gradient 
of  8  volt/cm.  For  increasing  the  sharpness  of  gel  fragments  Nuseive:  Seakem  (3:  1) 
gels  in  TBE  buffer  were  used.  SgI  of  5X  loading  buffer  (IS%  Ficoll,  0.25% 
Xylene  cyanol)  was  added  to  the  PCR  product  and  half  of  the  PCR  reaction  mix 
was  loaded  on  the  gel  and  electrophoresed  for  3  hours  at  10  volts/cm  then 
photographed. 
2.5.7  Southern  blot  analysis 
(A)  Prohe  preparation 
Digests  were  set  up  to  release  the  probe  inserts  MK-5  and  MK-29  from 
cosmid  DNA  in  50  ýd  total  volume  reactions.  14  pl  of  cosmid  DNA,  obtained  by 
the  CIRCLE  PREP  kit,  2  jil  (5  0  units)  EcoRI  restriction  endonuclease,  10  gl  I  OX 
enzyme  buffer  and  ddH20  up  to  50  gl  was  incubated  at  370C  for  2  hours.  The 
digest  was  electrophoresed  alongside  a  IKb  ladder  (Gibco  BRL)  on  1%  low 
melting  agarose  gel  (Seakem  agarose,  FMC  bioproducts)  for  3-4  hours  at  100 
volts.  The  gel  was  visualised  on  a  UV  transilluminator  and  the  1.9  kb  insert  band 
was  cut  by  a  sterile  scalpel  blade  and  placed  in  a  pre-weighed  1.5  ml  tube.  The 
sample  was  weighed  and  2  ml  of  sterile  T.  E.  buffer  was  added  for  every  gram  of 
104 sample.  The  insert  was  then  boiled  for  5  minutes  and  stored  at  -200C  until  used. 
(B)  Southern  blotting 
7  to  10  ýig  of  genomic  DNA  was  digested  using  the  appropriate  restriction 
endonuclease  in  a  total  volume  of  50  ýd  containing  IX  appropriate  enzyme  buffer 
and  40  units  of  the  specific  enzyme.  The  digests  were  incubated  in  a  water  bath  set 
at  the  recommended  temperature  for  16  hours.  Digests  were  stored  at  -200C  till 
used. 
The  digested  fragments  were  separated  alongside  aI  kb  ladder  in  0.8% 
agarose  gels  prepared  in  IX  TAE  buffer  and  containing  0.5  pg/mI  ethidiurn 
bromide.  The  gel  was  electrophoresed  at  2  volts/cm  for  16-20  hours.  At  the  end  of 
electrophoresis  the  gel  was  visualised  and  photographed  alongside  a  ruler  on  a  UV 
transilluminator.  The  gel  was  then  transferred  to  a  plastic  box,  rinsed  several  times 
in  water,  treated  in  a  depurination  solution  (0.2M  HCI)  for  15-20  minutes  then 
rinsed  in  water.  The  gel  was  then  treated  with  the  denaturation  solution  (O.  SM 
NaOH,  1.5M  Na  Cl)  for  30  minutes,  rinsed  in  water  and  neutralised  in  two 
changes  of  neutralisation  solution  (3M  NaCl,  O.  SM  Tris  pH  7.4)  for  15  minutes 
each. 
The  blotting  apparatus  was  set  up  by  placing  a  glass  plate  across  a  plastic 
box  contained  IOX  SSC.  The  glass  plate  was  covered  by  a  double  layer  of  3MM 
Whatman  paper  with  its  ends  dipped  into  the  SSC.  Any  air  bubbles  between  the 
paper  and  the  platform  was  smoothed  out.  The  treated  gel  was  placed  onto  the 
wick  making  sure  that  there  were  no  air  bubbles  between  the  gel  and  the  3MM 
paper.  The  gel  was  surrounded  by  a  plastic  wrap,  to  ensure  that  buffer  would 
proceed  only  through  the  gel.  A  sheet  of  Hybond  N  membrane  was  cut  to  size, 
then  layered  over  the  gel  avoiding  air  bubbles.  Two  layers  of  3MM  paper  soaked 
in  2X  SSC  were  then  placed  on  to  the  membrane  and  air  bubbles  were  removed.  A 
stack  of  paper  towels  (-  10  cm  high)  was  placed  on  top  of  the  filter  paper.  A  glass 
plate  and  a  weight  of  -  500  g  were  laid  on  top  of  the  absorbing  paper  stack.  The 
blotting  was  carried  out  overnight.  The  next  day  the  blot  was  dismantled  and  the 
filter  was  baked  for  4  hours  in  an  800C  oven  to  fix  the  DNA. 
105 (C)  Hybridisation  of  DNA  blot 
Prehybridisation  of  filter 
The  filter  was  placed,  in  the  hybridisation  bottle,  with  10  ml  of  the 
prehybridisation  solution  (6X  SSC,  0.5%  SDS,  5X  Denhardts)  and  10  ýd  boiled 
sonicated  salmon  sperm  DNA  (10  mg/ml)  and  incubated  in  an  650C  hybridisation 
oven  overnight. 
Probe  labelling  and  filter  hybridisation 
The  probe  was  radioactively  labelled  using  the  random  primed  DNA 
labelling  kit  (Boehringer  Mannheim)  according  to  the  supplier's  protocol.  24  gI  of 
the  probe  (in  low  melting  agarose)  were  boiled  for  10  minutes,  then  incubated  at 
370C  for  one  minute.  The  probe  was  then  added  to  a  mix  of  2  jil  each  of  dATP, 
dGTP  and  dTTP,  4  ýtl  of  the  reaction  mix,  1.5  gI  of  Klenow  enzyme  and  5  41  (50 
gCi)  Of  OC_32  P  dCTP  (Amersham).  The  tube  was  then  incubated  at  370C  for  2.5 
hours.  The  labelled  probe  was  then  separated  from  the  unincorporated  CC-  32  P  dCTP 
using  G-50  sephadex  NICKTm  columns  (Pharmacia  Biotech.  ).  The  column  was 
washed  with  3  ml  IX  SSC.  The  labelled  probe  (-  40  gl)  was  added  to  the  top  of 
the  column  and  then  400  pl  IX  SSC  was  added  and  allowed  to  drip  through.  A 
ftuther  400  ýfl  IX  SSC  was  then  added  to  the  column  and  the  drops  were 
collected. 
The  labelled  probe  was  boiled  for  4  minutes  and  added  to  the 
prehybridisation  solution.  The  filter  was  left  to  hybridise  overnight  at  650C. 
After  hybridisation,  the  hybridisation  solution  was  discarded  and  the  filter  was 
washed  in  2X  SSC/0.1%  SDS  for  10  minutes  at  650C.  The  filter  was  removed, 
monitored  and  placed  in  a  plastic  box  with  O.  SX  SSC/0.1%  SDS  and  washed  by 
shaking  at  650C  in  a  water  bath  for  5  to  10  minutes.  If  a  signal  greater  than  10 
cpm  (count  per  minute)  was  detected,  the  washing  was  continued  with 
increasingly  stringent  solutions  (650C,  0.25X  SSC/0.10/0  SDS  then  O.  IX 
SSC/0.1%  SDS)  until  the  filter  had  washed  down  to  less  than  5  cpm, 
106 (D)  A  utoradlography 
The  filter  placed  in  an  autoradiographic  cassette  with  intensifying  screens 
and  exposed  to  Kodak  Diagnostic  AR  Imaging  film.  The  cassette  was  stored  in  a- 
400C  freezer  for  at  least  one  week.  The  autoradiograph  was  then  developed  and 
analysed. 
2.5.8  Single  strand  conformational  polymori)hism  (SSCP)  analysis 
SSCP  analysis  was  applied  to  screen  for  point  mutations  using  MDETM 
gels  (mutation  detection  enhancement),  which  significantly  improve  the  resolution 
of  DNA  molecules  with  different  conformations. 
Radiolabelled  PCR  amplifications  of  exons  and  regions  of  interest  from 
different  genes  were  performed.  PCR  amplifications  were  done  using  the  standard 
PCR  protocol.  IS  ýd  PCR  reaction  mix  was  prepared  to  contain  IX  GeneAmp 
PCR  buffer,  100  ýM  of  each  dNTP,  1.5  pmol  of  each  primer,  100  ng  genomic 
DNA,  2  ýXi  oc-  32  P  dCTP  and  2  units  AmpliTaq  polymerase.  The  reaction  was 
overlaid  with  25  ýfl  mineral  oil  and  was  subjected  to  thermal  cycling  with  the 
appropriate  annealing  temperature  for  each  specific  exon  or  segment  (Appendix  I). 
All  segments  of  the  SR  Y  gene,  exons  2-7  of  the  AR  gene  and  exons  1  -11  of  the 
RBMI  gene  were  screened  by  SSCP  analysis. 
At  the  end  of  thermal  cycling  the  amplified  products  were  diluted  1:  9  in 
loading  buffer  (95%  formamide,  lOmM  NaOH,  0.5%  bromophenol  blue  and  0.5% 
xylene  cyanol),  heat  denatured  at  950C  for  3  minutes  then  quenched  on  ice  for  at 
least  5  minutes  before  loading  to  SSCP  gel.  3  pl  of  each  sample  was  loaded  on 
0.5X  MDE  non-denaturing  gel  containing  5%  glycerol.  The  gel  was 
electrophoresed  in  0.6X  TBE  buffer  at  5  watts  for  16  hours  at  room  temperature. 
After  gel  electrophoresis,  the  glass  plates  were  separated  gently  and  the  gel 
was  transferred  to  3MM  Whatman  paper  and  covered  with  Saran  wrap.  The  gel 
was  dried  under  vacuum  for  45  minutes  at  80'C,  with  the  Saran  wrap  upper  most 
on  a  gel  dryer  (Biorad,  Model  583). 
Autoradiography  was  carried  out  by  placing  the  dried  gel  with  the  DNA 
107 side  facing  the  X-Ornat  diagnostic  AR  film  (Kodak)  in  an  autoradiogrPhic  cassette 
with  intensifying  screens.  The  gel  was  autoradiographed  for  5  to  16  hours  at  - 
400C. 
2.5.9  Heteroduplex  analysis 
This  method  was  based  on  the  protocol  described  by  Keen  et  al  (199  1) 
with  some  modifications.  Non-radiolabelled  PCR  amplification  was  done  using 
the  standard  protocol  as  previously  mentioned.  At  the  end  of  the  PCR  cycles  the 
reaction  was  inactivated  by  adding  EDTA  to  a  final  concentration  of  5mM.  PCR 
products  of  a  test  sample  and  a  wild  type  control  were  mixed,  heated  to  95  OC  for 
5  minutes  and  cooled  slowly  to  room  temperature  over  20  to  30  minutes  to  form 
any  heteroduplexes.  Meanwhile,  a  50  cm,  I  mm.  thick,  IX  MDE  gel  was  prepared 
in  1X  TBE  buffer  and  allowed  to  set  for  at  least  1  hour.  Samples  were  prepared  by 
adding  10ýtl  of  6X  formamide  loading  buffer  (95%  deionized  formamide,  lOmM 
EDTA,  10  mg/ml  bromophenol  blue  and  10  mg/ml  xylene  cyanol)  for  every  5  41 
PCR  product.  5-10  41  of  samples  were  loaded  and  electrophoresed  in  0.6X  TBE 
buffer  alongside  aI  kb  ladder  and  a  positive  control  heteroduplex  sample  at  a 
constant  800  volts  for  20-24  hours.  The  gel  was  analysed  by  silver  staining  and 
photography.  This  technique  was  applied  to  exon  8  of  the  AR  gene  and  exon  12  of 
the  RBMI  gene. 
2.5.10  Silver  stainin 
The  gel  was  first  fixed  in  two  changes  of  fixation  solution  (10%  ethanol, 
0.5%  acetic  acid)  each  for  5  minutes  with  gentle  shaking.  Then,  it  was  stained  for 
15  minutes  in  freshly  prepared  0.1  %  silver  nitrate,  rinsed  briefly  with  distilled 
water,  incubated  in  developing  solution  (1  .  5%  NaOH,  0.1  %  formaldehyde  mixed 
just  before  use)  for  30  minutes,  treated  with  0.75%  Na2C03  solution  for  10 
minutes,  sealed  in  a  plastic  bag  and  photographed. 
108 2.5.11  Chemical  cleavage  of  mismatches  (CCM-) 
Chemical  cleavage  of  mismatches  analysis  was  applied  as  a  part  of  the 
mutation  detection  strategy.  The  technique  was  performed  according  to  Cotton  et 
al  (1989),  with  slight  modifications. 
(A)  Preparation  of  non-radiolabelled  test  DNA  and  radiolabelledprobe 
The  open  reading  frame  of  the  SRY  gene  was  amplified  by  PCR  using 
XEIO/XEII  primers  (Appendix  1-2)  from  four  patients  with  sex  reversal  and 
gonadal  dysgenesis  following  the  standard  protocol,  in  a  total  volume  of  50  ýtl.  A 
radiolabelled  PCR  product  (probe)  of  the  same  segment  from  a  normal  control 
male  DNA  was  also  amplified  by  direct  incorporation  of  2ýtCi  of  a_32  PdCTP  in 
the  PCR  reaction  mix.  5  V1  of  the  PCR  products  were  electrophoresed  in  a  1% 
agarose  gel  containing  0.5  Vg/ml  ethidium  bromide  and  visualised  with  a  UV 
transilluminator  to  confirm  the  specificity  of  the  PCR.  The  remaining  45  V1  PCR 
products  were  then  cleaned  using  GenecleanTm  purification  kit  (Bio  101  Inc.  ) 
following  the  supplier  protocol. 
( ""'Formation  of  heteroduplexes  "V 
Hybridisation  between  probe  and  target  DNA  was  set  up  in  10-20  fold 
molar  excess  of  target  DNA  over  the  probe  DNA.  For  each  modification  reaction 
approximately  5-10  ng,  of  probe  DNA  was  hybridised  with  100  ng  test  DNA  in  a 
mixture  containing  IX  hybridisation  buffer  (0.3M  NaCl;  O.  IM  Tris-HCI,  PH  8.0) 
in  TO.  IE  buffer  (lOmM  Tris-110,  PH  7.4;  O.  ImM  EDTA).  The  reaction  was 
layered  with  an  equal  volume  of  mineral  oil  in  0.5  ml  Eppendorf  tube,  boiled  for  5 
minutes  and  then  incubated  in  a  650C  water  bath  for  5-16  hours.  The  reaction 
mixture  was  then  equally  divided  into  two  1.5  ml  siliconiscd  Eppendorf  tubes. 
750  pl  of  stop/precipitation  mixture  (63  mM  Na  acetate;  20  PM  EDTA;  80% 
ethanol)  and  3  [d  of  muscle  glycogen  (20mg/ml)  were  added  to  each  tube,  mixed 
well  and  kept  on  dry  ice  for  10  minutes.  Tubes  were  then  centrifuged  in  a 
microcentrifuge  (Beckman,  California)  at  14,000  rpm  (12,000g)  for  10  minutes. 
The  pellets  were  washed  in  70%  ethanol,  air  dried  and  resuspended  in  7  ýtl  To,  IE 
109 buffer.  Tubes  can  be  stored  up  to  24  hours  at  -200C  before  being  used  in  the  next 
step. 
(C)  Chemical  modification  with  osmium  tetroxide  and  hydroxylamine 
A  mixture  of  osmium  tetroxide  and  pyridine  was  freshly  made  on  ice  by 
mixing  6.75  ýd  pyridine  with  1.5  ýd  of  4%  osmium  tetroxide  and  154  41  To,  IE 
buffer.  To  each  7  41  hybrid  mixture,  18  1A  of  osmium/pyridine  mixture  were 
added,  mixed  and  the  tubes  incubated  for  2  hours  at  370C.  Meanwhile,  1.39  grams 
of  hydroxylamine  was  dissolved  in  1.6  ml  of  water  and  the  pH  was  adjusted  to  6 
by  adding  approximately  1.5  ml  of  diethylamine.  20  pil  of  this  solution  was  mixed 
with  7  ýA  of  the  hybrid  mixture  and  the  reaction  was  then  carried  out  at  370C  for 
two  hours.  The  modified  reactions  were  stopped  and  precipitated  by  mixing  750  P11 
of  stop/precipitation  (63  mM  Na  acetate,  20  pM  EDTA,  80%  ethanol)  solution 
with  each  reaction.  Tubes  were  incubated  on  dry  ice  for  10  minutes  and  then 
centrifuged  at  14,000  rpm  (12,000g)  for  10  minutes  in  microcentrifuge  (Beckman, 
California).  The  pellets  were  washed  in  70%  ethanol  and  air  dried. 
(D)  Piperdine  cleavage  of  the  chemically  modified  mismatches 
50  jil  of  IM  freshly  prepared  piperdine  solution  in  water  was  added  to  each 
pellet,  tubes  were  mixed  by  vortexing  for  1  minute  and  incubated  at  900C  water 
bath  for  30  minutes.  At  the  end  of  incubation  the  reaction  was  precipitated  as 
mentioned  above.  The  pellets  were  dissolved  in  10  ýd  of  formamide  loading  buffer 
(95%  deionized  formamide;  I  OmM  EDTA;  I  Omg/ml  each  of  bromophenol  blue 
and  xylene  cyanol). 
(E)  Polyactylamide  gel  electrophoresis 
Samples  were  denatured  at  950C  for  5  minutes,  quenched  on  ice  and  then 
loaded  alongside  a  radiolabelled  I  kb  DNA  ladder.  The  gel  was  6%  polyacrylamide 
containing  7M  urea  and  prepared  in  IX  TBE  buffer.  Electrophoresis  was  at  a 
constant  2000  volts  for  approximately  3  hours  then  the  gel  was  dried  and 
autoradiographed  for  16  hours  at  -400C. 
110 2.5.12  Genomic  Seauencina 
The  amplified  PCR  DNA  was  directly  sequenced  using  single  stranded 
templates.  Asymmetric  PCR  was  performed  according  to  a  protocol  developed  by 
Mgone  et  al  (1992)  in  which  a  PCR  product  was  used  as  a  template  to  generate 
single  stranded  DNA  during  the  PCR  reaction.  DNA  targets  to  be  sequenced  were 
prepared  by  the  standard  PCR  technique.  Amplified  products  were  resolved  by 
agarose  gel  electrophoresis  and  the  desired  bands  were  cut  out,  placed  in  1.5  ml 
tubes  with  50  ýd  TE  buffer  and  kept  at  -200C  overnight.  5  gI  aliquots  were  then 
used  for  asymmetric  PCR  amplification  using  the  standard  protocol  of  40  cycles 
with  the  concentration  of  either  the  sense  or  antisense  primers  being  in  50-1  OOX 
excess  of  the  other  primer.  5ptl  of  each  reaction  was  checked  by  agarose  gel 
electrophoresis  for  the  production  of  single  stranded  DNA.  Prior  to  sequencing, 
the  asymmetric  PCR  products  were  cleaned  to  remove  excess  dNTPs,  salt  and 
primers.  An  equal  volume  of  4M  ammonium  acetate  and  two  volumes  of 
isopropanol  were  added  to  each  reaction,  mixed  briefly  and  incubated  at  room 
temperature  for  10  minutes  then  centrifuged  in  a  microcentrifuge  at  -14000  rpm 
(12,000g)  for  10  minutes.  Pellets  were  washed  in  70%  ethanol,  air  dried  and 
resuspended  in  7  gI  of  ddH20  and  used  directly  in  the  sequencing  reaction. 
Sequencing  protocol  using  USB  sequenase  version  ZO  sequencing  kit 
Direct  sequencing  was  carried  out  by  the  chain  termination  sequencing 
method  (Sanger  et  al  1977)  using  the  Sequenase  version  2.0  sequencing  kit  (USB). 
25ýd  of  the  T7  DNA  polymerase  was  diluted  with  25  pl  inorganic 
pyrophosphatase  and  150  pI  of  glycerol  enzyme  dilution  buffer  to  obtain  an  8  fold 
dilution  of  the  enzyme  to  its  working  concentration  of  1.6  units/gl. 
7  Al  of  the  purified  asymmetric  PCR  product  were  mixed  with  2  gl  5X 
sequenase  buffer  to  give  a  final  concentration  of  40  mM  Tris-HCI  pH  7.5,50  MM 
Na  CI  and  20  MM  MgC12-  I  gl  (I  pmol)  of  the  sequencing  primer,  either  limiting 
or  nested  and  complementary  to  the  synthesised  single  strand  was  also  added.  The 
mixture  was  vortexed,  briefly  centrifuged  and  annealed  by  heating  at  650C  in  a 
III PCR  block  for  2  minutes  then  slowly  cooled  to  less  than  350C  over  15  to  30 
minutes  and  quenched  on  ice  for  few  minutes.  I  gI  of  0.1  M  DTT,  2  gI  of  a  115 
dilution  of  labelling  mix  (1.5  gM  of  each  dNTP  except  dATP),  0.5  gI  of  a- 
35SdATP  (1000  Ci/mmol;  lOgCi/gl)  and  2  gI  of  a  1/8  dilution  of  T7  DNA 
polymerase  were  added,  mixed  well,  briefly  centrifuged  and  incubated  at  room 
temperature  for  2-5  minutes.  After  the  incubation,  3.5  gI  of  the  mixturewas 
transferred  to  2.5  gI  of  each  termination  mix  at  420C  incubated  at420C  for  5 
minutes.  The  termination  mixes  (4  mixes)  contained  80  gM  of  each  dNTP  and  8 
gM  of  the  appropriate  dideoxyribonucleoside  triphosphate  (ddNTP).  The  reaction 
was  then  terminated  by  the  addition  of  4  gl  formamide  dye  stop  solution  (95% 
fon-namide,  20  mM  EDTA,  0.05%  of  each  bromophenol  blue  and  xylene  cyanol). 
Tubes  were  then  stored  at  -200C  until  further  need. 
To  read  the  sequencing  close  to  the  primer,  I  gl  of  Mn  buffer  (0.1  5M  Na 
isocitrate,  O.  IM  MnC12)  was  added  to  the  labelling  mix  before  adding  the 
sequenase  enzyme.  Samples  were  denatured  at  750C  for  2  minutes  and  quenched 
on  ice  for  2  minutes.  2pl  of  each  termination  reaction  was  loaded  onto  a 
prewarmed  (500C),  8%  denaturing  polyacrylamide  gel  containing  7M  urea, 
prepared  and  run  in  IX  TTE  buffer  (glycerol  tolerant  buffer).  Electrophoresis  was 
carried  out  at  approximately  2500  volts  at  500C  for  2-4  hours  depending  on  the 
area  of  interest.  After  electrophoresis  the  gel  was  dried  in  a  vacuum  gel  dryer  then 
exposed  to  Kodak  X-Omat  AR  film  using  a  cassette  with  intensifying  screens  for 
16  to  40  hours  at  -400C. 
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RESULTS (3)  RESULTS 
3.1  Cvto2enetic  and  molecular  cvtoeenetic  studies: 
3.1.1  Establishment  of  FISH  technique  and  optimisation  of  probes: 
(1)  Unicolour  FISH  usin,  &,  alpha  satellite  DNA  probes 
To  become  familiar  with  the  FISH  technique,  initial  experiments  were  carried 
out  with  the  highly  repetitive  sequence  probes  DXZI  and  PDP97  specific  for  the 
centromeric  region  of  chromosomes  X  and  Y  respectively.  These  probes  were  used  to 
optimise  the  uni-colour  FISH.  The  DXZI  probe  was  obtained  commercially,  pre- 
labelled  with  either  biotin  or  digoxigenin.  The  probe  PDP97  was  available  as  glycerol 
stock  in  the  department.  This  probe  was  grown,  isolated  and  labelled  with  either 
biotin  or  digoxigenin  using  the  standard  nick  translation  method.  The  labelled  probes 
(DXZ  1,  PDP97)  were  then  hybridised  to  metaphase  spreads  from  peripheral  blood 
samples.  Imaging  of  FISH  results  was  carried  out  using  the  CCD  system  and 
Smartcapture  programme.  The  concentration  required  to  produce  intense  and  specific 
signals  using  each  of  the  probes  was  optimised  and  found  to  be  0.5-  1  ng  of  DXZ  1  and 
5  0-100  ng  of  probe  PDP79  per  2  cm2  hybridisation  area  (Figure  3.1). 
(A)  Optimisation  of  X-chromosome  specific  probes 
A  total  of  IS  probes  specific  for  chromosome  X  were  used  in  this  study 
(Figure  3.2).  Nine  were  commercially  available  [XIST  (Xql3.2),  KAL  (Xp22.3), 
DXZ4  (Xq24),  whole  X  chromosome  paint  (WCPX),  chromosome  arm  paint  for  the 
short  and  long  arm  of  the  X  chromosome  (CAP  Xp/CAP  Xq),  telomeric  sequences 
specific  for  the  short  and  long  arms  of  X  chromosome,  and  DXZI  (centromeric)]  pre- 
labelled  with  either  digoxigenin  or  biotin.  The  rest  (6  probes)  were  available  in  the 
department  as  glycerol  stocks.  Three  (cPTI,  cPT4  cAL24)  were  specific  for  the  DMD 
113 locus  at  Xp2l.  region  of  the  X  chromosome  and  three  (VK21,14  1  R,  G9L)  were 
specific  for  the  fragile  X  regions  (FRAXA/E)  at  Xq27-28.  The  glycerol  stocks  of  the 
probes  were  cultured,  isolated  from  the  host  cell  and  the  extracted  DNA  from  each 
probe  was  individually  labelled  with  biotin  and/or  digoxigenin. 
Initially  the  three  DMD  cosmids  cPTI,  cPT4,  and  cAL24  and  the  three 
FRAXA/E  probes  (VK21,14  1  R,  G9L)  were  optimised  individually.  Different  probe 
concentrations,  competitor  DNA  concentrations,  and  hybridisation  temperatures  were 
tried  and  optimised  to  obtain  clear  and  specific  signals.  The  optimal  final 
concentration  of  the  DNA  mixture  (probe  and  competitor  DNA)  per  2  crný 
hybridisation  area  was  found  to  be  200-300  ng  of  the  probe  and  20  ýig  of  the 
competitor  DNA.  The  optimal  hybridisation  temperature  was  found  to  be  39-400C  for 
14-16  hours  incubation  time  (Figure  3.3).  Using  individual  probes  gave  inconsistent 
results  and  occasionally  weak  signals.  To  improve  the  hybridisation  efficiency  and  to 
obtain  consistent  signals,  the  three  DMD  probes  were  equally  combined  to  produce  a 
probe  set  (contig)  at  a  final  concentration  of  200-250  ng/  2  cm2  hybridisation  area. 
Using  this  probe  set,  consistent  and  clear  signal  was  obtained  (Figure  3.4a).  A  probe 
set  using  the  three  FRAXA/E  probes  was  then  similarly  prepared,  assessed  and  also 
found  to  produce  satisfactory  results  at  concentration  of  250-300  ng/  2  crn2 
hybridisation  area  (Figure  3.4b).  These  studies  revealed  the  suitability  of  the  cosmid 
contigs  for  analysis  of  the  DMD  locus  at  Xp2l  and  of  FRAXA/E  loci  at  Xq27-28. 
The  commercial  probes  used  in  this  study  (XIST,  KAL,  DXZ4,  telomeric 
sequences,  CAP  and  WCP  of  X  chromosome)  were  applied  following  the  supplier's 
protocols  with  minor  modifications.  Clear  and  strong  signals  were  observed  upon 
using  these  probes  (Figure  3.5). 
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Figure  3.2:  Panel  of  probes  used  for  FISH  study  of  the  X  chromosome (B)  Optimisation  of  Y-chromosome  specific  probes 
Six  different  Y-specific  probes  (Figure  3.6)  were  optimised.  The  MK5  and 
MK29  cDNA  probes  (Ma  et  al,  1993)  specific  for  azoospermia  factor,  and  the 
hocSRY  probe  (Su  and  Lu  1991)  specific  for  testicular  determination  factor  (TDF)  in 
male  were  supplied  as  cosmid  DNA.  These  probes  were  individually  transformed  to 
an  appropriate  host  cell  for  culture  and  preparation  of  glycerol  stocks  for  further 
investigations.  The  amplified  probe(s)  were  then  isolated.  Five  ýtg  of  the  extracted 
DNA  was  digested  with  the  appropriate  restriction  enzyme  and  the  presence  of  the 
insert  was  ascertained  by  agarose  gel  electrophoresis  (Figure  3.7).  One  Pg  of  each 
extracted  DNA  probe  was  labelled  with  either  digoxiginin  or  biotin.  Uni-colour  FISH 
analysis  was  optimised  using  different  probe  concentrations,  competitor  DNA 
concentrations,  hybridisation  temperature,  and  detection  method.  The  optimal  final 
concentration  of  the  DNA  mixture  (probe  and  competitor  DNA)/  2  cm  2  hybridisation 
area  was  found  to  be  150-200  ng  of  the  probe  and  12  ýtg  of  the  competitor  DNA.  The 
optimal  hybridisation  temperature  was  between  39-400C  for  14-16  hours  incubation 
time  (Figure  3.8).  The  whole  chromosome  Y  paint  (WCPY:  Cambio)  produced 
complete  coverage  and  clear  signals  on  the  Y  chromosome  (Figure  3.8).  The  two 
repetitive  sequence  probes  GMGY  10  and  PHY2.1  were  treated  exactly  as  the  alpha 
satellite  DNA  probe  without  suppressionwith  competitor  DNA.  The  concentration  of 
the  probe(s)  and  the  hybridisation  temperature  were  assessed  at  5-100  ng/  2  crný 
hybridisation  area  and  at  37-420C  for  16  hours  incubation  time.  For  GMGY  10,  the 
concentration  required  to  produce  intense  and  specific  signals  was  found  to  be  10  ng/ 
2  cm2  hybridisation  area  at  39-42  OC.  The  PHY2.1  probe  was  found  to  give  strong  and 
clear  signals  at  a  concentration  of  100  ng/2  crn2  hybridisation  area  at  39-42  OC 
(Fig  3.8). 
120 hocSRY 
GMGY10 
]Ill.  L['7:  B  PDP97 
11A 
WCP 
11.23H  I  MK5  &  MK29 
12 
PHY2.1 
Figure  3.6: 
Panel  of  probes  used  for  FISH  study  of  the  Y  chromosome. 3  kl)  --f> 
8 
k,  1)  -: 
1.6  ki)  --80> 
100 
I 
'  p,  t 
1.9  k  I) 
Figure  3.7:  Scpýiration  ol'  MKS  (lancs  I  and  2)  and  MK21) 
(lanes  3  and  4)  cDNA  inserts  (  1.9  kb  EcoRI  fragment)  From 
the  plasnild  DNA  oil  an  CtIlIdiUm  bromide  stained  Plo  agarose 
gel  run  at  10  volt/cm  for  one  hour. 
L  --  I  kb  ladder. (2)  Dual  and  multi  colour  FISH 
Following  optimisation  of  uni-colour  FISH,  a  dual  FISH  approach  was 
employed  to  detect  simultaneously  two  different  probes  hybridised  to  the  same 
chromosome  or  to  different  chromosomes,  in  a  single  hybridisation  experiment.  A 
mixture  of  a  biotin  labelled  probe  and  a  digoxigenin-labelled  probe  was  hybridised  to 
metaphase  spreads.  Biotin-labelled  probe  was  detected  with  rhodamine-avidin  (red) 
and  digoxigenin-labelled  probe  was  detected  with  FITC  (green).  Each  of  the  red  and 
green  signals  was  amplified  using  an  extra  layer  of  rhodamine-avidin  and  FITC.  The 
chromosomes  were  counter-stained  with  DAPI,  which  allowed  visualisation  of  both 
red  and  green  signals  on  a  blue  background.  The  concentrations  of  probes  used  in  dual 
FISH  were  guided  by  the  optimal  concentration,  for  each  probe,  used  during  the  uni- 
colour  FISH  experiments  and  did  not  exceed  a  final  concentration  of  500  ng.  Signals 
produced  by  each  of  the  probes  were  strong,  distinct  and  easily  distinguished  using 
this  system.  Figure  (3.9a)  shows  a  normal  male  metaphase  spread  simultaneously 
hybridised  with  digoxigenin  labelled  DXZ1  (green)  and  biotin  labelled  PDP97  (red) 
probes. 
Once  the  reliability  of  the  probes  had  been  established  both  singly  and  in  pairs 
using  various  detection  systems,  a  three  colour  combinatorial  FISH  approach  was 
carried  out  to  detect  three  probes  simultaneously.  In  this  technique,  one  probe  was 
digoxigenin-labelled,  a  second  biotin-labelled  and  a  third  consisting  of  a  1:  1  ratio  of 
biotin  and  digoxigenin-labelled  probe  were  combined  in  a  hybridisation  mixture  of 
total  volume  12-34  gl.  Detection  of  the  probes  in  three  colour  ratio  mixing  FISH  was 
performed  as  in  the  dual  FISH  study.  Biotin  labelled  probes  were  detected  with 
rhodamine-avidin  (red)  and  amplified  once  with  biotin  labelled  anti-avidin  and 
rhodamine-avidin.  Digoxigenin  labelled  probes  were  detected  with  FITC  labelled 
monoclonal  anti-digoxigenin  (green)  and  amplified  by  anti-mouse  conjugated  with 
FITC.  A  third  colour  (yellow)  was  produced  by  detection  of  the  combinatorial- 
124 labelled  probe  with  both  rhodamine  and  FITC.  Figure  (3.9b)  shows  a  metaphase 
spread  simultaneously  hybridised  to  three  different  probes  specific  for  chromosome  X 
(XIST,  KAL  and  DXZI).  All  probes  used  in  this  study  were  optimised  to  provide 
strong  and  well-defined  signals  on  metaphase  spreads.  Although  some  slight 
background  labelling  can  sometimes  be  observed,  chromosome  identification  was 
always  unambiguous. 
3.1.2  Applications  of  FISH  technigue: 
(1)  Patients 
FISH  analysis  was  applied  to  two  groups  of  patients.  The  first  group  of  cases 
consisted  mostly  of  Turner  syndrome  and  its  variants  that  had  been  shown 
cytogenetically  to  have  a  chromosome  abnormality  involving  the  sex  chromosomes. 
The  karyotypes  of  these  patients  are  shown  in  table  3.1.  The  second  group  consisted 
of  cases  with  disorders  related  to  sex  determination  and  sex  differentiation  associated 
with  normal  karyotype  (Table  2.1).  This  group  will  be  discussed  later  in  the  molecular 
part  of  the  project. 
(2)  FISH  studies  ofX  and  Y  chromosomes  aberrations 
FISH  studies  were  applied  to  identify  more  precisely  the  chromosomal  origin 
of  the  abnormal  or  marker  chromosome  using  probes  specific  for  the  X  and/or  the  Y 
chromosome.  The  karyotypes  of  the  investigated  cases  were  performed  by  the 
cytogenetics  laboratory  of  Duncan  Guthrie  Institute  (DGI)  or  by  the  Kuwait  Medical 
Genetic  Centre  (KMGC),  Kuwait.  Between  20-50  metaphase  spreads  were  analysed 
in  each  case  (Table  3.1).  Mosaicism  was  detected  in  17/24  cases  (70.8%)  of  which 
fifteen  patients  (62.5%)  had  a  mosaic  karyotype  with  45,  X  cell  line  in  addition  to  the 
cell  line  of  interest.  Two  of  these  had  an  unidentified  marker  of  potential  Y  origin 
detected  by  PCR  analysis  performed  in  the  DGI  department  (cases  19  and  23). 
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(b Structural  abnormalities  of  X  or  Y  were  confirmed  in  20/  24  (83.3%)  cases,  including 
ring  X,  ring  Y,  i(Yq),  isochromosome  of  the  short  arm  and  long  arm  of  X 
chromosome,  deletion  of  Xp,  duplication  of  Xq,  as  well  as  X-autosome  and  X-Y 
translocations.  Seventeen  of  the  investigated  cases  had  X  chromosome  abnormalities 
(70.8%%)  and  six  had  Y  chromosome  aberrations  (25%).  Table  3.1  summarises  all 
the  findings  obtained  by  FISH  studies. 
The  objective  in  studying  these  cases  was  to  obtain,  if  possible,  additional 
information  about  the  composition  of  the  abnormal  chromosome,  to  confirm  the 
origin  of  the  material  present  and  to  identify  breakpoints  more  precisely. 
(A)  FISH  studies  of  cases  with  X  chromosome  abnormalities 
(1)  FISH  results  from  9  Turner  svndrome  cases  with  riii'a  chromosome 
The  subjects  of  this  study  were  females  ascertained  because  of  multiple 
congenital  abnormalities  or  with  features  of  Turner  syndrome,  with  or  without 
learning  difficulties  (cases  1-9).  The  clinical  and  cytogenetic  findings  of  these  patients 
are  summarised  in  table  3.2.  Routine  cytogenetic  analysis  of  20  metaphases  showed 
predominantly  45,  X  cell  line  and  a  second  cell  line  containing  a  ring  chromosome. 
Therefore  a  total  of  100  cells  were  scored  in  all  of  the  mosaic  cases.  In  four  of  these 
cases  the  ring  was  small  (smaller  than  chromosomes  21  and  22).  Further  identification 
was  not  possible  by  conventional  cytogenetic  techniques  on  any  of  these.  Four  cases 
contained  a  medium  sized  ring  (size  of  chromosomes  16,17  and  18)  and  were  thought 
to  contain  material  from  the  X  chromosome. 
In  the  remaining  case  (Table  3.2,  L.  D)  the  ring  was  large  but  contained  only 
one  centromere,  and  had  been  identified  in  the  routine  laboratory  as  containing  both 
long  and  short  arm  regions  of  the  X  chromosome.  However  given  the  lack  of  banding 
in  the  ring  chromosomes,  content  and  breakpoints  could  not  be  unequivocally 
129 identified  and  FISH  studies  were  undertaken  to  identify  the  content  of  these  ring 
chromosomes. 
(a) Detection  of  the  origin  of  the  ring  chromosomes  by  FISH 
Initially  slides  from  all  nine  cases  were  hybridised  with  whole  chromosome 
libraries  for  the  X  and  Y  chromosomes  and  with  centromeric  probes  DXZI  (X)  and 
PDP97  (Y).  All  the  ring  chromosomes  showed  complete  coverage  with  the  X 
chromosome  library,  and  the  X  centromeric  probe  showed  one  signal  in  each  ring 
(Figure  3.10).  No  signals  were  obtained  in  hybridisation  experiments  with  the  two  Y 
probes,  and  it  was  concluded  that  each  ring  was  derived  from  X  chromosome 
material.  FISH  analysis  using  DXZI  in  100  randomly  selected  metaphases  confirmed 
the  presence  of  the  two  cell  lines  (45,  X/46,  X,  r(X)  with  the  percentage  shown  in  the 
inserted  table.  The  rings  varied  in  size  from  small  to  large  ring  X  (Table  3.2).  The 
frequency  of  the  second  cell  line  r(X)  varied  from  12%  to  42%. 
Case)Vo  Coorenelic  results  FISH  results 
I  45,  X[731/46,  X,  r(X)  [271  45,  Xf681/46,  X,  r(X)  [321 
2  45,  Xf721/46,  X,  r(X)  r281  45,  XF78j/46,  X,  r(X)  [221 
3  45.  Xf  80]/46,  X,  r(X)  r2Ol  45,  Xf85l/46,  X,  r(X)  [  51 
4  45,  Xf5Ol/46.  X,  r(X)  [501  45.  xr581/46,  X,  r(X)  f421 
5  45,  Xf9Ol/46,  X,  r(X)  flOl  45,  Xf881/46.  X,  r(X)  f  121 
6  45,  Xf781/46,  X,  r(X)  f221  45.  Xf7ll/46,  X,  t(X)  f  191 
7  45,  Xf7ll/46,  X,  r(X)  f291  45,  Xf751/46,  X,  r(X)  r251 
8 
- 
45,  Xf671/46,  Xr(M  r331  45.  xr691/46.  X,  r(X)  f3  11 
F9  7 
45,  X[901/46,  X,  r(X)  r  101  45.  Xfg6l/46,  X,  t(X)  rl4l 
130 (b) Analysis  of  r  (X)  s  breakpoints  by  FISH 
The  ring  chromosomes  (cases  1-7)  were  hybridised  to  the  panel  of  X 
chromosome  probes  and  the  results  are  shown  in  Table  3.3.  As  can  be  seen,  it  was 
possible  to  differentiate  one  of  the  medium  sized  rings  which  contained  more  long 
arm  material  [(case  7)  (Figure  3.11)]  from  the  other  three  which  contained  more  short 
arm  material  [(cases  4,6  and  7)  (Figure  3.12-14)],  FISH  analyses  showed  that  the 
breakpoints  could  be  distal  to  Xp2l  and  Xq24  in  case  5  (C.  B)  and  could  be  distal  to 
Xp22  and  Xq  13  in  the  other  three  cases  with  medium  size  ring  X  (cases  4,6  and  7). 
FISH  study  also  showed  that  the  cases  with  medium  size  ring  (cases  3-7)  also 
contained  the  locus  for  X-inactivation  (XIST)  (Table  3.3  and  Figures  3.11-3.14). 
It  was  only  possible  to  study  three  of  the  four  small  rings  by  FISH.  All  three  were 
shown  to  contain  XIST  locus  (Xql3)  and  the  more  distal  probes  for  both  the  long  and 
short  arm  showed  no  signal  (Figure  3,15-17).  Cases  8  and  9  could  not  be  studied  in 
detail  due  to  lack  of  materials.  Unfortunately,  time  did  not  permit  the  use  of  additional 
probes,  which  might  improve  the  resolution  of  this  study  on  ring  chromosomes. 
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2. 
ý3 (2)  FISH  analvsis  of  duplication 
Two  cases  with  some  Turner-like  features  (Cases  10  and  11)  were  referred  for 
FISH  investigation  to  identify  and  characterise  their  abnormal  X  chromosome. 
Routine  cytogenetic  analysis  with  G-banding  in  case  10  showed  46,  X,  dir  dup(X) 
(qll.  2-).  q22.3)  karyotype,  and  case  11  had  mos  45,  X/46,  X,  dup(X)(q28-+q2l.  l) 
karyotype  suggesting  an  inverted  duplication. 
Case  10:  A  female  (D.  O.  B  2.7.82)  referred  to  DGI  with  clinical  features  of  febrile 
seizure,  poor  growth  and  deafness  (right  ear).  She  had  short  stature  and  some  mild 
stigmata  of  TS.  Routine  cytogenetic  analysis  of  G-banding  confirmed,  46,  X,  dir 
dup(X)(ql  1.2-->q22.3)  karyotype. 
Initially  slides  from  this  case  were  hybridised  with  whole  chromosome  library 
for  the  X  chromosome  in  order  to  determine  if  the  extra  material  of  the  abnormal  X 
was  derived  from  X  chromosome  or  another  chromosome.  FISH  study  using  whole 
chromosome  library  for  X  chromosome  on  metaphase  spreads  showed  a  complete 
coverage  of  the  normal  and  abnormal  X  chromosomes  and  revealed  the  extra 
chromosomal  region  to  be  either  duplication  of  Xq  or  other  X  chromosome  material 
(Figure  3.18a).  Slides  were  then  hybridised  to  a  panel  of  X  chromosome  specific 
probes,  DXZI  (centromere),  DMD  (Xp2l),  XIST  (Xql3)  and  DXZ4  (Xq24).  FISH 
study  of  this  case  showed  that  the  patient  had  two  copies  of  XIST  locus  (Xql3)  and 
one  copy  of  DXZ4  (Xq24)  on  the  long  arm  of  the  abnormal  X  chromosome  and  one 
copy  of  the  DMD  locus  on  the  short  arm  of  both  X  chromosomes  (Figure  3.18b). 
These  results  indicated  an  interstitial  duplication  of  Xq  region  confinning  and 
refining  the  cytogenetic  interpretation  with  the  final  karyotype  being  46,  X,  dir 
dup(X)(q  I  1.2->q22.3). 
Case  #  10  WCPX  DXZI 
X-cent 
DMD 
Xp2l 
XIST 
X03 
DXZ4 
Xq24 
46,  X,  dir  dup(X)(qll.  2-q22.3)  +  +  +  ++  + 
143 Case  11 
A  16  years  old  female  was  referred  due  to  clinical  features  of  Turner 
syndrome.  Routine  cytogenetic  analysis  using  G-banding  showed  mosaicism  for  X 
chromosome.  Four  out  of  25  cells  showed  45,  X  karyotype  and  the  remaining  showed 
a  count  of  46,  with  one  normal  X  chromosome  and  one  X  chromosome  Mth 
additional  material  on  the  distal  long  arm  at  Xq28  with  banding  pattern  suggesting  an 
inverted  duplication  of  the  region  (X)q28-*22.1.  Her  karyotype  was  interpreted  as 
mos  45,  X/46,  X,  dup(X)(q28  ->q21.1). 
Slides  from  this  case  were  hybridised  with  whole  chromosome  library  for  the 
X  chromosome  and  showed  a  complete  coverage  of  the  normal  and  abnormal  X 
chromosomes  (Figure  3.19b).  Slides  were  then  hybridised  to  a  panel  of  X 
chromosome  specific  probes,  DXZI  (centromere),  DMD  (Xp2l),  XIST  (Xql3)  and 
DXZ4  (Xq24).  FISH  analysis  of  case  II  revealed  two  copies  of  the  DXZ4  and  one 
copy  of  XIST  loci  on  the  long  arm  of  the  abnormal  X  chromosome  and  one  copy  of 
DMD  locus  on  the  short  arm  (Figure  3.19c  and  d).  These  results  confirmed 
duplication  of  Xq22.  I  ->Xq28. 
Unfortunately,  due  to  lack  of  material  and  probes  it  was  not  possible  to 
confinn  precisely  the  type  or  the  nature  of  duplication  (either  direct  or  inverted 
duplication  of  Xq).  This  could  have  been  confirmed  by  using  probes  in  the  region 
Xq25-28  or  telorneric.  The  FISH  analysis  findings  of  case  II  are  surnmarised  in  the 
inserted  tabIe. 
Case#  11  WCpX  -DXZI  DMD  XIST  -DXZ4 
X-paint  X-cent  Xp2l  Xql3  Xq24 
45,  X[10]/46,  X,  dup(X)(q22.1-q28)[901 
f 
145 f3)  FISH  studv  of  46,  X,?  i(Xp) 
Two  -cases  with  Turner  phenotype  and  with  cytogenetic  findings  of 
46,  X,?  i(Xp)  and  46,  =46,  X,?  i(Xp)  were  investigated  by  the  FISH  technique  to 
identify  the  status  of  the  presurned  isochromosome. 
Case  12 
This  female  was  referred  with  Turner  phenotype.  Routine  cytogenetic  analysis 
using  G-banding  showed  46,  X,  i(Xp)  karyotype. 
FISH  analysis  of  100  metaphase  spreads  using  X-centromeric  (DXZI)  and 
whole  X  chromosome  paint  on  old  slides  (-  4  months  old)  revealed  no  mosaicism  in 
this  patient.  FISH  analysis  using  probes  specific  for  the  short  and  the  long  anns  of  the 
X  chromosome  were  applied.  As  can  be  seen  from  Figure  3.20,  this  case  was  shown 
to  contain  one  copy  of  the  DMD  locus  (Xp2l.  2)  on  each  arm  of  the  abnormal  X 
chromosome  and  no  signal  for  the  FRAXA/E  probe  was  detected.  The  XIST  probe 
was  also  applied  and  clear  signals  were  observed  on  the  long  arm  of  the  normal 
chromosome,  however,  the  XIST  signal  could  not  be  delineated  precisely  on  the 
abnormal  X  in  the  15  cells  analysed  due  to  overlapping  or  superimposing  of  DXZI 
probe  (Figure  3.20d).  The  superimposing  of  DXZI  over  the  XIST  signal  could  be  due 
to  the  condensed  chromosome  seen  in  these  slides.  However,  this  observation  was  not 
detected  in  any  studied  cases  by  the  XIST  probes.  Therefore,  the  interpretation  of 
i(Xp)  may  be  incorrect  in  this  instance.  The  possibility  of  Xp;  Xp  translocation  has 
been  raised.  This  case  has  been  recently  reinvestigated  by  another  PhD  student  in  the 
department  DOI  (Glasgow),  and  it  has  been  proven  that  this  case  is  not  an  i(Xp)  (Dr. 
Boyd  personal  communication,  1999). 
Case  12  DXZI 
X-cent 
DMD 
Xp2l 
XIST 
Xq13 
FRAXA/E 
XQ27-28 
Normal  X  +  +  +  + 
AbnormalX  ++  ?*  not  clear 
147 This  8  year  old  female  was  referred  with  Turner  phenotype.  Routine 
cytogenetic  study  using  G-banding  confirmed  the  presence  of  two  cell  lines.  The  first 
cell  line  showed  an  apparently  normal  46,  XX  karyotype.  The  second  cell  line  showed 
one  normal  X  chromosome  and  one  structurally  abnormal  X  chromosome.  Her 
karyotype  was  interpreted  as  mos  46,  XX/46,  X,?  i(Xp)  in  the  ratio  of  52%  and  48% 
respectively. 
FISH  analysis  was  carried  out  to  delineate  the  structural  rearrangement  of  the 
derivative  X  chromosome  [der(X)l  using  probes  DXZI,  DMD,  KAL,  XIST,  and 
DXZ4.  FISH  results  in  this  mosaic  case  revealed  one  copy  of  both  DMD  and  XIST 
probes  on  the  normal  X  and  the  abnormal  X  chromosomes.  Hybridisation  with  KAL 
(Xp22)  probe  demonstrated  two  copies  of  KAL  signals  one  on  each  arm  of  abnormal 
X  and  one  copy  of  KAL  on  the  short  arm  of  the  normal  X  chromosome.  In  addition, 
hybridisation  with  DXZ4  probe  (Xq24)  to  the  same  case  showed  clear  signals  on  the 
long  arm  of  the  normal  X  chromosome,  while  no  signals  could  be  detected  on  the 
abnormal  X  chromosome  (Figure  3.21).  The  in  situ  hybridisation  studies 
demonstrated  this  abnormal  X  chromosome  to  be  a  derivative  chromosome  arising 
from  a  translocation  between  two  X  chromosomes  with  the  breakpoints  at  p22.1  and 
q22,  resulting  in  monosomy  for  the  region  (X)  q22-+Xq  ter  and  trisomy  for  the  region 
(X)  p22-+Xp  ter  in  this  cell  line.  These  studies  thus  reinterpreted  the  karyotype  to 
46,  XX/  46,  X,  der  (X)  t  (X;  X)  (p22.  I;  q22). 
Case  13 
, 
KAL 
__(Xp22)- 
DMD 
_(Xp2l) 
DXZI 
-(Xcen) 
XIST 
--(q]3) 
DXZ4 
M24) 
46,  XX[581/46,  derX,  t(X,  -X)1421 
--  Normal X  +  +  +  +  + 
Abnormal  X1  ++ 
---. 
+-  +-A  + 
149 (4)  FISM  result  of  i(Xq) 
Case  14 
Fixed  material  from  phytohaemaglutinin  (PHA)  stimulated  blood  culture  was 
obtained  from  a  Turner  syndrome  patient.  Chromosome  analysis  by  G  banding 
showed  the  presence  of  3  cell  lines.  The  first  had  45,  X  karyotype  in  3  out  30  cells 
examined,  while  the  second  had  a  46  count  with  one  normal  X  chromosome  and  one 
isochromosome  for  the  long  arm  of  the  X  in  25  out  of  30  cells  examined.  The  third 
cell  line  has  a  count  of  47  with  one  normal  X  chromosome  and  two  copies  of  the 
isochromosome  for  the  long  arm  of  the  X  in  2  out  of  30  cells  examined.  A  molecular 
study  of  her  DNA  by  Dr.  Chu  showed  the  presence  of  Y  chromosome  (Yq)  sequences. 
For  that  reason,  this  case  was  forwarded  for  FISH  study  to  determine  whether  low 
grade  mosaicism.  of  Y  chromosome  was  present. 
The  status  of  the  abnormal  X  chromosome  and  the  percentage  of  mosaicism 
was  confirmed  by  FISH  experiments  with  X-centromere  and  X-paint  probes.  The 
whole  X-paint  showed  a  complete  coverage  of  the  normal  X  chromosome  as  well  as 
the  abnormal  X  (iXq).  No  translocation  was  detected  on  any  other  chromosome.  X- 
centromere  probe  DXZ1  revealed  the  presence  of  two  copies  of  signals  on  the 
abnormal  chromosome  (dicentric)  and  one  copy  of  DXZ1  on  the  normal  X 
chromosome  (Figure  3.22).  Moreover,  X  chromosome  paint  for  the  long  arm  (CAP) 
revealed  complete  coverage  of  both  arms  of  the  abnormal  X  chromosome  confirming 
the  cytogenetic  diagnosis  of  i(Xq)  of  the  abnormal  chromosome.  FISH  analysis  using 
Y  specific  probes  (PDP97,  PHY2.1,  Y-paint)  on  metaphase  spreads  of  this  patient 
showed  no  signals  with  any  of  the  panel  of  Y  chromosome  specific  probes.  The 
molecular  cytogenetic  (FISH)  results  failed  to  detect  the  presence  of  Y  material  in  this 
patient  and  confirmed  the  cytogenetic  finding  of  the  patient  with  a  karyotype  of  45,  X 
/  46,  X,  i  dic  (Xq)  /  47,  X,  i dic(Xq)  i  dic  (Xq)  in  the  ratio  of  12%,  84%,  and  4% 
respectively. 
151 (5)  FISH  results  from  Turner  svndrome  with  Xp  deletion 
Case  15 
This  female  was  referred  with  clinical  features  of  Turner  syndrome.  The 
cytogenetic  studies  using  Giemsa  banding  technique  of  this  Turner  patient  revealed 
that  she  had  a  karyotype,  of  46,  XXp-  (pter-ýp  11).  FISH  analysis  using  DXZ  I  probe  on 
metaphase  spreads  of  her  peripheral  blood  lymphocytes  showed  hybridisation  signals 
at  the  centromeric  region  of  the  normal  chromosome  and  on  a  large  acrocentric  like 
chromosome.  Application  of  the  X-paint  demonstrated  a  complete  coverage  of  the  X- 
paint  over  the  normal  X  and  the  acrocentric  like  chromosome  (Figure  3.23).  FISH 
study  using  KAL  probe  specific  for  the  short  arm  of  X  chromosome  on  metaphase 
spread  from  patient's  blood  samples  demonstrated  the  presence  of  the  KAL  probe 
only  on  the  short  arm  of  the  normal  X.  Moreover,  X  chromosome  Paint  for  the  long 
arm  (CAP)  revealed  complete  coverage  of  the  paint  over  the  abnormal  X  indicating 
that  the  abnormal  chromosome  contained  only  Xq  material.  Hybridisation  analysis 
studies  thus  demonstrated  that  the  short  arm  of  the  abnormal  X  chromosome  was 
entirely  deleted  confirming  the  karyotype  to  be  46,  XXp-.  Summary  of  FISH  analysis 
is  shown  in  the  table  below. 
Case  15  DXZI  WCPX 
, 
KAL 
(Xp22 
CAP  Xq 
Normal  X  +  +  _  +  + 
Xp-  +  +-I  + 
153 (6)  FISH  investization  of  a  short  stature  Female 
Case  16 
A  16  years  old  female  who  presented  at  9  years  of  age  with  short  statue, 
solitary  right  kidney,  clitoral  hypertrophy,  urogenital  sinus  with  bladder  diverticulum 
and  enuresis.  She  was  later  found  to  have  an  absent  left  ovary  also.  Chromosomal 
analysis  of  20  metaphases  showed  an  apparently  nonnal  46,  XX  karyotype.  This  case 
was  referred  for  FISH  investigation  to  exclude  the  possibility  of  46,  =  46,  XY  or 
45,  X/46,  XX  mosaicism.  FISH  studies  on  100  metaphase  cells  and  100  interphase 
nuclei  of  the  patient  with  Y  chromosome  specific  probes,  PHY2.1,  PDP97,  and 
WCPY  (Y-paint)  revealed  that  the  patient  was  negative  for  all  three  tested  probes. 
FISH  study  using  DXZ  I  and  WCPX  (X-paint)  probes  specific  for  chromosome  X  on 
100  mitoses  demonstrated  two  cytologicaHy  normal  X  chromosomes.  These  findings 
indicated  that  the  patient  has  a  46,  XX  karyotype  with  no  detectable  aneuploidy  either 
for  X  or  Y  chromosomes. 
Case  16  WCPX  DXZ1  WCPY  PDP97  PHY2.1 
_(X-paint) 
(X-cen)  (Y-paint) 
_(Ygl2)  46,  XX  ++  ++ 
short  stature 
155 (7)  FISH  analvsis  of  45,  X146,  XY  Turner  smdrome 
Cases  17  and  18 
Both  female  cases  presented  at  a  few  months  of  age  with  failure  to  thrive  and 
went  on  to  have  short  stature.  Both  had  gonadectomy  at  6  years  and  2  years  of  age 
resPectively.  Routine  cytogenetic  analysis  of  50  G-banded  metaphases  confirmed 
mosaicism  45,  X/46,  XY  in  both  cases  in  the  ratio  of  40%,  60%  in  case  17  and  52%, 
48%  in  case  18. 
Fluorescence  in  situ  hybridisation  was  performed  on  those  two  cases  using 
centromeric  probes  and  whole  chromosome  paints  of  chromosomes  X  and  Y.  The 
percentage  of  mosaicism  using  interphase  nuclei  and  metaphase  FISH  study  revealed 
48%  of  the  45,  X  cell  line  in  one  case  and  42%  in  the  other  case.  No  structural 
aberrations  of  chromosomes  X  or  Y  were  detected.  Thus  the  status  of  the  cytogenetic 
finding  is  confirmed  by  FISH. 
Case  No  Karyotype  DXZI  WCPX  WCPY  PDP97 
17  45,  X  [421  +  + 
46,  XY  [581  +  + 
18  45,  X  [481  +  +I  .  " 
46,  XY  f521  -  .I  +  + 
156 (8)  A  case  with  marker  chromosome 
Case  19 
A  female  aged  21  years  old  presented  with  Tumer  phenotype.  Chromosomal 
analysis  by  G-banding  revealed  the  presence  of  two  cell  lines.  One  cell  line  showed  a 
45,  X  karyotype  and  the  second  showed  a  46,  X,  +a  small  marker  chromosome  of 
unknown  origin  in  6%  of  her  cells.  DNA  analysis  by  PCR  had  been  carried  out  and 
confinned  the  presence  of  Y-specific  sequences.  Dual  FISH  study  using  DXZ1  and 
PDP97  centromeric,  X  and  Y  probes  respectively  on  metaphase  chromosomes 
revealed  two  copies  of  PDP97  hybridisation  signals  on  the  mark-er  chromosome 
(dicentric,  Figure  3.24).  Dual  FISH  using  biotin  labelled  WCPY  and  digoxigenin 
labelled  WCPX  paints  detected  the  presence  of  both  X  and  Y  sequences  on  the 
marker  chromosome.  The  Y  sequence  was  sandwiched  between  X  material  suggesting 
X-Y  translocations  leading  to  isoclicentric  t(X;  Y)  (Figure  3.24).  These  signals  are 
most  likely  to  be  real  hybridisation  and  not  due  to  cross  hybridisation.  as  they  could 
not  be  detected  in  normal  male  control.  Therefore,  the  karyotype  of  this  case  can  be 
interpreted  as  45,  X/46,  X,  i  dic  t(X;  Y)  in  the  ratio  of  96%  and  4%  respectively. 
Unfortunately,  due  to  small  amount  of  sample,  fariher  investigation-using  panels  of 
both  X  and  Y  specific  probes  could  not  be  carried  out  to  delineate  the  rearrangement 
more  precisely. 
Case  19  WCPX  DXZ1  WCPY  PDP97 
(X-cen)  (DYZ3) 
-45, 
X  [961  +  +  - 
.  -46, 
X,  +  mar  [41  ++  +  ++  ++ 
157 (9)  FISH  studv  of  a  case  with  46AXP 
Case  20 
A  female  presenting  with  dysmorphic  features,  developmental  delay,  epilepsy 
and  anal  abnormalities  was  referred  to  the  cytogenetic  laboratory  to  investigate  her 
chromosomal  constitution.  G-banding  technique  revealed  an  abnormal  female 
karyotype  46,  XXp+.  This  case  was  then  investigated  by  FISH  technique  bearing  in 
mind  that  the  extra  material  could  be  from  chromosome  22  based  on  some  of  her 
clinical  features  such  as  heart  defect,  anal  abnormalities,  mental  retardation  and 
dysmorphic  features. 
FISH  analysis  using  whole  chromosome  libraries  for  X  and  22  chromosome 
(Cambio)  showed  a  normal  hybridisation  pattern  of  both  probes  (Figure  3.25a  and  b). 
No  translocation  or  deletion  could  be  detected  using  these  two  probes.  This  result 
implied  that  the  extra  material  could  originate  from  an  X  chromosome. 
The  slides  were  then  hybridised  to  a  panel  of  X-specific  probes.  Two  different 
probes  specific  for  the  short  arm  of  the  X  chromosome  were  used  (KAL  and  Xp- 
telomere)  and  one  signal  for  each  probe  was  observed  on  the  short  arms  of  both 
normal  and  abnormal  X  chromosomes  (Figure  3.25c  and  d).  However,  it  was  noticed 
that  the  Xp-telomeric  probe  on  the  abnormal  X  chromosome  consistently  showed 
reduced  signal  intensity  in  comparison  to  normal  X  chromosome.  Also  there  is 
material  distal  to  it. 
159 Three  specific  probes  for  the  long  arm  of  the  X  chromosome  were  also  applied 
(FRAXA/E,  DXZ4  and  Xq-telomere).  Normal  hybridisation  signals  were  detected  on 
the  normal  and  abnormal  chromosomes  (Figure  3.25e-g). 
Recently,  chromosome  arm  DNA  painting  (CAP)  probes  specific  for  the  X 
chromosome  were  obtained  and  applied  to  metaphase  spreads  from  this  patient. 
Application  of  Xp  CAP  showed  complete  coverage  of  the  paint  on  the  short  arm  of 
the  normal  X  chromosome  and  a  partial  coverage  on  the  short  arm  of  the  abnormal  X 
chromosome.  FISH  study  using  Xq  CAP  revealed  complete  coverage  on  the  long 
arms  of  both  normal  and  abnormal  X  and  no  signal  was  observed  on  the  short  arm  of 
the  X  chromosomes  (Figure  3.25h-i).  These  results  indicated  that  the  extra  material 
could  be  of  autosornal  or  Y  chromosomal  origin  and  that  there  was  a  misleading  result 
obtained  upon  using  the  whole  X  chromosome  library  (Figure  3.25a). 
The  fixed  materials  were  then  hybridised  to  individual  chromosome  library 
probes  for  all  autosomes  and  sex  chromosomes  using  the  Cytocell  Multiprobe  Kit 
(Cytocell),  and  the  extra  material  on  the  short  arm  of  the  abnormal  X  chromosome 
was  shown  to  have  originated  from  chromosome  16  (Figure  3.26).  This  result  was 
reconfirmed  upon  the  application  of  Cambio  whole  chromosome  16  library.  FISH 
study  using  chromosome  arm  paint  (CAP)  specific  for  the  short  arm  and  long  arm  of 
chromosome  16  was  applied  and  revealed  that  the  extra  material  on  the  X 
chromosome  originated  from  the  long  arm  of  chromosome  16  (16q)  (Figure  3.26b). 
Therefore  comprehensive  FISH  analysis  confirmed  X:  16  translocation  in  this  patient, 
leading  to  trisomy  16q  with  final  karyotype  of  (46,  X,  -X,  +  t(X;  l6)(p22.3;  q24]. 
Detailed  FISH  analysis  is  summarised  in  the  table  below. 
160 Case  20:  46,  YXp'  [t(X;  16)] 
Observation 
Probes 
Normal  X  Abnormal  X  IderMl 
WCPX  (CAMBIO)  +  + 
WCP22  (CAMBIO)  +  + 
DXZI  (X-cen)  +  + 
KAL  (Xp22)  +  + 
Xp  tel  +  +/-  (reduced  intensity) 
DXZ4  (Xq22)  +  + 
FRAXA/E  (Xq27-28)  +  + 
Xq  tel  +  + 
CAP  Xp  +  +/-  (incomplete  coverage) 
CAP  Xq  +  + 
Cytocell  MTK(1-22,  XY)  There  were  3  signals  for  16,  one  on  the 
abnormal  X  chromosome 
WCP16  (CAMBIO)  Confirmed  3  copies  of  chromosome  l6q,  one 
on  the  abnormal  X  chromosome 
CAP  16p 
CAP  16q  There  were  3  signals  for  l6q, 
one  on  the  short  arm  of  the 
abnormal  X  chromosome 
161 11 
11 
I  dim  (K)  16 
(C)  ((1) 
Figure  3.26:  Application  of  the  Cytocell  Multi  probe  revealed  a  complete 
coverage  of  the  Xpaint  over  the  normal  and  a  partial  coverage  over  the  abnormal 
X  chromosome  (a).  Whole  16  library  showed  a  complete  coverage  of  the  paint 
over  both  chromosome  16  and  extra  hybridisation  signal  was  detected  oil  the 
abnormal  X  chromosome  (b).  FISH  study  of  16q-CAP  showed  complete 
coverage  of  the  q  arm  of  chromosome  16  and  the  p  arm  of  the  abnormal  X 
chromosome  (c).  Partial  G-banded  karyotype  showing  the  derivative  X 
I  t(X,  16)  1,  non-nal  chromosomes  X  and  16  (d). 
Ab  =  abnormal. (B)  FISH  studies  of  cases  with  Y  chromosome  abnormalities 
Case  21 
A  phenotypically  normal  female  with  primary  amenorrhea  was  cytogentically 
investigated  and  showed  a  46,  X,  t(Xp;  Yq)  karyotype. 
FISH  analysis  using  Y-paint  probe  to  metaphase  spreads  of  this  case  showed 
the  presence  of  hybridisation  of  Y  sequences  on  the  abnormal  X  chromosome  (Figure 
3.27a).  FISH  analysis  using  DXZ1  and  PDP97  probes  to  metaphase  spreads  showed 
that  the  abnonnal  X  was  positive  for  the  X-centromeric  probe  (DXZI)  and  was 
negative  for  PDP97  probe  (Figurc3.27b).  Hybridisation  study  using  GMGYIO  and 
SRY  probes  (both  hybridise  to  the  TDF  region)  revealed  no  signals  of  these  probes  in 
either  metaphase  or  interphase  nuclei.  Y-chromosome  long  arm-specific  probes  (MK5 
and  PHY2.1)  hybridisation  studies  showed  clear  and  strong  signals  of  these  probes  on 
the  short  arm  of  the  abnormal  chromosome  X  (Figure  3.27b,  c,  d).  Dual  FISH  analysis 
using  XIST  (Xql3)  and  PHY2.1  (Yqh)  showed  clear  signals  of  both  probes  on  the 
abnormal  X  chromosome  and  revealed  that  the  abnormal  X  chromosome  carries  the  Y 
material  on  the  short  arm  (Figure  3.27d).  These  findings  of  FISH  analyses 
reconfirmed  the  cytogenetic  finding  of  translocation  of  Yq  to  the  short  arm  of  the  X 
chromosome  and  showed  the  absence  of  the  TDF  region  in  the  abnormal  X. 
WCP-Y  DXZI  PDP97  MKS  PHY2.1  XIST  GMGYIO  SRY 
Case  21  Y-paint  (X-cen)  (Y-cen)  (Yqll)  (Yql2)  (Xql3)  (Ypll)  (Ypll) 
46,  X,  t(X;  Y) 
II 
+ 
I 
+ 
I 
+ 
II 
+ 
I 
+ 
I 
II 
164 Case  22 
A  female  referred  with  history  of  primary  amenorrhea  was  investigated. 
Cytogenetic  analysis  using  G-banding  technique  confirmed  her  karyotype  as  mos 
45,  X/46,  X,  iY(q)  in  the  ratio  of  74%  and  26%  respectively. 
FISH  study  to  metaphase  spreads  using  PDP97  probe  showed  70%  of  the 
examined  cells  to  be  negative  for  this  probe  confiming  the  presence  of  45,  X  cell  line, 
while  30%  of  the  cells  showed  hybridisation  signal  of  the  Y  chromosome  (Figure 
3.28a).  Dual  FISH  study  using  both  X  and  Y  chromosome  paint  (WCP  X  and  Y) 
probes  and  unicolour  FISH  study  using  Y  chromosome  long  arm-specific  probe 
(PHY2.1)  revealed  X-paint  coverage  over  the  normal  X  chromosome  and  Y  paint  on 
the  abnormal  Y  chromosome  (Figure  3.28b)  and  two  copies  of  the  PHY2.1  signals  at 
both  arms  of  the  abnormal  Y  (Figure  3.28c).  Moreover,  hybridisation  with  Y- 
chromosome  short  arm-specific  probes  (GMGYIO,  SRY)  showed  no  signals  on  the 
abnormal  Y  indicating  absence  of  Yp  material  in  the  abnormal  Y  chromosome.  These 
results  confirmed  the  cytogenetic  interpretation  of  the  karyotype,  as  45,  X/46,  X,  i(Yq). 
Karyotype  PDP97 
Y-cent 
WCPX  WCPY  PHY2.1 
yql2 
SRY 
YpIl 
GMGYIO 
YpIl 
45,  X  (67%)  + 
46,  X,  i(Yq)(33%)  +  +  ++ 
166 Case  23 
A  male  patient  with  ambiguous  genitalia  with  the  karyotype  mos 
46,  XY/46,  X,  +mar  (?  derY)  was  reassessed  to  delineate  the  status  of  the  abnormal  Y 
chromosome  material.  FISH  analysis  using  centromeric  probe  (PDP97)  revealed  that 
the  abnormal  Y  chromosome  was  positive  for  Y  centromere.  However  dual  colour 
FISH  using  biotin  labelled  WCPY  paint  and  digoxigenin.  labelled  WCPX  paint 
revealed  a  complete  Y-paint  coverage  over  the  normal  and  abnormal  Y  chromosome 
(Figure  3.29).  Dual  colour  FISH  analysis  using  GMGY1O  (Ypl  1)  and  PHY2.1  (Yq12) 
probes  revealed  one  copy  of  each  probe  adjacent  to  each  other  on  the  abnormal  Y 
chromosome  (Figure  3.29)  suggesting  the  possibility  of  a  ring  Y  chromosome  [r(Y)] 
. 
Dual  colour  FISH  analysis  using  PDP97  and  MKS  (Yql  1)  probes  showed  one  copy  of 
apparently  large  Y  centromeric  probe  (PDP97)  sandwiched  between  two  copies  of  the 
MKS  probe  (Figure  3.29)  suggesting  the  possibility  of  dicentric  Yq  or  isodicentric 
Yq.  Therefore,  FISH  analysis  confirmed  the  karyotype  of  the  patient  contain  multiple 
cell  lines  mosaicism  involving  structural  abnormalities  of  the  Y  chromosome. 
Cytogenetic  reassessment  of  the  case  using  G,  C,  and  Q  banding  reconfinned  the 
FISH  results.  The  revised  karyotype  was  interpreted  as  mos  46,  XY[91]/46,  X,  i(Yq)[6] 
/46,  X,  r(Y)[3]  (Figure  3.30). 
Karyotype  WCPX  WCPY  GMGYIO 
(Ypll) 
PHY2.1  MK5 
11 
PDP97 
YZ3) 
46,  X,  i(Yq)r6l  -  +  Not  done  Not  done  ++  + 
46,  X,  r(Y)[31  -  +  +  +  N.  D  + 
168 4:  B 
Normal  Y 
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Figure  3.30:  C-banded  partial  inetaphase  spreads  of' 
cytogenelically  reinvestigated  case  #  23  showing  Y  chromosome 
abnorinalities.  (A)  Normal  Y  chrornosorne.  Two  partial  metaphase 
spreads  with  ring  Y  (B)  and  with  I(Yq)  (C). 3.1.2  X-inactivation  study 
In  addition  to  the  FISH  studies,  replication  status  of  the  ring  chromosomes  in 
7  patients  (cases  1-7)  out  of  the  previously  described  9  cases  and  in  one  case  with 
46,  XXp+  were  attempted  using  a  terminal  pulse  of  BrdU  (B-pulse)  and  Giernsa 
staining  (RBG)  according  to  Latt  et  al  (1977)  with  some  modifications.  Replication 
studies  were  performed  by  introducing  BrdU  (39lig/ml)  to  lymphocyte  culture  7  hours 
prior  to  harvest  (case  24).  This  technique  results  in  a  modified  R-banding  pattern  with 
lightly  stained  late  replicating  regions  (Figure  3.3  1).  One  hundred  cells  containing 
rings  were  analysed  in  each  case. 
(I)  X-inactivation  study  of  r(X)  [Cases  1-71 
Variation  in  the  presentation  of  the  rings  was  noticed  during  analysis  of  the 
stage  in  which  the  DNA  in  the  ring  chromosome  was  replicating.  Details  of  this  study 
are  as  follows: 
(1)  W.  L1. 
This  case  has  a  Turner  phenotype  with  normal  mentality.  The  cytogenetic 
study  of  her  peripheral  blood  showed  45,  X/46,  X,  r(X)  in  the  ratio  of  73:  27%.  The  r(X) 
was  found  to  be  small.  The  activation  status  of  the  X  chromosomes  was  investigated 
and  one  hundred  rings  were  examined.  The  normal  X  chromosome  was  always  active, 
and  the  ring  X  was  found  to  be  active  (early-replicating)  in  50%  of  cells  where  it  was 
present  (Figure  3.32). 
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I (2&3)  D.  C.  and  J.  H. 
Two  patients  with  Turner  phenotype  who  needed  an  extra  help  in  school  were 
found  to  have  45,  X/46,  X,  r(X)  karyotype  with  28  and  20%  respectively,  of  their  cells 
showing  small  ring  X  chromosome  on  routine  cytogenetic  analysis.  X-inactivation 
study  of  100  r(X)  showed  that  50  and  46%  of  their  rings,  respectively,  were  active 
whereas  their  normal  X  chromosome  was  active  (early-replicating)  in  all  cell  lines 
(Figure  3.33). 
(4)  F.  R. 
Cytogenctic  analysis  of  this  patient  with  Turner  phenotype  showed  a 
45,  X/46,  X,  r(X)  with  50%  of  medium  sized  ring.  The  X  inactivation  study  of  100 
rings  revealed  14%  of  the  rings  were  in  the  early-replicating  stage  (active).  The 
normal  X  chromosome  was  always  active  in  all  cells  irrespective  of  the  state  of  the 
ring  X.  Two  percent  of  her  rings  were  dicentric  and  always  inactive  (late-replicating) 
(Figure  3.34).. 
(5)  C.  B. 
A  45,  X/46,  X,  r(X)  patient  with  Turner  phenotype  showed  10%  of  her  cell  lines 
carrying  medium  sized  ring  X  chromosome.  X-inactivation  study  of  100  rings  showed 
88%  of  the  rings  were  late-replicating  (inactive).  One  large  ring  X  chromosome  was 
found  and  it  was  in  the  late-replicating  state  (Figure  3.35). 
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Figure  3.34:  BrdU  labelled  replication  study  in  a  Turner  Patient  (F.  R.  )  carrying  a 
medium  size  ring  X  chromosome.  (a)  14%  of  r(X)  were  observed  in  the  early 
state  of  replication  (active).  (b,  c)  show  late  replicating  r(X)  (inactive).  2%  of  rings 
were  dicentric  and  were  inactive  (c).  E.  R  =  early  replication;  L.  R  =  late  - 
replication;  Arrow  =  r(X). (a)  (b)  ## 
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LRL.  R (6)  C.  F. 
This  case  had  a  Turner  phenotype  and  needed  an  extra  help  in  schooling. 
Cytogenetic  analysis  of  mitosis  cells  showed  a  45,  X/46,  X,  r(X)  karyotype  with  20%  of 
her  cells  carried  medium  sized  r(X).  The  replication  pattern  of  the  X  chromosomes 
was  carried  out.  Critical  analysis  of  100  rings  (X)  showed  three  different  types  of 
rings  (Table  below).  The  majority  of  the  rings  were  of  medium  size  (87%)  while  8% 
were  small  and  5%  were  of  large  size.  3  1%  of  the  rings  were  active,  of  these  20% 
were  medium,  7%  were  small  and  4%  were  large  sized  rings  (Figure  3.36). 
Active  r(X)  Inactive  r(X)  Total  r(X) 
Small  Medium  Large 
7  20  4 
Small  Medium  Large 
1  67  1  100 
(7)  K.  R. 
Cytogenetic  study  of  the  peripheral  blood  of  this  case  showed  45,  X/46,  X,  r(X) 
[71:  29)  karyotype  with  29%  of  metaphase  spreads  carried  a  medium  sized  r(X).  The 
replication  patterns  of  the  normal  and  r(X)  was  done  and  100  cells  with  46,  Xr(X) 
were  analysed.  The  normal  X  chromosome  was  always  active.  20%  of  the  rings  were 
early-replicating  (active)  and  80%  of  the  rings  were  late  replicating  (inactive).  2%  of 
rings  were  of  large  size  and  all  were  active  (Figure  3.37). 
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L.  R (2)X-inactivation  study  of  a  case  with  46,  XXp+ 
Case  20 
In  this  case  FISH  investigation  revealed  an  X/autosome  [t(X;  16)] 
translocation.  The  short  arm  of  the  abnormal  X  chromosome  contained  materials  from 
chromosome  16  as  previously  mentioned  (Figure  3.25  and  3.26).  This  case  was  also 
studied  for  the  replication  pattern  of  the  abnormal  and  normal  X  chromosomes.  Fifty 
cells  were  examined  and  all  showed  the  abnormal  X  chromosome  was  late-replicating 
(inactive).  The  translocated  segment  16q-qter  on  the  short  arm  of  the  abnormal  X 
showed  differential  replication  pattern  (Figure  3.38). 
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Figure  3.38:  (a)  The  X-mactivation  study  ol'a  case  with  46.  X,  t(X:  16)  showing 
the  abnormal  X  chroniodoine  late  replicating  wrrow).  (b)  Sl  loWing  dl  111CI-entlal 
replication  ofthe  16q  on  the  short  arni  ofabnormal  X  chromosome  (arro%ýs). 
(c)  Partial  metaphase  ol'G-banded  chromosome  showing  the  abnornial  X 
chromosome  (arrow)  and  two  nornial  chromosome  16  X  and  16. 3.2  Molecular  studies: 
3.2.1  Androgen  Receptor  gene  (AR) 
The  subjects  evaluated  in  this  study  were  five  unrelated  individuals  with 
androgen  insensitivity  syndrome  (AIS).  All  subjects  had  normal  46,  XY  karyotype. 
Three  of  the  subjects  were  referred  as  the  complete  form  (CAIS),  previously  known  as 
testicular  ferninisation  syndrome.  Two  of  patients  were  presented  at  birth  with  genital 
ambiguity  and  diagnosed  as  the  partial  form  of  AIS  (PAIS). 
3.  ZI.  I  PCR  amplificatioll  ofthe  AR  gene  exonsfrom  genonlic  DNA 
Fourteen  pairs  of  oligonucleotide  primers  were  used  in  amplification  of  the 
eight  exons  of  the  coding  region  of  the  AR  gene  (2800  bp  coding  sequences).  Exons 
2-8  were  amplified  from  gcnomic  DNA  using  flanking  intronic  primer  sets.  Exon  1 
(1615  bp)  was  amplified  using  four  overlapping  primer  sets  (Figure  3.39).  PCR 
reactions  were  optimised  using  the  published  conditions  as  starting  points. 
3.  ZI.  2  Mutation  detection  strategy 
After  PCR  amplification  of  all  the  . 4R  exons  from  5  AIS  patients,  PCR 
products  were  analysed  on  ethidium,  bromide-stained  1%  agarose  gels  to  detect  major 
sequence  alterations.  If  no  alteration  was  detected,  PCR  products  were  screened  by 
the  means  of  SSCP  and  heteroduplex  analyses  to  detect  point  mutations  and  minor 
sequence  alterations.  Since  nearly  all  reported  mutations  in  the  AR  gene  were  detected 
in  exons  2-8,  direct  sequencing  of  these  exons  were  performed  from  all  AIS  patients 
to  detect  any  possible  mutation  that  may  not  be  detected  by  SSCP  or  heteroduplex 
analyses. 
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ý64 PCR  amplification  of  all  the  AR  exons  from  the  screened  patients  revealed  proper 
product  sizes  indicating  the  absence  of  major  sequence  alterations  (Figure  3.40). 
SSCP  analysis  was  optimised  and  performed  according  to  Orita  et  al  (1989). 
Since  SSCP  is  more  sensitive  when  smaller  PCR  fragments  were  used,  PCR  products 
from  exons  3,5,6  and  8  (171  to  347  bp)  were  used  in  this  analysis.  Denatured 
radiolabelled  PCR  products  were  analysed  on  0.5%  MDE  gels  with  or  without  5% 
glycerol  ran  at  room  temperature  and  at  40C.  A  mobility  shift  was  detected  in  PCR 
products  of  exon  8  from  one  CAIS  patient  when  compared  to  other  patients  and  a 
normal  control  (Figure  3.41). 
Heteroduplex  analysis  was  known  to  be  simple  to  perform  with  a  mutation 
detection  rate  comparable  to  that  obtained  upon  the  SSCP  analysis.  The  MDE  gel 
matrix  significantly  improved  resolution  of  conformationally  different,  heteroduplex 
DNA  molecules  and  was  used  by  many  researchers  to  detect  single  base  substitutions, 
deletions  and  insertions  in  variety  of  diseases  (Keen  et  al,  199  1;  Perry  et  al,  1992; 
White  et  al,  1992).  The  effective  range  for  comparison  of  DNA  containing  single  base 
pair  mismatches  is  approximately  200-600  bp.  Heteroduplex  analysis  of  PCR 
products  of  the  AR  gene  exons  1,2,4  and  7  (from  415-605  bp)  from  all  patients  was 
performed  on  50  cm  IX  MDE  gels.  No  abnormal  migration  was  detected  in  any  of 
them.  In  all  experiments  a  positive  heteroduplex  control  sample  were  included  (Figure 
3,42). 
To  confirm  the  nature  of  the  mobility  shift  detected  upon  SSCP  analysis  of  the 
CAIS  patient  direct  sequencing  of  the  asymmetric  PCR  products  from  AR  gene  exon  8 
185 from  this  patient  was  performed.  A  point  mutation,  4109  G->T  that  causes  a  missense 
Val  889  Leu  change  was  detected  (Figure  3.43).  The  4109  G-*T  change  created  an 
extra  AM  enzyme  restriction  site  which  upon  digestion  of  exon  8  PCR  products  (347 
bp)  revealed  four  bands  of  127,109,64  and  47  bp  respectively.  Digestion  of  exon  8 
PCR  products  from  normal  controls  revealed  only  3  bands  of  174,109  and  64  bp 
respectively  (Figure  3.44).  A  hundred  normal  controls  were  screened  using  AM 
restriction  analysis  of  their  AR  gene  exon  8  PCR  products  and  none  were  found  to 
have  this  mutation. 
To  detect  any  possible  mutations  in  the  AR  gene,  direct  sequencing  of  the 
asymmetric  PCR  products  obtained  from  exons  2-8  was  performed  and  revealed  no 
sequence  alterations. 
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Figure  3.40:  Ethidiurn  bromide  stained  I  ý,,  o  agarose  gels.  electrophoresed  at  100  volts 
for  45  minutes  and  photographed  under  UV  light.  (a)  PCR  prodUCtS  from  exons  2  to  8 
of  the  4R  gene.  (b)  PCR  products  from  the  four  segments  spanning  exon  one  ofthe.,  IR 
gene.  Normal  sized  products  were  obtained  from  all  screened  patients  indicating  tile 
absence  of  deletions.  insertions  or  structural  rearrangements.  LI=  100  bp  DNA  ladder, 
L2  =I  kb  DNA  ladder. 
L2  11  L2  III (a) 
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Figure  3.41:  (a)  Examples  of  radiolabelled  SSCP  screening  of 
exons  3,5  and  6  of  the  AR  gene.  NO  abnormal  band  shift  was 
detected  in  any  of  the  screened  patients.  (b)  SSCP  analysis  ofthe 
AR  gene  exon  8.  A  mobility  shift  (lane  4)  is  seen  in  one  of  the 
screened  patients.  The  PCR  prodticts  were  clectrophoresed  in 
0.5X  MDE  gel  containing  5%  glycerol  at  5  watts  for  16  hours  at 
room  temperatUre. 
Exon  3  Exon  5  Exon  6 
1 Exon  I  Exon  2  Exon  7 
Figure  3.42:  Examples  of  heteroduplex  analysis  of  exons  1,2  and  7  of 
tile  4R  gene.  No  heteroduplex  band  were  detected  in  any  screened 
patients.  Arrows  indicate  the  394  bp  heterodUplex  band  in  the  positive 
control  (C).  The  PCR  products  were  electrophoresed  in  IX  MDE  gel  at 
800  volts  for  20  hours.  The  gels  were  stained  with  silver  nitrate. 
L=I  kb  DNA  ladder,  C=  control.  P=  patient. N 
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Figure  3.43:  Direct  sequencing  of  the  asymmetric  PCR  product  from  exon 
8  of  the  AR  gene  revealed  4109  G  --b.  T  Mutation  in  the  patient  (P) 
compared  to  the  normal  control  (N).  The  PCR  products  were  resolved  in 
80/ýo  denaturing  polyacrylarnide  gel  containing  7M  urea.  Electrophoresis 
was  carried  out  at  500  C  (-2000  volts)  for  3.5  hours. 174  bp 
127  bp 
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Figure  3.44:  Alul  restriction  enzyme  digestion  of  PCR 
products  from  exon  8  of  the  AR  gene.  Lanes  I  to  4  show 
normal  digestion  products  of  174,109  and  64  bp.  Lane  5 
shows  the  digestion  products  from  the  patient  who  carries 
the  4109  G  ý--)  T  mutation.  The  normal  174  bp  product  was 
digested  into  two  products  of  127  and  47  bp  (arrow  heads) 
due  to  this  mutation.  The  PCR  digests  were  run  on  1% 
agarose  gel  at  100  volts  for  2  hours,  stained  with  ethidiUM 
bromide  and  v1suallsed  under  the  UV  light. 
L=  100  bp  DNA  ladder. 3.2.2  SRY-Rene 
Patients: 
Subjects  included  in  this  part  had  abnormal  sexual  differentiation.  Two  cases 
presented  as  46,  XY  females  with  primary  amenorrhea  and  were  diagnosed  as  pure 
gonadal  dysgenesis  syndrome.  The  ultrasound  scan  showed  no  ovaries  and 
laparotomy  study  revealed  streak  ovaries.  Two  cases  with  ambiguous  external 
genitalia  and  dysgenetic  gonads  were  referred  as  46,  XY  partial  gonadal  dysgenesis 
and  were  also  investigated.  Four  cases  with  46,  XX  sex  reversal  were  studied.  One 
was  referred  because  of  ambiguous  external  genitalia  (undescendent  testicles).  Three 
were  identified  at  the  infertility  clinic. 
3.2.2.1  46,,  YY  Females 
The  SRY  gene  (sex-determining  region  Y  gene)  was  proposed  as  a  candidate 
for  the  testis  determining  factor  (TDF)  (Sinclair  et  al.,  1990)  and  it  has  been  reported 
that  approximately  10%  of  46,  XY  females  with  gonadal  dysgenesis  show  point 
mutations  or  deletions  of  the  HMG  (high  mobility  group)  box-like  motif  of  the  gene 
(Jager  et  al.,  1992).  In  this  study,  four  46,  XY  females  with  gonadal  dysgenesis  were 
analysed  for  the  presence  of  major  deletions,  point  mutations  or  minor  sequence 
alterations  in  the  SR  Y  gene. 
In  order  to  detect  major  deletions  in  the  TDF  region,  fluorescence  in  situ 
hybridisation  (FISH)  analysis  using  hocSRY  (SRY-cDNA  specific  and  hybridises  at 
Yp11.2)  and  GMGY1O  (hybridises  to  the  TDF  region  at  Ypll.  l)  probes  was 
performed.  Hybridisation  study  on  metaphase  spreads  from  all  patients  revealed 
positive  signals  of  both  probes  at  Yp  II  region  of  the  Y  chromosome  indicating  the 
absence  of  major  deletion  of  the  SRY  gene  in  the  studied  patients  (Figure  3.45).  Two 
cases  [46,  X,  t(X,  Y)  and  46,  X,  i(Yq)]  with  cytogenetically  determined  deletions  of  the 
192 Yp  region  were  used  as  negative  controls  and  showed  no  hybridisation  of  hocSRY  or 
GMGY  10  probes  on  the  abnormal  Y  chromosomes  or  on  any  other  chromosomes. 
Since  the  SRY  gene  is  a  single  intronless  gene,  that  encodes  223  amino  acids, 
its  open  reading  frame  (ORF)  was  PCR  amplified  using  flanking  oligonucleotide 
primers  XES  I  ONES  11  from  the  four  studied  patients.  PCR  products  of  expected  size 
were  obtained  from  all  patients  excluding  deletions,  insertions  or  other  major 
sequence  alterations.  Moreover,  PCR  amplification  from  the  two  negative  controls 
(Yp  deleted  patients)  revealed  no  products  from  the  SRY  region  (Figure  3.46). 
With  one  exception  (Tajima  et  al.,  1994),  all  known  SRY  mutations  cluster  in 
the  HMG  box  of  the  gene.  Two  PCR  primer  sets  were  used  to  amplify  the  whole 
HMG  (conserved)  domain  in  two  overlapping  segments  (217  &  246  bp)  from  the  four 
studied  patients.  PCR  products  from  these  segments  were  used  in  the  SSCP  analysis 
study  as  a  first  attempt  to  detect  point  mutations  or  minor  sequence  alterations. 
MDIP  gels,  with  and  without  5-10%  glycerol,  running  at  room  temperature  were 
used  in  this  study.  No  abnon-nal  mobility  shift  was  detected  in  any  of  the  studied 
patients  (Figure  3.47). 
As  no  abnormalities  were  detected  upon  the  SSCP  analysis,  the  whole  open 
reading  frame  (ORF)  of  the  SRY  gene  was  PCR-amplified  from  all  patients  and 
screened  by  chemical  cleavage  of  mismatch  (CCM)  analysis,  yet  no  cleavage  products 
were  obtained  from  any  of  the  screened  patients  (Figure  3.48). 
As  a  last  attempt  to  screen  for  mutations  in  the  SRY  gene  of  these  patients, 
direct  sequencing  of  the  asymmetric  PCR  products  from  the  whole  ORF,  part  of  the 
promoter  sequences  and  part  of  the  3'  untranslated  end  of  the  gene  were  performed 
using  6  overlapping  primer  pairs  (Figure  3.49).  No  sequence  abnormalities  could  be 
detected  in  any  of  the  screened  patients  (Figure  3.50). 
193 (a) 
700  bp  -01- 
(b) 
500  bp 
Figure  3.46:  PCR  aniplification  products  (7  10  bp)  froill  (lie  open  reading  fraille 
of  the  SR)'gene.  (a)  No  major  sequence  alterations  could  be  detected  ill  aliv  of 
the  screened  patients.  (b)  Lanes  2  and  4  show  no  amplification  from  patients 
vvith  Yp  deletions  (negative  control).  Lane  I  (normal  male  control)  and  lanes  3. 
5  and  6  (three  46AY  female  patients)  sho\,  \-  the  710  bp  PCR  products.  The  IICR 
prodUCtS  were  rUn  oil  1%,  agarose  gel  at  100  volls  for  in  hour.  stained  with 
ethidaini  bromide,  visualised  and  photographed  under  UV  light.  C=  control.  P 
=  pat  lent.  LI=  100  bp  DNA  ladder,  L2  =I  kb  DN  A  ladder. 
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c  PI 
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Figure  3.47:  Radiolabelled  SSCP  analysis  of  tile  two  segments  that 
coverthe  HMG  domain  oftheSRYgene  usIngO.  5X  M[)El\lgel  with  5"o 
glycerol.  No  mobility  shift  could  be  detected  in  any  of  the  studied 
patients  (P).  Tile  PCR  products  were  rLin  at  5  watts  for  16  hours  at  room 
temperature.  C=  control. W  i. 
Figure  3.48:  An  example  of'chemical  c1ca\agc  ofmismatch  ()NIIIIIIIII 
tetroxide  (OT)  and  hydroxylarninc  (HA)  are  the  chemicals  Used  to  1110(lity  either 
T  or  C  mismatches  respectively.  The  CCM  of  the  whole  open  reading  Frame  of 
the  SR  Y  gene  from  four  fernale  patients  (  1-4)  with  46AY  gonadal  dysgenesis 
and  nomial  male  controls  (5-7).  No  cleavage  prodUCtS  were  detected  Upon  their 
HA  or  OT  modification.  C=  positive  control.  L=I  kb  DNA  ladder. C  -0  cn  " 
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46,  XX  male  syndrome  are  one  of  the  rarest  sex  chromosomal  disorders  in 
humans.  In  most  cases  the  cause  is  due  to  unequal  interchange  between  Xp  and  Yp 
termini  during  paternal  meiosis  as  was  proposed  by  Ferguson-Smith  (1966).  The 
pattern  of  Y-sequences  present  in  XX  males  shows  considerable  variations.  In  most  of 
the  reported  patients  the  Y  segment  includes  almost  75%  of  Yp  (Affara  et  al  1986). 
However,  in  very  few  cases,  the  translocated  segment  is  very  small  (3540  kb),  but 
since  it  includes  TDF,  sex  reversal  occurs  (Lopez  et  al  1995).  By  contrast,  most 
46,  XX  males  with  abnormal  genitalia  lack  sequences  for  SRY  in  genomic  DNA 
(Ferguson-Smith  et  al  1990). 
Patients: 
Four  phenotypically  male  individuals  confirmed  to  have  46,  XX  karyotype 
were  referred  for  molecular  investigation  to  exclude  sex  chromosome  mosaicism  or 
structural  abnormalities  of  the  X  and  Y  chromosomes.  Three  out  of  four  cases  (aged 
between  35-48  years  old)  had  a  history  of  primary  infertility.  One  5  year  old  male  was 
referred  with  bilateral  undescendent  testes  (cryptorchidism). 
FISH  study  of  46,  XX  males 
In  the  present  study,  a  46,  XX  karyotype  was  found  in  the  four  patients  vvith  sex 
reversal.  FISH  study  on  metaphase  spreads  from  all  patients  were  carried  out  with 
PDP97  (Y-centromeric)  and  PHY2.1  (Yqh)  probes,  which  detect  highly  repetitive  Y- 
specific  DNA  sequences  to  exclude  the  possibility  of  =Y  or  XX/XXY  mosiacism 
or  other  structural  rearrangement.  All  patients  were  negative  for  both  probes. 
200 To  detect  the  presence  of  a  translocation  of  chromosomal  material  encoding  TDF 
from  the  Y  to  X  chromosome  or  autosomes,  FISH  analysis  using  hocSRY  and 
GMGYlO  probes  which  both  hybridise  to  the  Ypl  1-12  region  of  the  Y  chromosome 
were  done.  Hybridisation  analysis  on  metaphase  spreads  revealed  3  cases  of  46,  XX 
males  with  clear  signals  of  the  hocSRY  and/or  GMGYlO  probes  on  the  short  arm  of 
one  X  chromosome.  The  fourth  case  showed  no  signals  with  either  probe 
(Figure  3.51,  Table  3.4). 
PCR  study 
To  examine  the  extent  of  transfer  of  Y-specific  sequences  in  the  four  46,  XX 
males,  four  different  Y-specific  PCR  primers  were  used.  Y1/Y2  (DYZ3)  primer  set 
was  used  to  amplify  Y-centromeric  sequences.  No  such  sequences  were  detected  by 
PCR  in  any  of  the  46,  XX  male  patients  compared  to  normal  male  controls  confirming 
the  FISH  analysis  results.  PCR  analysis  using  SRY,  ZFY  (zinc  finger  Y  protein) 
(Ypl  1.2)  and  PAR  (pseudo-autosomal  region)  primers  that  =plify  DNA  sequences 
from  Yp12  region  of  Y-chromosome,  showed  amplifications  of  the  corresponding 
regions  in  three  cases  of  XX  males.  The  fourth  case,  which  showed  negative  FISH 
analysis  for  SRY  probes,  showed  no  PCR  amplification  products  using  the 
aforementioned  PCR  primer  sets.  The  results  are  summarised  in  Table  3.4 
and  Figure  3.52. 
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Figure  3.52:  PCR  amplitication  of  DNA  t'I'OlII  thC  StUdiCd  4(),  XX  11411es  LI1,  IIIg  I'k)Lll' 
different  Y-specific  primers.  Primer  YI/Y2  (170  bp)  showed  no  ampl  It  icat  loll  In  aII 
four  patients  (bands  in  P  I.  P2.  P4  &  C2  are  non  specitic).  SRY  (710  bp).  ZFY  (735  bl)) 
and  PAR  (  1.1  kb)  primers  showed  arriplification  in  three  patients  (P2.113  and  P4).  No 
products  were  obtained  from  any  Y-specific  sequences  Upon  PCR  amplification  From 
PI  DNA.  The  PCR  products  were  run  in  1%  agarose  gel  at  100  volts  for  an  hour, 
stained  with  ethidiurn  bromide.  visualised  and  photographed  under  UV  light.  P 
patient,  Cl=  normal  niale  controls:  C2=  normal  fernale  control;  1.1  100  bp  DN  A 
ladder.  L2=  I  kb  DNA  ladder. 
I 
L2  Cl  Cl  C2  C2  PI  P2  P3  P4 3.2.3  Mutation  analysis  of  the  azoospermia  factor  (AZF)  region 
Cytogenetic  analysis  of  anomalies  in  YqI  1  of  the  human  Y  chromosome  in 
sterile  males  with  azoospermia  or  a  severe  oligozoospermia  suggests  the  location  of 
azoospermia  factor  (AZF)  controlling  spermatogenesis  in  distal  YqI  I  (Tiepolo  and 
Zuffardi,  1976;  Vogt  et  al,  1992a).  The  existence  of  genes  associated  with 
spermatogenesis  on  the  human  Y  chromosome  was  provided  by  the  detection  of 
interstitial,  usually  submicroscopic  Yq  deletions  in  azoospermic  men  (Chandley  ct  a], 
1989).  Ma  et  al.  (1993)  identified  two  closely  related  genes,  BMI  and  RDM2  whose 
absence,  they  proposed  might  be  the  cause  of  azoospermia.  Recently,  Reijo  et  al 
(1995)  identified  a  novel  gene,  called  DAZ  (deleted  in  azoospermia),  that  was  deleted 
in  a  proportion  of  idiopathic  azoospermic  men  and  they  claimed  it  to  be  the  AZF 
candidate  gene. 
3.  Z3.1  Patient  selection 
56  infertile  men  aged  from  22-53  years  old  were  enrolled  in  this  study.  The 
clinical  screening  of  sterile  patients  was  started  by  filling  in  a  questionnaire  during 
clinical  examination  of  each  patient  in  one  of  the  two  infertility  clinics  from  Kuwait 
participated  in  this  study.  Each  patient  was  asked  and  examined  for  potential  gonadal 
abnormalities,  testis  volume,  varicoceles,  prostatic  abnormalities,  chronic  illnesses, 
previous  genital  injury,  infection  or  orchitis,  toxic  environmental  exposure  or 
urological  surgical  procedures.  Twelve  patients  had  undergone  testicular  biopsy. 
Details  of  their  spermatogenetic  activity  and  histopathological  findings  were  known. 
Urological.  investigations  did  not  reveal  any  kind  of  physical  obstruction 
except  in  one  case,  which  was  then  excluded  from  the  study.  One  case  with  varicoccle 
was  also  excluded  from  the  study.  Quantitative  analysis  of  the  follick-stimulating 
205 hormone  (FSH),  luetinizing  hormone  (LH)  and  testosterone  were  done  in  all  cases. 
Patients'  hormone  levels  of  testosterone  were  within  the  normal  range  (5.2-22.9 
nmol/L).  The  level  of  the  follicle  stimulating  (normal  ranges  1.7-11  IUAL)  and 
leutinizing  (normal  ranges  0.5-5  IU/L)  hormones  were  normal  or  increased.  Sperm 
analysis  of  all  patients  showed  either  azoospermia  or  severe  oligozoospermia  (sperm 
count  <2x  106  /  MI). 
All  patients  were  then  asked  for  analysis  of  their  chromosomes  in  order  to 
exclude  the  cytogenetically  detectable  chromosome  abnormalities  known  to  be 
associated  with  infertility.  Chromosomal  study  using  G,  Q  and  C-banding  techniques 
were  performed  for  all  the  56  patients.  Q  and  C-banding  techniques  showed  intact  Y. 
heterochromatic  region  in  all  patients.  Four  patients  with  small  testis,  showed 
47,  XXY  karyotype  (Klinfelter's  syndrome).  As  this  karyotype  is  known  to  be 
associated  with  sterility  these  patients  were  excluded  from  the  molecular  analysis. 
One  case  showed  47,  XYY  karyotype.  Although  this  karyotype  was  not  known  to  be 
associated  with  male  infertility,  yet  this  case  was  excluded  because  of  varicocele  as 
previously  mentioned.  The  remaining  50  cases  showed  normal  46,  XY  male 
karyotype.  Table  3.5  summarises  the  clinical  and  cytogenetic  examination  of  sterile 
men. 
3.  Z3.2  Screeningfor  deletion  in  the  Yq11  region 
PCR  screening:  About  10%  of  idiopathic  sterile  males  were  found  to  have 
microdeletion  in  the  interval  six  of  the  Yq1  I  (Ma  et  al  1993).  In  the  present  study,  50 
idiopathic  sterile  males  with  46,  XY  karyotype  were  screened.  A  rapid  molecular 
screening  technique  was  applied  and  optimised  using  both  multiplex  and  single  PCR 
techniques  in  order  to  detect  small  interstitial  deletions  in  Yqll.  Thirty  pairs  of 
primers  covering  this  interval  were  used  in  either  single  or  multiplex  PCR  reaction. 
Twenty-eight  Y-specific  STS  (sequence-tagged  sites)  PCR  primer  pairs  were 
206 optimised  and  used  in  five  multiplex  PCR  reactions  (Figure  3.53).  Each  multiplex 
experiment  was  repeated  three  times  in  order  to  evaluate  the  sensitivity  and 
reproducibility  of  any  deletion  in  the  multiplex  reactions.  In  case  of  detected  deletion 
by  multiplex-PCR  analysis,  experiments  were  repeated  by  single  PCR  reaction  with 
primer  pair(s)  of  the  deleted  STS  loci.  Two  primers  specific  for  the  RBAf  genes  were 
also  optimised  and  used  in  single  PCR  reactions.  The  multiplex  PCR  study  detected 
microdeletions  in  only  one  case  (case  20)  out  of  50  patients.  Six  PCR  primer  products 
were  deleted  in  four  (out  of  five)  multiplex  reactions  (Figure  3.54).  The  deletions 
detected  in  the  multiplex  PCR  study  were  ftirther  confirmed  using  the  specific  primer 
sets  in  single  PCR  reactions.  Screening  of  fifty  normal  fertile  males,  using  the  five 
multiplex  PCR  reactions,  were  performed  and  revealed  no  deletion  with  any  primer 
pair.  False  deletions  upon  multiplex  PCR  analysis  were  detected.  PCR  amplification 
using  the  specific  primer  set  in  a  single  reaction  revealed  normal  amplification  from 
that  segment  (Figure  3.55). 
In  order  to  find  if  any  of  the  28  STS  primers  used  in  the  multiplex  reaction 
was  located  in  the  coding  sequence  of  the  RBMgene(s),  Southern  transfer  of  the  five 
multiplex  PCR  reactions  products  was  performed  and  the  membranes  were  then 
probed  using  both  MKS  and  MK29  cDNA  probes.  No  hybridisation  signals  were 
detected  in  any  of  the  filters  indicating  that  none  of  them  is  Part  of  the  RBAf  gene 
coding  sequences,  Because  of  this  RBM-specific  primers  were  used  to  screen  all 
patients'  DNA  for  deletions.  Normal  PCR  amplifications  from  the  RBAf  genes  were 
obtained  from  all  studied  cases  including  the  case  (case  20)  which  showed  deletions 
upon  the  multiplex  PCR  screening  (Figure  3.56). 
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Figure  3.53:  Pattern  of  multiplex  PCR  analyses  of  28  loci.  I  lic 
making  up  each  mixture  are  ordered  according  to  decreasing  length  of  their 
amplification  products  as  indicated  in  the  table.  The  PCR  products  were  resolved  oil 
ail  ethidium  bromide  stained  31/,  o  agarose  gel  (3  parts  NUSCive  :I  part  Seakem). 
clectrophoresed  at  10  volts/cm  for  3  hours  and  v1sualised  under  UV  light. 
I-  -  100  bp  DNA  ladder.  Arrm%  s  indicate  the  300  bp  DNA  band. 
MIX  I  mix  11  x  III  ML  MLX  IV  mix  v 
I  sY84  I  sY  143  1  sY86  I  sY  14  1  pY6Bati34pr 
(326bp)  (311  bp)  (320bp)  (472bp)  (9  1  Obp) 
2=  sY134  2  sY157  2  sY105  2-  sY9  2-  Fr-Ilpr 
(301  bp)  (285bp)  (301  bp)  (303  bp)  (313  bp) 
3=  sYl  17  3  sYSI  3  sY82  3=  sY127  3=  Y6HP52pr 
(262  bp)  (209  bp)  (264  bp)  (274  bp)  (258  bp) 
4ý  sY102  4  sY182  4=  Y6HP35pr  4=  sY109  4=  Y6HP35pr 
(218  bp)  (125  bp)  (226  bp)  (233  bp)  (226bp) 
5=  SY151 
%N  147 
5=  Y6PHc54pr  5=  sY149  5-  Y6Dl4pr 
(183  bp) 
(100  bp) 
(166bp)  (132  bp)  (134  bp) 
6=  sY94  6=  sYI53 
(150  bp)  (139  bp) 
7=  sY88  7-  sY97 
(123  bp)  (104  bp) 
L  \lixI 
I  rslixv Mix  IV 
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Figure  3.55:  Examples  of  false  deletion  upon  the  multiplex  IICR  screening  of 
46AY  intcrtile  maics.  (a)  and  (c)  sho",  the  apparently  deleted  bands  ill  two 
different  patients.  Single  PCR  reactiOll  LlSlllg  the  deleted  primer(s)  showed 
amplification  of  the  specific  segment  from  the  falsely  deleted  bands  ill  these  two 
patients  (b  and  d).  The  PCR  products  were  resolved  ill  all  ethidium  bromide 
stained  Yo  agarose  gel  (3  parts  NLISCIVC  :I  part  Seakem).  elect  rophoresed  at  10 
volts/cm  for  3  hours  and  photographed  Under  UV  light.  1,100  bp  DNA  ladder,  C 
=  control.  Pý  patient. 
Pi 
Single  PCR  Reaction 
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Figure  3.56:  PCR  analysis  of  patient's  DNA  using  RB.  M  and  RBM2  gene-specific 
primers.  Patient  (Px)  who  showed  ni  I  crodelet  ions  In  tile  111LIltiplex  PCR  (Figure  3.54) 
showed  no  deletion  with  these  primers.  The  PCR  products  were  clectrophoresed  on 
an  ethidium  bromide  stained  I  O,  o  agarose  gel  at  10  volt,  cm  for  45  mintiles. 
L=  100  bp  DNA  ladder.  C=  control RHMI 
CC  Px 
%ONO  800bp 
600bp 
'. 
RBA12 
Px 
Figure  3.56:  PCR  analysis  of  patient's  DNA  using  RBAII  and  RBA12  gene-specific 
primers.  Patient  (Px)  who  showed  rn  icrodelet  ions  in  the  multiplex  PCR  (Figure  3.54) 
showed  no  deletion  with  these  primers.  The  PCR  products  were  electrophoresed  oil 
an  ethidiurn  bromide  stained  Po  agarose  gel  at  10  volt/cm  for  45  minutes. 
L=  100  bp  DNA  ladder;  C=  control b)  FISH  study:  -  FISH  study  using  probe  PHY2.1  of  the  DYZ2  locus  showed  normal 
hybridisation  pattern  (Figure  3.57)  from  all  screened  patients  indicating  the  presence 
of  the  Yq12  (interval  7)  and  confirming  the  previous  cytogenetic  findings  obtained  by 
Q  and  C-banding  techniques.  To  detect  the  presence  of  deletions  in  the  RBM1  and 
RBM2  genes  cDNA  probes  MK5  and  MK29  were  used.  No  such  deletion  were 
detected  in  the  studied  patients  including  the  patient  who  showed  microdeletion  in  the 
Yq1  1  region  by  PCR  study  (Figure  3.57). 
3.  Z3.3  Mutation  analysis  of  the  RBMI  gene 
Since  the  RBM  genes  are  a  multicopy  gene  family,  Southern  blotting  analysis 
was  applied  to  detect  gene-copy  deletions  in  all  studied  50  idiopathic  sterile  males. 
Southern  blotting  analysis  using  MK5  probe  and  two  different  restriction  enzymes 
(EcoRI,  Taq])  revealed  multiple  RBM1  hybridisation  fragments  from  patients'  DNA. 
No  abnormal  pattern  was  detected  in  any  DNA  sample  compared  to  normal  male 
controls  (Figure  3.58).  Southern  analysis  of  DNA  from  the  patient  who  showed 
microdeletion  by  PCR  could  not  be  performed  due  to  DNA  degradation. 
To  characterise  the  molecular  pathology  of  the  RBMI  gene  in  idiopathic  sterile 
males,  DNA  samples  from  all  studied  patients  were  further  investigated  for  the 
presence  of  point  mutations  in  this  gene.  Exon-intron  boundary  sequences  of  the 
RBMI  gene  A  type  were  kindly  provided  by  Dr.  H.  J.  Cooke,  Medical  Research 
Council,  Human  Genetics  unit,  Western  General  Hospital,  Edinburgh.  He  also, 
generously  provided  the  exon/intron  boundaries  of  exon  2,  which  is  proposed  to  have 
an  RNA  binding  motif,  in  B,  C  and  D  copies  of  the  gene.  PCR  primers  to  amplify  all 
these  exons  were  designed  using  the  Oligý  program  and  PCR  reactions  were 
optimised  to  get  single  specific  amplification  product  from  each  of  them  (Figure 
215 3-59a  and  b).  Screening  for  point  mutation  in  the  RBM-I  gene  A  type  exons  2-11  and 
in  exon  2  of  B,  C  and  D  gene  copies  was  performed  by  means  of  the  SSCP  analysis. 
Radiolabelled  PCR  amplifications  of  the  specific  exons  were  analysed  by  non- 
denaturing  0.5X  MDE  gel  electrophoresis  with  and  without  5%  glycerol  at  room 
temperature.  Few  false  positive  results  were  detected  which  disappeared  upon  second 
gel  electrophoresis  of  the  same  samples  (Figure  3.60).  No  other  positive  SSCP  results 
were  obtained. 
For  exon  12  (43  7  bp)  of  the  RBM  gene  heteroduplex  analysis  using  IX  MDE 
gel  was  performed  to  screen  for  point  mutation  in  that  exon  from  all  screened 
patients.  No  abnormal  band  pattern  was  detected  in  comparison  to  normal  control 
(Figure  3.61). 
3.  Z3.4  Microdeletion  screening  of  the  DAZ  (Deleted  in  Azoospermia)  gene  in 
idiopathic  sterile  males 
Recently,  Reijo  et  al  (1995)  reported  anew  gene  called  DAZ  that  was  deleted 
in  some  azoospermic  idiopathic  sterile  males.  They  also,  refined  the  physical  map  of 
the  AZF  region  deleted  in  the  azoospermic  men.  Using  this  information,  theSO 
azoospermic  and  severe  oligozoospermic  infertile  men  included  in  this  study  were 
further  screened  for  microdeletion  in  YqlI  using  19  single  STS  PCR  primer  sets, 
included  two  sets  (sY254,  sY255)  within  the  DAZ  gene  and  one  DAZ  gene-specific 
PCR  primer  set.  No  further  patients  with  deletions  were,  detected  in  the  screened 
cohort.  The  patient  who  showed  microdeletion  upon  multiplex  PCR  analysis  showed 
deletion  of  the  DAZ  gene-specific  PCR  primer  set  and  of  16  STS  PCR  primer  sets 
including  the  two  sets  within  the  DAZ  gene  (Figure  3.63).  The  deletions  in  this  patient 
were  found  to  span  the  area  between  DYS232  and  DYS239  which  is  localised  to 
intervals  6C  and  6F  on  the  distal  part  of  YqI  I  (Figure  3.64). 
216 Figure  3.58:  Examples  of  Southern  blot  analysis  using  Mk5  cDNA  and  two 
different  restriction  enzymes  (1-.  *(-oRl  and  Kull).  Male  genomic  DNA  hybridised 
with  the  RBMI  (Mk5)  sequence  dernonstrated  IIILlltlple  locations  of  tile  RB,  %I 
gene.  No  deletion(s)  was  detected  in  any  screened  patient.  The  digested 
fragments  were  separated  in  0.8%  agarose  gel  containing  0.5  pg/nIl  etlildmill 
bronlide  and  electrophoresed  at  2  volts/cm  for  16-20  hOUrs. 
P=  patient,  C=  control. .  44- 
Exon  4  1,  Exon  5  Exon  7 
Figure  3.59a:  PCR  products  from  exon  2  of  the  RBM  gene  family  (A.  B&C-  113 
bp,  D-  100  bp)  and  from  the  RBM  /  gene  exons  3  (128  bp),  4(  190  bp).  5(  179  bp) 
and  7(  125  bp).  The  PCR  products  were  run  in  an  ethidium  bromide  stained  I"o 
agarose  gel  and  clectrophoresed  at  10  volts/cm  for  45  minutes.  Arrows  indicate  100 
bp  band.  L=  100  bp  DNA  ladder. 
Expn  2 
DcB  Exon  3 Exon  6  Exon  8  Exon  9 
1 
411M  411M 
1,  Exon  10 
Figure  3.59b:  PCR  products  from  the  RBAf  I  gene  exons  6  (119  bp),  8(  136  bp),  9 
(  150  bp).  10  (127  bp).  11  (105  bp)  and  12  (437  bp).  The  PCR  products  were  run  ,I  all 
ethidiUrn  bromide  stained  I%  agarose  gels  at  100  volts  for  45  Minutes.  v1suallsed  and 
photographed  under  UV  light.  Arrows  indicate  600  bp  band.  L  --  100  bp  DNA  ladder. 
Exon  IIL  Exon  12 (a) 
CD 
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0000 
we 
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Figure  3.60:  (a)  Examples  of  radiolabelled  SSCP  analysis  of  the 
RBAII  gene  exon  2  (A.  B,  C  and  D)  copies.  (b)  False  positive 
(arrows)  results  of  SSCP  analysis  of  exon  3  obtained  in  two 
different  patients.  The  PCR  products  were  run  in  0.5X  MDF.  gel 
containing  50o  glycerol  and  clectrophoresed  in  OM  TBE  buffer  at  5 
Watts  for  16  hours  at  roorn  temperature. 
AB PPCP 
Figure  3.61:  Example  of  the  heteroduplex  analysis  of  tile  RBAf  / 
gene  exon  12  on  aIX  MDE  gel  (run  at  a  constant  800  volts  for  18 
hours)  detected  by  silver  staining.  Arrow  indicates  tile 
heteroduplex  band  of  a  positive  control  sample. 
P-  patient,  C=  positive  control. (a) 
Ll  Px  ppp 
600I)p 
d0186% 
1*6 
'4-  sN'2154  (350hp) 
4000  SOW  '*-  sN255  (1261)p) 
(b) 
500bp  -go. 
44  13001)p 
.  *-  800hp 
Figure  3.62:  (a)  Multiplex  PCR  analysis  of  DNA  from  intlertile  men  using  two 
primer  sets  within  the  D.  4Z  gene  (sY254  and  sY255).  (a)  only  tile  previous 
patient  (Px.  Figure  3.54)  showed  deletion  of  both  primer  sets.  (b)  PCR 
analysis  of  the  patient  (Px)  showing  deletion  of  tile  whole  1)-4Z  gene  but  no 
deletion  of  the  RBM  I  gene.  The  PCR  products  were  rcsolVCd  Oil  all  ethidIL1111 
bronlide  stained  11o  agarose  minigel  for  45  minutes  at  10  voltcm.  Px  patient 
with  microdeletion,  P=  patient,  Ll=  100  bp  DNA  ladder.  L2=  I  Kb  DNA 
ladder. 
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Figure  3.63:  Deletion  map  of  the  AZF  region  on  human  Y-chromosome. 
(a)  Diagram  of  the  human  Y  chromosome.  (b)  Low  resolution  analysis  of  Y 
chromosome  of  one  case  of  azoospermia  with  microdeletion.  Along  top  border  are 
listed  deletion  intervals  1-7  and,  immediately  below,  22  STS  and  YRRM  loci. 
Shown  below  are  results  of  tested  fertile  and  infertile  men  for  the  presence  (solid 
black  line  or absence  (minus  sign)  of  each  STS.  (c)  Higher  resolution  map  of  AZF 
region.  Along  top  border  are  listed  the  STS  intervals  used  in  this  study.  Below  are 
shown  the  results  of  the  deletions  detected  on  the  same  patient.  (Reijo  et  al  1995 
with  modifications). CHAPTER  4 
DISCUSSION (4)  DISCUSSION 
Detection  of  mutations  is  one  of  the  most  important  areas  of  molecular 
biology  and  it  plays  an  important  role  in  the  diagnosis  of  human  inherited  diseases 
(Cotton  P,  1993;  Grompe  M,  1993).  The  present  study  focused  on  application  of 
different  screening  strategies  that  could  detect  large  or  minor  sequence  alterations 
in  patients  with  sex  chromosomes  aberrations,  sex  determination  (e.  g.  in  the  SRY 
gene),  sex  differentiation  (e.  g.  AR  gene)  and  in  male  patients  with  non  obstructive 
infertility  (RBMI  gene).  These  strategies  involved  the  application  of  cytogenetic, 
molecular  cytogenetic  (FISH)  and  molecular  investigations.  The  spectrum  of  the 
investigated  mutations  ranged  from  cytogenetically  visible  chromosome 
abnormalities  to  microdeletion  and  finally  to  single  base  alteration  (Table  4.1). 
4.1  Cytogenetic  and  molecular  cytogenetic  studies 
In  this  study  the  24  cases  included  had  different  clinical  manifestations 
and  chromosomal  abnormalities  identified  by  standard  cytogenetic  techniques 
(Giemsa  banding,  G-banding,  late  replication  of  X).  Two  thirds  of  these  patients 
(16/24)  were  ascertained  because  they  had  phenotypes  suggestive  of  Turner 
syndrome  or  its  variants.  Reassessment  of  the  chromosomal  constitution  of  these 
patients  using  fluorescent  in  situ  hybridization  technique  was  carried  out  to 
delineate  and  characterize  the  chromosomal  abnormalities  more  precisely. 
In  only  4/24  (16.7%)  cases  were  the  cytogenetic  findings  fully  consistent 
with  the  FISH  results  (one  case  of  46,  XX,  one  with  48,  XXXX,  and  two  cases  with 
45,  X/46,  XY  karyotype).  In  the  remaining  20  cases  (83.3%)  application  of  FISH 
yielded  additional  information  not  available  by  the  standard  cytogenetic  method. 
Mosaicism  of  X  and  Y  chromosomes  and  structural  rearrangements  of  the 
sex  chromosomes  are  two  of  the  major  causes  for  gonadal  dysfunction,  infertility 
or  abnormal  sexual  development  in  both  males  and  females  (Therman  and 
Susman,  1990;  Hsu  L,  1994;  Ogata  and  Matsuo,  1995). 
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9 Since  the  first  cytogenetic  report  of  45,  X  karyotype  in  females  with  Turner 
syndrome  (TS)  by  Ford  et  al  (1959),  a  variety  of  numerical  and  structural 
abnormalities  of  X  and  Y  chromosomes  have  been  reported.  Recent  studies  have 
confirmed  that  the  majority  of  cases  with  45,  X  demonstratqs  mosaicism  as 
confirmed  by  applying  molecular  techniques.  These  individuals  present  with 
varying  degrees  of  clinical  and  pathological  manifestations  (Therman  et  al,  1990; 
Ogata  and  Matsuo,  1995).  At  conception,  loss  of  an  X  chromosome  resulting 
from  mciotic  nondisjunction  is  lethal.  Almost  all  females  with  45,  X,  karyotype 
have  gonadal  dysgenesis,  with  few  exceptional  cases,  in  whom  the  possibility  of 
mosaicism  (45,  X/46,  XX)  cannot  be  absolutely  excluded  (Zinn  et  al,  1993;  Jacobs 
et  al,  1997).  Since  the  development  of  banding  techniques  there  is  a  consensus 
that  a  minimum  of  20  cells  or  even  more  should  be  scored  to  exclude  low  grade 
mosaicism.  Recently,  application  of  FISH  (X  specific  probes)  has  confirmed  that 
-99%  of  the  Turner  syndrome  cases  are  mosaic  and  the  pure  45,  X  cell  line  is  very 
rare  (Fernandez  et  al,  1996;  Jacobs  et  al,  1997).  The  high  percentage  of  fetal  and 
embryonic  miscarriage  with  45,  X  karyotype  points  to  the  necessity  of  mosaicism 
for  survival  (Hook  and  Warburton,  1983).  Routine  analysis  of  20-30  metaphases 
has  limited  the  ability  to  exclude  low  grade  mosaicism.  The  rate  of  detection  of 
mosaicism  is  affected  by  many  factors;  (a)  tissue  types  and  number  of  tissues 
analysed,  number  of  cells  analysed,  (b)  sensitivity  of  the  techniques  applied,  (c) 
cell  selection,  leading  to  disappearance  of  cell  lines  (Fernandez  et  at,  1996).  The 
most  frequently  observed  mosaicism  is  45,  X/46,  XX,  occurring  in  about  30-35% 
of  the  cases  (Fernandez  et  al,  1996).  Mosaicism,  for  structural  abnormality  of  one 
of  the  X  chromosomes  (isochromosome  for  Xq  or  Xp  )  has  been  reported  to  occur 
in  20-25%  of  cases  and  an  unidentified  'marker'  chromosome  or  fragment  (der  X 
or  Y)  has  been  observed  in  12-15%  of  the  cases  (Fernandez  et  al,  1996). 
Application  of  molecular  techniques  such  as  FISH  and  PCR  substantially 
improves  the  rate  of  detection  of  low  frequency  cell  lines  and  possible  structural 
rearrangements. 
The  first  advantage  of  application  of  FISH  technique  is  to  confirm  the 
cytogenetic  finding  especially  in  an  unusual  situation.  For  instance,  the  female  in 
case  #  16  with  short  stature  and  solitary  right  kidney  was  thought  to  have  a  46,  XX 
karyotype  by  routine  cytogenetics.  Application  of  FISH  using  whole  X  and  Y 
229 chromosomes  paint  and  centromeric  probes  for  X  and  Y  chromosomes  did  not 
show  any  mosaicism  or  structural  rearrangement  of  the  X.  FISH  study  excluded 
the  presence  of  Y  material  in  this  case.  Thus,  application  of  FISH  technique  has 
been  useful  in  excluding  low  grade  mosaicism  in  this  patient  who  presented  with 
short  stature  and  some  stigmata  of  Turner  phenotype. 
A  young  female  (case  #  24)  with  minor  dysmorphic  features  and  multiple 
congenital  anomalies  was  confirmed  to  have  48,  XXXX  karyotype.  Whole 
chromosome  painting  of  X  and  centromeric  probe  for  X  analysis  in  this  patient 
confirmed  4  copies  of  the  X  chromosome.  No  mosaicism  was  detected.  Late 
replication  studies  using  BrdU  technique  showed  3  inactive  X  chromosomes. 
This  case  was  investigated  as  a  positive  control  for  X  inactivation  analysis  as  well 
as  to  ascertain  the  specificity  of  the  X  chromosome  specific  probes.  Females 
with  tetra  X  resulting  from  post  zygotic  nondisjunction  have  been  reported  with 
clinical  features  of  microcephaly  and  dysmorphic  features  (Nielsen  et  al,  1977; 
Therman  and  Susman,  1993). 
Marker  or  ring  X{r(X))  chromosomes  of  varying  size  have  been 
reported  in  5%  of  Turner  syndrome  patients  (Jacobs  et  al,  1997).  The  phenotypic 
effects  of  the  r(X)  chromosomes  are  variable.  Some  had  typical  Turner  syndrome 
phenotype,  while  others  had  a  more  severe  phenotype  including  mental 
retardation,  and  other  abnormalities  (Cole  et  al,  1994).  The  more  severe 
phenotype  was  usually  associated  with  very  small  r(X)  chromosomes  which  did 
not  include  the  X-inactivation  (XIST)  locus  (Migeon  et  al,  1993;  Janie  et  al, 
1995).  Presumably,  the  abnormal  phenotype  was  due  to  functional  disomy  for  the 
duplicated  X  chromosome  regions  (Callen  et  al  1995;  Turner  et  al,  1998). 
However,  not  all  the  findings  were  in  favor  of  this  suggestion.  Severe  phenotypes 
were  also  observed  in  patients  with  late  replicating  markers  (Dennis  et  al  1993). 
Regardless  of  the  inclusion  of  XIST  locus  on  the  mar  (X),  clinical  findings  of  the 
45,  X/46,  X,  +mar(X)  karyotype  differ  from  those  found  in  the  present  study 
(Tumer  et  al,  1998). 
The  second  advantage  of  FISH  application  is  to  identify  the  nature  of  the 
marker  or  unknown  chromosome.  This  goal  was  achieved  in  the  first  nine  cases 
(cases  #1-9)  included  in  the  present  study.  In  all  these  cases  the  nature  of  the  ring 
chromosome  was  identified  and  proved  to  be  X  chromosome  derived  with  no  Y 
material.  In  addition,  application  of  the  FISH  technique  demonstrated  the  presence 
230 of  the  XIST  locus  in  the  7  patients  tested  (cases  #  1-7)  with  ring  X  chromosome. 
In  Turner  patients  with  small  ring  X  (cases  #  1-3)  in  the  present  study,  DXZ1 
(centromeric)  and  XIST  (Xql3)  were  present  while  DMD  (Xp2l)  and  KAL 
(Xp22)  were  absent,  suggesting  the  breakpoints  in  these  3  patients  to  be  proximal 
to  Xp2l.  and  distal  to  Xql3.  Due  to  lack  of  other  pericentromeric  probes  suitable 
for  FISH  analysis,  finer  assessment  of  the  breakpoints  were  not  possible,  Turner  et 
al,  (1998)  by  applying  FISH  have  reported  two  patients  with  small  ring  (Xs)  with 
breakpoints  Xpll.  23-Xqll.  2  and  XpII.  23-XqII.  I.  In  the  same  respect,  Callen  et 
al,  (1995)  reported  two  patients  with  small  ring  (Xs)  with  the  breakpoints  of 
Xpll.  21-Xql2  and  Xpll.  21-Xql3.  Recently,  a  breakage  hot  spot  in  a  3Mb 
region  of  Xpl  1.21  has  been  suggested  (Wolff  et  al,  1994).  Based  on  the  presence 
of  this  hot  spot  at  Xpl  1.21  and  on  the  comparison  of  the  ring  size  in  the  present 
cases  and  of  those  reported  ones,  the  short  arm  breakpoint  of  these  3  cases  with 
small  rings  is  most  likely  to  be  at  Xp  11.2  1.  However,  further  studies  defining  the 
Xp  breakpoints  of  these  3  cases  are  needed. 
Four  cases  of  the  present  study  had  medium  size  ring  (Xs).  Three  of  them 
(cases  #  4,6  and  7)  showed  the  presence  of  KAL  (Xp22)  and  XIST  (Xq  13)  loci 
and  absence  of  DXZ4  (Xq24)  so  demonstrating  the  breakpoints  to  be  distal  to 
Xp22  and  proximal  to  Xq24.  The  last  case  (#  5)  gave  positive  signals  with  DXZI, 
XIST  and  DXZ4  and  negative  signals  with  the  short  arm  probes  (DMD  and  KAL) 
suggesting  the  site  of  the  breakpoints  to  be  proximal  to  Xp2l.  and  disW  to  Xq24. 
The  XIST  gene  is  a  candidate  for  a  gene  which  determines  X  inactivation 
since  it  is  only  expressed  from  the  inactive  X,  and  maps  to  the  region  known  to 
contain  the  X  inactivation  region  (Brown  et  al,  1992).  Ring  chromosomes 
containing  XIST  are  likely  to  contribute  to  the  patient's  phenotype.  When  XIST  is 
absent,  the  euchromatin  of  the  marker  will  be  active  resulting  in  a  disomic 
expression  of  normal  genes.  The  subsequent  over  expression  and  interactions  of 
these  genes  is  the  genetic  basis  for  the  abnormal  phenotype. 
It  is  now  established  that  patients  with  a  small  ring  marker  derived  from 
the  X  chromosome  in  association  with  a  45,  X  karyotype  show  the  typical  Turner 
phenotype  if  the  X  inactivation  centre  is  present  (Callen  et  al,  1995).  In  the 
present  work  late  replication  studies  of  7  cases  with  r(X)  (cases  #  1-7)  showed 
that  some  of  the  r(X)  were  early  replicating,  in  the  range  of  12%-54%,  while 
others  were  late  replicating  ranged  from  46%-88%.  In  all  seven  cases  the  normal 
231 X  in  the  cell  line  containing  the  r(X)  was  always  active.  However,  no 
phenotype/genotype  correlation  could  be  made  for  those  cases  with  r  (X)  and  the 
size  of  the  ring  or  the  replication  pattern.  This  is  due  to  the  presence  of  the  45,  X 
cell  line,  which  invalidates  the  attempts  of  genotype-phenotype  correlation  (Ogata 
and  Tsutomu,  1995).  On  the  other  hand  the  lack  of  additional  phenotypic 
abnormalities  might  be  attributed  to  inactivation  of  the  ring  (X)  (Callen  et  al, 
1995).  Although  an  association  of  ring  (X)  with  mental  retardation  has  been 
previously  reported  in  Turner  syndrome  (Cole  et  al,  1994),  the  nine  cases  with 
ring  (X)  in  the  present  study  were  associated  with  a  typical  Turners  phenotype 
with  normal  mentality. 
The  third  advantage  gained  from  FISH  application  is  the  precise 
identification  of  the  breakpoint  of  chromosomal  rearrangement.  This  was  obvious 
in  the  cases  #10  and  #11  where  the  duplicated  region  has  been  verified  precisely. 
These  two  cases  represent  a  very  rare  cytogenetic  finding  with  46,  X,  dir  dup(X) 
(ql  1.2-ýq22.3)  and  mos  45,  X/46,  inv  dup(X)  (q28->q22.2)  respectively. 
Reassessment  of  their  karyotype  by  applying  FISH  technique  using  whole 
chromosome  paint  (WCPX)  and  X-specific  probes,  XIST  (Xql3),  DXZI 
(centromere),  DMD  (Xp2l)  and  DXZ4  (Xq24)  has  precisely  verified  the 
duplicated  region  in  each  case.  In  case  #10  two  copies  of  XIST  and  one  copy  of 
DXZ4  loci  on  the  long  arm  of  the  abnormal  X  chromosome  were  observed 
indicating  duplication  of  the  segment  ql  1.2-*q22.3.  In  case  411  FISH  analysis 
confirmed  the  presence  of  45,  X  cell  line  and  duplication  of  the  segment 
Xq22.1  ->q28.  However,  a  more  precise  assignment  of  break  points  could  have 
been  possible  by  using  single  copy  probes  for  the  segment  Xq25-Xq28  or 
telomeric  specific  probes.  Direct  or  inverted  duplication  of  the  long  arm  of  the  X 
chromosome  is  very  uncommon  and  has  been  reported  in  only  25  cases  (Garcia- 
Heras  et  al,  1997;  Zhang  et  al,  1997).  In  the  majority  of  cases  the  rearrangement  is 
maternally  inherited  (Zhang  et  al,  1997).  In  only  two  cases  was  mosaicism 
reported,  suggesting  a  post-zygotic  error  in  the  carrier  mother.  Alternatively  an 
inverted  duplication  may  have  resulted  from  an  unequal  interchange  (crossing- 
over)  between  homologous  chromosomes  (Zhang  et  al,  1997).  Dup(X)  in  males 
have  been  often  associated  with  severe  growth  and  mental  retardation,  hypoplastic 
genitalia  (undescended  testes)  and  hypotonia  (Yokoyama  et  al,  1992).  In  females, 
232 dup(Xq)  is  associated  with  gonadal  dysgenesis,  short  stature,  minor  anomalies  and 
developmental  delay.  These  phenotypic  features  are  probably  due  to  expression  of 
genes  on  the  active  X  chromosome,  imprinting  effect  and/or  gene  dosage  effect 
(Aughton  et  al,  1993;  Zhang  et  al  1997).  In  the  majority  of  non  mosaic  cases  with 
dup(Xq),  a  pre-zygotic  origin  is  suggested  by  the  absence  of  a  normal  cell  line. 
Aughton  et  al  (1993)  have  suggested  that  the  clinical  effects  of  dup  Xq  reflect  the 
extent  of  duplication  and  the  break  points.  Larger  Xq  duplications  have  been 
exclusively  reported  in  females  (Zhang  et  al,  1997).  Females  with  dup(X)  may 
present  with  apparently  normal  phenotype  and  or  minor  anomalies/delayed  mental 
development  (Ogata  and  Matsuo,  1995).  The  pathogenesis  could  be  attributed  to 
the  replication  pattern  in  the  different  tissues  and/or  mosaicism.  De  novo 
inversion  duplications  are  an  extremely  rare  occurrence.  Sporadic  cases  with  dup 
Xql3.1  -+Xq2l.  2  seem  to  have  no  effect  on  the  fertility  in  females  (Garcia  et  al, 
1997;  Zhang  et  al,  1997).  Parental  origin  of  the  der(X)  could  also  contribute  the 
phenotype  in  de  novo  duplications  of  Xq. 
Application  of  FISH  in  case  #  15,  presenting  with  the  stigmata  of  Turner 
syndrome  and  46,  XXp-(pter-p  11)  karyotype,  identified  the  nature  of  the 
derivative  chromosome,  excluded  the  presence  of  mosaicism  and  detected  the 
breakpoints.  FISH  study  has  shown  that  this  patient  has  deletion  of  the  whole 
short  arm  of  the  X  chromosome.  Patients  with  terminal  Xp  deletions  have  short 
stature  and  may  have  some  somatic  traits  of  Turner  syndrome  while  gonadal 
function  is  generally  preserved  (James  et  al,  1998).  Short  stature  has  recently  been 
shown  to  be  a  result  of  the  deletion  of  a  homebox  gene  SHOX,  which  escapes  X- 
inactivation  and  is  located  in  the  pseudoautosomal  region  Xp  (Rao  et  al,  1997). 
Regions  of  both  Xp  and  Xq  are  thought  to  carry  genes  involved  in  normal  ovarian 
function.  Recently  it  has  been  proposed  that  the  gene  DFFRX  located  at  Xpl  1.4 
may  play  such  a  role  (James  et  al,  1998).  The  genes  responsible  for  the  other 
somatic  features  of  the  Turner  phenotype  have  not  been  identified.  Studies  of 
patients  with  deletions  of  Xp  have  led  to  the  suggestions  that  a  gene  (s) 
responsible  for  the  stigmata  of  Turner  syndrome  may  lie  proximal  to  Xpl  1.2  or 
along  the  length  of  Xp  and  in  Xq2l  -q26  (Ferguson-Smith,  199  1;  Rao  et  al,  1997). 
Isochromosome  of  the  short  arm  of  the  X  chromosome  [i(Xp)]  does  not 
seem  to  be  viable  (Dalton  et  al,  1998).  Indeed  monocentric  constitutional  i(Xp)s 
with  no  long  arm  material  appear  not  to  exist,  presumably  because  of  the  lack  of 
233 the  XIST  locus  and  their  consequent  failure  to  inactivate  (Dalton  et  al,  1998). 
Therefore,  two  cases  with  suspected  i(Xp)  (cases  412  and  413)  in  the  present 
study  were  investigated  by  FISH  technique  in  order  to  identify  the  status  of  the 
presumed  isochromosome.  Case  #  12  was  diagnosed  by  conventional  cytogenetics 
as  46,  X,  i(Xp).  Reassessment  of  this  case  by  FISH  analysis  using  FRAXA/E 
(Xq27-28),  DXZl  (centromeric),  XIST  (Xql3)  and  DMD  (Xp2l)  probes 
confirmed  the  presence  of  a  monocentric  chromosome  containing  two  short  arms 
(one  copy  of  DMD  locus  was  pre§enton  each  arm  of  the  abnormal  X).  The  long 
arm  material  (Xq27-28)  was  absent.  Unfortunately,  the  XIST  probe  gave  an 
inconclusive  result.  DXZ1  and  XIST  probes  application  showed  a  big  fused  signal 
on  the  abnormal  X  chromosome,  which  has  not  been  seen  in  any  other  cases  of  the 
present  study.  The  old  condensed  chromosomes  of  this  case  might  be  the  cause  of 
the  fusion  of  the  signals  of  the  DXZ1  and  XIST  probes  in  such  case.  Therefore, 
the  diagnosis  t(Xp;  Xp)  has  been  raised.  Late  replication.  study  could  not  be 
performed  due  to  the  lack  of  blood  sample  and  the  application  of  other  probes 
specific  for  Xp  and  Xq  was  also  not  possible. 
On  the  other  hand,  case  #  13  was  identified  by  G-banding  as 
46,  XX/46,  X?  i(Xp).  FISH  study  using  different  X-specific  probes  demonstrated 
the  abnormal  chromosome  to  be  a  derivative  X  in  the  form  of  (X;  X)  translocation. 
Hence,  FISH  has  provided  the  final  diagnosis  and  identified  the  breakpoints  as 
t(Xp22;  Xq22). 
In  the  mean  time  G-banding  for  case  #  14  showed  i(Xq)s  (defined  as 
monocentric).  It  is  difficult  to  distinguish  between  mono-  and  dicentric 
isochromosomes  by  GTG-banding  due  to  the  fact  that  one  centromere  in  a 
dicentric  is  often  inactivated  which  means  that  its  site  is  not  marked  by  a 
constriction  (Fernandez  et  al,  1996).  This  limitation  has  been  overcome  by  the  use 
of  the  DXZI  X-specific  centromere  probe  in  FISH  technique,  which  gave  two 
copies  of  the  DXZI  in  the  i(Xq)  cell  lines.  This  isodicentric  chromosome  is  shown 
to  have  two  copies  of  the  q  arm  and  two  centromeres  located  very  close  to  each 
other.  The  idic(Xq)  generated  complex  mosaics  of  three  cell  lines. 
Isochromosomes  for  the  long  arm  of  the  X  chromosome  are  the  most  common 
structural  abnormalities  of  the  X  being  found  in  15%  of  Turner  syndrome  patients 
(Hook  and  Warburton,  1983;  Fernandez  et  al,  1996;  Fernandez  and  Pasaro,  1998). 
Isochromosomes,  can  originate  either  in  meiosis  or  in  mitosis.  Wolff  et  al  (1996) 
234 suggested  that  the  majority  of  i(Xq)s  arise  not  by  centromere  misdivision  but  via 
breakage  and  reunion  of  susceptible  regions  of  the  short  arm.  The  resulting  i(Xq)s 
would  be  dicentric,  leaving  unstable  acentric  Xp  fragments  to  disperse.  The 
absence  of  a  detectable  46,  XX  cell  line  indicates  the  meiotic  origin  of  these 
chromosomes.  Dicentric  X  chromosome  of  different  derivatives  were  reported 
using  FISH  by  Fernandez  and  Pasaro  (1998).  De  La  Chapelle  and  Stenstrand 
(1974)  first  suggested  that  some  isochromosomes  might  be  mitotically  unstable 
and  therefore  give  rise  to  a  45,  X  cell  line.  The  degree  of  instability  would  depend 
on  the  amount  of  material  between  centromeres,  so  that  a  stable  i(Xq)  would  be 
possible  only  when  the  centromeres  are  very  close  and  acting  in  coordination  or 
when,  if  relatively  distant,  one  is  rendered  effectively  inactive.  Wolff  et  al  (1996) 
observed  in  i(Xq)  a  direct  correlation  between  the  distance  between  centromeres 
and  the  presence  of  45,  X  cell  line,  suggesting  that  a  structurally  dicentric  i(X) 
might  originally  include  two  ftinctionally  active  centromeres.  These  can  form  an 
anaphase  bridge  causing  the  isochromosome  to  break  during  early  division  of  the 
zygote,  thus  giving  rise  to  a  45,  X  cell  line.  The  remaining  cells,  which  still  contain 
the  isochromosome,  would  survive  only  if  one  of  the  centromeres  become 
inactive,  thus  conferring  stability  (James  et  al,  1997;  Dalton  et  al,  1998). 
Moreover,  application  of  Y  centromeric  and  PHY2.1  (Yql2)  probes  failed  to 
detect  any  Y  sequences  in  this  patient  although  PCR  analysis  of  her  genomic 
DNA  revealed  the  presence  of  Yq  sequences  (DYZ1  and  DYZ2).  Although  FISH 
technique  can  detect  low  grade  mosaicism,  this  requires  scoring  large  numbers  of 
cells.  In  such  situation  PCR  analysis  is  widely  used  for  detection  of  cryptic 
mosaicism  of  Y  material  (Chu  et  al,  1995,  Osipava  et  al,  1998).  It  has  been 
reported  that  4%-30%  of  Turner  patients  are  positive  for  Y  material,  Thus  it  is 
highly  recommended  to  screen  Turner  patients  by  FISH  as  well  as  by  PCR  in 
order  to  detect  hidden  Y  chromosome  mosaicism  (Chu  et  al,  1995;  Lopez  et  al, 
1998;  Patsalis  et  al,  1998;  Robinson  et  al,  1999). 
The  patient  #  20  presented  with  multiple  congenital  anomalies  and  proved 
to  have  46,  XXp+  karyotype  by  G-banding  technique.  Detailed  FISH  analyses 
using  a  panel  of  X-specific  probes  and  whole  chromosome  libraries  of  all 
chromosomes  revealed  that  the  extra  material  on  the  abnormal  Xp  was  derived 
from  chromosome  16.  This  finding  was  reconfirmed  by  using  chromosome  16 
arm  paints  (CAP  16p  and  l6q)  which  revealed  that  the  Xp+  segment  is  of  16q 
235 origin.  Therefore,  the  comprehensive  FISH  analysis  has  detected  the  cryptic 
unbalanced  translocation  X:  16  in  this  patient,  leading  to  trisorny  16q  and  Xp 
monosomy.  FISH  analysis  enabled  the  precise  delineation  of  the  karyotype  in  this 
case,  which  was  not  diagnosed  by  routine  cytogenetic  methods  and  the  final 
karyotype  was  interpreted  as  46,  X,  -X,  +t(X:  l6)(p22.3;  q24). 
The  abnormal  phenotype  in  this  patient  could  be  due  to  partial  trisomy 
16q(q24-*qter)  or  monosomy  for  Xp22.  Late  replication  analysis  confirmed  that 
the  der(X)  was  inactive  in  all  the  50  cells  scored.  In  females  with  balanced 
X/autosome  translocation  a  preferential  inactivation  of  the  normal  X  in  all  the 
cells  is  exclusive.  In  case#  20,  the  der(X)  due  to  t(X;  16)(p22;  q24)  was  confirmed 
to  be  inactive.  However,  the  translocated  segment  16q24-*qter  showed 
differential  replication  pattern.  Thus  the  minor  anomalies  in  the  index  case  could 
be  attributed  to  partial  trisomy  16q  as  a  result  of  unbalanced  translocation. 
Parental  karyotypes  were  normal. 
The  occurrence  of  balanced/unbalanced  structural  rearrangements 
involving  an  X  chromosome  and  an  autosome  is  very  rare.  They  are  associated 
with  normal  to  severe  pathogenesis,  depending  on  the  chromosomes  involved  and 
the  extent  of  monosomy/trisomy  of  the  segments  involved.  Inactivation  and 
spreading  effect  may  also  contribute  to  the  severity  of  the  phenotype  and 
pathogenesis.  In  human  X/autosome  translocations  have  been  reported  for  all 
autosomes  (1  -22),  The  most  frequently  involved  autosomes  are  15,21  and  22 
(Schmidt  and  DuSart  1992;  Borgaonkar  1997).  The  clinical  significance  of 
inactivation  pattern  in  X/autosome  translocations  has  been  extensively  reviewed 
by  Schmidt  and  DuSart  (1992).  Unbalanced  t(X;  16)  has  not  been  reported 
previously.  Davies  et  al  (1976)  have  reported  a  case  of  familial  balanced 
t(X;  16)(pll;  q24)  in  two  normal  female  sibs  inherited  from  the  mother.  The  der  X 
was  confirmed  to  be  late  replicating  in  100%  of  the  cells.  Partial  trisomies  16q 
have  been  reported  in  many  cases  compatible  with  survival  up  to  a  year  (Savary  et 
al  1991).  Most  of  the  cases  reported  are  de  novo  mutations,  except  for  the  case 
reported  by  Hirai  et  al  (1981),  resulting  from  unbalanced  segregation  of  a  parental 
translocation.  Savary  et  al  (199  1)  reported  a  case  of  trisomy  16q23-*qter  resulting 
from  maternal  balanced  t(13;  16)(pl2;  q23).  However  the  trisomyl6q  phenotype 
has  not  been  delineated  as  a  clinical  entity  due  to  concomitant  occurrence  of 
236 partial  monosomy/trisomy  of  different  autosome  involved.  The  smallest  segment 
of  16q  trisomy  reported  by  Savary  et  al  (1991)  presented  with  low  birth  weight, 
hypotonia,  failure  to  thrive,  and  abnormal  shape  of  the  skull  and  high  prominent 
forehead. 
Normal  male  development  depends  on  the  presence  of  Y  chromosome  in 
human  and  other  mammalian  species.  This  chromosome  is  involved  in  numerous 
structural  abnormalities  (Hsu,  1994),  and  the  phenotype  of  individuals  with  Y 
chromosome  abnormalities  depends  on  the  deleted  genes. 
One  of  the  important  aspects  of  application  of  FISH  in  screening  patients 
with  Turner  syndrome  mosaics  is  to  look  carefully  for  the  presence  of  a  46,  XY  or 
46,  X,  +mar  (?  Y)  cell  line  as  these  females  have  an  increased  risk  (10%-20%)for 
the  development  of  gonadoblastoma  (Page  D,  1987).  The  possibility  of  XY  or 
marker  chromosome  (?  der  Y)  should  be  suspected  if  the  phenotype  presents  with 
ambiguous  genitalia  and  mild  stigmata  of  Turner  syndrome.  Here,  two  cases 
(cases  #  17  and  18)  presented  with  failure  to  thrive  and  developmental  delay,  and 
their  karyotype  was  interpreted  as  mos  45,  X/46,  XY  in  the  ratio  48:  52  and  42:  58 
respectively.  Application  of  FISH  using  X  and  Y  specific  probes  confirmed  the 
mosaicism  in  both  cases.  In  one  study,  either  an  entire  Y  chromosome  or  a  portion 
of  it  (e.  g.,  marker  derived  from  aY  chromosome)  was  present  in  90%  of 
individuals  with  dysgenetic  gonads  who  develop  germ  cell  tumors  (Toeche  and 
Hernandez,  1986).  Other  recent  studies  have  implied  that  genes  within  the 
pericentromeric  region  of  the  Y  chromosome  are  important  in  the  causation  of 
gonadoblastorna.  Tsuchiya  et  at  (1995)  implicated  a  4Mb  region  proximal  to  the 
centromere,  while  Salo  et  at  (1995)  implicated  a  1-2  Mb  region  just  distal  to  the 
centromere.  These  studies  suggest  that  any  female  with  aY  chromosome  (or 
partial  Y)  containing  these  regions  would  be  at  an  increased  risk  for  the 
development  of  a  gonadoblastoma  (Schwartz  et  at  1997). 
In  the  present  study  two  cases  (#  19  and  #  23)  interpreted  by  conventional 
cytogenetics  using  G-banding  as  having  45,  X/46,  X,  +mar  and  46,  XY/46,  X,  +mar 
(?  Y)  karyotypes  respectively  were  investigated.  Reassessment  of  the  karyotypes 
by  applying  FISH  has  delineated  the  marker  chromosome  in  case  19  as  iso  die 
t(X;  Y).  The  detection  of  Y  material  in  this  patient  has  an  important  implication  for 
increased  risk  of  gonadoblastoma  development.  In  the  second  case  (#  23),  FISH 
identified  the  46,  XY  cell  line  in  42  cells  examined  (84%),  5  cells  (10%)  were 
237 demonstrated  by  using  different  Y-specific  probes  to  be  i(Yq)  while  r(Y)  was 
detected  in  3  cells  (6%).  Application  of  FISH  technique  had  delineated  the 
presence  of  a  third  cell  line.  Thus  these  findings  demonstrate  successfully  the 
value  and  necessity  of  FISH  utilizing  DNA  probes  in  the  identification  of  sex 
chromosome  markers. 
Two  females  with  primary  amenorrhea  have  been  ascertained  by  FISH 
analysis  to  have  structural  Y  chromosome  abnormalities  with  absence  of  the  SRY 
sequences.  Application  of  FISH  using  a  panel  of  X  and  Y  specific  probes  in  case  # 
21  who  presented  with  the  karyotype  of  46,  X,  t(Xp:  Yq)  by  GTG-banding  had 
precisely  delineated  the  breakpoints  in  this  case.  Her  final  karyotype  was 
interpreted  as  46,  X,  der(X)t(X;  Y)(Xqter-->Xp22::  Yqll-+Yqter).  This  is  the  most 
common  type  of  X/Y  translocation.  Twenty-five  of  such  cases  have  been  reported 
and  reviewed  by  Hsu  (1994).  In  this  type  of  translocation  there  is  a  normal  X 
chromosome  and  the  second  X  chromosome  is  a  derivative  X  with  a  portion  of  Y 
(Yql  I  to  Yq12)  translocated  onto  the  distal  short  arm  (Xp22).  All  the  cases 
reported  were  females.  Because  of  the  deletion  of  the  distal  short  arm  of  the  X 
including  the  telomere  (monosomy  for  Xp22.3),  many  of  these  patients  were  short 
with  short  limbs.  Most  patients  were  either  proven  to  be  fertile  or  said  to  have 
normal  ovaries.  Some  had  mental  retardation  (Hsu,  1994).  Application  of  FISH 
analysis  on  the  second  case  #22  confirmed  her  karyotype  as  45,  X/46,  Xi(Yq).  The 
i(Yq)  was  found  to  be  monocentric.  Fisher  et  al  (1990)  proposed  that  the  haplo- 
insufficiency  of  a  gene  (ribosomal  protein  gene,  RPS41)  mapped  on  Yp 
contributes  to  the  Turner  phenotype  and  concluded  that  one  or  more  Turner  genes 
are  probably  located  in  the  interval  IAL  The  almost  exclusively  monocentric  Yq 
isochromosomes  may  arise  because  inactivation  of  one  of  the  centromeres  renders 
stability  to  the  chromosomes  and  prevents  their  loss  at  anaphase. 
The  basic  sex  determining  factor  responsible  for  switching  on  male 
development  is known  as  the  SRY  gene,  located  at  Yp  11.2  (Sinclair  et  al,  1990) 
Cases  #  19  and  #21  in  the  present  study  were  females.  No  SR  Y  gene  was  found  in 
those  two  cases  and  thus  their  female  phenotype  might  be  attributed  to  the 
absence  of  a  regulatory  SRY  gene  product.  Individuals  with  no  Yp  and  therefore 
lacking  SRY  are  all  phenotypic  females  with  sexual  infantilism  and  streak  gonads 
(Hsu,  1994). 
238 Several  previous  studies  have  used  PCR  and  PCR-Southem  blot  analysis 
to  detect  the  presence  of  SRY  and/or  other  Y  specific  loci  in  Turner  syndrome 
patients  after  conventional  cytogenetic  technique  failed  to  identify  aY 
chromosome  cell  line  in  their  karyotype  (Binder  et  al,  1995;  Henegariu  et  al, 
1998;  Lopez  et  al  1998).  Recently  Kocova  et  al  (1993)  and  Chu  et  al  (1995)  have 
shown  that  when  Y-specific  PCR  is  combined  with  Southern  blotting,  4%-30%  of 
45,  X  patients  are  positive  for  some  part  of  the  Y  chromosome.  Medelj  et  al  (1992) 
detected  SRY  gene  in  1  (2.5%)  of  40  patients  using  PCR  amplification.  This  low 
prevalence  identified  in  a  low  level  of  Y  mosaicism  was  confirmed  by  Binder  et  al 
(1995)  and  Patsalis  et  al  (1998). 
4.2  Molecular  studies 
4.2.1  Mutational  analysis  of  the  AR  gene 
Androgen  insensitivity  syndromes  (AIS)  are  the  clinical  manifestations  of 
end-organ  resistance  to  androgen  actions.  In  this  inborn  error  of  sexual 
differentiation,  the  most  common  cause  of  end-organ  resistance  is  altered 
androgen  receptor  (AR)  function.  It  is  an  X-linked  disorder  in  46,  XY  subjects  in 
whom  normal  male  sexual  differentiation  in  utero  is  altered  and  subsequent 
neonatal  and  pubertal  virilization  is  absent  or  impaired  (Brown  1995;  Quigley  et 
al  1995).  The  mechanism  of  action  of  the  androgen  receptor  involves  binding  of 
the  ligand,  which  promotes  conformational.  changes  to  overcome  the  inhibition  to 
dimerization.  The  receptor  is  translocated  to  the  nucleus  then  it  binds  to  a  specific 
region  of  DNA,  the  hormone  response  element,  eliciting  its  actions  within  the 
target  cells  (Siegel  SF,  1995). 
Many  qualitative  and  quantitative  AR  abnormalities,  causing  a  broad  range 
of  AIS  phenotypes,  have  been  described  (Gottlieb  et  al  1996).  The  spectrum  of 
phenotypes  ranges  from  individuals  with  completely  female  external  genitalia  and 
absence  of  Mullerian  and  Wollfian  duct  derivatives  (complete  AIS)  to  patients 
with  ambiguous  genitalia  or  with  mild  hypospadias  (partial  AIS)  (De  Bellis  et  al 
1994;  Quigley  et  al  1995).  Infertility  in  phenotypically  normal  men  has  also  been 
reported  as  a  manifestation  of  androgen  insensitivity  (Wang  et  al  1998). 
Quantitative  and  qualitative  alterations  in  androgen  receptor  binding  activity  can 
usually  be  demonstrated  in  cultured  genital  skin  fibroblasts  from  affected  subjects. 
239 More  recently,  the  molecular  lesions  responsible  from  AIS  have  been  identified  as 
a  variety  of  mutations  in  the  AR  gene  (Batch  et  at  1992;  McPhaul  et  at  1993).  The 
greatest  numbers  of  different  mutations  so  far  identified  are  located  within  exons 
encoding  the  steroid-binding  domain  properties  (Brown  et  at  1994;  Murono  et  at 
1995). 
The  androgen  receptor  is  encoded  by  a  single  gene  containing  eight  exons 
located  on  the  Xqll-12  (Lubahn  et  at  1989).  Like  the  other  steroid  hormone 
receptors,  the  AR  consists  of  distinct  functional  domains.  The  N-terminal  part  is 
involved  in  transcription  activation  and  is  encoded  by  exon  I  (Faber  et  at  1991). 
Two  highly  conserved  DNA-binding  zinc  clusters  recognizes  specific 
consequences,  whereas  the  C-terminal  zinc  cluster  is  involved  in  dimerization 
(Jenster  et  at  199  1;  Luisi  et  at  199  1).  Parts  of  exon  3  and  4  encode  the  hinge 
region,  which  contains  a  nuclear  import,  and  exons;  4-8  encode  the  ligand-binding 
domain  (McPhaul  et  at  1993). 
The  patients  investigated  in  the  present  study  constituted  a  heterogeneous 
group  according  to  their  clinical  phenotype.  Two  individuals  presented  with 
classical  features  of  testicular  feminisation  (complete  AIS:  CAIS),  while  three 
patients  had  a  predominantly  male  phenotype  and  clinical  findings  consisted  of 
hypospadias  and/or  micropenis  (partial  AIS:  PAIS).  The  coding  regions  of  the 
gene  were  amplified  by  the  polymerase  chain  reaction  and  screened  for  mutations 
by  means  of  SSCP  and  HA.  Then  was  followed  by  DNA  sequencing  of  putative 
mutant  segments. 
Initially,  cytogenetic  and  molecular  studies  showed  no  deletion  in  the  Y 
chromosome  or  in  the  coding  region  of  the  AR  gene  in  all  investigated  patients. 
Around  5-10%  of  the  AR  gene  mutations  causing  AIS  are  due  to  deletions. 
Complete  AR  gene  deletion  in  two  families  and  partial  deletions  involving 
multiple  exons  (4-8,3-8,  and  6-7)  and  single  exons  (2,3,  or  5)  have  been  reported 
for  families  with  complete  AIS  (Brown  TR,  1995). 
PCR-SSCP  analysis  in  the  present  study  revealed  an  abnormal  migration 
in  a  347  base  pair  fragment  amplifying  exon  8  of  the  AR  gene  in  one  patient  (Fig 
3.40).  This  substitution  resulted  from  point  mutation  at  nucleotide  4109  G  -+T 
transversion  causes  Val  889  Leu.  Screening  100  chromosomes  from  unrelated 
individuals  revealed  absence  of  this  base  pair  substitution  indicating  that  it  was 
not  a  polymorphism.  This  and  other  studies  (Batch  et  al  1993;  De  Bellis  et  al 
240 1994;  Quigley  et  al  1995;  Gottlieb  et  al  1996;  Bruggenwirth  et  al  1997)  indicate 
that  complete  as  well  as  partial  AIS  could  arise  from  altered  function  of  the  DNA 
and  steroid-binding  domains  of  the  AR.  The  possibility  of  associated  mutations  in 
noncoding  regions  of  the  AR  gene  has  not  been  excluded  completely. 
In  the  present  study  conversion  of  valine  to  leucine  at  amino  acid  889 
resulted  from  a  single  base  mutation  in  exon  8  was  associated  with  complete  AIS. 
Previous  studies  of  alternative  amino  acid  substitutions  at  the  sarne  given  codon 
Val  889  in  the  AR  gene  were  also  reported  in  CAIS  subjects  (Pinsky  et  al  1992; 
De  Bellis  et  al  1994).  Valine  at  codon  889  was  replaced  by  methionine  in  two 
unrelated  subjects  with  complete  AIS.  Conversion  of  valine  to  leucine  was 
reported  in  exon  7  of  the  AR  gene  four  times  in  AIS  patients  (Gottlieb  et  al,  199 
' 
6). 
Both  valine  and  leucine  are  non-polar  amino  acids.  However,  there  are  known 
examples  of  conservative  missense  mutations  that  can  results  in  a  disease 
phenotype  if  they  occupy  sites  in  the  protein  that  are  key  determinants  of  stability 
or  function  (Pinskey  at  al,  1992;  De  Bellis  et  al,  1994;  Gottlieb  et  al,  1996). 
The  valine  889  by  leucine  substitution,  which  lies  in  the  ligand-binding 
domain  of  the  receptor  within  the  conserved  region,  postulated  to  function  as  a 
dirnerizaton  domain  (Fawell  et  al  1990).  This  is  a  relatively  conservative  amino 
acid  change  and  even  though  the  mutation  was  not  detected  in  any  of  the  other  4 
patients  or  100  normal  males  screened,  it  could  not  formally  discount  the 
possibility  that  it  is  a  polymorphism,  with  no  effect  on  receptor  function. 
Functional  studies  of  an  androgen  receptor  containing  this  mutation  will  provide 
an  unequivocal  resolution  of  this  uncertainty.  However,  this  effectofVal889 
replacement  by  Leu  alone  could  be  sufficient  to  cause  the  complete  lack  of 
masculinization  during  fetal  development.  The  mutation  also  created  a  restriction 
site  for  Alul,  which  could  allow  the  carrier  status  of  female(s)  to  be  determined, 
and  a  prenatal  diagnosis  to  be  performed.  This  mutation  in  the  steroid-binding 
domain  provided  more  insight  into  the  mechanisms  of  receptor  function  and  could 
attribute  also  to  the  growing  database  of  the  structure  function  map  of  the  AR 
gene. 
Great  numbers  of  different  mutations  so  far  identified  are  located  within 
exons  encoding  the  steroid-binding  domain  properties  (Murono  et  al  1995; 
Gottlieb  et  al  1996).  Relatively  few  mutations  occur  within  the  most  C-terminal 
region  of  the  steroid-binding  domain  encoded  by  exon  8.  However,  the  occurrence 
241 of  AIS  related  to  these  mutations  demonstrates  the  critical  nature  of  this  region  for 
maintenance  of  steroid  binding  and  transcriptional  activity  of  .  4R  (Brown  TR, 
1995). 
Mutations  at  several  different  sites  in  exons  2-8  encoding  the  DNA  and 
androgen-binding  domains  with  a  relatively  high  number  of  mutations  in  two 
clusters  in  exons  5  and  7  have  been  recently  been  identified  in  AR  gene  in  subjects 
with  both  complete  and  partial  androgen  insensitivity  (Evans  et  al  1996).  The 
number  of  mutations  in  exon  one  are  extremely  low  (Batch  et  al  1993;  Brown  TR, 
1995;  Gottlieb  et  al  1996;  1997).  CAIS  is  most  often  attributed  to  point  mutations 
in  the  AR  gene  causing  amino  acid  substitutions,  aberrant  splicing,  or  premature 
termination  (Shkolny  et  al  1995;  Bruggenwirth  et  al  1997).  The  evidence  to  date 
indicates  that  a  mutation  of  the  AR  gene  is  responsible  for  most  if  not  all  cases  of 
CAIS  (70%)  (Emery  and  Muller  1992).  In  contrast,  many  patients  with  PAIS 
demonstrate  no  defect  in  the  androgen  binding  and  no  AR  gene  mutation  could  be 
identified  in  them  (Batch  et  al  1992;  McPhaul  et  al  1993).  In  such  cases,  it  must 
be  assumed  that  partial  androgen  insensitivity  is  the  result  of  defects  in  other 
genes,  whose  expression  is  controlled  by  the  androgen  receptor  gene  during 
genital  development  (Batch  et  al  1992;  Viner  et  all  996). 
Recently,  a  database  of  the  AR  gene  mutation  has  been  established  and 
described  by  Gottlieb  et  al  1996.  It  shows  the  androgen-binding  phenotype  of  the 
mutant  AR,  the  clinical  phenotype  of  the  affected  persons,  the  family  history  and 
whether  the  pathogenicity  of  a  mutation  has  been  proven.  The  database  has 
allowed  substantiating  and  amplifying  the  observation  of  mutational  hot  spots 
within  exon  encoding  the  AR  binding  (exon  4-8). 
Molecular  genetic  analysis  for  diagnostic  purposes  employing  SSCP  has 
proven  to  be  a  very  use1l  approach  to  a  variety  of  diseases  (Orita  et  al  1989).  It 
has  been  used  with  success  by  several  groups  for  characterization  of  point 
mutations  in  the  AR  gene  (Hiort  et  al  1994;  Bruggenwirth  et  al  1997;  Wang  et  al 
1998).  SSCP  has  the  advantage  that  laborious  sequencing  reaction  can  be  limited 
to  the  very  few  samples  that  have  shown  a  different  migration  pattern  on  the  gel 
electrophoresis.  Using  PCR-SSCP  analysis,  three  cases  with  PAIS  and  one  case 
with  CAIS  in  the  present  study  were  found  to  have  no  mutation  in  the  coding 
region  of  the  . 4R  gene.  The  present  study  and  other  reported  ones  showed  that  in 
242 some  individuals,  clinically  diagnosed  as  having  AIS,  no  mutation  was  found  in 
the  coding  region  and  exon-flanking  intronic  sequences  of  the  AR  gene 
(Bruggenwirth  et  al  1996;  Weidemann  et  al  1996)  and  DNA  sequencing  (Morel  et 
al  1994),  in  spite  of  clear  phenotypic,  endocrinological,  and  biochemical  evidence 
for  AIS.  Mutations  might  be  missed  because  PCR-SSCP  is  not  100%  sensitive. 
Often,  only  the  exonic  sequences  and  their  flanking  intronic  regions  are  screened, 
leaving  mutations  in  important  intronic  and  promoter  regions  undetected. 
Recently,  Bruggenwirth  et  al  (1997)  reported  intronic  mutation  in  a  family  with 
PAIS.  By  sequencing  part  of  intron  2,  a  T->A  mutation  was  found  11  bp  from 
exon  3.  Furthermore,  mRNA  analysis  of  the  same  family,  revealed  that  splicing 
involved  a  cryptic  splice  site,  located  71nObp  upstream  of  exon  3,  resulting  in 
generating  mRNA  with  an  insert  of  69  nucleotide.  For  the  AR  gene,  if  cells  from 
patients  are  available,  RT-PCR  studies  and  western  immunoblotting  can  be  very 
informative,  in  particular  when  mutations  are  present  in  intronic  regions  (Ris- 
Stalpers  et  al  1990;  1994).  Expression  of  a  number  of  genes  involved  in  male  sex 
differentiation  and  development  is  regulated  by  the  androgen  receptor  (AR). 
There  are  other  explanations  for  the  apparent  absence  of  AR  mutations  in 
several  AIS  cases.  Neutral  mutations  for  example  have  to  be  interpreted  with 
caution.  Ritchard  and  Beckmann  (1995)  have  found  a  'neutral'  point  mutation  in 
the  cDNA  of  the  calpain  (CANP3)  gene,  which  turned  out  to  be  pathogenic, 
because  a  splice  donor  site  was  created.  Kallio  et  al  (1996)  suggested  that,  in 
46,  XY  subjects  without  a  mutation  on  the  AR  gene  and  with  a  typical  AIS 
phenotype,  post  receptor  defects  might  be  the  cause  of  the  disease.  This  may 
involve  receptor-specific  cofactors  or  corepressors.  Recently,  a  family  with 
dominant  inheritance  of  thyroid-hormone  resistance  was  reported,  which  could 
not  be  linked  to  defects  in  the  thyroid  hormone-receptor  alpha  or  beta  gene  (Weiss 
et  al  1996).  It  was  postulated  that  an  abnormal  cofactor,  playing  a  role  in 
regulation  of  thyroid-hormone  action,  might  be  involved.  Most  cofactors  reported 
to  date  are  not  AR  specific,  so  mutations  in  these  factors  will  probably  be  lethal  or 
give  rise  to  a  complex  phenotype.  Yeh  and  Chang  (1996)  have  reported  one 
coactivator,  ARA70,  which  binds  specifically  to  the  ligand-bound  AR.  It  is  not 
known  whether  mutations  in  the  gene  encoding  ARA70  correlate  with  certain 
forms  of  AIS  (Bruggenwirth  et  al  1997). 
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and  require  counseling,  gonadectomy,  hormone  therapy,  and  sometimes 
vaginoplasty  (Davies  et  al  1995).  Many  families  therefore  request  genetic 
counseling.  On  the  other  hand,  PAIS  is  a  much  more  variable  condition,  which 
present  with  an  intersex  phenotype  at  birth.  Therefore,  management  of  PAIS 
requires  a  decision  regarding  sex  rearing  based  on  the  genital  phenotype,  genital 
reconstruction  surgery  and  hormone  therapy. 
Once  a  mutation  is  found,  it  may  be  used  to  provide  infon-nation  for 
genetic  counseling  of  other  family  members.  Alternatively,  the  intragenic 
trinucleotide  repeats  in  the  N-terminal  region  of  the  receptor  may  be  used  as 
polymorphisms  to  follow  the  affected  X  chromosome  through  the  family  (Davies 
et  al  1995). 
4.2.2  Mutational  analysis  of  SRY  gene  in  sex  reversed  patients 
Sex  differentiation  is  a  complex  physiologic  process  that  most  likely 
involves  the  products  of  many  genes,  not  only  on  the  Y  chromosome,  but  also 
several  that  are  X-linked  and  autosomal.  For  an  infant  to  develop  as 
phenotypically  complete  male  or  female  a  cascade  of  complex  molecular  and 
morphologic  events  must  occur  at  the  appropriate  time  and  in  the  correct 
sequence  during  ontogeny.  Normal  human  sex  differentiation  consists  of  three 
basic  steps  (Jost  A,  1972).  Each  of  these  steps  involves  a  number  of  complex, 
sequential  processes,  The  first  step  is  the  establishment  of  genetic  sex,  which  is 
determined  at  fertilization.  In  the  second  step  an  indifferent  gonad  differentiates 
into  a  testis  in  the  XY  male  or  an  ovary  in  the  XX  female.  In  the  absence  of  they 
chromosome,  a  tests-determining  pathway  fails  to  be  initiated  or  is  blocked,  and 
development  of  the  fetal  gonads  follows  an  inherent  ovarian  pathway.  Testis 
development  from  the  embryonic  bipotential  gonad  depends  on  the  inheritance  of 
aY  chromosome-encoded  gene,  which  was  previously  referred  to  as  the  testis 
determining  factor  (TDF)  and  subsequently  identified  as  the  SRY  (sex- 
determining  region  Y)  gene  (Sinclair  et  al,  1990).  SRY  most  likely  activates  a 
succession  of  other  genes  which  switch  the  inherently  female  pattern  of 
development  to  that  of  the  male,  beginning  with  testis  formation.  The  final  step  in 
the  pathway  of  normal  sexual  differentiation,  the  translation  of  gonadal  sex  into 
phenotypic  sex,  depends  on  the  type  of  gonad  formed.  Indifferent  internal  and 
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on  whether  or  not  a  testis  develops  (with  notable  exceptions  exemplified  by  the 
testicular  feminization  syndrome).  Hormones  produced  by  the  fetal  testis  are 
responsible  for  the  induction  of  masculinizatoin  of  the  external  genitalia  and 
development  of  the  structures  of  the  male  reproductive  tract,  as  well  as  prevention 
of  the  development  of  the  uterus  and  fallopian  tubes  (Angle  et  al,  1997). 
The  investigation  of  subjects  with  sex  reversal  has  been  a  central  strategy 
in  the  study  of  mechanisms  responsible  for  normal  gonadal  and  genital 
differentiation.  Information  from  the  study  of  2  types  of  sex  reversal  was  used  to 
map  the  locus  of  the  testis-determining  factor  (TDF)  gene  to  the  distal  short  arm 
of  the  Y  chromosome  (Vergnaud  et  al,  1986).  One  type  included  the  so-called 
46,  XY  females.  The  other  included  subjects  with  46,  XX  sex  reversal  (Turner  et  al, 
1995). 
4.2.2.1  XY  females 
Studies  in  the  past  few  years  have  clearly  established  the  SRY  gene  (sex 
determining  region,  Y)  to  be  the  primary  testis-determining  gene  in  humans 
(Sinclair  et  al,  1990;  Koopman  et  al,  1990).  The  SRY  gene  is  located  on  the  short 
arm  of  the  Y  chromosome  and  consists  of  a  single  exon.  Analysis  of  the  SRY  open 
reading  frame  (ORF)  has  identified  a  domain  termed  the  HMG  box,  which  is 
conserved  with  regard  to  a  number  of  proteins  associated  with  DNA,  including  the 
high  mobility  group  (HMG)  nuclear  proteins  (Gubby  et  al,  1990;  Sincalir  et  al, 
1990)  and  various  transcriptional  factors,  such  as  T  cell  factor  I  and  lymphoid 
enhancer  factor  I  (Ferrari  et  al,  1992).  Mutations  in  the  SRY  gene  can  cause  a 
failure  of  testicular  development  that  may  result  in  complete  or  partial  male  to 
female  sex  reversal.  In  some  cases,  these  mutations  have  been  demonstrated  to 
alter  the  DNA-binding  and/or  bending  properties  of  the  SRY  protein  (Pontiggia  et 
al,  1994;  Veitia  et  al,  1997). 
The  term  46,  XY  gonadal  dysgenesis  has  been  used  to  describe  various 
conditions  of  abnormal  gonadal  differentiation.  The  46,  XY  complete  gonadal 
dysgenesis  is  characterized  by  absence  of  testes,  affected  subjects  presenting  with 
female  genitalia,  normal  Mullerian  structures  and  streak  gonads  like  those  of 
Ulrich-Turner  syndrome.  This  condition  is  also  called  46,  XY  pure  gonadal 
dysgenesis  (Sohval  AR,  1965).  In  some  individuals,  there  is  partial  testis 
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Mullerian  and  Wolffian  structures  and  dysgenetic  gonads.  These  cases  are 
referred  as  46,  XY  partial  or  incomplete  gonadal  dysgenesis  (Berkovitz  et  al, 
1992),  although  terms  such  as  46,  XY  dysgenetic  male  pseudohermophroditism 
(Federman  DD,  1967)  have  also  been  applied  (Marcantonio  et  al,  1994). 
Swyer  (1955)  was  the  first  author  to  document  cases  of  XY  gonadal 
dysgenesis,  and  this  condition  was  initially  referred  to  as  Swyer  syndrome.  Over 
120  cases  of  gonadal  dysgenesis  have  been  reported  (Bercu.  and  Schulman1980). 
Sporadic  cases  occur,  but  many  have  been  familial,  compatible  with  autosomal 
recessive  inheritance  limited  to  karyotypic  males  or  X-linked  recessive 
inheritance  (Hersh  et  al,  1980;  Phansey  et  al,  1980). 
In  the  present  study  cytogenetic,  molecular  cytogenetic  (FISH)  and 
molecular  studies  of  4  subjects  with  46,  XY  sex  reversal  were  carried  out  to 
delineate  their  molecular  pathology.  Two  cases  presented  as  pure  gonadal 
dysgenesis  (complete  gonadal  dysgenesis  and  the  other  two  presented  with 
ambiguous  genitalia  and  dysgenetic  gonads  (partial  gonadal  dysgenesis). 
Cytogenetics  and  molecular  cytogenetics  (FISH)  using  X  and  Y  centromeric 
probes  analyses  performed  on  blood  failed  to  detect  45,  X  and/or  46,  XX  cell  lines 
in  all  investigated  cases.  In  some  patients,  intersex  abnormality  is  associated  with 
sex  chromosomal  mosaicism,  particular  45,  X  (Wolman  et  al,  1985;  Liou  et  al, 
1997).  Thus,  it  is  very  unlikely  that  the  abnormal  sexual  development  in  all 
patients  is  related  to  the  presence  of  Y  chromosome  mosaicism.  Yet,  cytogenetic 
analysis  of  cells  from  both  gonads  was  not  studied  and  it  needs  to  be  investigated 
in  all  patients  in  order  to  exclude  gonadal  mosaicism.  Moreover,  in  situ 
hybridisation  to  the  XY  female's  chromosome  using  hocSRY/GMGYIO  probes 
specific  for  SRY  region  (Figure  3.45)  showed  that  the  SRY  gene  was  located  on 
the  short  arm  of  their  Y  chromosomes.  Therefore,  the  possibility  of  presence  of 
microdeleltion  or  Y  chromosome  rearrangement  was  also  excluded  in  all  4 
investigated  patients.  The  pathogenesis  of  the  XY  gonadal  dysgenesis  phenotype 
appears  to  be  heterogeneous,  resulting  from  a  variety  of  defects  in  the  testis- 
dctermining/differentiation  pathway.  Some  XY  females  with  gonadal  dysgenesis 
have  lost  the  sex-determining  region  of  the  Y  chromosome  by  terminal  exchange 
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(Davis  RM,  198  1;  Page  et  al  1990). 
A  790  bp  PCR  product  of  SRY  open  reading  frame  (ORF)  encompassing 
the  HMG-box  was  amplified  from  genomic  DNA  from  4  unrelated  XY  sex 
reversal  subjects.  The  radiolablied  PCR  products  were  analysed  for  mutations  by 
CCM  assays  revealed  none  of  the  PCR  products  from  the  SRY  open  reading  frame 
region  showed  aberrant  CCM  pattern.  As  confirmed  in  this  study,  the  majority  of 
XY  females  with  gonadal  dysgenesis  show  no  evidence  for  alteration  in  the  DNA- 
binding  domain  of  the  SRY  In  some  cases,  sex  reversal  could  result  from 
mutations  in  regulatory  regions  of  the  SRY  gene,  which  manifest  itself 
immediately  because  of  the  hemizygous  state  of  the  Y  chromosome  (McElearvey 
et  al,  1992b).  In  this  study  a  422  bp  segment  of  the  SRY  promoter  region  was 
included  in  the  SSCP  analysis.  Two  overlapping  PCR  fragments,  together 
spanning  position  -444  to  -22  of  the  SRY  promoter  region  (Behlke  et  al,  1993)  and 
at  position  429-650  of  poly  A  tail,  were  amplified  for  DNA  of  the  same  patients 
also  revealed  that  these  two  regions  have  no  aberrant  SSCP  pattern  in  all 
investigated  patients,  Sequencing  of  the  SRY  ORF,  promoter  and  poly  A  tail 
regions  further,  indicated  all  4  patients  harbor  normal  sequences.  The  absence  of 
mutations  in  the  SRY  promoter  region  is  consistent  with  a  recent  study  that 
described  a  single  strand  confonnation  polymorphism  screening  of  360  bp 
including  the  minimal  promoter,  in  a  group  of  45  patients  in  whom  no  sequence 
variants  were  detected  (Schmitt-Ney  et  al,  1995).  An  independent  analysis  of  2  kb 
DNA  immediately  5'  to  the  SRY  ORF  of  49,  XY  females  and  XY  intersex  subjects 
detected  two  base  changes;  one  was  the  common  polymorphism  and  the  other  was 
unique  but  familial  (Kwok  et  al,  1996).  This  suggests  that  mutations  in  the 
promoter  regions  essential  for  gene  expression,  although  documented  in  a  few 
cases,  are  rare  events  when  compared  with  the  frequency  of  mutation  in  coding 
regions  (Koivisto  et  al,  1994).  These  results  suggest  that  there  may  be  other 
sequences  crucial  for  the  regulation  of  the  SRY  gene  lying  outside  the  regions 
studied  or  other  sex  reversing  gene(s)  able  to  produce  indistinguishable 
phenotype. 
To  date,  24  mutations  have  been  described  in  the  coding  region  of  the  SRY 
gene,  most  of  them  being  located  in  the  HMG  box.  However,  these  mutations 
have  been  identified  in  only  about  10-15%  of  XY  females  without  aY 
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et  al,  1992;  Schmitt-Ney  et  al,  1995;  Kwok  et  al  1996;  Veitia  et  al,  1997).  The 
majority  of  mutations  that  have  been  tested  are  de  novo  and  are  not  share  by  the 
fathers  of  these  XY  daughters  (McElreavey  et  al,  1996;  McElrearvy  and  Fellous, 
1997;  Brown  et  al,  1998),  yet  familial  type  of  SRY  mutations  have  been  reported 
(Zeng  et  al,  1993;  McElreavey  et  al,  1996).  In  other  cases  male  to  female  sex 
reversal  in  the  presence  of  a  wild-type  SRY  ORF,  the  phenotype  may  result  due  to 
mutations  in  the  regulatory  region  of  the  SRY  gene  (Schmitt-Ney  et  al,  1995),  or 
because  of  mutations  in  other  sex-determining  genes  may  be  located  on  the  X 
chromosome  or  autosomes  (Eicher  and  Washburn,  1986;  Bennett  et  al,  1993; 
Foster  et  al,  1994). 
To  date,  genetic  approaches  in  sex  reversed  patients  have  identified 
several  genes  and  regions  involved  in  sex  determination.  An  autosomal  sex 
reversal  locus,  SRAI,  has  been  identified  in  XY  females  with  campomelic 
syndrome  (Tommerup  et  al,  1993).  Mutation  in  the  Wilms  tumor  (IFTI) 
suppressor  gene  in  XY  individuals  reported  to  show  abnormal  development 
(Pelletier  et  al,  1991).  Another  autosomal  sex  reversing  genes  are  located  on  distal 
9p  and  distal  10q  (Bennett  et  al,  1993;  McElreavey  and  Fellous,  1997).  A  gene 
which  regulates  SR  Y  has  not  yet  been  discovered.  Regulation  of  SRY  may  involve 
the  autosomal  or  X-linked  genes  describes,  or  an  unknown  locus.  Thus,  XY 
gonadal  dysgenesis  is  heterogeneous  phenotype  (Angle  et  al,  1997). 
X-linked  genes  have  been  implicated  in  several  familial  cases  of  XY 
gonadal  dysgenesis.  Recently,  a  locus  termed  DSS  (dosage  sensitive  sex  reversal) 
has  been  defined,  which  consists  of  160  Kb  located  at  Xp2l,  3.  Male  to  female  sex 
reversal  has  been  observed  in  individuals  to  be  associated  with  duplications  of  this 
regions  in  individuals  with  46,  XY  karyotype  (Am  et  al,  1994;  Bardoni  et  al, 
1994).  The  severity  of  the  abnormalities  appears  to  depend  upon  the  extent  of  the 
duplication.  The  DSS  region  at  Xp2l.  3  was  not  screened  for  duplication  in  this 
study.  Therefore  it  could  not  exclude  the  existence  of  a  small  duplication  of  this 
region.  These  results  are  in  agreement  with  the  previously  reported  studies 
(McElreavey  and  Fellous,  1997;  Veitia  et  al,  1997).  These  cases  may  be  candidate 
for  harboring  mutations  at  autosomal  loci  or  X-linked.  These  results  indicate  that 
mutations  involving  the  SRY  gene  on  the  Y  chromosome  are  an  infrequent  cause 
of  46,  XY  gonadal  dysgenesis. 
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The  46,  XX  male  syndrome  represents  the  most  common  condition  in 
which  the  testes  develop  in  the  absence  of  a  cytogenetically  detectable  Y 
chromosome.  Most  cases  are  sporadic.  The  incidence  is  estimated  at  about  I  in 
20,000  newborn  male  infants  (de  la  Chapelle  A,  1981).  As  early  as  1966, 
Ferguson-Smith  suggested  that  the  male  phenotype  in  XX  males  arise  as  a  result 
of  unequal  X-Y  interchange  during  paternal  meiosis. 
During  normal  meiosis  in  male,  crossover  occurs  between  the  tip  of  the 
short  arm  of  the  Y  chromosome  and  the  tip  of  the  short  arm  of  the  X  chromosome. 
These  regions  of  the  X  and  Y  chromosomes  contain  highly  similar  DNA 
sequences.  Because  this  crossover  resembles  the  behavior  of  autosomes  during 
meiosis,  the  distal  portion  of  the  short  arm  of  the  Y  chromosome  is  known  as  the 
pseudoautosomal  region.  It  spans  approximately  2.5  Mb.  Just  centromeric  to  the 
pseudoautosomal  region  lies  a  gene  known  as  sex  determining  region  on  the  Y 
(SRI).  This  gene,  which  is  expressed  in  embryonic  development,  encodes  a 
product  that  interacts  with  other  genes  to  initiate  the  development  of  the 
undifferentiated  embryo  into  a  male  (e.  g.,  Sertoli  cell  differentiation,  secretion  of 
mullerian  inhibiting  substance  (Koopman  et  al,  199  1).  The  SR  Y  gene  was  mapped 
to  a  35-kb  segment  on  the  distal  region  of  Yp  (Palmer  et  al,  1989;  Sinclair  et  al, 
1990). 
The  identification  of  SR  Y  gene  as  the  gene  for  TDF  (Koopman  ct  al,  199  1) 
made  it  possible  to  confirm  Ferguson-Smith's  (1966)  hypothesis  by  demonstrating 
that  genomic  DNA  from  most  normal  appearing  subjects  with  46,  XX  maleness 
contained  sequences  for  SRY.  By  contrast,  most  46,  XX  males  with  abnormal 
genitalia  lack  sequences  for  SRY.  Similarly,  almost  all  subjects  with  46,  XX  true 
hermaphroditism  lack  sequences  for  SRY  in  genomic  DNA  (Ferguson-Smith  ct  al, 
1990;  McElreavey  et  al  1993a;  Turner  et  al,  1995). 
In  the  present  study  cytogenetic  analysis,  fluorescent  in  situ  hybridisation 
(FISH)  and  molecular  amplification  have  been  used  to  detect  the  presence  or 
absence  of  Y  sequences  and  to  characterise  the  transfer  of  Yp  fragments  to 
Xp22.3  in  4  XX  males.  PCR  amplification  of  the  SRY  gene,  ZFY,  PAR  and 
Yl/Y2  sequences  along  the  Y  chromosome  were  applied  to  characterise  the  Y 
chromosome  sequences  present  in  4  XX  males,  In  three  cases,  PAIZ,  SRY,  and 
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amplify  (negative).  Some  authors  have  reported  that  the  Y  sequences  present  in 
the  XX  males  extend  from  distal  Yp  to  Y  centromere,  showing  a  variation  in  the 
size  of  the  fragment  exchanged  from  less  that  40  kb  (Sinclair  et  al,  1990)  to  more 
than  II  Mb  (Affara  et  al,  1986;  Ferguson-Smith  et  al  1990).  The  similarity  of  the 
clinical  features  in  all  cases  reported  in  the  literature  confirms  that  SRY  gene  is 
responsible  for  testicular  determination,  and  that  other  genes  on  the  Y 
chromosome  are  not  so  important  in  defining  the  phenotype.  XX  males  wich  are 
SRY  positive  are  the  most  frequent  type  of  XX  males  reported  (Affara  et  al,  1986; 
Page  et  al,  1987).  This  confirms  the  relative  frequency  of  an  Xp/Yp  interchange 
originating  through  unequal  crossing  over  between  homologous  pseudoautosomal 
regions  in  the  paternal  meiosis  extending  the  exchange  to  sex  specific  sequences 
(Ferguson-Smith  1966;  Weil  et  al,  1994).  Some  cases  of  Y;  autosome  translocation 
have  been  described  in  45,  X  subjects  with  sex  reversal  (Munke  et  al,  1988). 
However,  only  one  subject  of  46,  XX  male  with  a  Y;  autosome  translocation  has 
been  reported  by  Ester  et  al  (1998). 
In  this  study  all  patients  had  the  Y  chromosome  DNA  transferred  to 
Xp22.3  as  found  in  all  other  reported  cases  (Van  der  Auwera  et  al,  1992; 
Anderson  et  al,  1986;  Magenis  et  al,  1987).  The  phenotype  described  in  these 
cases  is  that  of  males  with  sterility  owing  to  the  absence  of  germinal  cells  and 
hypogonadism.  without  sexual  ambiguities,  consistent  with  the  clinical  data 
detected  in  patients  investigated  in  this  study.  The  clinical  features  were  very 
similar  in  those  3  cases,  showing  a  male  phenotype  with  small  testes,  testicular 
atrophy,  and  azoospermia.  These  patients  had  normal  intelligence  and  a  stature 
within  normal  male  range. 
Only  one  subject  presented  in  this  study  had  46,  XX  sex  reversal  and 
absence  of  SRY.  This  was  demonstrated  by  failure  to  detect  SRY  sequences  in 
genomic  DNA  by  PCR  amplification  and  FISH  analysis,  In  addition,  all  4  subjects 
lacked  sequences  for  Y  centromere,  Hidden  mosaicism  with  a  Y-bearing  cell  line 
was  ruled  out  due  to  the  absence  of  Y  centromeric  sequences  by  FISH  analysis 
(Figure3,51)  using  PDPY97  probe  and  by  PCR  using  YI/Y2  primer  sets. 
Therefore,  FISH  analysis  and  PCR  test  confirmed  this  finding. 
Direct  detection  of  Y  sequences  in  XX  males  has  been  previously  shown 
to  be  possible  by  isotopic  in  situ  hybridisation  (Anderson  et  at,  1986;  Magenis  et 
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the  results  is  facilitated  in  FISH  (Fan  et  al,  1990).  The  first  report  in  which 
translocation  of  an  SRY-bearing  fragment  to  an  X  chromosome  in  XX  males 
could  be  directly  demonstrated  using  FISH  (Van  der  Auwera  et  al,  1992).  Ester  et 
al  (1998)  have  used  cytogenetic,  FISH  and  PCR  amplification  to  characterise  the 
transfer  of  Yp  fragments  to  Xp22.3  in  six  XX  males  and  they  have  prenatally 
diagnosed  XX  male  in  the  fetus  with  male  genitalia  detected  by  ultrasound  and  a 
46,  XX  karyotype  in  aniniocytes  and  fetal  blood.  Molecular  analysis  of  fetal  DNA 
showed  the  presence  of  the  SRY  gene.  FISH  techniques  also  showed  Y 
chromosomal  DNA  on  Xp22.3  in  metaphase  cells  of  a  fetus.  This  is  the  second 
molecular  prenatal  diagnosis  reported  of  an  XX  male  but,  the  first  one  to  be  of  aY 
positive  XX  male,  as  the  only  other  prenatal  case  reported  was  XX  male  fetus 
lacking  any  Y  sequences  (Vilain  et  al,  1994).  The  case  of  a  prenatally  diagnosed 
XX  male  is  especially  interesting  as  an  example  of  the  problems  that  may  arise  in 
a  laboratory  when  the  sex  of  a  fetus  is  different  from  that  expected  based  on 
prenatal  cytogenetic  analysis.  FISH  and  molecular  studies  allowed  the 
confirmation  of  the  XX  male  diagnosis  in  the  fetus.  Other  cases  were  detected 
only  after  the  birth  of  a  male  following  cytogenetic  prenatal  diagnosis  of  46,  XX 
(Sachs  et  al,  1992),  and  where  postnatal  allowed  the  possibility  of  a  sample  error 
or  maternal  cell  contamination  to  be  ruled  out  (Ester  et  al,  1998). 
46,  XX  males  can  be  classified  as  Y  positive  or  Y  negative,  depending  on 
the  presence  or  absence  of  Y-sPecific  sequences  (Ferguson-Smith  et  at,  1990).  In 
Y  negative  cases,  autosomal  or  X-linked  mutations  may  be  responsible  for 
testicular  determination  in  the  absence  of  SRY  (de  la  Chapelle,  1987;  Ferguson- 
Smith  et  al,  1990).  Most  46,  XX  male  patients  with  normal  genitalia  are  SRY 
positive.  In  contrast,  the  majority  of  the  XX  males  with  genital  ambiguity  are 
SRY  negative  (Ferguson-Smith  et  al,  1990;  McElreavey  et  al,  1993b). 
Nevertheless,  exceptions  do  occur  and  Y  negative  XX  males  may  exhibit 
complete  masculinization  (McElreavey  et  al,  1993b;  Ramos  et  al,  1996;  Zenteno 
et  al,  1997)  while  genital  ambiguity  can  be  observed  in  Y-positive  XX  males 
(McElreavey  et  al,  1992a;  McElreavey  et  al,  1993a;  Lopez  et  al  1995). 
The  present  study  also  confirmed  the  existence  of  one  SRY  negative  XX 
male.  This  SRY  negative  XX  male  was  also  negative  for  all  other  Y  sequences 
tested  by  FISH  or  PCR  test.  Other  analysis  using  DNA  amplification  also  revealed 
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(Oster  and  Clayton,  1989)  or  SRY  (Ferguson-Smith  et  al,  1990)  and  excluding 
XX/XY  or  XX/der  (Y)  mosaics  with  an  unprecedented  sensitivity.  The  male 
phenotype  in  such  cases  might  be  explained  by  mutation  (s)  in  one  or  more 
gene(s)  downstream  from  SR  Yin  the  sex-determining  pathway.  The  elucidation  of 
the  different  steps  and  genes  involved  in  the  mechanism  of  testis  developments 
may  allow  testing  of  this  hypothesis.  With  respect  to  the  phenotype,  some  authors 
have  described  abnormalities  in  the  external  genitalia  (hypospadias, 
cryptochidism)  and  a  more  prominent  gynecomastia  in  Y  negative  XXmales 
(Abbas  et  al,  1990;  Ferguson-Smith  et  al,  1990). 
XX-individuals  lacking  SRY  who  exhibit  masculinization  (complete  or 
partial)  are  proposed  to  be  defective  in  other  genes  and  are  able  to  express  male 
sex  determination  in  the  absence  of  the  master  gene  (SRI)  of  a  regulatory  cascade. 
On  the  contrary,  XY  sex  reversal  with  an  intact  SRY  gene  can  carry  a  mutation 
that  renders  another  gene  of  the  cascade  insensitive  to  SRY  action  (McElreavey  at 
al,  1993a).  Many  familial  cases  have  been  negative  for  Y  chromosome-specific 
probes  (Abbas  et  al  1990;  McElreavey  et  al,  1993b).  Pedigree  analysis  lead  to  the 
hypothesis  that  they  carry  recessive  mutations  (McElreavey  at  al  1993a). 
Three  clinical  categories  of  sex-reversed  46,  XX  individuals  have  been 
identified:  phenotypic  males,  male  with  ambiguity,  and  true  hermaphrodites  (de  la 
Chapelle  A,  1987).  All  patients  are  shorter  than  normal  XY  males,  which  is 
probably  due  to  the  absence  of  Yq-specific  growth  gene(s)  (Ogata  and  Matsuo, 
1992)  and  to  the  lack  of  an  appropriate  testosterone-dependent  pubertal  growth 
spurt  (Boucekkine  et  al,  1994).  Although  all  XX  males  have  similar  genotypes, 
different  phenotypes  have  been  described,  suggesting  that  in  the  same  cases  SR  Y 
alone  is  adequate  for  complete  male  sexual  differentiation  while  in  others  it  is  not 
sufficient  for  normal  virilisation.  In  contrast,  SRYnegative  males  have  ambiguous 
genitalia  and  bilateral  testes  or  ovotestes,  i.  e.;  they  are  true  hermaphrodites  (Lopez 
et  al,  1995). 
The  availability  of  specific  DNA  probes  for  different  regions  of  the  Y 
chromosome  demonstrated  that  approximately  80-  90%  of  XX  males  carry  Y 
sequences  due  to  an  illegitimate  X/Y  interchange  during  paternal  meiosis  (Abbas 
et  al,  1990;  Ferguson-Smith  et  al,  1990;  Weil  et  al,  1994).  The  rest  who  lack  Y 
material  their  maleness  is  probably  due  to  mutations  in  autosomal  genes  as  in 
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linked  testis  determining  genes  as  in  DSS  gene  (McElvery  et  al,  1993a,  b;  Wolf  U, 
1995;  Ramos  et  al,  1996).  Molecular  studies  in  this  study  confirmed  the  absence 
of  Y-derived  material  (PAR,  SRY,  ZFY,  and  Yl/Y2  centromeric)  in  one  patient 
with  ambiguous  genitalia,  as  all  the  specific  sequences  analysed  did  not  amplify, 
while  they  were  present  in  male  controls. 
To  explain  the  occurrence  of  Y-negative  XX  males,  McElreavy  et  al 
(1993a)  proposed  that  the  SRY  gene  act  by  inhibiting  a  regulatory  autosomal 
recessive  gene,  termed  Z,  whose  product  is  a  negative  regulator  of  male  sex 
deten,  nination.  According  to  this  model,  XX  individuals  lacking  SR  Y  who  exhibit 
a  complete  male  phenotype  would  be  homozygous  for  aZ  null  mutation.  In 
contrast,  XX  males  with  genital  ambiguity  and  XX  true  hermaphrodites  may  carry 
leaky  Z  mutations  that  conserve  some  residual  activity,  thus  explaining  the 
phenotypic  variability.  An  alternative  model  suggested  by  Jimenez  et  al  (1996) 
who  proposed  that  X-linked  locus,  DSS  located  in  Xp2l  and  subject  to  X 
inactivation,  may  act  as  a  repressor  of  the  male  pathway.  This  implies  that  a  single 
active  copy  of  this  gene  can  repress  the  male  pathway  in  XX  females,  while  in  XY 
males  it  is  inactivated  by  SRY,  equating  DSS  to  the  hypothetical  Z  gene. 
According  to  this  model,  SRY-negative  XX  males  with  normal  genitalia  are 
homozygous  for  deletions  or  loss-of-function  mutations  in  DSS,  while  SRY- 
negative  XX  males  with  genital  ambiguities  could  be  heterozygous  for  a  DSS 
allele,  such  that  the  proportion  of  cells  of  the  indifferent  gonad  in  which  the  DSS 
+  is  inactivated  would  determine  the  degree  of  residual  maleness.  A  gene  isolated 
from  the  Xp2l  region  DAM,  has  been  proposed  to  be  identical  to  DSS  (Bardoni 
et  al,  1994;  Zenteno  et  al,  1997). 
In  summary,  PCR  amplification  of  SRY,  PAR,  ZFY,  and  DXZ3  (YI/Y2 
centromeric)  sequences  could  be  effectively  used  in  cases  where  cytogenetic 
analysis  fails  to  detect  the  Y  chromosome.  PCR  is  more  effective,  and  can  provide 
detection  of  Y  chromosome  material  in  as  few  as  I  of  1,000  cells  (Osipova  et  al, 
1998).  Further,  it  is  more  specific,  and  can  be  used  for  the  precise  detection  of 
sequences  responsible  for  the  development  of  testicular  tissue  (SRY),  or  for 
regions  implicated  in  the  development  of  gonadoblastorna  development  (e.  g., 
AMGLY).  In  this  cohort,  this  approach  considerably  improved  the  diagnosis 
compared  to  classical  cytogenetic  analysis  in  3  of  4  cases,  and  may  be 
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markers  or  virilization  of  unknown  origin. 
In  conclusion,  the  present  study  has  shown  that  FISH  is  a  valuable 
technique  for  the  rapid  detection  of  Y  sequences  in  XX  males.  This  technique 
provides  direct  evidence  for  the  presence  of  Y  sequences,  including  SRY,  on  the 
Xpter  in  XX  males,  and  allows  the  detection  of  Y  material  with  Yp-specific 
probes  hocSRY  and  GMGYlO  in  metaphase  and  interphase  nuclei  of  all  Y 
positive  males.  Furthermore,  PCR  amplification  using  markers  along  the  Y 
chromosome  has  allowed  the  Y  sequences  present  in  each  patient  to  be  defined 
and  correlation  with  the  phenotype  to  be  established.  Subsequently,  the  location  of 
Y  fragments  has  been  further  determined  by  in  situ  hybridisation  on  metaphase 
chromosomes. 
Molecular  and  FISH  techniques  are  very  useful  for  detecting  and  locating 
Y  sequences  in  cytogenetically  XX  males,  allowing  an  accurate  diagnosis  and 
correct  management  of  the  patient.  Testing  new  Y  chromosome  markers  in  XX 
males  will  make  it  possible  to  narrow  the  breakpoints  fixther  in  each  case  and  to 
establish  correlation  with  the  clinical  features,  identifying  the  Y  region  implicated 
in  the  definition  of  the  phenotype  (Ester  et  al,  1998). 
4.2.3  Mutational  analysis  of  male  infertility 
Between  2%  and  12%  of  couples  world  wide  are  infertile,  with  the  man 
responsible  in  approximately  half  of  the  cases  (Cooke  et  al,  1998).  Large 
proportions  of  these  men  are  infertile  either  because  of  insufficient  sperm 
(oligoospermia)  or  lack  of  sperm  (azoospermia).  Proposed  causes  of  infertility  in 
men  include  varicocele,  obstruction  of  the  spermatic  ducts,  agglutination  of 
sperm,  high  semen  viscosity,  necrospermia,  low  volume  of  ejaculate,  ejaculatory 
dysfunction,  and  high  sperm  density.  When  no  cause  is  known,  the  man  is 
described  as  having  idiopathic  infertility  (Proyor  et  al,  1997).  The  cause  of  these 
defects  in  sperm  production  is  unclear,  but  recent  work  points  to  both  potential 
environmental  and  genetic  causes. 
In  this  study,  56  patients  with  either  azoospermia  or  oligoospermia,  were 
screened  for  the  presence  of  mutation  in  the  AZF  region  using  5-step  strategies. 
To  screen  for  large  deletion  and/or  other  structural  rearrangements,  all  patients 
254 included  in  this  study  were  examined  by  (1)  routine  cytogenetic  study,  (2) 
multiplex  PCR  analysis,  (3)  Southern  blot  hybridisation  and  (4)  FISH  analysis 
with  RBM  cDNA  probes,  Lastly,  to  screen  for  point  mutation  and/or  minor 
sequence  alterations  in  the  RBM1  gene  family,  all  patients  were  screened  by 
SSCP,  HA  analyses  and  by  DNA  sequencing. 
Cytogenelic  study 
Chromosome  banding  allows  an  analysis  of  the  entire  karyotype  at  one 
time,  and  is  the  preferred  technique  for  routine  diagnosis;  therefore  all  patients 
were  first  analysed  for  chromosomal  study  in  order  to  exclude  the  cytogenetically 
detectable  chromosome  abnormalities.  Among  the  56  men  with  infertility,  the 
most  common  assigned  diagnosis  were  idiopathic  infertility  with  normal  male 
karyotype  (50  men  or  89.2  %)  (Table  3.5).  Abnon-nal  karyotype  were  found  in  5 
(8.9%)  of  the  56  subj  ects  studied.  Of  these  5  subj  ects,  4  (7,1  %)  exhibited  47,  XXY 
(80%)  karyotype,  the  remained  1  (1.8%)  had  47,  XYY  karyotype.  Thirty-two  of 
the  men  with  infertility  (57.1  %)  had  azoospermia,  four  had  47,  XXY  karyotype 
and  one  had  evidence  of  spermatic  duct  obstruction.  As  47,  XXY  karyotype  is 
known  to  be  associated  with  sterility,  these  patients  were  excluded  from  the 
molecular  analysis.  One  azoospermic  subject  with  46,  XY  karyotype  was  also 
excluded  from  molecular  study  because  of  obstructive  azoospermia.  Twenty-four 
(42.9  %)  had  severe  oligoospermia,  one  of  them  had  47,  XYY  and  varicocele.  This 
case  was  also  excluded  from  the  molecular  study  because  of  the  presence  of 
varicocele.  Thus,  only  50  idiopathic  infertile  men  with  normal  46,  XY  karyotypes 
were  further  investigated  by  different  molecular  strategies  in  order  to  establish 
their  pathogenesis. 
Association  between  human  male  infertility  and  chromosomal  anomalies 
has  been  known  for  a  long  time  (Chandley  A,  1979;  Faed  et  al,  1979).  The 
incidence  of  karyotype  abnormalities  among  infertile  men  has  been  reported  to 
range  between  2.2  and  19.6%  (Pandiyan  et  al,  1996;  Gunduz  et  al,  1998;  Mclaren 
A,  1998).  Thus,  it  would  not  be  unusual  to  find  chromosomal  abnormalities  in 
men  attending  infertility  clinics.  Therefore,  karyotyping  every  male  attending  the 
infertility  clinic  would  be  necessary  to  identify  or  exclude  those  with  genetic 
defects. 
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is  not  clear.  It  is  likely  that  the  presence  of  abnormally  distributed  chromatin  may 
interfere  with  meiotic  division,  therefore,  reduces  sperm  production.  Spermatozoa 
bearing  abnormal  chromosomes  may  cause  abnormal  embryonic  development  that 
can  in  turn  cause  early  pregnancy  loss  (Evans  et  al,  1978).  In  the  presence  of  the 
47,  XXY  abnormality  in  Klinefelter  syndrome,  severe  spermatogenesis  failure 
causing  a  marked  reduction  in  testicular  size  and  azoosperrnia  is  the  rule.  Thus  the 
reason  for  the  patient's  infertility  is  clear.  In  the  47,  XYY  abnormalities,  however, 
testicular  histology  may  be  either  normal  or  abnormal.  Testicular  size  may  be 
normal  with  only  minor  changes  in  the  seminal  profile  (Pandiyan  et  al,  1996). 
Multiplex  and  single  PCR  screening 
Clinical  experience  indicates  that  large  deletions  of  the  Y  chromosome, 
which  can  be  seen  under  the  microscope  in  late  prophase  and  are  detectable  on 
routine  karyotype,  are  uncommon  in  infertile  men.  However,  submicroscopic 
deletions  of  the  long  arm  of  the  Y  chromosome,  not  detectable  on  karyotype  and 
therefore  called  microdeletions,  are  present  in  10-15%  of  azoospermic  men  (Vogt 
et  al,  1993;  Nagafuchi  et  al,  1993;  Henegariu  et  al,  1994;  Najmabadi  et  al,  1996). 
These  microdeletions  can  be  detected  by  polymerase  chain  reaction  (PCR)-based 
sequence  tagged  sites  (STS)  mapping  or  by  Southern  hybridisation  or  by  FISH 
analysis  (Ma  et  al,  1992;  Henegariu  et  al,  1994). 
In  the  present  study,  molecular  analysis  of  sequence  tagged  sites  (STS)  in 
azoospermic  and  oligoospermic  males  was  done.  The  screen  was  focused  to 
Yql  1;  the  region  of  genetic  Y  factors  controlling  spermatogenesis  defined  as  AZF 
(i.  e.  azoospermia  factor:  Tieplo  and  Zuffardi,  1976).  A  rough  molecular 
estimation  of  the  length  of  the  DNA  region  in  YqI  1,  where  AZF  should  be 
localised,  indicates  a  minimum  extension  of  3-5MB  (Vogt  et  al,  1993). 
Consequently,  Y  DNA  probes  used  to  screen  for  deletions  of  AZF  gene  sequences 
have  to  be  spread  along  this  Y  region.  However,  a  focus  of  the  screening 
programme  can  be  proximal  and  distal  to  Yql  1,  since  microdeletions  in  this 
region  have  already  been  diagnosed  in  some  azoospermic  males  (Vogt  et  al, 
1992a;  Nagafuchi  et  al,  1993;  Henegariu,  et  al,  1994;  Kaboyashi  et  al,  1994).  In  a 
series  of  PCR  experiments  it  can  be  shown  that  polymorphic  amplification 
products  are  not  visible  and  deletion  breakpoints  can  be  mapped  reliably  using  the 
256 maps  of  Ma  et  al  (1992).  Since  Us  PCR  Y  analysis  is  possible  without 
sophisticated  blotting  techniques  and  radio-labelled  DNA  probes,  it  became 
feasible  to  screen  the  Y  chromosome  of  idiopathic  sterile  males  ininfertility 
clinics. 
A  total  of  49  Y-specific  STSs  sets  of  primers  covering  Yq  region  were 
used  in  this  study.  28  pair  sets  were  used  in  5  multiplex  PCR  reactions  and  the  rest 
(21  pairs  of  primers)  were  used  in  single  PCR  reactions.  Two  pairs  were  RBM 
specific  and  two  were  within  DAZ  gene  and  one  pair  was  DAZ  gene  specific.  Most 
of  STSs  are  located  within  YqI  I  region. 
Of  the  50  men  with  idiopathic  infertility  only  one  azoospermic  male  (2%) 
was  found  to  have  aY  chromosome  microdeletion.  This  approach  showed,  in  one 
patient  (case  25  in  table  3.6),  no  amplification  of  six  pairs  PCR  primers  detected 
in  4  out  5  multiplex  reactions.  These  deletions  involved  sY153  (subinterval  Q, 
sY147  and  Y6HP52pr  (subinterval  D),  sY  157  and  sY  149  (subinterval  E),  and 
Fr15-1  lpr  (not  determined).  No  amplification  failure  was  observed  in  50  normal 
male  controls  including  the  father  of  the  patient  with  microdeletions.  The  absence 
of  an  STS  amplification  product  indicates  the  presence  of  a  microdeletion  in 
interval  6.  Therefore,  by  molecular  deletion  analysis  using  multiplex  PCR,  the 
breakpoints  in  Yq  II  was  estimated  to  be  in  subinterval  MX-MXII  of  the  Ma  map 
(Ma  et  al,  1992)  between  interval  6C  and  6F  according  to  Vollrath  deletion  map 
(1992). 
Detailed  deletion  analysis  using  21  STS  primers  within  intervals  5  and  6  of 
Yq1  I  region  showed  that  this  patient  had  deletions  in  16  more  STSs.  These 
refined  physical  map  results  confirmed  the  deletion  between  DYS232  and 
DYS239  which  is  localised  to  interval  6C  and  6F  on  the  distal  part  of  Yq1  I 
according  to  Vollrath  et  al  (1992)  deletion  map. 
Nearly  all  DNA  loci  listed  in  appendix  Il  are  single  copy  loci,  which  mean 
that  their  location  in  Yq1  I  is  unique.  It  has  been  shown  that  lower  repetitive  DNA 
sequences  are  spread  in  Yql  I  (Vogt  et  al,  1992b;  Ma  et  al,  1992;  Vollrath  ct  al, 
1992).  A  deletion  of  an  Y-specific  repetitive  DNA  locus  can  be  detected  by  PCR 
analysis  only  if  all  sequence  copies  of  this  DNA  locus  are  deleted.  However,  a 
critical  analysis  of  PCR  experiments  should  stress  not  only  its  higher  sensitivity 
but  also  its  sensibility  for  experimental  artifact.  It  is  highly  recommended  that  the 
reproducibility  of  any  deletion  in  the  multiplex  PCR  experiment  to  be  tested  as 
257 well  in  single  PCR  experiment  using  the  corresponding  primer  since  false  deletion 
events  are  possible  (Henegariu  et  al,  1994).  This  was  the  case  when  a  few  false 
deletions  were  detected  by  multiplex  PCR,  but  the  corresponding  primer(s)  was 
extended  during  a  single  PCR  experiment. 
Great  interest  has  been  devoted  in  the  last  several  years  to  the 
identification  of  the  gene(s)  within  the  Y  chromosome  which  are  involved  in  the 
etiology  of  idiopathic  male  infertility  (Vogt  et  al,  1992b;  Nagafuchi  et  al,  1993). 
Two  Y-specific  candidate  gene  families  have  been  cloned  by  deletion  mapping  of 
infertile  men  with  Yq1  1.23  (interval  6)  deletions  and  proposed  as  candidates  for 
the  putative  AZF  locus,  the  RNA-binding  motif  (RBM)-containing  gene  family 
(Ma  et  al,  1993;  Naimabadi  et  al,  1996),  and  the  deleted-in-azoospermia  (DAZ) 
gene  family  (ReiJo  et  al,  1995).  Both  are  multiple-copy  gene  families.  The  RBM 
gene  family  has  more  than  30  copies  spread  through  the  Y  chromosome 
(Meschede  and  Horst,  1997).  Most  of  the  copies  are  located  in  deletion  interval 
6A  and  6B  (Bhasin  et  al,  1997).  The  DAZ  gene  family  has  6-10  copies  (Cooke  ct 
al,  1998)  located  in  interval  6D  and  6E.  At  least  two  members  of  the  RBM  gene 
f=ily,  RBM-1  and  RBM-2  are  expressed  in  the  testis  (NaJmabadi  et  al,  1996). 
The  presence  of  RBM  in  the  predicted  protein  sequence  suggests  that  these  genes 
play  a  role  in  RNA  processing.  However,  the  precise  role  of  the  RBM  protein(s) 
in  germ  cell  development  remains  unclear.  On  the  other  hand,  DAZ  has  a  testis- 
specific  pattern  of  expression  and  encodes  RNA-binding  protein  of  yet 
undetermined  function  (ReiJo  et  al,  1995).  In  the  present  study,  using  RBMI  and 
RBM2  specific  primer  pairs  revealed  that  all  patients  included  the  patient  with 
Yql  I  microdeletions  have  retained  RBM  gene  family.  This  could  mean  that 
RBM  I  is  not  the  only  gene  involved  in  the  failure  of  spermatogenesis.  In  addition, 
because  of  the  multigenic  and  dispersed  nature  of  R13M  sequence,  only  very  large 
deletions  would  be  expected  to  remove  the  entire  possible  PCR  target. 
Using  DAZ  specific  primer  pairs  revealed  that  all  patients  and  controls 
retained  the  DAZ  gene,  yet  it  was  deleted  in  the  patient  with  microdeletion.  The 
father  of  the  patient  retained  DAZ  gene.  Therefore,  the  patient  in  this  study 
retained  the  RBMI  and  RBM2  genes  but  has  a  deletion  of  the  DAZ  gene.  The  role 
of  the  RBM  genes  in  male  infertility  has  been  challenged  by  the  observations  that 
many  infertile  men  with  Y  deletions  have  had  RBM  sequence  present.  In  fact, 
deletions  of  interval  6  have  been  detected  in  infertile  subjects  retaining  RBM 
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deletions  of  DAZ  have  been  identified  inpatients  with  different  spermatogenic 
disorders  (Reijo  et  al,  1995;  Vogt  et  al,  1995).  Although  deletions  involving  the 
DAZ  gene(s)  appear  to  be  the  most  frequent,  several  groups  have  described  Y 
deletions  that  are  outside  the  DAZ  regions  (Vogt  et  al,  1996;  Pryor  et  al,  1997), 
which  suggests  that  AZF  could  be  owing  to  more  genes  (Reijo  et  al,  1995;  1996). 
Furthermore,  only  10-15%  of  infertile  men  have  Y  deletions.  These  data  suggest 
that  additional  Y-specific  and/or  autosomal  genes  may  be  involved  in  the 
infertility  phenotype.  Some  observations  suggest  that  RBM  and  DAZ  are  not  the 
only  genes  responsible  for  idiopathic  infertility  (Meschede  and  Horst,  1997). 
Microdeletions  in  Yq  11  were  reported  in  up  to  10%  of  idiopathic  sterile 
males  (Ma  et  al,  1992;  Vogt  et  al,  1993)  while  in  the  present  study  only  2%  of 
idiopathic  sterile  men  showed  microdeletion.  When  the  PCR  experiment  fails  to 
detect  a  deletion  event  in  the  Y  chromosome  of  sterile  males,  different 
explanations  are  possible.  First,  the  Y  chromosome  of  the  patient  is  normal  with 
no  deletion  of  AZF  gene  sequences  in  Yq1  1.  Second,  mutation  in  the  gene 
structure  of  AZF  can  not  be  detected  because  they  are  either  point  mutations  or 
very  small  deletions  not  hit  by  current  set  of  screening  probes.  Clearly,  analysis  of 
deletions  in  Yql  1  generally  gives  only  an  indication  of  the  deletion  of  the  AZF 
gene  sequences  as  long  as  the  gene  structure  of  AZF  is  not  known  at  the 
molecular  level.  Therefore,  the  PCR-Y-screening  programs  can  hint  at  the 
deletion  of  AZF  gene  sequences  but  can  not  yet  prove  that  this  occurs.  It  is 
essential  to  prove  that'the  extension  of  any  DNA  deletion  detected  on  the  Y 
chromosome  by  multiplex  PCR  analysis  is  restricted  to  the  patient's  Y 
chromosome  and  is  not  present  as  a  rare  polymorphic  event  in  the  male  of  the 
patient's  family  (Henegariu  et  al,  1994).  Interestingly,  the  microdeletion  detected 
in  one  patient  was  not  detected  in  the  rest  of  patients'  investigated  and  male 
controls  including  the  father  of  the  patient  with  microdeletion.  Therefore,  this 
deletion  probably  includes  at  least  part  of  the  AZF  gene  structure.  Moreover, 
clinical  diagnostic  tools  for  selecting  patients  with  a  potential  disruption  of  AZF 
gene  sequences  out  of  the  large  idiopathic  patient  group  are  still  very  crude  (Vogt 
et  A  1992a;  1992b).  Microdeletions  in  Yql  I  have  been  found  in  azoospennic  as 
well  as  in  severe  oligozoospermic  males  (sperm  count  between  1.5  X  106  per  ml). 
The  patient's  hormone  level  of  LH  and  testosterone  is  usually  normal.  The  level 
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et  al,  1994). 
Recently,  the  rate  of  reported  microdeletion  ranges  from  3-18%  (Vogt  et 
al,  1996;  Meschede  and  Horst,  1997).  The  variability  is  most  likely  explained  by 
different  selection  criteria  for  the  study  subjects.  Most,  but  not  all,  Yq 
microdeletions  described  so  far  includes  the  DAZ  gene  cluster  (Qureshi  et  al, 
1996;  Vogt  et  al,  1996).  This  has  led  Vogt  et  al  (1996)  to  postulate  the  existence 
of  three  non-overlapping  regions  containing  different  azoospermia  factors,  termed 
AZFa,  AZFb  and  AZFc.  On  the  basis  of  the  testicular  histology  in  these  men,  the 
deletion  of  AZFa  was  associated  with  the  presence  of  only  Sertoli  cells.  The 
deletion  of  AZFb  was  associated  with  the  developmental  arrest  of  germ  cells  at 
the  pachytene  stage,  and  the  deletion  of  AZFc  with  the  developmental  arrest  of 
germ  cells  at  the  spermatid  cells  (Vogt  et  al,  1995).  The  AZFc  coincides  with  the 
DAZ  locus,  but  no  candidate  genes  for  AZFa  and  AZFb  have  been  designated  yet. 
Vogt  (1996)  also  postulated  that  the  different  categories  of  Yq  microdeletions 
might  be  specifically  associated  with  particular  types  of  testicular  histopathology. 
However,  studies  by  other  groups  have  not  confirmed  this  claim  (ReiJo  et  al, 
1995;  Qureshi  et  al,  1996;  Meschede  and  Horst,  1997). 
In  this  study  the  ultrasound  examination  in  the  patient  with  the 
microdeletion  of  interval  6  displayed  normal  testes  without  any  appearance  of 
obstruction.  The  levels  of  FSH,  LH,  and  testosterone  were  within  normal  range 
and  it  seems  that  this  patient  has  a  deletion  in  AZFc  associated  with 
spermatogenic  arrest. 
In  infertile  men  with  DAZ  deletions,  both  meiotic  arrest  and  the  Sertoli- 
cell-only  phenotypes  have  been  described  (ReiJo  et  al,  1995).  It  is  possible  that 
germ  cell  degeneration  may  occur  secondarily.  Testicular  biopsies  often  reveal 
some  tubules  that  show  meiotic  arrest  and  other  tubules  with  the  Sertoli-cell-only 
phenotype.  It  remains  unclear  whether  these  two  histological  phenotypes  represent 
two  ends  of  the  same  spectrum  or  whether  they  are  the  result  of  distinct 
genotypes. 
Several  investigators  have  shown  that  some  infertile  men  carry 
submicroscopic  deletions  in  Yq  that  are  not  present  in  their  fathers'  or  brothers'  Y 
chromosome  (Ma  et  al,  1993;  Kaboyashi  et  al,  1994;  Reijo,  et  al,  1995;  Qureshi  et 
al,  1996;  Vogt  et  al,  1996).  However,  Stuppia  et  al  (1996b)  showed  both  a 
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actually  larger  compared  with  that  in  his  father  as  the  proband's  deletion  also 
involved  STSs  sY243  and  sY  269  which  are  located  within  the  more  proximal 
subinterval  E  of  interval  6.  They  confirmed  the  critical  role  of  interval  6  in  the 
spermatogentic  process,  which  suggests  that  deletions  of  subinterval  F,  per  se,  is 
not  associated  with  infertility.  An  additional  point  of  interest  is  that  both  the 
proband  and  his  father  retained  RBMI  and  STSs  sY254  and  sY255,  which  are 
mapped  within  DAZ  in  subinterval  D.  The  segment  deleted  in  the  proband  only, 
which  is  likely  related  to  infertility,  lies  within  subinterval  E,  which  is  outside  the 
DAZ  region.  They  implied  that,  in  oligoospermic  patients  at  least,  other  genes  in 
the  region  distal  to  DAZ  and  RBM  I  may  be  involved  in  the  spermatogensis 
process.  Moreover,  they  argued  that  some  deletions  should  not  lead  necessarily  to 
infertility,  but  these  deletions  make  the  Y  chromosome  more  liable  to  a  second 
mutation  resulting  in  spermatogenesis  failure,  as  a  consequences  of  DNA 
instability  (Stuppia  et  al,  1996a). 
The  precise  physiological  function  and  role  of  RBM  and  DAZ  gene 
families  in  human  spermatogenesis  remain  unclear.  The  RNA  molecules  that  are 
the  targets  of  these  RNA-binding  proteins  have  not  been  identified.  It  is  also  not 
clear  how  deletions  of  one  or  two  copies  could  explain  infertility  when  there  are 
multiple  copies  of  these  genes  elsewhere  on  the  Y  chromosome. 
On  the  basis  of  the  infertility  rate  among  men  and  the  percentage  of 
infertile  patients  showing  deletions  of  the  Y  chromosome,  Reijo  etal  (1995)  have 
suggested  that  these  mutations  should  occur  in  -1  in  104  male  newborns  and  that 
this  high  figure  could  arise  by  a  mechanism  involving  repeated  sequences 
flanking  the  gene. 
Y-chromosome  deletions  are  relatively  frequent  (10%)  and  their 
frequency  increases  with  the  severity  of  the  spermatogenic  defect.  However,  Y- 
chromosome  microdeletions  can  not  be  predicted  on  the  basis  of  clinical  findings 
or  even  the  result  of  semen  analyses.  The  role  of  analyses  of  Y-chromosome 
microdeletions  in  evaluating  men  with  infertility  remains  to  be  determined.  With 
the  advent  of  intra.  cytoplasmic  sperm  injection  (ICSI)  in  the  field  of  reproductive 
technology,  the  potential  for  passing  on  these  defects  to  offspring  is  real  and 
should  be  considered  when  infertile  couples  are  counseled  about  this  procedure 
((Pryor  et  al,  1997).  This  raises  issues  of  informed  consent  and  ethical  concerns. 
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transmitting  this  genetic  disorder  to  their  offspring  provide  a  compelling  rationale 
for  screening  of  infertile  men  prior  to  ICSI.  Considering  the  ease  of  PCR-based 
STS  mapping,  this  screening  could  become  readily  available  in  clinical 
cytogenetic  laboratories.  The  couples  undergoing  ICSI  should  be  counselled  about 
the  potential  risk  of  transmitting  this  genetic  disorder  to  offspring.  In  addition, 
there  is  a  pressing  need  for  developing  mechanisms  for  worldwide  monitoring  of 
ICSI  babies  for  genetic  disorders,  including  Y  deletions  (Bhasin  et  al,  1997). 
Mutation  detection  in  RBMZ  gene 
If  RBM  is  involved  in  human  spermatogenesis  and  altered  in  a  proportion 
of  infertile  males,  then,  because  it  is  a  multicopy  gene  family  on  the  human  Y 
chromosome  (Ma  et  al,  1993),  it  is  possible  that  deletion  or  rearrangement  would 
be  a  more  common  route  to  infertility  than  point  mutation.  However,  if  point 
mutations  do  play  a  part,  a  possible  region  for  an  effective  single  base  change 
would  be  the  RNA-binding  domain  of  the  protein,  particularly  in  the  RNP  I  and 
RNP2  amino  acid  motifs  (Prosser  et  al,  1996). 
To  rule  out  the  possibility  of  structural  rearrangement  or  deletion  of  the 
RBM  gene  family,  all  DNA  samples  from  50  infertile  and  50  normal  men  were 
screened  by  means  of  FISH  analysis  and  Southern  blot  hybridisation. 
In  situ  hybridisation  with  MK5  and  MK29  to  metaphase  spreads  of 
infertile  and  normal  males  showed  intense  and  multi-signals  on  both  chromatids 
of  the  Y  chromosome.  Interphase  in  situ  hybridisation  also  showed  the  presence 
of  multiple  clustered  hybridisation  signals.  These  findings  confirmed  that  RBAf 
gene  family  is  multicopy  as  reported  by  Maet  al  (1993).  No  deletion  or  structural 
rearrangement  was  detected  in  all  cohorts  including  the  patient  who  showed 
microdeletion  in  Yqll  upon  multiplex  PCR  experiments.  Because  theRBMI 
sequences  are  known  to  be  multigenic  and  dispersed  throughout  intervals  5  and  6, 
are  likely  to  hinder  detection  of  small  deletion,  large  deletions  are  required  to 
remove  all  specific  RBM  targets  in  order  to  be  detected  by  FISH  analysis  (Ma  et 
al,  1993). 
DNA  samples  from  50  infertile  and  50  normal  men  were  digested  with  two 
restriction  enzymes  EcoRl  and  Taql.  In  the  present  study  the  resulting 
hybridisation  with  MK5  pattern  was  the  same.  No  deletion  or  structural 
rearrangement  was  detected  in  all  investigated  individuals.  Molecular  deletion 
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microdeletions  in  some  azoospermic  men  (Vogt  et  al,  1992a;  Ma  et  al,  1993).  In 
this  study  Southern  blot  analysis  failed  to  detect  microdeletions  in  the  RBM  gene 
family  confirming  the  FISH  studies  and  multiplex  PCR  experiments. 
In  summary,  FISH  analysis  and  Southern  blot  hybridisation  to  DNA  from 
50  infertile  men  and  50  controls  with  cDNA  encoding  RBMI  and  RBM2 
respectively  revealed  the  presence  of  multicopies  of  the  gene  and  no  deletion  or 
structural  rearrangements  were  detected  in  all  investigated  cases.  These  results  are 
in  agreement  with  the  multiplex  PCR  studies.  Therefore,  the  possibility  that 
deletion  or  rearrangement  of  RBM  gene  family  would  be  the  cause  of  infertility  is 
ruled  out  in  the  cases  of  the  present  work. 
To  provide  proof  that  defects  in  a  gene  result  in  the  disease  for  which  it  is 
a  candidate  remains  problematic.  One  convincing  route  is  to  demonstrate  a  new 
point  mutation  in  the  gene  in  one  or  more  patients  with  the  disease.  Therefore  an 
attempt  was  done  for  the  RBM  gene  family  in  a  patient  set  (50  cases)  with  no 
visible  chromosome  deletions  and  with  idiopathic  defects  in  spermatogenesis.  To 
search  for  mutations  in  the  multicopy  RBM  genes  that  might  be  associated  with 
male  infertility,  sequence  data  from  the  reported  cDNA  clones  was  used  (Ma  et  al, 
1993).  This  gene  has  12  exons,  three  of  which  encode  the  putative  RNA  binding 
domain  of  the  protein.  Two  particular  sequence  arrays  in  RBM  are  believed  to  be 
potentially  important  for  its  function  (Ma  et  al,  1993).  The  RNA  recognition  motif 
(RRM)  extends  from  amino  acid  I  to  87  with  the  two  evolutionarily  highly 
conserved  sequences,  RNP1  in  exons  3  and  2  respectively.  (Prosser  et  al,  1996) 
The  so-called  SRGY  (Serine-Arginine-Glycine-Tyrosine)  box  domain  extends 
from  amino  acids  227  to  347  (exons  7-11)  and  may  be  characteristic  of  human 
RBM.  It  has  been  postulated  that  the  SRGY  box  acts  in  protein-protein  interaction 
related  to  gene  function  and  specificity  (Prosser  et  al,  1996). 
With  this  in  mind,  the  DNA  of  50  patients  with  no  known  Y  chromosome 
deletion  was  amplified  with  intronic  primers  specific  for  exons  1-12.  Single  strand 
conformation  polymorphism  (SSCP)  analysis  was  optimised  to  screen  exons  1.11 
and  three  different  copies  of  exon  2  (B,  C,  D),  and  heteroduplex  analysis  (HA) 
was  optimised  to  screen  exon  12  of  the  RBM1  gene  in  all  cohorts  of  the  studied 
patients.  For  SSCP  study,  different  running  conditions  were  used.  0.5X  MDETM 
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the  study.  No  band  shift  was  detected  upon  analysis  of  all  screened  exons. 
However,  in  some  instances,  variant  bands,  which  were  interpreted  as  mobility 
shifts,  were  detected  upon  SSCP  analysis  of  the  PCR  product  from  different  exons 
of  the  RBM1  gene.  In  all  of  them,  except  one,  reloading  of  the  same  PCR  product 
on  a  newly  prepared  gel  was  associated  by  disappearance  of  such  band.  There  is 
no  clear  explanation  for  this  observation,  but  errors  in  sample  loading  (over 
loading),  uneven  gel  running,  improper  gel  polymerisation,  and  improperly 
flushed  wells  or  combination  of  these  may  play  a  role  in  producing  false  results. 
Differentiation  among  polymorphic  molecules  by  SSCP  is  not  entirely  predictable 
and  the  method  can  result  in  false  negatives,  ambiguous  results  and  experimental 
artifacts  (Sheffield  et  al,  1993). 
in  one  case,  the  abnormal  band  shift  pattern  persisted  upon  re-running  of 
the  same  PCR  product  while  it  disappeared  upon  electrophoresis  of  a  newly 
amplified  product  from  the  same  exon  from  the  same  patient.  To  know  the  cause 
of  this  condition,  the  PCR  product  which  showed  abnormal  band  pattern  was 
recovered  from  low  melting  point  agarose  gel.  Then  I  ul  aliquot  was  used  in 
asymmetric  PCR  amplification  reactions  to  generate  single  stranded  DNA. 
Sequencing  of  this  product  revealed  the  misincorporation  of  a  single  base,  most 
probably  due  to  PCR  error.  The  DNA  Taq  polymerase  isolated  from  Thermus 
aquaticus  currently  used  in  most  PCR  studies  lacks  3'  to  5'  proof-reading  activity 
and  has  an  error  rate  of  approximately  1/10000  bases  (Shibata  1992).  In  the 
previous  case,  such  a  PCR  error  must  be  produced  early  in  the  PCR  amplification 
to  make  sufficient  PCR  products  detectable  by  SSCP  analysis  and  DNA 
sequencing. 
It  was  not  possible  to  screen  cDNA  since  testis  RNA  is  not  easily 
available,  especially  from  patients,  and  break  through  transcription  in 
lymphocytes  was  undetectable. 
No  data  has  been  published  regarding  the  detection  of  RBMI  and  RBM2 
point  mutations  in  idiopathic  infertile  men  although  several  hundred  cases  have 
been  studied  and  were  only  screened  for  microdeletion  in  Yq  II  particularly  RBM 
and  DAZ  gene  families.  The  only  study  for  mutation  analysis  of  RBM  was  done 
by  Pressor  et  al  (1996).  They  scanned  exons  2-4  for  mutation  by  SSCP  on  DNA 
from  30  normal  and  60  infertile  men.  They  found  a  point  mutation  that  alters  the 
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also  found  in  his  father.  Whether  the  point  mutation  found  in  the  patient  and  his 
father  is  a  polymorphism  or  a  mutation  of  significance  remains  to  be  determined. 
There  are  a  number  of  potential  reasons  for  this  to  find  more  mutations 
failure.  The  gene  may  be  unimportant  in  the  process  of  spermatogenesis  although 
its  conservation  on  the  mammalian  Y  chromosome,  testis-specific  and  germ  line 
nuclear  confined  pattern  argue  against  this  (Elliot  et  al,  1996).  Alternatively, 
point  mutations  may  not  be  present  or  difficult  to  detect,  or  in  regions  of  the  gene 
not  yet  analysed  in  these  patients.  RBM  is  a  multicopy  family  of  genes  and 
mosaicism  is  not  easy  to  demonstrate.  In  this  study  it  was  not  possible  to  find  de 
novo  point  mutation  that  proves  that  the  RBM  gene  family  is  involved  in  the 
failure  of  spermatogenesis  in  all  investigated  patients.  However,  although  this 
approach  has  not  provided  proof  of  identify  between  RBM  and  AZF,  it  has  given 
basic  information. 
To  provide  proof  that  defects  in  a  gene  result  in  the  disease  for  which  it  is 
a  candidate  remains  problematic.  The  RBM  genes  provide  an  example  of  the 
difficulty  of  this  approach,  which  is  unfortunately  the  only  one  available  at 
present.  Firstly,  the  gene  is  normally  expressed  only  in  the  testis,  a  tissue  not 
readily  sampled  either  the  normal  population  or  in  patients.  This  means  that  the 
analysis  of  transcripts  in  vivo  is  impracticable.  Secondly,  the  gene  is  not 
ectopically  expressed  at  a  detectable  level.  Thirdly,  the  gene  has  12  exons,  any  of 
which  could  potentially  be  mutated  in  any  patient.  Fourthly,  and  most 
significantly,  the  gene  or  sequences  related  to  it  are  multicopy  and  give  rise  to 
transcripts  that  vary  in  the  number  of  copies  of  the  SRGY  repeat  as  well  as  in  a 
multitude  of  bases  differences.  A  fifth  complication  is  that  some  of  these  changes 
represent  polymorphisms. 
Several  RBM  sequences  remain  uncharacterised  as  yet,  Until  the  detailed 
genomic  layout  of  the  gene  family  members  is  established,  the  high  degree  of 
similarity  between  family  members  and  their  dispersal  throughout  the  distal.  part 
of  intervals  5  and  6  are  likely  to  hinder  detection  of  small  deletions,  and  hence, 
the  identification  of  the  individual  genes  responsible  for  effects  on 
spermatogenesis. 
265 4.3  Conclusions  and  recommendations 
In  conclusion,  the  most  appropriate  screening  strategies  for  the  detection 
of  molecular  pathology  are  influenced  by  the  expected  nature  of  the  mutations, 
size  and  structure  of  the  gene  in  question  and  the  availability  of  sample  (e.  g. 
DNA,  *fixed  chromosomes  or  RNA).  Table  4.2  summarises  the  sequence  of  events 
for  mutation  detection.  Therefore,  for  each  of  the  four  groups  studied,  a  different 
mutation  strategy  was  chosen  and  optimised.  The  present  study  showed  the 
importance  of  cytogenetic  and  FISH  approaches  in  the  identification  of  marker 
chromosomes,  the  precise  analysis  of  X  and  Y  chromosomal  aberrations  as  well 
as  the  detection  of  low  grade  mosaicism.  Each  of  these  methods  has  its  own 
advantages  and  drawbacks,  which  should  be  carefully  considered  before 
application. 
Classical  cytogenetic  methods  provide  more  general  information  on 
karyotype  structure  and  chromosomal  rearrangements  but  are  hardly  applicable 
for  identification  of  marker  chromosomes  or  detection  of  the  exact  breakpoint. 
The  latter  might  be  much  more  easily  attained  with  FISH,  which  is  more  rapid, 
precise,  and  efficient.  Unlike  techniques  requiring  DNA  for  analysis,  in  situ 
hybridisation  does  not  require  additional  samples,  as  unstained  slides  or  fixed  cell 
pellets  are  usually  available  and  =enable  to  analysis.  Additionally,  modification 
of  standard  FISH  techniques  allows  the  use  of  previously  banded  slides  for 
immediate  determining  of  the  nature  of  the  marker  chromosome.  This  can  be 
crucial  for  counselling  in  cases  with  prenatally  detected  markers.  Most 
importantly,  reliable,  high  quality  DNA  probes  are  easily  available  for 
hybridisation,  allowing  unequivocal  determination  of  the  origin  and  structure  of 
the  marker  chromosomes. 
On  the  other  hand,  molecular  approaches  such  as  single  strand 
conformational  analysis  (SSCP),  heteroduplex  analysis  (HA),  Chemical  cleavage 
mismatch  (CCM)  are  the  most  common  and  rapid  methods  for  detecting  minor 
sequence  alterations.  DNA  sequencing  is  the  most  accurate  method  for  screening 
small  genes  such  as  SRY.  Multiplex  PCR  and  Southern  blot  analyses  are  more 
applicable  for  genes  or  loci  prone  to  deletions  such  as  the  AZF  locus.  These  have 
proven  to  be  a  very  useful  approach  to  many  diseases  and  are  highly 
recommended  methods. 
266 The  importance  of  the  combined  application  of  molecular  cytogenetic  and 
molecular  genetic  techniques  can  enable  adequate  chromosomal  analysis  in 
patients  with  marker  chromosomes  or  with  complex  chromosome  rearrangements 
involving  the  X  and  Y  chromosomes,  which  can  not  be  confirmed  by  standard 
cytogenetic  methods. 
The  strategies  of  using  DNA  as  template  for  PCR  such  as  SSCP,  HA  and 
DNA  sequencing  analyses  were  the  main  screening  methods  applied  in  the  present 
study,  and  have  proved  to  be  a  useful  method  in  screening  for  mutations  within 
the  AR,  SRY,  and  RBM1  (AZF  region)  genes. 
Molecular  investigations  indicate  that  mutations  involving  the  SRY  gene 
on  the  Y  chromosome  are  an  infrequent  cause  of  46,  XY  gonadal  dysgenesis. 
These  mutations  have  been  identified  in  only  about  10-15%  of  XY  females. 
Accordingly  the  mutations  in  the  promoter  regions  might  be  essential  for  gene 
expression.  The  existence  of  other  sequences  crucial  for  the  regulation  of  the  SRY 
gene  lying  outside  the  regions  studied  or  other  sex  reversing  gene(s)  ableto 
produce  indistinguishable  phenotypes  may  be  an  alternative  explanation. 
Molecular  and  FISH  techniques  are  very  useful  tools  in  detecting  and 
locating  Y  sequences  in  cytogenetically  XX  males.  Testing  new  Y  chromosome 
markers  in  XX  males  will  make  it  possible  to  identify  and  narrow  the  breakpoints 
in  each  case  which  could  help  in  establishing  genotype  phenotype  correlation. 
PCR  amplification  of  Y  sequences  could  be  effectively  used  in  cases 
where  cytogenetic  analysis  fails  to  detect  the  Y  chromosome.  Furthermore,  it  is 
more  specific,  and  can  be  used  for  the  precise  detection  of  sequences  responsible 
for  the  development  of  testicular  tissue  (SRY),  or  for  regions  implicated  in  the 
development  of  gonadoblastorna  (e.  g.,  AMGLY).  This  approach  considerably 
improves  the  diagnosis  if  compared  with  the  classical  cytogenetic  analysis  and  is 
recornmended  as  an  important  tool  in  cases  of  cytogenetically  undetectable 
markers  or  in  the  visualization  of  cases  of  unknown  origin. 
The  role  of  analyses  of  Y-chromosome  microdeletions  in  evaluating 
infertile  men  remains  to  be  determined.  Considering  the  case  of  PCR-based  STS 
mapping,  this  screening  could  become  readily  available  in  clinical  cytogenetic 
laboratories.  With  the  advent  of  intra  cytoplasmic  sperm  injection  (ICSI)  in  the 
field  of  reproductive  technology,  the  potential  for  passing  on  these  defects  to 
267 offspring  is  real  and  should  be  considered  when  infertile  couples  are  counseled. 
This  raises  issues  of  informed  consent  and  ethical  concerns.  In  addition,  there  is  a 
pressing  need  for  developing  mechanisms  for  worldwide  monitoring  of  ICSI 
babies  for  genetic  disorders,  including  Y  deletions. 
General  screening  for  point  mutations  in  the  RBM  gene  family  seems  to  be 
unwarranted  at  this  time.  No  data  has  been  published  regarding  the  detection  of 
RBM  gene  family  point  mutations  in  idiopathic  infertile  men.  Screening  for 
mutation  in  gene(s)  involved  in  male  infertility  alone  such  as  the  DAZ  gene  should 
be  considered. 
268 Table  4.2  (a):  Methods  for  mutation  detection  (Scanning  methods) 
Method  Advantages  Limitations 
Cytogenetics  Detects  major  alteration  (>3-5  Mb)  Can  not  detect  minor 
General  method  for  chromosome  studY.  alteration. 
Gives  a  comprehensive  view  of  the  23  pairs  Hardly  applicable  for  marker 
of  chromosome.  identification  or  detection  of 
Very  simple  the  exact  breakpoints. 
Requires  highly  skilled 
cytogeneticists 
FISH  Detects  major  DNA  alteration  (1-3  Mb)  Expensive 
Used  as  an  adjunct  to  routine  cytogenetic  to  Can  not  detect  minor 
achieve  a  higher  sensitivity  and  better  alteration 
resolution  of  chromosome  aberrations 
Simple 
Southern  blot  Large  scale  alteration  (>500bp)  Laborious 
hybridisation,  Very  sensitive  Biohazard  (radioactive) 
Heteroduplex  Detects  minor  DNA  alteration  (I  bp)  Suitable  for  short  DNA 
analysis  (HA)  Very  simple  sequences  (optimal<300  bp) 
Limited  sensitivity 
Does  not  show  position  of 
the  change  in  the  PCR 
product 
Single  strand  Detects  minor  DNA  alteration  (I  bp)  Suitable  for  short  DNA 
conformation  Simple  sequences  (optimal<200  bp) 
polymorphism  Limited  sensitivity 
(SSCP)  analysis  Does  not  show  position  of 
the  change  in  the  PCR 
product 
DNA  Sequencing  Detects  all  changes  Laborious 
Mutations  fully  characterised 
Mismatch  cleavage  Detects  minor  DNA  alteration  (I  bp)  Toxic  chemicals 
(i)  Chemical  High  sensitivity  Experimentally  diff  icult 
(ii)  Enzymatic  Can  easily  scan  up  to  1.7Kb  of  DNA 
DNA  or  RNA  may  be  used  as  templates 
Shows  position  of  change Denaturing  Detects  minor  DNA  alteration  (I  bp)  Choice  of  primers  is  critical 
gradient  gel  High  sensitivity  GC-clamped  primers 
electrophoresis  Expensive 
(DGGE)  Does  not  show  position  of 
the  change 
Reverse  Requires  mRNA  as  a  template  to  check  for 
transcriptase  PCR  splicing  errors  (deletions  and  insertions)  by 
(RT/PCR)  simple  gel  electrophoresis. 
Long  segment  of  peptide  coding  region  can 
be  analysed. 
Detects  changes  in  the 
coding  sequences  only 
Gene  may  not  be  expressed 
in  accessible  specimens 
(tissue  specific). 
Mutations  in  promoter  and 
intronic  splice  junctions  are 
not  detected. 
Because  the  coding  sequence 
is  a  fraction  of  the  size  of  the 
gene,  SSCP,  HA  etc,  can  be 
used  as  initial  screen, 
followcd  by  DNA 
sequencing Table  4.2  (b):  Methods  of  testing  for  a  specific  mutation 
Method  Application 
Restriction  enzyme  digestion  of  PCR-  Only  when  the  mutation  creates  or  abolishes  a 
amplified  DNA;  check  size  of  products  on  natural  restriction  site  or  one  engineered  by  use 
gel  of  special  PCR  primers 
Molecular  hybridisation  of  PCR-amplified  General  method  for  point  mutations 
DNA  to  allele-specific  oligonucleotides 
(ASO)  on  a  dot-blot,  slot-blot  or  Southern 
blot 
PCR  using  allele-specific  primers  General  method  for  point  mutations 
(ARMS  test) 
Check  size  of  expanded  trinucleotide  repeat  Trinucleotide  repeats  diseases  only;  large 
expansions  may  require  Southern  blots,  smaller 
ones  can  be  visualized  by  PCR-based  methods. 
Multiplex  PCR  Applied  to  loci  of  known  sequences  prone  to 
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307 Appendix  I 
Table  1.1:  PCR  primers  used  in  analysis  of  the  AR  gene. 
1A'F'  GCCTGTTGAACTCTTCTGAGC  427  600C  DeSellisetal(1992) 
1XR'  GCTGTGAAGGTTGCTGTTCCTC 
I  BT  CACAGGCTACCTGGTCCTGG  415  600C  DeBellisetal(1992) 
IBW  CTGCCTTACACAACTCCTTGGC 
ICT  GCTCCCACTTCCTCCAAGGAC  527  600C  DeSellisetal(1992) 
1  C,  Fr  CGGGTTCTCCAGCTTGATGCG 
ID  IF'  CCAGAACACAGAGTGACTCTGCC  605  600C  DeElellisetal(1992) 
i  D'R'  CCAGAACACAGAGTGACTCTGCC 
27  GCCTGCAGGTTAATGCTGAAGACC  379  600C  DeSellisetal(1992) 
2'R'  CCTAAGTTATTTGATAGGGCCTTGCC 
VRI  TTATCAGGTCTATCAACTCTTGT  313  600C  DeBellisetal(1992) 
3'R'  CTGATGGCCACGTTGCCTATGAA 
47  GATAAATTCAAGTCTCTCTTCCT  360  580C  DeBellisetal(1992) 
4'R'  GATCCCCCTTATCTCATGCTCCC 
57  TCTTCTTCTCCAGGCTTCCGC  171  58  OC  Lobaccaro  et  al  (1993) 
5'R'  CAGGAGCACTTACTCATTGAA 
VFI  CTCTGGGCTTATTGGTAAACTTCC  292  580C  DeSellisetal(1992) 
VR'  GTCCAGGAGCTGCCTMCCCTA 
771  CMCAGATCGGATCCAGCTATCC  416  580C  DeBelllsetal(1992) 
7  'RI  CTCTATCAGGCTGTTCTCCCTGAT 
8'Fl  GAGGCCACCTCCTTGTCAACCCTG  347  580C  Dol3ellisetal(1992) 
8'R'  GGAACATGTTCATGACAGACTOTACACTA 
F  stands  for  forward  and  R  stands  for  reverse  primers. 
A Table  1.2:  PCR  primers  used  in  analysis  of  the  SR  Y  gene. 
Name  Primer  sequence  (5'  to  3'  end)  Size  Reference 
XES77  CCCGAATrCGACAATGCAATCATATriCTTCTG  609bp  Hawkins  etal  (1992) 
XES2'R'  CTGTAGCGGTCCCGTTGCTGCGGTG 
XESIO  IF'  GGTGTTGAGGGCGGAGAAATGC  778bp  Hawkins  eta]  (1992) 
XESIVR'  GTAGCCAATGTTACCCGATTGTC 
SRY  A  CCATGAACGCAITCATCGTGTG 
SRY  B  GCCTTCCGACGAGGTCGATACT 
217  bp  Zeng  et  al  (1993) 
SRY  C  GAGATCAGCAAGTAGCTGGGA 
SRY  D  ACAACCTGTTGTCCAGTTGC 
SRY  E  =CAGOACAGCAGTAGAGCA 
SRY  F  TTGAAAGGTGCCAGAOTTCGA 
226  bp  Zeng  et  a]  (1993) 
251bp  Self  designed 
SRY  G  TGGACAAAGCTGTAGGACAATC  248  bp  Self  designed 
SRY  H  ATAGGCAGGCTCACTTCTGGA 
F'stands  for  forwards  and'R'stands  for  reverse  primers 
All  sets  of  primers  are  annealed  at  58  OC. 
B Table  1.3:  PCR  Primers  used  in  XX  male  study. 
_Name 
gelion  Primer  sequences  Size*  Temp  Reference 
XES7'F'  SRY"  CCCOAATTCOACAATGCAATCATATGCTrC  609  600C  Hawkins  etal  (1992) 
XES2  IRI  CTGTAGCGGTCCCOTTGCTGCGGTG 
MY  5.1  IF  ZFY  CGAATTCATACCGGCGAGAAGCCATACC  735  610C  Barbosactal(1995) 
MY  6.1  'R'  AAAGCTTGTAGACACATCGTTAGGG 
PART'  PAR-Y  CTGAGAGTGOAAGTGTCGCAG  1100  550C  Barbosatta](1995) 
PAR  IR'  GTACTACCTTTAGAAAACTAGTATTTTCcc 
YVF'  Y-cený  ATGATAGAACGGAAATATG  170  540C  Wittetal(1989) 
y2  IR,  AGTAGAATGCAAAGGGCTCC 
F  stands  for  forwards  and  'R!  stands  for  reverse  primers. 
Size  in  base  pairs  (bp). 
Amplifies  the  HMO  box  of  the  SR  Y  gene 
b  y_  centrorneric  sequences  (  DYZ2). 
C Table  14:  Sets  of  primers  used  in  the  multiplex  PCRO*. 
IA-  Y-specific  primer  pairs  of  pY6H  sequence  family 
Y6Dl4pr  DYS20S  GGCTAGGTGCCAGCAAGTAGATCA  GTTCTCTTCCCCTGCATCAAG  134 
Y6BaH34;  DYS206  OCCCTTTOGTAAAAGCO  CTGAATTrOCAACGGCTOC  910 
H6YP35pr  DYS274  GGTACAr-ACTCCATCCTOGAC  CTACAGOCTACCTMAGOTGo  226 
Y6HP52pr  DYS239  OGAACTGGCAGGATTAOCCTTC  GCTCAGAATCTGCOATCAG  258 
Y6PHc54p  ND  rCAGAAGAGTTCAOC  GTGGAGTGCTOCATTAAAGG  166 
113-  Primers  pairs  from  DNA  loci  in  Yq  II  according  to  to  Foote  et  a]  (1992)  and  Scherer  et  W  (1991). 
Name  Locus*  Forward  Reverse  Product  size  (bp) 
_ 
FrIS-Ilpr  ND  TACCTTOGTTTTOCACCAGACOC  CACCCTCTOTATATGACCTCGC  313 
sY14  SRY  GAATATTCCCGCTCTCCGGA  OCTOGTOCTCCATTCTTGAG  472 
Sys)  DYS271  AGGCACTGGTCAGAATGAAG  AATGGAAAATACAGCTCCCC  209 
SyS2  DYS272  ATCCTOCCCTTCTGAATCTC  CAGTOTCCACTOATOGATcA  264 
sY84  DYS273  AGAAGGOTCTGAAAGCAGGT  GCCTACTACCTOGAGO  MC  326 
sY86  DYS148  GTOACACACACAGACTATOCTTC  ACACACAGAGGGACAACCCT  320 
SM  DYS276  TTGTAATCCAAATACATGGGC  CACCCAGCCATTTGTTTTAC  123 
SY182  KALA  TCAGAAGTGAAACCCTGTATO  GCATGTGACTCAAAGTATAArjC  132 
sY152  KAL-V  AAATCTGTAGTCTCATATCAATCTG  TTACTTGATTTACCAATAAAAAor  183 
sY49  DYS279  TCATOACAGCCAGCtGTATIT  MGGACATAGTTTTTTGGTCC  ISO 
SY95  DYS280  TCCTACAGATGTCCAAAGTGC  GATGAOTGACCCCAGAATTG  303 
sY97  DYS281  AACTTCATCAOTGTTACATCAAGO  TGTGQCATMGTTATGTGG  104 
sY102  DYS198  CACTACCACATTTCCTGGTTGG  CGCTGAOTCCATTCTTTGAG  218 
SY105  DYS201  AAGGGCTTCTTCTCTTCCTr  AGGOAGCTTAAACTCACCOT  301 
SY109  DVF43SI  AGGAGATOTCAGGACTATCAriC  TCCATCCAGCTGOTCATATT  233 
sYI17  DS209  GTTGOTTCCATCCTCCATAC  CAGGGAGAGAGCCTTTrACC  262 
SY127  DYS213  GOCTCACAAACOAAAAGAAA  CTGCAG(3CAGTAATAAGOGA  274 
sY134  DYS224  GTCTGCCTCACCATAAAACO  ACCACTGCCAAAACTTTCAA  301 
sY143  DYS231  GCAGGATGAGAAGCAGGTAG  CCGTGTGCTGGAGACTAATC  311 
sY147  DYS232  iijCjCGMGATGATCCTAG  TTAATATOAGAATGAGAACAGATC)T  100 
sY149  DYSI  TOTCACACTOCCCTAATCCT  TGOTCATGACAAAAGACGAA  132 
sYI53  DYS237  GCATCCTCATTTTATOTCCA  CAACCCAAAA(3CACTGAGTA  139 
&YI57  DYS240  CTrAGGAAAAAGTGAAGCCG  CCTGCTGTCAGCAAGATACA  283 
*  Y-DNA  locus  as  defined  m  Genome  Data  Base  (GDB).  Utunore,  MD,  USA, 
ND  -  not  yet  defined  in  GDB. 
$*  Henegariu  et  &1  (1994). 
All  acs  of  primers  am  annealed  at  58T. 
D Table  1-5:  Y-chromosomal  STSs  used  in  male  infertility  study" 
STS  Forward  Reverse  Product  size  Mp) 
sY231  ATTGATGTGTTGCCCCAAAT  AGAGTGAACTTTAAATCCCAGCC  149 
sY232  GACTCTACCACTTGGGCTCAATTT  AGATGTACCCAAGOCCACTO  91 
sY233  AGTTAGTAAGCCCCAGTTATCCTCC  TTTGGAAAAGGACACCTTATTAGCCA  115 
sY236  CCCCATCGGTAAACCAAATCA  CCCATTGAAGT77CAAGGTOTCA  94 
sY239a  CA7rCATCTTCCCTTTTGAAGG  ATGCAAGTCGCAGOAAATCT  200 
sY240a  TCAAATAGCAGCAATTTAATAT  GCACCTGAAGAGCTOCT70  247 
sY242  ACACAGTAOCAGCWGAGTT  TCTGCCACTAAACTOTAAGCTCC  233 
sY243  GTTTCTTCATAAGCAACCAAATTG  CAGATTATGCCACTGCCCTT  Ila 
sV245  TTACTTCCTTAAGTCAAAGCOG  CTGAGACAGCAAGACCAATCC  101 
sY247&  CTGGACAAAGCCTTGGAAAA  CTGCATOTCAATTGTGGOAC  114 
sY248a  CATTGGCATGAATGTGTATTC  CTCTOGGACAAGTOTTCCTT  94 
sY249  GACAAAGGOCTGATGATTTA  CATCACCTTTACTTMAAATOO  114 
sY254  b  GGGTGTTACCAGAAGOCAAA  GAACCGTATCTACCAAAGCAGC  350 
sY255  b  OTTACAGOATTCCvGCGTGAT  CTCGTCATGTGCAGCCAC  126 
sY257  AGGTTGT7rrjGCCTTGAOC  TCTATOATCTGTACCCGGTGC  123 
sY262  AGCCACTGCAAGCAACAGA  CCACCATCCCCCTTCTTC  100 
sY267  GAATGTGTATTCAAGGACTTCTCO  TACTTCCTTCGGGGCCTCT  102 
sY273  GGTCT'TTAAAAGGTGAGTCAAATT  AGACAGAGGOAACTTCAAGACC  95 
a  Anneal  at  62  OC;  otherwise,  anneal  at  58  OC.  b  Within  DAZ  gene, 
"From  Reijo  et  al  (1995 
E Table  1.6:  Primers  sequences  of  4  different  genes  involved  in  male  germ  cell  development  that  were  used 
in  male  infertility  study  **. 
Name  Forw2rd  Reverse  Size  (bp)  Temp* 
RBMI  ATGCACTTCAGAGATACGO  CCTCTCTCCACAAAACCAACA  goo  580C 
RBM2  AGAGATGCACTTCAGAGG  CCTCTCTCCACAAAACCAACA  goo  58*c 
DAZ  GOAACTCTOCTTTGGTAGATAC  TAGOTTTCAOTOTTTGOATTCCO  1300  380C 
SPGY1  MCACATACAOCCATTAAGTTTAOC  ACAATTrTGATAGTCTGAACACAAGC  460  580C 
Table  11.6:  Primers  designed  and  used  for  PCR  amplificatiorn  of  RBM  (YRRM)  gene. 
Exon  Forward  Reverse  Size  (bp  )  Temp* 
2A  CGGCACGACAATGGTAGAA  GGGACCATGTrTCCCAAAT  113  540C 
2B  AATGGTAGAAGCAGA77GTCA  GATAGGGGACCATG7MG  113  56  CC 
2C  CGCACGACATGGTAGAG  GGGACCATATTTCCCAAAC  113  560C 
2D  GTTTACAGCACAATCATCC  TATGGGACCGTGTTTCAC  100  54  CC 
4  GTCTTrGCATGGAAAAGCAATA  TAAAACATTACCCAGGTGCC  190  540C 
5  GAAATACAGATGATOGTGGA  ATCAGGCAGCATTTACCTTG  178  540C 
6  TGAATGTTAAAGOTCCCATGT  GGTTTACCCATCGTTAGTTGC  119  540C 
7  GCACACAGAAATCATCCAAGT  CAGTACCTATATCCTCTAGAGG  125  600C 
8  TATGCATACAGAAATCATCG  AAAAGTTACAGTACCTGTATCC  136  580C 
9  M  CTGCATACAGAAATCGT  CAGAAAAATTACAGTACCTATA  580C 
10  ACTCGTGCACGCAGAAATCA  ACCTATATCCTCTAGAGOAATG  127  540C 
11  CAATT7AGTrATCATGATGGCT  ACCCTTACCGTATCTCTGAA  105  580C 
12  AACCCTGCAGGGACCTCTCA  CTACCTCTCTCCACAAAACCAA  437  580C 
*  Annealing  temperature. 
"From  Vogt  et  al  (1996) 
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